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Abstract 
Background:  The number of patients dying with advanced liver disease is rising 
dramatically. However, little is known about the exp riences of these patients and 
their families in respect of their care and everyday life with the disease. Palliative 
care services are traditionally focused on cancer and more recently on other types of 
organ failure, but liver disease is relatively neglected. 
Aim and objectives:  This study aimed to broaden our understanding of the 
experience of living and dying with advanced liver disease. Specifically, it sought to  
explore the dynamic physical, psychosocial, existential and information needs of 
patients and their lay and professional carers, and to review their use of health, social 
and voluntary services. Additionally, this study examined the utility of a qualitative 
longitudinal, multi-perspective methodology in end-of-life research. 
Methods:  This study employed qualitative, multi-perspective s rial in-depth 
interviews. Patients with different aetiologies of liver disease were recruited in 
hospital. They and their lay carers were interviewed up to three times over one year. 
Single interviews were undertaken with case-linked professionals. Interviews were 
recorded, transcribed and analysed using grounded theory techniques and NVivo 9. 
Results:  15 patients, 11 lay carers and 11 professional carers were recruited, and 53 
interviews conducted. Uncertainty was the key experience at all stages of the illness, 
across all domains, and for all participants: patients, lay carers and professionals. 
This uncertainty related to the nature of the illness, the unpredictability of disease 
pathway and prognosis, poor communication and information-sharing, and 
complexities of care. Coping strategies demonstrated  continuous quest to manage 
uncertainty. Current care arrangements were a poor fit with the high levels of 
physical and psychosocial need identified. The ubiqitous uncertainty meant that a 
care planning approach was difficult to introduce. Employing a qualitative 
longitudinal, multi-perspective approach emerged as a useful and effective way in 
which to conduct research with this patient group and contributed new learning with 
regard to its application in end-of-life research. 
 
  iii 
Conclusion:  This study identified uncertainty as the central pervasive factor in the 
experiences of patients, lay and professional carers. The needs of this patient group 
are currently poorly met from diagnosis to bereavement. Uncertainty makes advance 
care planning important, but difficult to know when to start. More needs to be done 
to ensure that people living and dying with advanced liver disease and their families 
benefit from appropriate and timely supportive and palliative care.   
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Glossary and abbreviations 
Aetiology Disease cause. 
ALD Alcohol-related liver disease. 
Ascites Accumulation of fluid in the abdominal cavity. The 
most common complication in advanced liver disease. 
Biographical disruption A key theoretical concept in chronic illness research 
developed by Bury (1982), which denotes the disruption 
of all aspects of the ill person’s life world on account of 
their illness. 
Cirrhosis Extensive scarring of the liver caused by long-term 
continuous liver damage which inhibits normal 
functioning of the liver. 
COPD Chronic obstructive pulmonary disease. 
Cryptogenic liver 
disease 
A type of liver disease for which there is no easily 
identifiable cause. 
Decompensation The functional deterioration of the liv r. 
DEPCAT Deprivation category. An indicator of socioec nomic 
status. 
Diuretics Medication which encourages the expulsion of excess 
water and salt from the body. 
Endoscopy 
 
A procedure where a thin, flexible telescope 
(endoscope) is passed through the throat or anus to 
examine the inside of the body. 
HCC Hepatocellular carcinoma, or primary liver cancer. 
HCV Hepatitis C. A type of liver disease caused by viral 
infection.  
HE Hepatic encephalopathy. A neuropsychiatric 
dysfunction in patients with advanced liver disease. 
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Hepatology A branch of medicine with a specialist interest in the 
liver. 
HRQoL Health-related quality of life. 
MELD 
 
Model for end-stage liver disease. A scoring system 
used to determine the severity of liver disease and a 
predictor of mortality. 
NAFLD Non-alcoholic fatty liver disease. Caused by a build-up 
of fat in liver cells. 
Non-malignant disease A disease that is non-cancerous. 
Paracentesis Procedure to remove excess fluid that has accumulated 
in the abdominal cavity (ascites). 
PBC Primary biliary cirrhosis. An autoimmune type of liver 
disease. 
PPI Patient and public involvement. 
PSC Primary sclerosing cholangitis. An autoimmune type of 
liver disease. 
QLL Qualitative longitudinal. 
SPICT Supportive & Palliative Care Indicators Tool. A guide to 
identifying people at risk of deterioration and death. 
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Overview of the thesis 
Chapter one  provides an introduction to the subject matter. It describes current  
developments in advanced liver disease in the UK, and issues related to the care of 
people living with the disease. It further sets out the aim and objectives of the present 
study and delineates its importance and scope. 
Chapter two  provides a review of the literature in respect of what is currently 
known about the patient experience in advanced liver disease and life with a chronic 
disease more generally. It goes on to define the intellectual problem posed by the 
current gaps in knowledge, which provides the basis of this study. 
Chapter three  describes the methodological and ethical considerations 
underpinning this research endeavour. It further sets out and justifies the study plan, 
i.e. the strategies chosen for participant recruitment and data generation. 
Chapter four  provides details of how the study was conducted in practice, 
including recruitment, participants, interviews and data analysis. It also offers 
reflections on the benefits and challenges of the chosen approaches, as well as on the 
researcher experience.  
Chapters five to nine each describe a key aspect of the experience of living, dying 
and caring in advanced liver disease. Each chapter first presents the study findings 
relating to the topic in question, and concludes with a brief discussion of these 
findings in the context of the wider empirical and theoretical literature. 
Chapter five  sets the scene by reporting on the pathway to and experience of 
receiving a diagnosis as well as on the physical complications that commonly 
defined everyday life with the disease. It also highlights people’s understanding of 
their condition and, relatedly, their information needs.  
Chapter six  describes the challenges inherent in everyday life w th the disease and 
how people coped with them. It also highlights their holistic support needs and 
barriers to accessing support.  
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Chapter seven  describes patients’ use of services. It details their experiences in the 
care setting and considers the extent to which these s rvices met their needs.  
Chapter eight  presents issues around prognostication and facing an uncertain 
future, including death. It also considers the experience of death and dying with 
advanced liver disease through retrospective lay carer accounts.  
Chapter nine  describes the experiences of those caring for people with advanced 
liver disease. It first considers the support needs and experiences of lay carers. It then 
sets out the challenges faced by those in the professional care setting.   
Chapter ten  synthesises the study findings of the previous chapters to respond to 
the specific research objectives set out in Chapter 1. It also acknowledges the 
limitations of this study and discusses the implications of its findings. Finally, it 
provides recommendations for future research and practice. 
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Chapter 1: Introduction 
This chapter outlines the rationale for undertaking this research. It describes the 
nature of the problem, both in relation to chronic liver disease and current care 
provision for people living and dying with non-malignant disease. It also sets out the 
purpose and importance of this study and details its aim and objectives. Finally, it 
defines the scope of the research and the key terms and language used in this thesis. 
1.1 Background and statement of problem  
1.1.1 The rise of chronic liver disease 
Chronic liver disease constitutes a significant cause of morbidity and mortality 
worldwide (Bosetti et al., 2007, Lim and Kim, 2008). Liver disease currently ranks 
fifth among the leading causes of death in the UK, but is a growing problem (British 
Association for the Study of the Liver and British Society of Gastroenterology, 
2009). Cirrhosis (extensive scarring of the liver) and primary liver cancer both 
signify the final stage in the chronic liver diseas trajectory and thus reflect 
associated mortality. A review of the UK General Practice Research Database 
identified increases of 45% in the incidence and 68% in the prevalence of cirrhosis 
between 1992 and 2001 (Fleming et al., 2008).   
An increase in deaths from chronic liver disease contrasts with falling mortality rates 
for many other major diseases. For example, between 1970 and 2010 UK-wide 
standard mortality rates for ischaemic heart disease and cerebrovascular diseases 
decreased by 71% and 72% respectively. Conversely, mortality rates for chronic liver 
disease and cirrhosis increased by almost 300% (World Health Organisation, 2012). 
Current UK-wide trends indicate that by 2030 more people will die from liver 
disease than heart disease (Moore and Sheron, 2009). Figure 1 overleaf illustrates the 
dramatic rise of chronic liver disease in the UK compared to other common causes of 
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Figure 1: UK rate of liver-related deaths compared with other causes 1971-2008  
  (Source: British Liver Trust, 2013)  
Across Europe, including Scotland, the leading causes of chronic liver disease are 
alcohol misuse, metabolic syndromes linked to rising levels of overweight and 
obesity, and viral hepatitis B and C (Blachier et al., 2013, Scottish Government, 
2008a). The most common cause of chronic liver disease in the UK is alcohol-related 
liver disease (ALD) (Thomson et al., 2008). There is also a growing prevalence of 
non-alcoholic fatty liver disease (NAFLD) linked to increases in obesity (Fleming et 
al., 2008) and a large cohort of individuals with latent hepatitis C infection 
(McDonald et al., 2010). In the UK, hepatitis C is a sociated with intravenous drug 
use and infected blood transfusions prior to the introduction of blood screening in the 
early 1990s. In addition, some individuals develop autoimmune liver diseases.  
1.1.2 The patient with chronic liver disease 
Chronic liver disease affects people of a younger a than is typical in other chronic 
diseases such as heart or lung failure. The average age of death in liver disease is 59 
(British Association for the Study of the Liver and British Society of 
Gastroenterology, 2009), and in England more than 1 in 10 of deaths of individuals 
in their 40s are now attributable to liver disease (National End of Life Care 
Intelligence Network, 2012). Deaths from liver disea  are relatively more common 
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in men and deprived populations, and most frequently occur in hospital (National 
End of Life Care Intelligence Network, 2012). 
While liver cirrhosis is irreversible, removing the causative factor can halt or delay 
further disease progression and reduce complications even once the disease has 
developed to this advanced stage. Hence, a termination of harmful behaviours such 
as alcohol or drug misuse as well as pharmaceutical tre tment of hepatitis viruses can 
allow patients to return to good health. Given the insidious nature of chronic liver 
disease, however, many individuals remain unaware of its presence, resulting in a 
lack of timely treatment. Moreover, not all patients will succeed in overcoming the 
causative factors underlying their disease. This means that many individuals will 
progress to end-stage liver disease. The only viable life-prolonging treatment option 
at this stage is liver transplantation. This route, however, is only open to a small 
subset of patients who meet strict criteria, and subject to the availability of a suitable 
donor organ at a time of diminishing organ supplies (Sanchez and Talwalkar, 2006). 
1.1.3 Patient care in advanced non-malignant diseas e 
Palliative care is an approach that improves the quality of life of patients and their 
families facing the problem associated with life-threatening illness, through the 
prevention and relief of suffering by means of early identification and impeccable 
assessment and treatment of pain and other problems, physical, psychosocial and 
spiritual. (World Health Organisation, 2010) 
As can be seen from the above definition, palliative care has a vision of holistic care 
for all progressive life-limiting diseases. Although the ‘modern’ palliative care 
movement, instigated by Dame Cicely Saunders in the 1960s, sought to treat all 
people and all progressive diseases, palliative carh s traditionally focused on the 
needs of cancer patients nearing the end of life, and is thus commonly understood by 
both public and many clinicians to hold this primary function. Yet most deaths in the 
population are in fact due to diseases other than cancer, and in particular those linked 
to major organ failure including the liver (Addington-Hall and Higginson, 2001). 
Access to specialist palliative care services is widen ng, but many people with organ 
failure remain poorly supported by existing services. This is despite evidence that 
patients with non-malignant disease such as heart or liver failure experience similar 
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levels of symptom burden and support needs as cancer pati nts (Murray et al., 2002, 
Roth et al., 2000).  
Extending palliative care provision to better integrate non-malignant disease has 
been recognised as desirable but challenging (Addington-Hall, 1998, Addington-Hall 
and Higginson, 2001). One issue of particular consequence is the less predictable 
illness trajectory compared with that of cancer patients (Lunney et al., 2003, Murray 
et al., 2005). Figure 2 provides a comparison of the illness trajectories typically seen 
in cancer, organ failure and frailty/dementia.  
 
Figure 2: Typical illness trajectories in progressive chronic illness  
  (Source: Murray et al., 2005) 
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As the diagram shows, the typical disease progression in cancer is relatively fast, 
with a brief but dramatic decline towards death. In contrast, the pathway in organ 
failure is characterised by a slow but constant deterioration, punctuated by episodes 
of acute exacerbation which often require hospitalisation. A person with advanced 
liver disease may thus experience sudden death at any point throughout their illness 
trajectory, typically during an acute episode of, fr example, gastrointestinal bleeding 
or severe infection. 
This presents difficulties in terms of identifying the appropriate time for the 
introduction of supportive and palliative care for such patients. The traditional, and 
increasingly challenged, notion is that palliative care equates to the terminal phase of 
an illness. This perception results in support servic s being engaged only in the final 
days or weeks of a patient’s life (Zheng et al., 2013). Given the lack of a clear 
terminal phase in the progression of chronic liver disease, and in the interest of 
optimising patients’ quality of life and wellbeing in the last months (or even years) of 
life, supportive and palliative care should be initiated at the very earliest opportunity 
in the illness trajectory. This notion is supported by the World Health Organisation’s 
vision of implementing palliative care approaches as e rly as possible in the course 
of a life-threatening illness (World Health Organisat on, 2010). Early attention is also 
appropriate given the cognitive decline often associated with liver failure, which may 
challenge patients' ongoing decision-making abilities as their condition deteriorates 
and thus makes timely forward-planning desirable (Larson and Curtis, 2006).  
The early introduction of a palliative care approach in chronic liver disease presents 
potential challenges for resourcing (Williams, 2005), and the effective management 
of a patient's holistic care across a number of relevant parties such as hospital-based 
clinicians, community-based primary care and palliative care staff, and social work 
services. Some evidence, however, suggests that closer integration of services can 
work effectively (Medici et al., 2008). Moreover, as most dying patients spend much 
of their last year in the community, primary care professionals are well placed to 
build on their existing relationships with patients (Murray et al., 2004). As such, their 
role in providing supportive and palliative care in the community should be further 
explored and professionals’ capacity built accordingly (Barclay, 2001). 
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1.2 Research aim and objectives 
To recap, current trends in some of the risk factors associated with chronic liver 
disease as well as diminishing donor organ resources point towards a dramatic 
increase in the number of patients living and dying with chronic liver disease in the 
coming years. At the same time, existing supportive and palliative care provision is 
often geared towards the needs of cancer patients ad poorly configured and 
equipped to effectively support those with non-malignant disease.  
The aim of this research is to broaden our understanding of the experience of living 
and dying with advanced liver disease, with a view to learning about individuals’ 
needs and priorities in this context and to determine the suitability of current service 
provision.  
The specific research objectives are as follows: 
1. To explore the dynamic experiences, priorities and support needs of people with 
advanced liver disease, their lay carers and key health or social care 
professionals, and in particular their physical, psychosocial, existential and 
information needs in the last year of life. 
2. To explore the use of health, social and voluntary sector services by this group 
and the extent to which existing services are perceived to meet their needs.  
3. To contribute to the methodological knowledge base regarding the effectiveness 
of longitudinal, multi-perspective qualitative methods in end-of-life research. 
1.3 Importance of this study  
This research is considered important for a number of reasons:  
• Given increasing morbidity rates vis-à-vis diminishing donor organ supplies, the 
number of patients living and dying with chronic liver disease is likely to rise 
dramatically in the coming years. An understanding of their needs and priorities 
is therefore needed to ensure appropriate and effective are and support for 
patients and their families.  
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• There is growing recognition that palliative care should be available on the basis 
of need and not simply diagnosis. Some headway is being made in this respect, 
as evidenced by the recent publication and growing use of the UK Gold 
Standards Framework for palliative care, giving progn stic guidance on a range 
of life-limiting illnesses (Royal College of Practitioners, 2006). Guidance 
relating to advanced liver disease, however, is not included.  
• It is important to understand the progression of a disease in order that patients 
can be provided with the most appropriate care (Murray et al., 2005). While it is 
likely to resemble that of other major organ failures such as chronic obstructive 
pulmonary disease (COPD) or congestive heart failure, little is currently known 
about the illness trajectory in advanced liver disease, and in particular key 
dimensions such as psychological, social or existential wellbeing.  
The above points were highlighted in a recent co-authored paper (see Appendix 1), 
which sought to stimulate further research to inform appropriate palliative care 
guidance for this patient group (Boyd et al., 2012). It was therefore hoped that the 
study data would serve to make a contribution to practice development in 
anticipation of the increasing number of people living and dying with advanced liver 
disease in the coming years.  
1.4 Scope of this study 
This research set out to explore the lived illness xperience of people with advanced 
liver disease. It constituted broad, exploratory research to gain an overview of the 
range of issues that may affect individuals in everyday life and how these are 
understood and managed. Although this thesis attemps to provide a comprehensive 
account of this issue, it cannot be considered to describe the complete picture.  
Most notably, the study findings relate only to an adult population and to a specific 
stage of the illness. Also, by targeting patients with a range of aetiologies, the data 
are unable to comment definitively on the collective experiences of any specific 
causal group. Finally, as this research was undertaken in fulfilment of a PhD award 
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and thus undertaken by an independent researcher, it was subject to resource 
limitations inherent in this arrangement.  
This research aimed to contribute to the existing kowledge base in advanced liver 
disease. It did not specifically set out to formulate policy and practice development 
in supportive and palliative care. The recommendations offered in this thesis must 
therefore be understood in the context of the scale of this research and the limitations 
acknowledged both here and in Section 10.2. 
1.5 Clarifying key terms and language 
There is currently no clinical definition of what exactly constitutes advanced or end-
stage liver disease. For the purposes of this study, a vanced liver disease was 
considered the final phase of deterioration in the liv r disease trajectory; that is, the 
stage of decompensated cirrhosis. A compensated livr is able to function normally 
despite progressive damage with cirrhosis. This phase can continue for many years 
and remain entirely asymptomatic. Decompensation relates to the point at which the 
liver’s ability to adequately perform its range of functions ceases, resulting in serious 
symptoms and complications such as ascites (fluid accumulation in the abdomen), 
gastrointestinal bleeding, or hepatic encephalopathy (disordered mental and 
neuromuscular function) (Ginés et al., 1987). I therefore considered individuals 
experiencing the tangible symptoms and complications f decompensation as having 
advanced liver disease. 
The term ‘participant’ will be used where this is meant to refer to those taking part in 
the research. In documenting the individual illness experiences, however, I 
considered it neither appropriate nor helpful to reduce study participants to a faceless 
status of ‘patient’ and ‘lay carer’. All patient and carer participants were assigned a 
pseudonym, which I will use throughout the thesis except where clarification of their 
status is necessary to aid understanding (see Table 3, Section 4.3, for a list of 
pseudonyms used). Where the generic term ‘patient(s)’ is used this is done for ease, 
and in full recognition that no individual is wholly defined by their condition. 
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The term ‘lay carer’ used in this study refers to the person who provides the most 
help and support to the patient at home, irrespectiv  of their relationship to the 
patient or the nature of the support provided. I considered this more inclusive than 
the term ‘family carer’ often seen in the literature (a sentiment which was borne out 
by the variety of lay carers who participated in this study; see Section 4.1.2 for 
details), and less stilted than ‘informal carer’, another commonly used term. As 
above, this term is used to aid description and discus ion; again, I acknowledge that 
no ‘lay carer’ is solely defined by their caregiving role.  
The ‘health and social care professionals’ referred to in this thesis relate to any 
individual providing some aspect of care for people with advanced liver disease in a 
professional capacity.  
A glossary of key terms and abbreviations regularly used in this thesis can be found 
on page v. 
A comment on language 
This thesis is written from a first-person perspectiv . While there is some 
disagreement regarding the appropriateness of reporting esearch in this manner, 
using this approach here is informed by the following considerations. Firstly, using a 
first-person voice reflects the theoretical perspectiv  underpinning the present study, 
which acknowledges the central role of the researcher in any research endeavour (see 
Section 3.1 for an elaboration on this matter). Secondly, it reflects my commitment 
to a reflexive stance throughout the research process, which constitutes good practice 
in qualitative research (see Section 3.7.2 for further detail in this respect). Lastly, I 
was keen to make this thesis accessible to as largen audience as possible and 
considered this best achieved by avoiding overly abstr ct and artificially detached 
language.  
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Chapter 2: Literature review 
This chapter provides a review of relevant empirical and theoretical literature to 
contextualise the aims of this research. First, the review strategy is described. The 
second section gives an overview of what is currently known about the patient 
experience of advanced liver disease as well as an appraisal of this literature in terms 
of its contribution and current limitations. (A modified version of this section of the 
literature review was recently published (Kimbell and Murray, 2013), see Appendix 
2.) The third section of this chapter outlines key theoretical literature relating to the 
experience of living with chronic illness. The final section summarises the 
intellectual challenges this review points towards, highlighting current gaps in 
knowledge and consequently the value of conducting this study. 
2.1 Review strategy 
Literature searches were conducted in MedLine, Web of Science, CINAHL and 
PsychINFO databases. The search was conducted in an iter tive manner, with search 
terms and strategy evolving as familiarity with the lit rature increased and key 
papers were identified. Searches were also adapted to suit the different formats of the 
individual databases. Figure 3 shows the keywords an  terms selected and searched 
for in abstracts.  
 
Figure 3: Literature review - Keywords and search terms 
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I supplemented this search with hand-searches of key journals such as Palliative 
Medicine and the British Medical Journal (BMJ), and set up email alerts for other 
relevant journals. I also consulted grey literature (e.g. conference proceedings, 
government reports), internet resources, bibliographies, reference lists, and the 
websites of key organisations such as the British Liver Trust, NHS Liver Care, 
Foundation for Liver Research, National Institute for Health and Care Excellence 
(NICE) and Healthtalk Online (DIPEx).  
I excluded papers whose main focus was paediatric liver disease, treatment 
development, acute liver failure, or outcomes relating o the patient experience post-
liver transplantation. I did, however, retain qualitative studies exploring experiences 
post-liver transplantation where findings also made reference to the patient 
experience prior to the intervention.  
2.1.1 Overview of the literature 
Many studies focused on health-related quality of life (HRQoL) in general or in 
relation to liver transplantation. The studies employed a variety of quantitative 
assessment tools to measure physical and psychosocial aspects of liver disease 
(Martin, Sheridan and Younossi, 2002), ranging from generic instruments such as the 
Short Form SF-3 questionnaire to disease-specific tools like the Chronic Liver 
Disease Questionnaire (CLDQ), and psychological instruments such as the Becks 
Depression Scale.   
In contrast, there were few qualitative studies. Of the 13 papers identified, six 
focussed on patients’ experiences of liver transplantation. The remainder pertained to 
specific types of liver disease, in particular primary biliary cirrhosis (PBC). Only one 
study employed a longitudinal design. Table 1 overleaf provides an overview of the 
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Table 1: Qualitative studies (or studies containing a qualitative element) retrieved 
AUTHOR(S) 
(YEAR) 











and waiting for 
liver transplant. 
• Interviews 
• Data analysis as 
per Kvale (1996) 
21 patients on 
transplant waiting 
list.  
17 male, 4 female.  
Average age 46 yrs 
(27–62). 
Mostly (?) post-
hepatitis and primary 
sclerosing cholangitis 
(PSC) (not clear from 
description) 
• Overwhelming lack of energy. Perceived linear 
relationship between lack of energy, physical 
limitations and mental distress.  
• Great uncertainty related to life and death.  
• Plethora of physical problems and discomfort, 











(plus a range of 
validated 
psychological scores) 
24 patients.  
Gender split not 
stated.  




Results linking to specifically to qualitative porti n 
of study not given. Overall key results: 
• High fatigue linked to higher levels of distress and 
perceived quality of life and lower self-efficacy 
for undertaking everyday activities.  
Bornschlegel 
et al. (2011) 
To describe the 





• Data analysis 
method not stated 
180 patients.  
98 male, 82 female. 
Overall age range or 
mean age not stated 
but 77% of sample 
between 42-61 yrs. 
Hepatitis C Unmet information needs relating to: 
• basic information about the virus 
• available support groups 
• counselling about preventing further liver damage 
and transmission prevention 
Brown et al. 
(2006) 
To explore what 
meaning people 
with liver failure 
ascribe to the 
experience of 




data analysis  
• 9 interviews with 6 
participants 
(details of follow-
up not stated) 
6 patients on 
transplant waiting 
list.  
4 male, 2 female. Age 
range 46-63. 




• Illness experience transformative and disruptive 
• Lack of positive care felt to contribute to 
depression, hopelessness and worsening health 
• Pervasive experience of loss relating to perceived 
loss of personal control and freedom, important 
roles, and increasing disability 
• Feelings of frustration and boredom, sense of 
isolation and loneliness 
• Patients develop new perspectives on time 
 
 









Fan and Eiser 
(2012) 
To explore how 
patients perceived 
the impact of 
HCC on their 
lives and coped 






33 patients.  
22 males, 11 females.  




• Many physical symptoms and psychological 
distress. 
• Disrupted social relationships 
• Adjustment to illness a dynamic process 
influenced by physical health, stage of disease, 
patients' illness perceptions and coping strategies.  
• Illness understanding added to patients' sense of 
control.  
• Observed transitions in patients' coping.  
Forsberg et al. 
(2000) 
To explore the 
subjective 
experiences of the 
meaning of 





• Interviews covered 
experiences pre- 
and post-transplant 
12 patients 1 year 
post transplant.  
3 males, 9 females.  









• Feelings of grief and fear of the unknown 





To explore the 
lived experience 
of end-stage liver 
failure and liver 
transplantation. 







Not stated Pre-transplant experience: 
• Uncertainty 
• Feelings of loss of control related to increasing 
dependence, confusion/disorientation, 
anger/frustration and fear 




To understand the 
lived 
experience of 






8 patients.  
1 male, 7 females.  
Age range 38-60. 
Primary biliary 
chirrhosis 
• Experience of fatigue all-encompassing and 
overwhelming, unrelenting, insidious and difficult 
to control  
• Patients plan lives around fatigue to preserve 
energy 
• Struggle to maintain normality 
• Feelings of dysphoria and general apathy 
 
 









Lasker et al. 
(2005) 









posts to a Friends 
and Family listserv 
52 spouses, family 
members or friends 
Primary biliary 
cirrhosis 
• Males felt less affected than females by loved one’s 
illness 
• Giving emotional support and being more 
accommodating most important support strategies 
• 54.5% overall access Internet-based support, but 
more females than males 
• Males’ support action-oriented, females’ socio-
emotional 
Lumby (1997) To explore the 
experiences of 
surviving a liver 
transplant. 
• Focus groups and 
storytelling  
• Analysis using 
NUDIST software 
• Longitudinal (2ys) 
8 patients post-
transplant.  
2 males, 6 females. 
No ages given. 
No details given but 
a variety.  
Pre-transplant experience: 
• Range of physiological states 
• Trust in medics even where poor care management 
• Effort to maintain independence throughout illness 
• Facing both life and death, but hope dominates 
Montali et al. 
(2011) 
To explore the 
illness experience 
of women with 








23 female patients. 
Mean age 59 (39-77). 
Primary biliary 
cirrhosis 
• Denial of patients’ sick role by family and health 
professionals, trivialisation of fatigue, lack of 
consideration of patients’ needs. 
• Fear of rejection and losing their social role 






the effect of 
transplantation on 
quality of life. 
• Semi-structured 
interviews  
• Cluster analysis 
5 patients post-
transplant.  
No gender split or 
ages given. 
No details given Pre-transplant experience: 
• Physical symptoms impeded independence and 
limited activities and social life 
• Quality of life perceived as poor 
• Little acknowledgement of possible death 
Wainwright 
(1997) 










No gender split or 
ages given. 
No details given • Main debilitating complaint fatigue, many 
gastrointestinal symptoms, some mental impairment 
• Negative feelings due to physical limitations 
• Experience of stigma regardless of aetiology.  
• Desire to retain independence and self-manage 
illness 
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2.2 The patient experience in advanced liver diseas e 
The following sections outline the key findings from the literature in relation to 
patients’ experiences of living with advanced liver disease. They draw on both 
quantitative and qualitative studies identified through the review process in order to 
provide as comprehensive a picture as possible of the topic at hand. Findings are 
grouped into four broad areas: physical experience, psychological experience, socio-
demographic variations, and supportive and palliative care. 
2.2.1 The physical experience 
Research with 575 people with end-stage liver disease nd/or their surrogate 
decision-makers found that patients experienced substantial levels of pain, which 
compared with those reported by advanced cancer patients and exceeded those of 
patients with chronic obstructive pulmonary disease (COPD) and chronic heart 
failure (Roth et al., 2000). Pain was particularly marked in cirrhotic patients with 
additional hepatocellular carcinoma (Bianchi et al., 2003). However, as these were 
cross-sectional studies the nature and extent of the reported pain over time are 
unclear. The present study allowed me to explore this important experiential aspect.  
Liver impairment also compromises the effective processing of nutrients. As such, 
malnutrition was found to be widespread among patients with advanced liver disease 
(Kalaitzakis et al., 2006). Panagaria and colleagues compared the nutritional status of 
participants with alcohol-related and non-alcoholic liver disease, alcohol addicts, and 
healthy controls (Panagaria et al., 2007). Features of malnutrition, such as nutrient 
and calorie deficiencies, were seen in all patients regardless of disease cause, but 
were particularly frequent and severe in those with alcohol-related liver disease 
(ALD). Malnutrition was also linked to gastrointestinal complications in cirrhotic 
patients, which may progressively impair their HRQoL (Kalaitzakis et al., 2006). 
Patients with decompensated cirrhosis experience higher levels of fatigue than those 
with compensated cirrhosis and compared with healthy controls (Van der Plas et al., 
2003, Van der Plas et al., 2007). Fatigue was particularly well investigated in the 
realm of primary biliary cirrhosis (PBC), where it constitutes a major debilitating 
symptom (Huet et al., 2000, Jorgensen, 2006). However, comparative research using 
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the Fatigue Impact Scale suggests that the negative effect of fatigue on patient 
wellbeing is in fact comparable across different types of liver disease (Jones, Gray 
and Newton, 2009). Similar to the overall aim of the present study, qualitative 
research by Wainwright (1997) sought to enlighten the holistic patient experience of 
living with advanced liver disease. He interviewed liver transplant survivors about 
their experience of living with the disease prior t the intervention. Respondents 
described several gastrointestinal complications and mental impairments, but felt 
particularly frustrated with the physical limitations caused by their high levels of 
fatigue. Overwhelming fatigue was also reported by patients awaiting liver 
transplantation (Bjørk and Nåden, 2008). The present tudy can add to current 
understanding of the experience of fatigue in advanced liver disease by virtue of its 
longitudinal design, which allows the consideration of the severity and persistence of 
fatigue over time.  
Sleep problems are likely to contribute to the fatigue reported elsewhere. In their 
prospective survey study of cirrhotic patients, Cordoba and colleagues observed 
extensive sleep disturbance unrelated to any cognitive impairment (Cordoba et al., 
1998). Problems such as short sleeping time, difficulties falling asleep, and 
fragmented nocturnal sleep were seen alongside poor daytime functioning marked by 
excessive sleepiness and frequent napping. The level of sleep problems seen in 
cirrhotic patients compared with that of gender- and age-matched controls with 
chronic renal failure, and was significantly higher than that of healthy controls 
(Cordoba et al., 1998, Mostacci et al., 2008). In other research, 69% of participants 
with cirrhosis suffered from some type of sleep disorder, with related negative 
impact on their psychological health (Bianchi et al., 2005). 
Survey research with 544 cirrhotic patients reported that, compared with the general 
population, they perceived that most areas of their da ly life had been affected by 
their illness, particularly the physical domain (Marchesini et al., 2001). Surprisingly, 
however, respondents felt significantly more affected by relatively minor symptoms 
such as muscle cramps and itching than some of the major, possibly life-threatening 
complications. This prompted the authors to suggest the inclusion of such symptoms 
in existing survey tools in order that they are considered in future research. The 
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findings also suggest that health professionals should give due attention to patients’ 
symptom reporting, as effective treatment of these relatively minor ailments could 
facilitate significant improvements in their quality of life. The qualitative design of 
the present study had the potential to generate further insight in this area by 
encouraging participants to share freely the issues of greatest concern to them 
regarding living with advanced liver disease, including the physical complications 
they perceived as causing the most negative impact in everyday life.   
2.2.2 The psychological experience 
A common debilitating feature of advanced liver disea e is increasing cognitive 
dysfunction. Hepatic encephalopathy (HE) is one of the main complications that may 
afflict patients in the latter stages of the disease nd can manifest in a variety of 
neurological symptoms affecting attention, memory and psychomotor functions. HE 
often necessitates inpatient hospital treatment and precedes the death of many 
patients with advanced liver disease. While not all p tients will develop this level of 
cognitive decline, studies have shown that a large number of patients will experience 
some cognitive impairment at a sub-clinical level (Pantiga et al., 2003), although 
reported prevalence rates for this vary widely (Collie, 2005). Nevertheless, research 
by Groeneweg et al. (1998) highlights the clinical relevance of sub-clinical hepatic 
encephalopathy (SHE). In their tests with 179 cirrhotic outpatients, those with 
confirmed SHE displayed significantly more impairment on both physical and 
psychosocial aspects of the Sickness Impact Profile scale than those without it. Given 
its evident impact on individuals' quality of life and daily functioning then, the 
authors suggest that routinely assessing and treating sub-clinical levels of cognitive 
dysfunction in this population may enhance the experience of living with the disease.  
People with advanced liver disease reported more substantial levels of psychological 
distress than those with other types of organ failure such as COPD or congestive 
heart failure (Roth et al., 2000, Younossi et al., 2001), and age- and gender-matched 
controls (Bianchi et al., 2005). Impairment in patien s’ psychological wellbeing has 
been linked to both physical factors, e.g. fatigue (Blackburn et al., 2007), and social 
factors, e.g. stigma (Sogolow et al., 2010). A questionnaire study by Fritz and 
Hammer (2009) examined the impact of gastrointestinal symptoms on the quality of 
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life of 75 cirrhotic patients. 80% of the study sample experienced one or more 
symptoms which not only affected their quality of life, but also their psychological 
wellbeing. The authors concluded that treating psychological problems may effect an 
improvement in individuals’ physical symptoms, and i  turn in their overall quality 
of life. Indeed, it has been suggested that psychological distress is the best predictor 
of quality of life in people with liver cirrhosis (Kim, Oh and Lee, 2006).  
Depression was particularly prevalent in this population, irrespective of disease cause 
(Gutteling et al., 2010). Assessing depression in 156 cirrhotic patients, Bianchi et al. 
(2005) found that over that half of their sample were depressed. Moreover, few had a 
known history of depression, thus suggesting that teir liver disease was impacting 
on their mental health. In a prospective study by Singh et al. (1997), 64% of 
participants were positively assessed as suffering f om depression. Compared with 
their non-depressed counterparts, depressed individuals reported significantly more 
adverse outcomes in several areas, such as adaptive coping, physical pain, and 
perceived quality of life. They also displayed a higher level of negative thinking 
about future prospects, and perceived themselves a greater burden to their carers. 
Most significantly, the researchers found that among patients waiting for a liver 
transplant, those with depression were more likely to die than non-depressed patients, 
regardless of the severity of their disease. The prevalence of depression in people 
with advanced liver disease is likely to be higher than currently estimated, in 
particular when one considers the large number of patients for whom transplantation 
is contraindicated (Heneghan and O'Grady, 2001). With such a dramatic effect on 
both illness experience and prognosis, depression in this patient group warrants 
dedicated attention in any therapeutic intervention. 
Finally, a recent qualitative interview study explored the illness experience of 33 
patients with hepatocellular cancer (Fan and Eiser, 2012). Patients’ psychological 
adjustment to the illness was found to be a dynamic process influenced by their 
physical health, the stage of the disease, the patient’s illness perceptions and their 
coping strategies. It appeared that understanding the nature of their illness, especially 
its causes, prognosis and treatment plans, was particul ly important in promoting 
patients’ sense of control. As this research focused on a specific type of liver disease 
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however, it is unclear how this experience compares to non-malignant aetiologies. 
The cross-sectional design of the study also limits insights into the dynamic nature of 
individuals’ psychological experience as proposed by the authors. The design of the 
present study allowed me to contribute understanding in both these areas.  
2.2.3 Socio-demographic variations 
People with liver disease constitute a relatively younger patient population compared 
with other major diseases (British Association for the Study of the Liver and British 
Society of Gastroenterology, 2009, Roth et al., 2000). An assessment of cirrhotic 
patients of various aetiologies using the Short Form SF-36 questionnaire found age 
significantly correlated with worsening HRQoL (Afendy et al., 2009). Comparable 
survey research reported that the impact of cirrhosis was experienced more acutely 
by younger participants (Marchesini et al., 2001). The age differences observed in 
both studies may reflect a relatively more widespread impact of the disease on 
younger patients’ lives in terms of their employment, family life and adjustment to a 
diagnosis of a life-limiting illness, compared with older individuals who are already 
beyond the most active phase of their lives.  
Both studies also observed gender differences in the patient experience of advanced 
liver disease. Afendy et al. (2009) found that female patients showed more 
impairment in some areas of HRQoL than males. In the study by Marchesini et al. 
(2001), male participants cited paid employment andsexual function as their main 
worries in relation to their illness. In contrast, female respondents highlighted their 
home life and social life as primary concerns. As socio-demographic variations in the 
patient experience of advanced liver disease have so far received little attention, this 
research offered an opportunity to contribute insights in this area.  
2.2.4 Supportive and palliative care 
While there was some literature pertaining to the clinical management of symptoms 
and complications relating to the end stages of liver disease, there was a dearth of 
publications which considered the holistic aspects of upportive and palliative care 
for this patient group. It is important that professionals make it their business to 
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understand their patients’ goals in this regard, as they constitute the difference in 
treatment for palliative care and disease-focused care (McGrew, 2001).  
As discussed in Section 1.1.3, a typically erratic trajectory makes defining the right 
time at which to introduce palliative care in non-malignant disease difficult. McGrew 
(2001) posits that palliative care in liver disease should be introduced at the point at 
which symptoms of decompensated cirrhosis become evident. Alternatively, 
transplant assessment has been suggested as a good time at which to initiate 
conversations about palliative care (Adam, 2000, Hope and Morrison, 2011, Larson 
and Curtis, 2006). However, this approach does not accommodate the many people 
for whom transplantation is contraindicated. There is often a concern that patients 
may be unduly alarmed by a suggestion of a change i treatment towards palliative 
care. In a study of nearly 3000 patients with various advanced diseases including 
liver cirrhosis, however, a large minority (44%) expressed a preference for palliative 
care over life-prolonging treatment (Fox et al., 1999).  
Effective holistic supportive and palliative support relies on the successful 
integration of disease-directed and palliative care goals. It has been suggested that 
palliative care is easily integrated into the standard management of advanced liver 
disease (Sanchez and Talwalkar, 2006). Medici and colleagues argue that concurrent 
access to hospice care for selected patients waiting for transplantation may improve 
their overall care experience (Medici et al., 2008). Their study found that hospice-
based interdisciplinary staff and liver transplant teams were easily able to integrate 
their respective goals of care and develop effectiv partnership working. 
2.3 Methodological critique of the empirical litera ture  
HRQoL research employing survey-based methods has contributed greatly to our 
quantitative understanding of symptom burden and psychological distress in 
advanced liver disease, and provides the basis of many recommendations to more 
effectively target treatment and care. Moreover, asses ing liver patients' HRQoL 
does not just serve as an assessment measure in its own right, but has also been found 
to be a useful predictor of mortality (Kanwal et al., 2009).  
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There are several limitations to this approach, however. Most HRQoL studies 
employ a variety of generic and/or disease-specific survey questionnaires. A 
literature review by Martin and colleagues cautions that these instruments tend to 
differ greatly from one another, and that researchers also use varied terminology to 
describe quality of life, thereby affecting its interpretation (Martin, Sheridan and 
Younossi, 2002). It is thus difficult to draw overall conclusions from the available 
research. The inherent failure of HRQoL measures to be truly patient-centred has 
also been noted (Carr and Higginson, 2001). This is in part due to the lack of an 
agreed definition of HRQoL, but is more importantly down to the individual nature 
of what constitutes quality of life, which is shaped by a person’s culture, socio-
demographics, and personal factors like experiences, expectations and beliefs. 
HRQoL studies are also subject to several methodological shortcomings, such as a 
lack of longitudinal comparisons and the arbitrary timing of QoL investigations 
(Cirrincione et al., 2002). Finally, the suitability of common HRQoL measures in the 
realm of palliative care has been questioned due to their lack of context-specific 
constructs such as symptom control, spirituality or family support (Kaasa and Loge, 
2003). Importantly, patients themselves feel that pre-formulated questionnaires give 
no opportunity to make personal comment on their subjective illness experience 
(Benz, 2001, Lowe et al., 1990). Speaking from a patient perspective, Benz (2001, 
p203) argues that, “traditional questionnaires focus on how far function and pain 
affect the patient, but are only indicative of health status. Quality of life is 
determined by what a person says it is.” 
The literature focused on liver transplantation uses the same or similar quantitative 
assessment tools as HRQoL research to examine and compare patients’ quality of life 
before and after transplantation. It is therefore subject to similar limitations as those 
outlined above. The qualitative liver transplantation literature identified relates to a 
very particular set of circumstances: awaiting transplantation. Many patients with 
advanced liver disease do not qualify for transplantation on account of co-
morbidities, general frailty or continued drinking or drug-taking. While much can be 
learned from the insights of these patients awaiting transplantation, their experiences 
may not reflect those of the wider patient population with advanced liver disease. 
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Indeed, marked differences between transplant and no -transplant patients have been 
observed (Price et al., 1995). 
Several studies recruited patients with different causes of liver disease. Their results 
indicate some variation in HRQoL and related factors, suggesting that there may be 
differences between aetiologies in the way advanced liv r disease is experienced. At 
the same time, there is much aetiology-specific research into the patient experience 
with PBC and hepatitis C for example, but comparatively little in the realm of non-
alcoholic fatty liver disease. This is also important given that PBC affects 
disproportionately more females; as described earlier, some studies suggest gender 
variations in the experience of living with advanced liver disease. This implies that it 
may be inappropriate to extrapolate from one type of liver disease to another, or to 
suggest that there exists a universal patient experience in advanced liver disease. This 
matter was given due attention during the data analysis phase of the present study. 
So far this chapter has set out what is currently known about the patient experience 
of advanced liver disease, and offered an appraisal of the empirical literature. The 
following section provides additional context to this study by detailing some key 
theoretical literature with respect to living with c ronic illness. 
2.4 Theoretical perspectives in chronic illness 
Over recent years, psychosocial theorising in the context of health and illness has 
increasingly challenged the dominance of the biomedical view, and generated 
growing interest in the patient perspective (Armstrong, 2000, Engel, 1977). This 
constitutes an important shift away from the concept of the ‘sick role’ which had 
previously dominated discourse in health and illness (Parsons, 1951). Parsons argued 
that being granted the sick role comes with certain rights and responsibilities for the 
ill person. Importantly, their key obligation is toactively strive towards recovering 
their health as soon as possible. However, this notio  has been challenged in the 
context of chronic illness, where recovery of complete health is not an option 
(Nettleton, 1995). Indeed, there is increasing recognition of the need to gain a more 
subjective understanding of illness and its impact on daily life (Lawton, 2003). 
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2.4.1 Defining chronic illness 
The key defining aspect of chronic illness is its temporal character. In chronic illness 
such as advanced liver disease, the person’s conditi  is of an enduring nature. 
Unlike in acute illness, the chronically ill person’s life is affected not solely in terms 
of temporary physical disability, but also the wider psychosocial context of their life 
world. Relationships, employment and expectations for the future all need to be 
adjusted to accommodate this permanent change to the person’s life. As Charmaz 
(2000, p277) states, “Experiencing chronic illness means much more than feeling 
physical distress, acknowledging symptoms and needig care. It includes metaphor 
and meaning, moral judgements and ethical dilemmas, identity questions and 
reconstruction of self, daily struggles and persistent roubles.” 
The illness experience is defined by internal and external factors (Radley, 1994). 
Internal refers to the experience that is particular to the ill person, while external 
aspects concern the experience in relation to their social world. Radley gives the 
example of adjustment style as something that is comm nly assumed to be closely 
related to a person’s personality traits. However, the influence of others on an ill 
person’s adjustment, such as their reactions to the illn ss and support provided, 
cannot be underestimated, and highlights the important social component in the 
individual illness experience (Charmaz, 1983, Radley, 1994, Radley and Green, 
1987). Kleinman (1988, p180) similarly notes that, “Chronicity is not simply a direct 
result of pathology acting in an isolated person. It is the outcome of lives lived under 
constraining circumstances with particular relationships to other people.” 
Radley (1994) further argues that it is important to distinguish between the terms 
disease, illness and sickness, which are often usedint rchangeably in the context of 
chronic illness. In doing so, it becomes evident that medical knowledge alone, as 
applied by clinicians to the treatment of disease, cannot give a genuine insight into 
the reality of illness as experienced by the affected individual. Likewise, Kleinman 
(1988) urges for a distinction to be made between th  patient and the sick person. He 
argues that the term ‘patient’ belongs firmly in the realm of biomedicine, as those 
living with chronic illness in fact spend more time in their everyday roles of ill 
family member or ill employee than in that of the patient. My agreement with this 
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assertion was highlighted in Section 1.5 and is reflected in my decision to refer to 
participants using pseudonyms so as to not reduce them o a status of ‘patient’ only.   
2.4.2 Living with chronic illness 
Illness as biographical disruption 
A seminal concept in the study of long-term conditions is that of illness as 
biographical disruption (Bury, 1982). Bury suggests that the onset of chronic illness 
shakes up a person’s entire life world. It exposes them to the realities of pain, 
suffering and possible death, severely disrupts their relationships at home, work and 
their wider social network, and throws into disarray expectations and plans held for 
the future. It also represents a severe disturbance to an individual’s self-concept, 
requiring re-evaluation and adaptation. The experience of biographical disruption in 
the context of advanced liver disease was indicated in a small-scale interview study 
of six patients waiting for a liver transplant, who described their illness as both 
disruptive and transformative (Brown et al., 2006). 
In recent years, however, the idea of illness as a biographical disruption has 
increasingly been questioned, and there have been calls to update and extend the 
concept in light of limitations to the original account (Lawton, 2003, Williams, 
2000). Lawton (2003) puts forward several studies which challenge Bury’s notion of 
illness being necessarily experienced as biographiclly disruptive. She argues that the 
experience of living with existing morbidities or in difficult personal circumstances, 
such as poverty or drug misuse, may dampen the potential disruptive impact of a new 
diagnosis of illness. Consequently, such individuals may simply ‘slot’ this new 
experience into their already challenging lives. It was conceivable that this scenario 
might arise in the case of some individuals living with liver disease on account of 
long-term alcohol or drug misuse. The current study thus provided an opportunity to 
explore this notion within the context of advanced liver disease. 
Loss of self  
Charmaz builds on Bury’s notion of chronic illness a  a critical disturbance to a 
person’s self-concept (Charmaz, 1983, 1987, 2002). She contends that long-term 
illness presents a serious challenge to the ill person’s sense of self, forcing them to 
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reconsider and continually adjust their notion of who they are and see themselves 
becoming as a result of their circumstances and illess experiences. In her seminal 
1983 paper, Charmaz focuses on the diminishing self-concept and subsequent loss of 
self as a fundamental form of suffering. She identifies four challenges to one’s self 
which may be experienced by the chronically ill and those close to them: living a 
restricted life; social isolation; discrediting definitions of self; and becoming a 
burden (Charmaz, 1983). Charmaz concludes that often the experience of suffering is 
conceptualised too narrowly, focusing solely on its physical expressions like pain or 
disability, while disregarding the many other ways in which individuals may 
experience suffering due to long-term illness. An interview study exploring the 
experiences of women living with PBC supports this notion (Montali et al., 2011). 
Their illness was found to impact greatly on the women’s identities, particularly in 
relation to fears of losing their traditional social role and social rejection, and posed a 
challenge to biographical continuity.  
Stigma 
Experiencing stigma is a common feature of chronic disease (Stuenkel and Wong, 
2013). Due to their condition, an ill person may be considered deviant from social 
norms and tarnished in character (Goffman, 1968). Stigma may be experienced in 
two ways: enacted and felt (Scambler and Hopkins, 1986). Enacted stigma relates to 
actual instances of stigmatisation experienced by aperson on account of their illness 
rendering them different. Felt stigma relates to the ill person’s perception or fear of 
being the victim of stigmatising behaviour by others, as well as feelings of shame 
and guilt they may hold about their circumstances.   
The experience of stigma relates to a societal reaction towards an illness (Kleinman, 
1988), and as such varies between conditions, settings and individuals. While some 
of the consequences of chronic ill health, such as disability or unemployment, may 
elicit stigmatising reactions in any disease context, some types of chronic disease are 
considered inherently more stigmatising than others (Charmaz, 2000). This is 
especially true where a disease may be blamed on the person engaging in high-risk 
behaviours, such as smoking as a cause of lung cancer (Chapple, Ziebland and 
McPherson, 2004). In the context of chronic liver disease in the UK, the dominance 
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of alcohol-related and viral causes of the disease alongside popular perceptions of the 
disease being generally self-inflicted render those living with liver disease likely 
victims of stigmatisation. Indeed, liver patients are often accused of having brought 
about their illness through excessive drinking or drug use, regardless of the true 
cause of their condition (Wainwright, 1997, Sogolow et al., 2010). 
The ‘hard work’ of living with chronic illness 
Chronic illness requires continuous effort by the ill person to remain actively 
involved in ‘normal’ life while managing the reality of being different on account of 
their illness. Three particular areas of ‘work’ forthe ill person have been highlighted 
(Corbin and Strauss, 1985). They have to engage in ‘illness work’ involving ongoing 
symptom and routine disease management, ‘everyday life work’ relating to their 
daily tasks and responsibilities in the home or at work, and ‘biographical work’ in 
relation to the repeated biographical adjustments requi ed along the illness trajectory.  
This has been referred to as the ‘hard work’ of living with chronic illness (May, 
2006). May (2006, p161) suggests that, “the physiological burden of illness is 
paralleled not only by a psychological burden, but also by a kind of social 
exhaustion.” He asks some pertinent questions about the efforts required by sick 
people to negotiate the practicalities of everyday living as well as the intricacies of 
interpersonal relationships, wider social organisation, and the healthcare system. 
Research confirms May’s notion of illness as ‘hard work’. In a participatory research 
study, people with various life-limiting conditions described a constant struggle to 
retain their independence in the face of the physical, social and emotional challenges 
associated with their illness as well as increasing dependence (Cotterell, 2008).  
2.4.3 Professional care in chronic illness 
The ill person actively seeking to establish control over their situation is commonly 
considered to have accepted their fate, and therefor  to be adapting to their illness in 
a ‘healthy’ manner. In contrast, the ill person who expresses unrealistic optimism in 
relation to their situation, or fails to comply with medical instructions, may be 
perceived as living in denial about their circumstances. Heyink et al. (1989), for 
example, studied 18 patients who had been rejected for liver transplant. Many 
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expressed optimism about their future, which was clearly at odds with their actual 
medical prognosis.  
Telford and colleagues argue that the concepts of acceptance and denial have, over 
time, developed negative connotations (Telford, Kralik and Koch, 2006). 
Nevertheless, health professionals use them widely and somewhat unquestionably in 
their assessment of patients’ adjustment to chronic illness. Related to this is an 
implicit understanding that acceptance of one’s fate regarding living with a chronic 
condition is a desirable and ‘healthy’ outcome, andthat it reflects a person’s coming 
to terms with their situation. Denial is seen at best as a necessary phase in the journey 
towards adjustment and acceptance, but one that must be swiftly overcome.  
Relatedly, chronically ill people consider their growing dependence exacerbated by 
professionals’ assumptions and paternalistic attitudes (Cotterell, 2008). Kleinman 
(1988) argues that current approaches to medical training are too narrowly focused 
on pathology, favouring those with treatable acute conditions. As a result, many 
healthcare professionals lack the skills and confide ce to adequately recognise and 
support the complex holistic needs of the chronically ill person and their lay carer, 
who must struggle on by themselves in managing their increasingly challenging life 
circumstances. Kleinman (1988) likens this situation t  an ‘oppressive iron cage’, 
often leading to a mutually frustrating relationship between the individual and the 
healthcare system. Indeed, patients waiting for liver transplantation felt that poor 
medical care was contributing to their low mood anddeclining health (Brown et al., 
2006). This negative experience may in part be related to the current shortfalls in 
service provision and lack of specialist staffing observed in liver care services 
(Williams, 2004, Williams, 2009).  
Having provided an overview of empirical and theoretical literature relevant to the 
patient experience of advanced liver disease, the following section summarises the 
intellectual problem highlighted by the literature review with a view to clarifying the 
rationale for the present study.  
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2.5 Defining the intellectual problem 
The literature suggests that people living with advanced liver disease experience 
many physical and psychosocial challenges, and often f a greater severity than those 
reported in other chronic diseases. However, my review found the literature limited 
in the extent to which it was able to describe the lived patient experience of advanced 
liver disease. Some physical and psychological support needs can currently only be 
inferred from more clinically-focused research. While there has been some interest in 
the psychosocial experience of undergoing liver transplantation, I found only two 
studies that explicitly explored the everyday, holistic patient experience in advanced 
liver disease: one study of people with hepatocellular carcinoma (Fan and Eiser, 
2012), and one exploring the experiences of females with PBC (Montali et al., 2011).  
We currently lack understanding of liver patients’ main concerns and priorities in 
relation to their illness. We also do not know how patients with advanced liver 
disease experience their medical treatment and care, and in particular their supportive 
and palliative care, and to what extent the support rovided is perceived to meet their 
needs and goals (Boyd et al., 2012, Hope and Morrison, 2011). Similarly, there is 
currently little insight into liver patients’ social, emotional, existential or information 
needs, and how these might change over time. All of these issues are likely to have a 
significant bearing on the perceived quality of life and overall illness experience of 
both the patient and their family, and may be especially pertinent as their illness 
progresses towards liver transplantation or death (Osborne et al., 2012). As discussed 
in Chapter 1, this is of particular interest given o going concerns regarding poorer 
availability of supportive and palliative care services for patients with non-malignant 
life-limiting diseases compared with cancer patients (Boyd and Murray, 2010).  
The typical organ failure trajectory is marked by an erratic progression towards death 
(Murray et al., 2005) and liver patients’ quality of life deteriorates with increasing 
disease severity (Younossi et al., 2001). This suggests that the patient experience 
may differ dynamically along the liver disease pathway. It is important to understand 
how people experience these fluctuations in their condition to allow changing needs 
to be recognised and responded to with acceptable and effective care. Current 
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research in liver disease is largely cross-sectional and quantitative. Qualitative 
longitudinal research which explores and captures th  changing nature of patients’ 
health in depth has the potential to provide useful insights here (Murray et al., 2009). 
This literature review found only one qualitative study using a longitudinal approach 
to explore patients’ experiences of liver transplantation (Lumby, 1997).  
In addition, there is currently only a very limited amount of qualitative research in 
this area. Of the 13 qualitative studies identified, many are situated in the liver 
transplantation literature and therefore not necessarily representative of the wider 
patient population with advanced liver disease. Moreover, they commonly employ a 
retrospective design, asking transplant survivors t recall their experiences prior to 
transplantation, and are therefore subject to the biases inherent in this approach.  
Lawton’s review of developments and changes in our conceptual understanding of 
lay experiences in health and illness stresses the importance of considering timing, 
setting and individual biographies to help illuminate the complex and diverse ways in 
which people experience illness (Lawton, 2003). By undertaking research that is 
qualitative, longitudinal, prospective and generic (i.e. not aetiology- or transplant-
focused) I sought to respond to this notion, and to contribute new insights in the 
realm of advanced liver disease specifically.  
2.6 Summary 
There are many physical and psychosocial challenges for people living with 
advanced liver disease. However, no research was identified which describes the 
holistic, lived patient experience of advanced liver disease in depth. Given the erratic 
and unpredictable trajectory of the condition, it is imperative that a longitudinal, 
patient-centred approach is taken to illuminate the dynamic illness experience. I 
found no research which seeks the views of the individual who experiences and 
manages this condition through time. Insights have either been provided from a 
professional perspective or generated from predetermin d standard questions. Only 
by letting affected individuals' illness experiences be told in their own words, and 
allowing them to speak freely and focus on the issue  of greatest importance to them, 
will we be able to ascertain whether or not their needs are sufficiently supported 
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through current care structures and pathways. Given th  rapidly increasing number of 
people predicted to be living with and dying from adv nced liver disease in coming 
years, this deserves urgent attention. This study therefore sought to address this gap 
in our knowledge and understanding. 
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Chapter 3: Methodology 
This chapter sets out the plan for this study, including justification for the choices 
that were made in the process. It first outlines the eoretical framework and 
methodology which informed the study design. It then provides details regarding 
study participation and the data sources used. Finally, it reflects on issues relating to 
research quality and ethics pertinent to the design and conduct of this study. (How 
this plan worked out in practice will be described and discussed in Chapter 4.) 
3.1 Theoretical considerations 
Research in the realm of health has traditionally centred on biomedical enquiry and 
has been dominated by a positivist, natural science paradigm which uses quantitative 
methods to verify or falsify a priori hypotheses about a phenomenon. This stance is 
based on the premise that there exists an objective reality or ‘truth’ independent of 
human perception, and that to gain an understanding of phenomena the researcher 
must extract that knowledge from the appropriate source by means of quantifiable 
methods, thus generating observable, testable and ge eralisable ‘hard’ data. This 
dominant approach has attracted increasing criticism over the years, however, and its 
ability to enlighten phenomena in the realm of human beliefs and behaviour has been 
questioned (Guba and Lincoln, 1994).  
3.1.1 Qualitative research 
As the illness experience is inherently a very personal, subjective and sensitive 
phenomenon, it seems appropriate for the purposes of this study to favour qualitative 
research methods over the use of more detached and st ardised quantitative 
approaches. This notion is supported by previous end-of-life research showing that 
patients have a strong preference for a more personal interview approach over 
questionnaires when sharing such intimate and sensitive matters (Kendall et al., 
2007, Sherman et al., 2005). 
Despite being commonly presented as a unified approch there is no agreed 
definition for qualitative research. This is because qualitative research draws on a 
multitude of different philosophical theories, and a variety of methodologies and 
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methods are employed under this label. The key commn feature of all qualitative 
research is its primary concern with meanings, perceptions and experiences. As such, 
it focuses on areas of interest less amenable to quantitative research methods and 
their focus on measurement and quantification.  
Qualitative research employs an inductive approach to facilitate the exploration of 
poorly understood topics which lack existing theoris to describe them. In doing so, 
it aims to capture the multi-faceted and value-rich contextual dimensions underlying 
and influencing the phenomenon in question by taking as its focus the perspective of 
the participant rather than that of the researcher.  
3.1.2 Theoretical perspective 
It is also important at the start of any research endeavour to acknowledge the 
theoretical perspective which will underpin and inform the design and conduct of the 
study (Carter and Little, 2007). This theoretical perspective reflects the fundamental 
beliefs that the researcher holds and is informed by ontological considerations (i.e. 
how they understand the nature of reality) as well as epistemological considerations 
(the theory of knowledge and how it can be demonstrated). The researcher’s 
assumptions in both these areas directly influence the methodology and methods they 
will select for their study. 
There is a wealth of literature describing different theoretical stances and 
methodologies common in contemporary research (e.g. Creswell, 2007, Crotty, 
1998). It has been argued that there is no paradigm that is fundamentally correct or 
should be elevated above others, as all perspectives are based on human construction 
and therefore prone to error (Guba and Lincoln, 1994). Nevertheless, as mentioned 
earlier, the positivist paradigm with its focus on bjectivity and quantification has 
proven particularly dominant in research enquiry. In health research, it is particularly 
suitable for describing population estimates of a disease problem or the functional 
relationships between patient characteristics and their health status.  
In consulting the theoretical literature to identify my personal belief system 
underpinning my research, I was mindful of Creswell’s argument that the adoption of 
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a particular stance did not oblige the researcher to always frame their research within 
that perspective (Creswell, 2007). Rather, different approaches may feel appropriate 
for different research endeavours. I found myself generally sympathetic to a 
pragmatist worldview which does not subscribe to a particular philosophical 
perspective, leaving the researcher to select those methods or procedures deemed 
most appropriate to answer their research questions within the parameters of the 
project in question. In respect of the subject matter and aim of the present study, 
however, I identified most closely with the construc ivist paradigm as reflective of 
my own views and assumptions on the nature of reality in this context.  
The constructivist paradigm 
Constructivism takes as its focus the construction of meaning within the context of 
interaction with others (Berger and Luckmann, 1967). As such, it rejects the 
positivist notion of an objective truth and argues in tead that there exist in fact 
multiple realities which are constructed by means of human interaction. This 
thinking constitutes an important shift away from ontological realism towards a more 
relativist stance. In the present study, this relativism is reflected in the notion that the 
illness experience is an inherently subjective experience as represented by individual, 
context-bound accounts. 
Constructivism holds the epistemological premise that meaning and knowledge do 
not exist independently, simply awaiting excavation by the researcher, as suggested 
by conventional approaches. Conversely, it contends that both meaning and 
knowledge are actively constructed and understood through social interaction (as a 
result this approach is commonly referred to as ‘social constructivism’). In the 
context of the research endeavour then, it is impossible to separate the researcher 
from their inquiry, as they play an active role in the construction of the reality they 
seek to investigate (Mantzoukas, 2004). Moreover, as e ch party brings their own 
values to knowledge construction, it is similarly impossible to remain free of the 
effects of those values and biases (Guba and Lincoln, 1989).  
This is counter to the conventional tradition, which seeks to eliminate from its 
research any contextual variables that may confound the data. Rather than view the 
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influence of values as a contaminating factor in the research process, Guba and 
Lincoln (1989, p102) argue that, “values must be accorded a central place in human 
study because they come closer to the core of humanness than most other 
characteristics of people.” Consequently, it is necessary as a qualitative researcher to 
acknowledge the value-laden character of one’s study and to be reflexive and 
transparent about one’s own positioning in the research report (see Section 4.8 for 
my reflections on my role as researcher).  
Given the above assumptions, a constructivist approach is unable to respond to 
positivist demands for the verification of scientific ‘truth’. Rather, its particular aim 
is discovery and the creation of a deeper understanding of a phenomenon (Schwandt, 
1994). Consequently, understanding of the lived experience is sought through 
naturalistic methodologies and the viewpoint of those whose experiences are the 
object of investigation. A constructivist approach therefore responds well to the 
broad, exploratory intentions of this research, at the core of which lies the 
exploration of the dynamic needs and experiences of pe ple with advanced liver 
disease and those of their carers.  
3.2 Methodology 
3.2.1 Selecting a research method 
I assessed a number of methods for their suitability to help meet my research 
objectives. As outlined in the literature review, a number of studies in the realm of 
health-related quality of life in advanced liver disease sought to gather this type of 
information by way of questionnaire surveys. However, such an approach can only 
illuminate pre-determined topic areas, and can therefore only verify the researcher’s 
assumptions rather than generate a broad set of data reflective of the participant’s 
perspective. Moreover, a survey approach is limited in the extent to which it can tap 
into people’s thoughts, feelings and understandings of their situation. This subjective 
insight is crucial in enlightening the lived experience of advanced liver disease, 
however. Finally, patients are keen to share more personal experiences than a 
questionnaire allows (Kendall et al., 2007, Lowe et al., 1990, Sherman et al., 2005).  
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In considering my options within qualitative research then, I rejected the use of 
observational methods. I felt that such an approach would be unlikely to generate the 
same breadth of insight as could measures based on self-report, especially given the 
changeable and unpredictable nature of the advanced liv r disease trajectory. I 
further anticipated challenges in relation to recruitment and ethics which could not 
easily be accommodated within the scope of this project. 
I also rejected the use of text analytical methods like the diary method; that is, to 
collate participants’ thoughts on their needs and experiences as written up in their 
own words. I deemed this approach inappropriate for this study on the grounds that 
people in the advanced stages of liver disease would likely be too unwell to be 
expected to sustain keeping a regular diary over the duration of a year. It would also 
require a much greater time investment on the part of the participants than other 
methods. Given their challenging and time-limited circumstances, I considered this 
too much of an imposition to place on these individuals. 
I also ruled out the use of group interviews, or focus groups, on the basis of two 
considerations. Firstly, I felt that the topic in question was too personal and sensitive 
to be shared in a group setting. While some participants may appreciate the 
supportive environment a group discussion among peers can provide, there is the 
potential for causing distress in others, especially in relation to uncertainty or 
ignorance as regards prognosis and the contemplation of matters around death and 
dying in which some may not wish to engage. Secondly, I dismissed group 
interviews based on the supposition that different causes of chronic liver disease may 
bring about different needs and experiences for both pa ient and carer; I felt that this 
may be easier to establish using an individual approach.  
Based on the above considerations, as well as a review of relevant literature, I 
concluded that the use of serial individual interviws would be best suited to the 
intended outcomes of this study. 
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3.2.2 Making the case for qualitative interviews 
Bury (2001, p264) argues that, “Not only do language nd narrative help sustain and 
create the fabric of everyday life, they feature prominently in the repair and restoring 
of meanings when they are threatened.” As such, narrative constitutes a key vehicle 
for exploring the lived experience of serious illness. Allowing individuals to speak 
freely about their life with illness sets this experience within the context of their life 
as a whole, and therefore enables an insight into how t e illness interacts with the 
complexities of everyday life and how this is experienced and managed by the ill 
person. It also has the potential to go beyond the s ory itself to reveal how the illness 
affects the person’s sense of self and the strategies they employ to reconcile such 
challenges. 
Open-ended or unstructured interviews are the most flexible approach by which to 
gather relevant data and are therefore well suited to the exploration of topics where 
little is currently known. Their loose format allows respondents to focus on the issues 
of greatest importance or relevance to them and thus o guide the direction of the 
conversation, thereby promoting the exploratory nature of the study. If conducted 
ethically and diligently, it is also an approach which is sensitive to participants’ 
needs, as it allows them maximum agency and control over what, when, how much 
and in what way to share information as part of the int rview process. As Corbin and 
Morse (2003, p338) explain, “Unstructured interviews are shared experiences in 
which researchers and interviewees come together to create a context of 
conversational intimacy in which participants feel comfortable telling their story.” 
Interviews also reflect the essence of constructivism by virtue of their grounding in 
human interaction and construction (Mason, 2002). Interviews are, by their very 
nature, inescapably active and constructive (Holstein and Gubrium, 2004). Asking 
questions of a person is an unavoidably interactive process which engages the 
respondent in a process of making sense of their world, and consequently fosters the 
active creation of meaning and understanding.  
Kvale (1994) explores a number of objections regularly levied against the 
contribution qualitative research interviews make to scientific inquiry, many of 
which originate from a positivist stance. However, some of these objections must be 
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challenged on the basis of being grounded in terminology which in itself is poorly 
defined and at times ambiguous. He also argues that there is too strong a focus on a 
perceived dichotomy between qualitative and quantittive concepts which, on closer 
inspection, is not borne out in reality. Indeed, some of the criticisms against 
qualitative interviews are equally applicable to quantitative methods. Kvale (1994, 
p169) concludes that, “in the long run the scientific merits of qualitative research will 
not be established by arguments of legitimation, but by contributions of significant 
new knowledge about a linguistically constituted social world.” 
Multi-perspective interviewing 
The present study employed a multi-perspective approach by seeking the views not 
only of patients, but also their main lay and professional carers. The intention was to 
gain as complete a picture as possible of the multi-dimensional experience of living 
with advanced illness by effectively creating in-depth, multi-perspective case studies, 
while also allowing for the consideration of the individual needs of those 
interviewed.  
While a multi-perspective approach poses challenges in terms of time investment and 
complexities of data analysis, it provides a number of important benefits (Kendall et 
al., 2009). Multi-perspective research not only generates a deeper understanding of 
the lived illness experience, but also has real value in practice development by 
facilitating the formulation of recommendations for more supportive or effective 
practice as informed by the different perspectives and needs of those consulted.  
Single versus joint interviewing 
Giving participants the option of undertaking indivi ual or joint interviews may 
improve research participation (Kirchhoff and Kehl, 2008). In similar research 
involving patients and lay caregivers around half preferred to be interviewed together 
(Kendall et al., 2009).  
This was also true for studies conducted by Gysels and colleagues, which led to the 
researchers undertaking both individual and joint interviews as per participants’ 
preferences (Gysels, Shipman and Higginson, 2008). They argue that conducting 
joint interviews generated interesting data on how the illness situation was 
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experienced and negotiated in a close relationship. At the same time, they found this 
arrangement to generate different data from when individuals were interviewed 
separately. These findings, however, contrast those of Morris (2001), who undertook 
joint interviews with cancer patients and their carers and found that they produced 
similar accounts to those conducted individually.  
While joint interviewing may cause some participants to hold back on certain 
information they do not wish to disclose or discuss in front of the other person, 
individual interviews can equally lead to tension between patient and carer by 
creating a sense of secrecy and challenges relating to the disclosure or non-disclosure 
of what each party had shared in their respective int rviews (Morris, 2001). 
Moreover, joint interviewing can lighten the burden o  particularly vulnerable or 
poorly patients, as it allows that person to take rests during the interview as needed 
but still continue to participate (Morris, 2001).  
3.2.3 Longitudinal approaches in qualitative resear ch 
Drawing on the findings from the literature review in Chapter 2, this study was 
formulated around a qualitative, longitudinal (QLL) research design. This allowed a 
consideration of the dynamic experience of living with advanced liver disease by 
studying key points and changes in participants’ experiences and needs over time. 
Longitudinal approaches are traditionally more common in quantitative research, but 
the value of applying a longitudinal approach in the qualitative realm is increasingly 
recognised, particularly in relation to informing and influencing policy and practice 
(Holland, Thomson and Henderson, 2006). There is currently no consensus on the 
timeline that is considered to constitute longitudinal research and a number of 
approaches are in use (Saldaña, 2003). In the realm of patient research, it has been 
posited that the timeframe for data generation must be sufficiently long to enlighten 
and understand the trajectory under investigation (Murray et al., 2009).    
Based on considerations regarding the nature of advanced liver disease, previous 
end-of-life studies as well as the realistic scope f a PhD project, it was decided that 
data generation should be conducted over the course of 12 months, with the aim to 
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seek up to three interviews with each participating patient and lay carer. This reflects 
criteria set out by Young, Savola and Phelps (1991), who stipulate that in order to be 
considered truly longitudinal, QLL studies in the social sciences should aim for at 
least 2-3 data collection points over the course of at least a year. 
Saldaña (2003) provides comprehensive guidance on the conduct of QLL research 
and identifies duration, time and change as the core principles underlying this 
approach. He also advises giving attention to the context in which change is observed 
and examined. It is these aspects which make QLL research particularly valuable, as 
their consideration makes it possible to illuminate characteristics of human 
experience not usually amenable to one-off research endeavours. Serial interviews 
can generate a variety of types of findings (Murray et al., 2009), thus demonstrating 
the potential of QLL methods as an effective ‘means of discovery’ (Holland, 
Thomson and Henderson, 2006). In the context of this study, it was anticipated that 
the longitudinal design would capture changes in the needs and experiences of 
patients and carers as the illness progressed, and highlight key points in the illness 
trajectory.  
A QLL approach renders data analysis more complex and time-consuming than does 
‘snapshot’ research and tends to generate large amounts of data, which may 
subsequently be difficult to manage (Holland, Thomsn and Henderson, 2006). One 
characteristic of QLL research that requires particular attention is the way in which it 
increases the need for ethical considerations and co uct throughout the research 
process, such as seeking consent repeatedly at each data point and ensuring 
confidentiality in the face of large personal data sets being generated for each 
participant (Neale and Hanna, 2012).  
It is particularly important to be mindful of the dveloping research relationship and 
its influence not only on the research process, but on researcher and researched alike 
(Thomson and Holland, 2003, White and Arzi, 2005). A QLL approach allows 
participants and researcher to develop their relationship over time, thereby 
supporting both parties to feel more at ease with the exploration of sensitive and 
personal issues in relation to the illness experience. It consequently facilitates the 
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sharing of more private accounts over primarily public illness discourse (Cornwell, 
1984), and enables a more in-depth insight into their experiences than may be 
possible through a single interview (White and Arzi, 2005). A further benefit in QLL 
research is the flexibility it allows the researcher throughout the research process, 
especially in terms of being able to feed findings from earlier interviews back into 
the process to allow for further exploration or clarification.  
3.3 Patient and public involvement 
Despite a current lack of rigorous research into the benefits and efficacy of patient 
and public involvement (PPI) in palliative care, it is considered good research 
practice to consult and collaborate with individuals representative of the study 
population throughout the research process (Payne et al., 2005). Indeed, turning 
participants from passive objects of investigation nto active participants in the 
shaping of palliative care research and practice is considered an ethical imperative 
(National Council for Palliative Care and NHS Centr for Involvement, 2009). Co-
researching with a group of palliative care patients has been reported as an 
empowering experience for participants, creating ownership among those the 
research is targeting, and greatly enriching the study by harnessing their expertise 
and insight (Cotterell et al., 2007). Moreover, PPI helps to ensure that research 
priorities reflect those of the target population; this is vital for ensuring patient-
centred, resource-efficient delivery, planning and evaluation of healthcare provision. 
PPI is regularly employed in the realm of cancer, but less commonly seen in non-
malignant disease (Black, 2008). 
PPI can take many forms. The chosen method should be informed by the nature and 
aims of the activity in question as well as available resources (National Council for 
Palliative Care and NHS Centre for Involvement, 2009). As a novice researcher in 
the realm of advanced liver disease, I was especially keen to work in partnership with 
lay ‘expert’ participants to guide my thinking and decision-making as the study 
evolved. Patient involvement in the context of this study was promoted as follows: 
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• Informal discussion with two individual liver disease patients who volunteered to 
share their experiences in the formative stages of the project. These conversations 
helped to develop my understanding of living with adv nced liver disease, and 
informed the content of the interview guide and patient information sheet. They 
also provided an opportunity to reflect on the potential emotional impact of 
participants’ illness stories on me as researcher.  
• Regular meetings with a lay advisory group to scope, explore and discuss lay 
members’ own experiences as liver patients as well as to seek their concerns, 
thoughts and advice in relation to the research process. Their involvement 
contributed to the data generation, analysis and dissemination aspects of the study. 
A description of the lay advisory group and reflections on its contribution to this 
research are provided in Section 4.5.  
3.4 Participation 
3.4.1 Sampling 
In contrast to quantitative approaches which typically employ probability sampling, a 
qualitative approach commonly utilises purposive sampling methods. This reflects 
not only its primary aim of exploring social process  where achieving statistical 
representativeness is of less relevance, but also the commonly more time and cost 
consuming nature of qualitative research. In this study I employed a variation of 
purposive sampling referred to as selective or criterion sampling (Sandelowski, 
1995). By selecting a sample that reflects a range of aetiologies typical in liver 
disease (e.g. alcohol-related, viral, autoimmune), the study gives due attention to 
what can be considered a key variable in the phenomn under investigation and 
renders the sample representative of the varied livr disease patient population. 
Qualitative research is frequently accused of using ample sizes that are considered 
too small or unrepresentative to generate reliable data. However, as described earlier 
in this chapter, its key aim is not to achieve generalisability, but to generate 
information-rich data through the in-depth investiga on of a phenomenon. I agree 
with Sandelowski’s notion that sample size should be determined on the basis of case 
appropriateness as opposed to pre-determined formulae (Sandelowski, 1995). She 
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contends that, “An adequate sample size in qualitative research is one that permits – 
by virtue of not being too large – the deep, case-ori nted analysis that is the hallmark 
of all qualitative inquiry, and that results in – by virtue of not being too small – a new 
and richly textured understanding of experience.” (Sandelowski, 1995, p183). Kvale 
(1994) similarly feels that sample size depends on the purpose of one’s study, and 
that if the purpose is to generate a general understanding then it is better to focus on a 
smaller sample but to investigate it more intensely. In palliative care research 
specifically, the argument of qualitative methods being less effective due to a small 
yield has been shown not to hold up, with some quantitative studies in the field 
achieving recruitment rates of 17% or less (Hopkinson, Wright and Corner, 2005).  
I aimed to recruit 16 to 20 patients with advanced liver disease of different 
aetiologies to the study, with an expectation that is would generate around 30 co-
participants (15 lay carers and 15 professionals). This decision was guided by a 
number of key considerations, such as the scope of the study and the nature of the 
topic itself (Morse, 2000). It was also informed byprevious studies in this field, 
which suggested this target number sufficient to achieve data saturation without 
generating an amount of data too unwieldy for in-depth analysis. The purposive 
selection of the sample to contain the most representative contributors, however, 
goes some way towards ensuring that the insight generated is as illustrative as 
possible of the wider liver patient population.   
3.4.2 Identification of participants 
Defining the patient with advanced liver disease 
Unlike other organ failures, there is currently no agreed clinical definition of what 
constitutes advanced or end-stage liver disease. A r view of the research literature in 
end-stage liver disease revealed a range of indicators used to define this population. 
The most commonly used tools for mortality assessment in advanced liver disease 
are the Child-Pugh and MELD (Model of End-Stage Liver Disease) scoring systems. 
However, these scores were not routinely calculated for patients at the recruiting 
centre and were therefore not a convenient selection r terion.  
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There is also no agreed method for defining the patient population in palliative care 
research (Borgsteede et al., 2006, Van Mechelen et al., 2012). For the purposes of 
their longitudinal study involving cancer, COPD and chronic heart failure patients, 
Steinhauser and colleagues defined ‘end of life’ broadly to include individuals with a 
50% one-year mortality, a figure which was in line with the expected attrition rate for 
the present study (Steinhauser et al., 2006). The authors argued that a 50% one-year 
survival for an advanced disease means that most research participants should be 
able to take part in the study effectively and across multiple time points. At the same 
time, in the event of a patient’s death during the study, it provides an opportunity to 
gain valuable insight into the final stages of the illness experience through 
retrospective follow-up with their carer. As this notion reflected the intentions of the 
present study it informed the adoption of the following recruitment criteria. 
Inclusion criteria 
In consultation with hepatology consultants it was decided to recruit patients with the 
presence of ascites (accumulation of fluid in the abdomen). Ascites constitutes the 
most common complication of advanced liver disease and an indicator of 
decompensation (i.e. the point at which the liver’s ability to adequately perform its 
range of functions ceases) (Ginés et al., 1987). Ascites is also indicative of a poor 
prognosis; once developed, cirrhotic patients’ expected mortality is approximately 
50% at 2 years (Guevara et al., 2005). While this represents a wider window of time 
than that used by Steinhauser and colleagues, this approach was more likely to 
capture people with advanced disease more generally as opposed to those in the end 
stages, thereby responding more effectively to the broad, exploratory intentions of 
this project. Recruitment targeted both patients whose ascites were for the most part 
well controlled by diuretic medication, and those with diuretic-resistant ascites 
requiring regular draining of the excess fluid through a procedure called paracentesis. 
Exclusion criteria 
I excluded from the study those patients who were listed on the liver transplant 
register. This was due to the consideration that such patients were likely to have 
differing needs and experiences from those for whom this potentially life-saving 
intervention was contraindicated on the grounds of general frailty, co-morbidities or 
   
  44 
 
continued drinking or drug-taking. Unlike their counterparts for example, liver 
transplant candidates receive dedicated care and support from a specialist hospital 
transplant team. They are also likely to be nurturing a strong sense of hope that their 
illness can be reversed through a transplant and that they will eventually be able to 
return to a normal, healthy life. Given the relatively small sample size of this study, I 
therefore felt that data gathered from these patients may dilute the overall findings. 
Moreover, there is already a substantial body of literature on the specific experiences 
of patients pre- and post-liver transplant, which is in contrast to a distinct dearth of 
literature on the experiences of patients who do not qualify for this intervention. 
Patients were therefore excluded from the study if they: 
• had another long-term condition or cancer as their most significant conditions, 
• were judged by ward staff to have cognitive impairment, emotional distress or 
communication difficulties of a severity that would prevent them from 
participating in the study, 
• were listed on the liver transplant register. 
3.4.3 Recruitment 
Consultation with the liver specialists also informed the decision to target adult 
patients attending the ward as inpatients due to a liver-related event. Patients were 
recruited from a 30-bed specialist gastroenterology and hepatology inpatient unit. 
This was deemed to be the most convenient location t which to access people in the 
advanced stages of the disease. The same liver unit had also recently hosted another 
research project in the realm of supportive and palliative care, and ward staff were 
therefore supportive and ideally ‘primed’ to assist with this study.  
Patient recruitment procedure 
I set out to recruit 16 to 20 socially diverse patien s with a range of disease causes to 
the study. In consultation with clinical staff at the liver unit a recruitment strategy 
was formulated and agreed. Figure 4 overleaf provides a flowchart of the agreed 
recruitment strategy. 
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Figure 4: Flowchart of recruitment process 
• The hepatology charge nurse identifies 
potential study participants among inpatients. 
• Following approval by the consultant in charge 
to approach the identified patient, the charge 
nurse seeks verbal approval from the patient 
to be approached directly by the researcher. 
 
Permission refused.  
No further action taken. 
• The researcher approaches the patient on the 
ward, briefs them further about the study and 
hands out the patient information sheet. 
• The researcher contacts the patient at least 
24hrs later to clarify further questions and 
seek their verbal consent to participate. The 
researcher also seeks consent to contact the 
patient’s GP and to review their patient record 
for further case information.  
No further action taken. 
• The researcher arranges a suitable time and 
place for the first patient interview and seeks 
written consent prior to this first interview.  
• The researcher asks the patient to nominate 
their main lay carer and health/social care 
professional and seeks the patient’s consent 
to recruit them to the study. 
No further action taken with 
carer and/or health/social 
care professional interviews. 
The researcher contacts the patient’s carer and 
seeks verbal consent and a suitable time and 
place for the interview. 
No further action taken. 
• The researcher undertakes repeat interviews 
at places and times convenient to patient and 
carer. 
• Repeat written consent is obtained at each 
interview. 
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Recruitment of lay and professional carers 
In keeping with a patient-centred approach, participants were asked to nominate the 
person they felt provided most of their support andcare at home to be approached 
about contributing to the study. They were also asked to nominate the health or social 
care professional they felt was most involved in their clinical support and/or social 
care in respect of their liver disease.  
Lay and professional carers were sent an information sheet explaining the purpose of 
the study and their involvement alongside a letter inviting them to participate in the 
research. This was followed up with a telephone call some days later to allow for 
questions to be clarified. If carers agreed to take part, arrangements were made for a 
convenient time and place to conduct the first interview. 
3.4.4 Attrition 
Given participants’ advanced illness status, attrition was a key consideration in this 
research. The study design was informed by the experience of previous similar 
studies suggesting an average attrition rate of 50%at one year. Loss to death was an 
anticipated and intentional aspect of this study, serving to gain important insights 
into the needs and experiences of participants around this critical time through 
bereavement interviews with both lay and professional carers where appropriate. 
3.5 Data sources 
This study drew on three data sources: qualitative in-depth interviews, extensive field 
notes and patients’ medical records. 
3.5.1 Interviews 
Interviews were guided by a loose topic guide based on the main areas of interest 
within the chronic illness experience such as receiving a diagnosis, managing the 
illness in everyday life, and care and support provisi n. Guides were used flexibly, 
however, to allow participants to be in control of the flow of the conversation and to 
speak as freely as possible about the issues of greatest concern to them. Copies of the 
interview topic guides can be found in Appendix 3.  
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Patient and lay carer interviews 
Up to three in-depth interviews were conducted with each patient and lay carer over 
12 months to facilitate the exploration of their needs and experiences over time. The 
interviews sought to elicit participants’ accounts of their experiences leading up to 
the present circumstances, their current physical, psychosocial, existential and 
information needs and issues, and their thoughts about the future. Follow-up 
interviews sought to explore the evolving needs of patients and lay carers, and the 
adequacy of services and support provision.  
Bereavement interviews 
Where a patient died during the interview period a card of condolence was sent to 
their lay carer. Further contact was made about three months later to establish carers’ 
interest in participating in a bereavement interview. Bereavement interviews sought 
to explore the patient’s final episode of decline and the support and care offered to 
both patient and carer during that time.  
Professional carer interviews 
One-off interviews were conducted with the health or s cial care professionals. 
These interviews were undertaken at the end of the serial interview period for each 
patient and explored professionals’ views of the illness trajectory and care of that 
patient as well as the wider patient population with advanced liver disease, and any 
perceived challenges in providing effective care. Given the difficulty of accessing 
busy professionals for research activity and the principal focus of this study being the 
person living with the disease, one-off rather than serial interviews with 
professionals were deemed sufficient to add important contextual information to the 
overall research endeavour.  
3.5.2 Field notes 
Extensive field notes were recorded in parallel to the recruitment and data generation 
phases to contextualise the interview data. The field notes document interactions 
with study participants during telephone conversations and interviews, events 
observed on the liver ward, and early analytical hunches. They also provide a record 
of reflections on practical and personal challenges and successes during the 
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recruitment and interview phases, ethical issues or dilemmas, and on my own skills, 
behaviour and prejudices as researcher.  
3.5.3 Patient records 
All patient participants consented to basic details being extracted from their medical 
records in order to provide supplementary clinical context to their experiences, and to 
allow for general comparisons to be made between participants and the wider patient 
population with advanced liver disease. Data recorded includes age, disease cause, 
co-morbidities, clinical parameters to calculate patients’ MELD scores, frequency of 
hospital admissions relating to their liver disease, and death-related information 
where applicable. DEPCAT (deprivation category) scores, which give an indication 
of participants’ socioeconomic status, were also calcul ted. An overview of some of 
these details is provided in Appendix 4. 
3.6 Data analysis 
The study data were analysed using analytical techniques drawn from grounded 
theory. Grounded theory has its origin in the work f Glaser and Strauss (1967), but 
has since been developed further by a number of its proponents (Charmaz, 2006, 
Strauss and Corbin, 1998). Grounded theory centres on an exploratory, iterative 
analytical process which seeks to move beyond description to generate new, or 
modify existing, theory about a phenomenon directly from the data as opposed to a 
priori hypotheses as is typical in scientific enquiry. Its particular focus is on the 
processes underlying people’s experiences of a phenom on. It is therefore a useful 
approach when looking to explore topics where little is currently known (Creswell, 
2007), and is frequently employed in chronic illness research. Additionally, a central 
tenet of grounded theory is its consideration of individuals not as passive recipients, 
but as active agents in the research endeavor, a notion which is consistent with my 
theoretical position outlined earlier in Section 3.1.2  Charmaz’ grounded theory 
approach in particular reflects a more subjective and reflexive, and as such more 
constructivist, stance than those purported by others (Charmaz, 1990). I consequently 
chose this approach to inform the data analysis of this study (Charmaz, 2006). 
Details of the analytical process itself are set out in Section 4.4. 
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Like other methodological approaches, grounded theory analysis is subject to 
limitations (e.g. Cutcliffe, 2000, Elliott and Jordan, 2010) and prone to 
misinterpretation (Suddaby, 2006). It has, for example, been criticised for some of its 
basic assumptions, its messy, non-linear approach to analysis, and what is perceived 
to be an over-fragmentation of data. I drew on practic l strategies suggested by 
Elliott and Jordan (2010) to avoid some of the common pitfalls in grounded theory 
analysis.  
3.7 Quality assurance  
3.7.1 Rigour in qualitative research 
Qualitative research is commonly accused of being less rigorous than quantitative 
approaches due to its perceived inability to adhere to scientific principles like 
validity, reliability and generalisability. At the same time, there are those who argue 
that it is in fact inappropriate to impose similar quality criteria to approaches that 
differ so widely in their underlying philosophies and the type of knowledge they 
seek. Mays and Pope (1995) argue in defence of qualitative research and claim that 
all research methods carry particular strengths and weaknesses, and that rigour in any 
type of research relies on a systematic, reflexive and transparent research process. 
Being explicit about one’s approach and decisions should enable an independent 
researcher examining the data to arrive at corresponding conclusions. This 
consequently serves to confirm a study’s rigour, thus making its findings acceptable 
and of value to the wider scientific community. 
I question the applicability of this thinking to all qualitative research, however. As 
stated in Section 3.1.2, this study is underpinned by a constructivist philosophy. This 
stance sees knowledge as created through interaction, w th the researcher playing an 
active role and shaping the process through their own perspective, values and 
experiences. I would argue that the same holds true for an independent researcher 
engaging with the data at a later stage. They too are likely to be influenced in their 
analysis by the personal background and perspective they bring to the activity, 
resulting in further manipulation and interpretation of the research product. 
Consequently, while it must be considered good research practice to operate in an 
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open and auditable manner, I disagree with Mays and Pope’s notion that doing so 
provides a basis on which qualitative research studies should be assessed for their 
achievement of rigour (Mays and Pope, 1995). 
Indeed, I share Rolfe’s viewpoint in this matter (Rolfe, 2006). He criticises ongoing 
attempts to impose quality criteria from quantitative approaches to qualitative 
research, but also declares it a futile endeavour to try and develop a set of standards 
specific to the characteristics of qualitative research. This is because, as highlighted 
earlier in Section 3.1.1, qualitative research is not a unified, coherent paradigm as 
commonly presented in research text books, but incorporates a multitude of different 
beliefs and methods, with some in fact more closely aligned to a positivist stance 
than interpretive counterparts.  
Rolfe also observes that the assessment of the quality of a piece of research in reality 
entails making subjective judgements on the way it is presented to the reader as 
opposed to the study per se - this applies to both qualitative and quantitative work. 
As such, he highlights the importance of providing a comprehensive audit trail which 
details considerations and decisions throughout the res arch process as well as 
reflexive notes from the researcher’s perspective. Th se should then be considered in 
conjunction with the research report itself to allow for overall quality judgements to 
be made. In the present study, I have sought to respond to this idea by recording 
detailed information on my decisions throughout theresearch process as well as 
reflexive thoughts in relation to my role and experience as researcher; Chapter 4 
presents details in this respect. This also reflects my theoretical ‘home’ within 
constructivism as it acknowledges that, as a result of my involvement, I am both 
explicitly and implicitly represented in the work that I present (Mantzoukas, 2004). 
3.7.2 Reflexivity 
It is considered important that researchers seek complete neutrality in order to avoid 
contaminating their research. However, both research r and researched have been 
shown to influence the research process through a multitude of factors such as their 
positionality (Moser, 2008, Reinharz, 1997), personality (Moser, 2008), different 
‘selves’ (Reinharz, 1997), unconscious processes (Bondi, 2003), and intersubjective 
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dynamics (Gadd, 2004). It is therefore vital that researchers acknowledge and reflect 
upon these issues in order to make their research more transparent and present data 
generation and analysis within the context in which they were created.  
In line with recommendations by Finlay (2003), a reflexive stance was taken at all 
stages of the research process, employing both introspective and intersubjective 
reflection. Introspective reflection involves an in-depth consideration of my own role 
as researcher and the ways in which I may influence the process and outcomes of the 
study as described above. It also requires a consciu  awareness and focus on both 
discursive and embodied self-reflexive processes as ources of insight and learning 
(Pagis, 2009). Intersubjective reflection refers to the close consideration of the 
researcher-participant relationship and their respectiv  contributions to the research 
process. My learning in relation to these issues is reflected upon in Chapter 4. 
3.8 Ethics of conducting research in palliative car e 
Four ethical principles underlie all professional conduct in the health sphere: 
autonomy (i.e. self-determination), beneficence (maxi ising good), non-maleficence 
(avoiding harm) and justice (i.e. fairness and equity) (Beauchamp and Childress, 
1989). They constitute a “common moral commitment, common moral language, and 
common analytical framework for reflecting on problems in health care ethics” 
(Gillon, 1994, p184) and as such constitute key guidance for the conduct of research 
in the healthcare setting. Guillemin and Gillam (2004) distinguish between 
‘procedural ethics’, which are generally subject to approval by an ethics committee, 
and ‘ethics in practice’, that is, the everyday ethical issues that may arise in the 
process of conducting a study. They argue that ethics in practice are of particular 
importance, as it is the researcher’s conduct through t the research process which 
ultimately determines a study’s ethical appropriateness. It is therefore vital that the 
researcher remains alert to any potential ethical issues arising in the course of the 
study and continuously reflects on their conduct and decisions. 
There has been much debate around involving patients nearing the end of life in 
consultations. A review of the main ethical debates in palliative care research 
concluded that no clear consensus exists on some issu s, with some areas requiring 
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further exploration (e.g. the impact of such research on the researcher) (Duke and 
Bennett, 2010). However, there seems to be an increasing shift towards a general 
acceptance that it would be ethically and morally wrong to exclude these individuals 
from research involvement based on an assumption that i  is too challenging, 
potentially harmful, or imposes on their limited time. Studies increasingly show that 
palliative care patients are in fact no more vulnerable than others (Addington-Hall, 
2002, Casarett and Karlawish, 2000). Additionally, many ethical challenges levied 
against palliative care research are not unique to that realm (Casarett, Knebel and 
Helmers, 2003).  
Most importantly, patients themselves wish to participate in research and particularly 
in qualitative research (Kendall et al., 2007, Sherman et al., 2005). It offers a purpose 
and role at a time when they may feel isolated and excluded from their social world 
due to advanced illness, and provides an opportunity to leave behind a legacy by 
being instrumental in helping others to experience improved care and support. Jubb 
(2002) contends that there is no justification for not undertaking research with 
palliative care populations to improve their standards of care, provided that the 
research is ethically sound. Keeley (2008) goes one step further, calling it a ‘moral 
obligation’.  
3.8.1 Qualitative interviewing in palliative care r esearch 
The choice of qualitative interviewing in this study was in part informed by its 
previous successful application in several end-of-life studies (e.g. Cavers et al., 2012, 
Murray et al., 2002, Pinnock et al., 2011). Despite th  important insights that this 
approach has generated, there remains some debate about whether it may in fact be 
harmful to participating patients and their carers.  
Corbin and Morse (2003) examine some of the issues in relation to conducting 
interviews on sensitive topics. They suggest that te risks of breaking confidentiality 
or causing distress are actually greater when individuals confide in family or friends 
than when they participate in an ethically conducted, risk-controlled qualitative 
interview study. They conclude that while qualitative interviews may have the 
potential to cause some emotional upset, “there is no indication that this distress is 
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greater than in everyday life or that it requires follow-up counselling” (Corbin and 
Morse, 2003, p335). If anything, they contend, existing evidence suggests that there 
is more benefit than harm in taking part in potentially emotive research studies. This 
argument is supported by Gysels, Shipman and Higginson (2008), who assessed how 
palliative care patients and their carers taking part in two different qualitative studies 
had experienced being interviewed. Most of their respondents reported a positive 
experience and none of them considered being intervewed distressing. Furthermore, 
despite the authors observing their interviews with carers as very emotional events, 
carers themselves did not relate their distress to the interview process.  
In light of the debates outlined above, participants’ welfare was of paramount 
importance in this study. I describe the steps undertak n to ensure both participant 
and researcher welfare in this study in Sections 4.7.1 and 4.7.2 respectively.  
3.8.2 Ethical approval  
This study was granted full ethical approval by South East Scotland Research 
Committee 1. Management approval was conferred by the NHS Research & 
Development Programme. Copies of the approval letters are provided in Appendix 5. 
3.9 Summary 
The research methodology and design for this study were informed by a 
constructivist theoretical perspective. Qualitative s rial in-depth interviews were 
selected as the method most appropriate to help meet th  research aim. Patient 
participants were sampled purposively and according to criteria agreed with liver 
specialists. They were recruited from an inpatient liver unit with the help of clinical 
staff. Patients nominated lay and professional carers involved in their support and 
care to approach to take part in the study. Data were analysed using methods based 
on the constructivist grounded theory approach advocated by Charmaz (2006). 
Patient and public involvement was sought to support the research process. Quality 
assurance and ethical study conduct were given utmost consideration. 
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Chapter 4: Conducting the study: process and 
reflections  
The previous chapter outlined the plan for the study and the reasons behind it. This 
chapter describes how this plan worked out in practice. It documents the conduct of 
the study with regard to recruitment, participation, interviews and data analysis. It 
also details the involvement of the lay advisory group and its contribution to this 
study. I reflect upon the strengths and weaknesses of the chosen approaches and 
describe successes and challenges encountered during the research process. Finally, I 
consider my own place within this process as the res archer conducting this study. 
4.1 Participants 
4.1.1 Patients 
Recruiting patients to this study proved challenging for several reasons (see Section 
4.2.1 for some of the difficulties encountered in relation to patient recruitment). 38 
patients were invited to participate in the study, of whom 25 agreed. Ten of these 
were lost to the study prior to their first interview, as they withdrew due to declining 
health, died, or could not be tracked down for interviewing. As a result, a total of 15 
patients participated in this study. (My thoughts on the appropriateness of the sample 
size achieved are given at the end of this section.) 
Fourteen patients remained in the study until they ad completed three interviews or 
until their death, whichever came first. One patient was lost to follow-up as her 
condition deteriorated after the first interview and remained so poor that she had to 
be withdrawn from further participation. Nine participants died during the study.  
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Number of patient participants 15 
Male/Female 7/8 
Mean age (range) 58.8 (35-84) 
Primary aetiology:  
Alcohol-related liver disease 8 
Non-alcoholic fatty liver disease 3 
Hepatitis C 1 
Hepatocellular carcinoma     1 
Autoimmune hepatitis 1 
Cryptogenic  1 
Mean MELD1 score at time of recruitment (range) 16.3 (9-26) 
   Table 2: Overview of patient participants 
4.1.2 Lay carers 
11 of the nominated lay carers agreed to take part in the study. Two patients 
nominated two persons each and four did not nominate anyone. Two nominees 
declined participation. The nature and scope of the individual carer roles varied 
greatly and was defined by the type of relationship t at patient and lay carer shared. 
Of the participating carers, seven were live-in spouses or partners and two were a 
patient’s mother and sister. They provided the broad, holistic support typical of a 
close, familial relationship. One carer participant, however, was the patient’s closest 
friend, who lived some distance away in another town and provided support mainly 
by telephone. Another carer participant was the patient’s neighbour who looked in on 
him daily and assisted mainly with minor household chores.   
Finally, one patient’s carer participant changed in the course of the study. At the time 
of his first interview John2 was living with his partner Jane, who supported him 
following his first acute hospital admission and sub equent diagnosis with advanced 
liver disease; she participated in a first interview. By the time of the second interview 
                                                 
1 The MELD score is used as an indicator of the severity of liver disease and predictor of mortality. It 
is derived from three clinical parameters (serum bilirubin, prothrombin time international normalised 
ratio, serum creatinine). A score of 15 or more is considered an appropriate level at which to consider 
a patient for liver transplantation. (MERION, R. M. 2004. When is a patient too well and when is a 
patient too sick for a liver transplant? Liver Transplantation, 10, S69-73.) 
2 Not his real name. As stated in Section 1.5, all ptients and lay carers were assigned pseudonyms. 
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John had returned to his wife Lisa; she participated in the remaining two interviews. 
This highlights a need to be mindful of the varied nature and scope of lay caregiving 
that can exist in patients’ lives, which may also affect the extent to which individuals 
relate to the label of ‘carer’ in the role that is provided (Morris, 2001). 
4.1.3 Professional carers 
Ten patients nominated a health or social care professional involved in their ongoing 
clinical support and/or social care; one patient nominated two individuals. All agreed 
to be interviewed for this study. This group of 11 professional carers comprised of 
eight general practitioners (GPs), one consultant hepatologist, one hospital-based 
alcohol liaison nurse, and one community palliative care nurse.  
A comment on sample size 
The sample size of 15 patients and associated lay and professional carers was less 
than initially targeted, but proved sufficient for the exploratory aims of this study. A 
relative uniformity of views and experiences across patient, carer and professional 
accounts emerged early on in the interviews, suggesting that themes were 
approaching saturation. The sample was also large enough to accommodate the 
predicted attrition rate of 50%, and thus satisfied the intentions of this study with 
respect to being able to follow patient participants over what for many would be their 
last year of life, while also being able to learn fom the experiences of those who 
died in the course of the study.  
4.2 Recruitment  
4.2.1 Recruiting patients 
During the recruitment phase I regularly attended the liver unit’s daily multi-
disciplinary staff handover meeting in order to learn bout any new patients admitted 
to the ward. This meeting was usually chaired by a ch rge nurse and attended by the 
physiotherapist, occupational therapist, pharmacist, junior doctors, and occasionally 
by an alcohol liaison nurse or a hepatology consultant. Each inpatient was discussed 
in turn, highlighting clinical developments, care and discharge plans, and associated 
challenges. Attending these meetings helped me to bec me a familiar face on the 
liver ward and build a good relationship with ward staff. My presence also helped to 
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keep the study at the forefront of staff’s mind in what is a very busy, fast-paced 
working environment, and so aided the recruitment process. 
Success with patient recruitment slowed considerably fter the first weeks. This was 
mainly due to the same patients repeatedly returning to the ward for both routine and 
acute liver care, resulting in the pool of potential new recruits reducing steadily. To 
counter this, agreement was sought from clinicians and the local ethics committee to 
also recruit participants from outpatient clinics, whereby the attending consultant or 
registrar would advise eligible individuals of the study and pass on the information 
sheet. However, this did not prove a successful strategy due to clinicians’ competing 
priorities in a hectic outpatient setting, and did not yield additional recruits. 
Lessons learned from the recruitment process 
Recruiting from an acute hospital ward was an interesting and educational, but very 
time-intensive process. I encountered several challenges during my time recruiting 
from the liver unit. The following outlines some of these challenges which serve as 
learning points for future research. 
Unsurprisingly, liver patients are often very unwell during their hospital stay due to 
an acute exacerbation (including temporary cognitive impairment such as hepatic 
encephalopathy) and the unpredictable nature of the disease. Potential recruits to the 
study were usually identified to me by the charge nurse following the morning 
handover meeting. However, sometimes patients’ poor c ndition meant that having 
staff approach a patient about the study at that time was not always possible. 
Additionally, patients were often asleep or away from their bed for medical 
procedures. Therefore, approaching patients about the study often meant having to 
monitor them over some days to catch them at an opportune moment where their 
condition and circumstances allowed them to have a considered conversation about 
research participation. This meant returning to the liv r unit frequently at different 
times and days, taking up a lot of additional resources.  
Relatedly, the unpredictable nature of the disease meant that sometimes inpatients 
would be on the road to recovery only to take a turn for the worse and deteriorate 
unexpectedly, in some cases leading to their death. The opposite could also be the 
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case, with patients making an unexpected recovery and being discharged sooner than 
anticipated. There were occasions where I would monitor a potential recruit for some 
days for a chance to speak to them about the study only to find that they had either 
suddenly died or been discharged. This proved especially hallenging as I was not 
based near the hospital and so necessitated daily return visits to ensure that patients 
would not be missed. 
Another challenge was the sometimes long turnover time for patients. John, for 
example, was an inpatient for four weeks before returning home. Where patients had 
agreed to participate in the research and were able and willing to, I interviewed them 
in a quiet room on the hospital ward. However, not everyone was comfortable with 
this, meaning that I sometimes had to wait several weeks before I was able to 
interview a participant in their own home, during which time they could be lost to the 
study as described above. For example, one patient who had agreed to participate in 
the study did not wish to be interviewed while in hospital. However, after three 
weeks on the liver ward he took a sudden turn for the worse and was transferred to 
the intensive care unit where he remained for a further two weeks. It was difficult for 
me to follow his progress during that time as I didnot have access to this unit or its 
staff. The patient subsequently recovered and return d to the liver ward once more, 
but died a short while later. This case not only demonstrates the challenge of 
recruiting patients with advanced liver disease in an acute hospital setting, but also of 
retaining them in the study even at this very early stage. 
There were positives to delayed discharge, however. My frequent presence in the 
liver unit helped to develop an early rapport with those who had agreed to participate 
in the study, sharing hellos and little chats during their days and weeks on the ward. 
By the time of their discharge and the subsequent first interview they were therefore 
already familiar and comfortable with me, which is likely to have aided retention and 
made the interview situation less threatening. Unexpectedly, my presence on the 
ward also attracted patients’ interest more generally. Due to many patients returning 
regularly, I became a well-known face among inpatients also. This led to me being 
approached by patients curious as to my role on the ward and subsequently 
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proactively expressing their interest in participating in the study, although none of 
the participants were recruited in this manner. 
Finally, recruiting from the acute hospital setting proved a challenge to achieving the 
desired spread of liver disease aetiologies among study participants. The majority of 
acute admissions to the liver ward were patients wih alcohol-related liver disease 
(ALD). This is in part reflective of the distribution of aetiologies in the liver disease 
population (ALD being the most common cause of liver disease in the UK), but also 
of the more acute impact of these patients’ lifestyl  on disease progression. Few 
patients with autoimmune types of liver disease or primary liver cancer presented on 
the ward during the recruitment phase. Future reseach seeking a varied sample of 
liver disease patients may therefore find it easier to access different aetiologies from 
settings such as outpatient clinics or liver patient support groups.  
4.2.2 Recruiting professionals 
I was surprised about my success in recruiting professionals to this study, a group 
which can be difficult to engage in research due to their challenging workloads. All 
nominated professionals were prepared to participate, nd many granted me an 
unexpectedly long time out of their busy schedule to accommodate the interview.  
The success in this case may be due to requests being linked to a specific patient’s 
study involvement as opposed to a generic request for research participation. Having 
been nominated by a patient as key to their care may have made professionals more 
willing to engage with this study, as it constituted support for both their patient and 
the research. However, many also demonstrated a real int rest in the subject matter, 
particularly regarding the provision of palliative care to patients with non-malignant 
diseases, which may have contributed to their willingness to be involved. 
4.3 Interviews 
4.3.1 Patient and lay carer interviews 
Overall, this study gathered 53 individual patient a d carer perspectives through a 
combination of individual and joint interviews across a maximum of three time 
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points per patient/carer dyad. Up to three in-depth in erviews were conducted with 
each patient and lay carer over 12 months.  
Seven patients completed all three interviews. Interviews lasted between 30 minutes 
and 2.5 hours. 11 interviews were conducted jointly with patient and lay carer in 
accordance with their wishes. All except two of thecarer interviews were conducted 
face-to-face. Three carers agreed to take part in bereavement interviews. The 
majority of interviews took place in the patient’s or carer’s home. A small number 
were conducted in a quiet room on the hospital ward or in a University office.  
In order to best capture the nature of the liver disease trajectory and to promote 
participant retention, it seemed inappropriate to arrange the interviews according to a 
set timetable over the year of data collection. Rather, I maintained bi-monthly 
telephone contact with study participants after the initial interview in order to keep 
abreast of any changes in their condition or general circumstances. During the active 
recruitment phase I was also able to keep in touch wit many of the existing 
participants during their frequent returns to the hospital ward for acute or routine 
admissions. This provided an additional unexpected m ans of keeping informed of 
important developments in participants’ circumstances. Follow-up interviews were 
then scheduled accordingly to try and capture key changes in the trajectory whilst 
being sensitive to the needs of the participant at that time.  
Regularly reconfirming participants’ commitment to remaining in longitudinal end-
of-life research is a matter of importance (Kendall et al., 2007). Upon being briefed 
about the study, participants initially consented verbally to taking part. They were 
then asked to confirm their consent in writing prior t  their first interview taking 
place. This written consent was renewed before each subsequent patient or carer 
interview. Additionally, the bi-monthly telephone calls to check in with participants 
served as a means of process consent, allowing thema further opportunity to 
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4.3.2 Professional carer interviews 
One-off interviews were undertaken with the 11 healthc re professionals nominated 
by the patients as key to their support and care. Professional carer interviews lasted 
between 11 and 53 minutes. Six of the interviews were conducted face-to-face and 
five over the telephone in accordance with professionals’ preferences.  
Table 3 presented overleaf gives an overview of the patient and lay carer participants 
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Table 3: Overview of patient and lay carer participants and interviews conducted 
 Patient  
(pseudonym) 
Lay carer  
(pseudonym) 
Total no. of 




Interviews per time point 
(P=patient; C=carer; P&C=joint) 
Professional 
interviewed 
1 John Partner Jane; Wife Lisa 12 3 P&C1, P&C2, P&C3 --- 
2 Sarah Friend Pamela 12 3 P1, P2, P3, C1, C2, C3 GP 
3 Mary None nominated 5 2 P1, P2  --- 
4 Fraser Neighbour Betty 7 2 P1, P2, C1, Bereavement Consultant 
5 Fay None nominated 11 3 P1, P2, P3  --- 
6 Donald Wife Martha 1 1 P1, Bereavement GP 
7 Martin Wife Cora 9 3 P1, P&C2, P&C3 GP, PC Nurse 
8 Thomas Declined participation 6 1 P1 GP 
9 Ben Partner Tamsin 12 3 P1, P2, P3, C1, C2  Alcohol liaison 
nurse 
10 Aidan None nominated 6 1 P1 --- 
11 Kate Husband Michael 8 3 P&C1, P2, C2, P&C3 GP 
12 Nadia None nominated 6 1 P1 --- 
13 Carol Declined participation 7 2 P1, P2 GP 
14 Polly Husband Jeff 5 1 P&C1, Bereavement GP 
15 Rebecca Mother Julie; Sister Sue 9 3 P&C1, P&C2, P&C3 GP 
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4.3.3 Transcription of interviews 
The manner in which interviews are transcribed can affect how the data is 
subsequently interpreted (Lapadat and Lindsay, 1999). With participants’ agreement, 
all interviews were digitally recorded and transcribed verbatim in full. Colloquial 
speech was retained to remain close to the original dialogue, and emotions and non-
verbal language noted to aid interpretation. All person-identifiable features were 
removed from the transcripts. Participants were also located a unique identification 
code unrelated to their name or personal details to be used for the duration of the 
study. Place names and other individuals’ names mentioned in the interviews were 
removed. The identities of professionals were disguised where necessary in order to 
ensure that they could not be identified from their position or gender. Assistance with 
transcription was provided by two administrative helpers experienced in transcription 
in the realm of palliative care research. All transcripts were checked against their 
recordings to ensure accuracy of detail. 
4.4 Analytic process 
4.4.1 Use of qualitative data analysis software 
There are advantages and disadvantages to using computer programmes for 
qualitative data analysis (Creswell, 2007). Importantly, they do not remove the 
researcher’s task of coding, categorising and interpreting the data. I opted for QSR 
NVivo version 9 analytic software to help manage th large amount of data generated 
in the course of this study. NVivo software is not aligned to a particular analytical 
method, but presents a generic means by which to collate, sort and handle large 
volumes of qualitative data and undertake basic modelling and diagramming to 
support analysis (Bazeley and Jackson, 2013).  
I imported into the programme all interview transcripts and related documentation 
pertaining to each patient case, as well as any notes generated in the course of 
analysis. My use of the software focused mainly on its coding facility and the 
recording of annotations and memos. I also kept an analytic journal in NVivo to 
record coding decisions as they happened for future reference. All analytical coding 
was conducted using this software. 
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4.4.2 Analytic approach 
Based on the consideration of data analysis literature as well as previous similar 
studies I had initially identified narrative analysis as a suitable data analytic 
approach. Narrative research methods are usefully employed to explore the meanings 
embedded in individuals’ narratives and thus generate a broad overview of subjective 
experiences (Bingley et al., 2008). This approach was therefore considered a good fit 
with the overall aim of this study, which sought to gain an understanding of liver 
patients’ personal illness ‘stories’ from diagnosis to the present day.  
However, early interview data indicated a lack of an ‘ dvanced liver disease story’ 
displaying the typical ‘beginning, middle, end’ narrative pattern to their experience. 
This was in part due to many participants only discovering their illness when it was 
already at a very advanced stage. Theirs was therefor  often a rather short-lived 
experience of chronic illness marked by confusion, uncertainty and disjointed events. 
A more traditional ‘story’ was most often proffered by those with alcohol-related 
liver disease, whereby their alcohol dependency and associated struggles formed the 
core of their account due to its chronicity and tangible impact on all aspects of their 
life. While the apparent absence of an ‘advanced liver disease story’ must be 
regarded as an important observation in its own right, I felt that pursuing a narrative 
analytical approach would ultimately not serve to answer the research questions 
satisfactorily. Further consideration of analytical methods suited to the aims of the 
study as well as the lack of existing theory in this area of interest led me to draw on 
the analytical techniques of grounded theory, and specifically Charmaz’ approach to 
data analysis (Charmaz, 2006). An outline of the philosophy underlying this 
approach was given in Section 3.6. 
4.4.3 Applying grounded theory techniques 
Charmaz’ analytical approach provides a set of interpretive principles and practices, 
which may be applied and adapted flexibly (Charmaz, 2006). However, the key 
analytical techniques of coding, constant comparison and memo-writing, which are 
typical of a grounded theory approach, remain central here.  
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Coding 
Grounded theory coding is an iterative process of separating, sorting and 
synthesising the data, leading the researcher from generic substantive coding to 
increasingly abstract and theoretical coding. Initial coding helps to ‘open up’ 
narratives to aid interpretation and gain a deeper sense of the overall data content.  
I opted to conduct initial coding on a case-by-case basis, that is, to code all 
transcripts pertaining to one patient case (patient, lay carer, professional carer), 
before moving on to the next. To start this process I selected a case that I considered 
particularly rich in content and data variety to help create a good number of ‘base 
codes’ upon which to build the evolving coding struc ure. Coding was conducted 
line-by-line or by small text segment to highlight core meanings or actions expressed 
in participants’ accounts. In doing so I asked question  of the data (Glaser, 1978); 
this helped to identify and assign provisional labes to the coded text segments. I was 
mindful of Charmaz’ advice to conduct this phase spedily and spontaneously, 
remaining as open as possible so as to not prematurely close the mind to alternative 
interpretations and to promote “theoretical playfulness” (Charmaz, 2006, p71). 
I stayed as close to the original text as possible, employing ‘in vivo’ codes wherever 
suitable. In vivo coding involves lifting codes directly from participants’ own words. 
This helps to retain actions and meaning, and places emergent codes more firmly in 
participants’ worlds. In vivo codes using participants’ own words were, for example, 
‘Everybody’s dealt their hand’, ‘It was like I wasn’t there’ and ‘You’re always 
waiting for something’. Some of the early in vivo cdes, however, were eventually 
changed to more inclusive labels as comparative events emerged across transcripts.   
Initial coding of the first 9 of the 15 patient cases (equating to 27 transcripts) 
generated over 250 provisional codes. As the amount f codes started to become too 
unwieldy to manage, I decided to pause at this point and ‘tidy’ this extensive list of 
codes. This involved scrutinising each code in turn, clarifying its properties and 
boundaries, reviewing associated data for its fit, and reallocating data or renaming 
codes as necessary. Codes with comparable content were merged where appropriate. 
In addition, I applied a tentative sequential structure to the codes to aid locating them 
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within the expanding code list. I opted to follow what could be considered a ‘typical’ 
chronic illness pathway, grouping codes under the headers ‘Becoming ill’, ‘Living 
with liver disease’ and ‘Dying with liver disease’, which fitted well with the 
emergent codes. I retained lay and professional carers’ codes outwith this structure. I 
subsequently completed initial coding of the remaining transcripts. To illustrate the 
evolving coding structure, Appendix 6 contrasts sections of the structure after coding 
the first patient case with the structure at the end of the initial coding process.   
Initial coding was followed by a phase of focused co ing. Focused coding serves to 
move early codes from a purely descriptive level to m re conceptual, generic 
categories, and as such lays the foundation for more abstract theorising. Using as a 
basis those codes emerging as most significant, larger segments of data are 
synthesised and assigned the label most representativ  of their meaning. Codes were 
thus refined, modified and reassembled as appropriate, and those which appeared of 
lesser frequency or importance eliminated. Great care w s taken to note deviant cases 
in the data to test my assumptions and decisions taken in this process. Next, axial 
coding helped to define and organise the emerging higher level categories by 
exploring linkages and overlaps between categories and subcategories and 
determining their relationships using basic diagramming. 
The final analytical step was that of theoretical coding. This is the process of 
examining the relationships between the categories and concepts identified through 
focused coding to inform a theory which “weaves the fractured story back together” 
(Glaser, 1978, p72). Doing so necessitated a return to the literature to identify 
existing models and theories which might help to make sense of and explain the data. 
Analytic discussions with the research team also helped to advance theoretical 
thinking at this point. Theories pertaining to the experience of biographical 
disruption (Bury, 1982) and loss of self in the context of chronic illness (Charmaz, 
1983) were found to usefully explain several observations across the data. 
Ultimately, however, the theory of uncertainty in chronic illness was identified as 
providing the most extensive explanatory power to help bring together the overall 
‘story’ of living, dying and caring in advanced liver disease (Mishel, 1990). 
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Constant comparative method 
The constant comparative method was employed througout all stages of coding to 
guide analytical decisions. Constant comparison demands direct interaction with the 
data by constantly comparing data, codes and categories l oking for differences and 
similarities, and refining and modifying codes accordingly. This process is a useful 
test of any inferential leaps made during coding, leading those which are not viable 
to be rejected. Comparisons were also made sequentially by comparing data from 
earlier interviews with later ones for each patient case. 
Memo-writing 
Memo-writing is a key technique in grounded theory analysis and was undertaken 
throughout the analytical process. Memos are personal notes which encourage the 
researcher to take a step back from coding to explore, scrutinise, clarify and record 
their thoughts and assumptions about the data and emerg nt codes. Memos are not 
generally intended to be shared with an audience, but constitute a tool that helps the 
researcher to make sense of the coding process and provide a record of their 
intellectual analytical leaps from early substantive towards more formal theorising. 
Evaluating the choice of analytic method 
Employing grounded theory strategies for data analysis proved an effective means by 
which to meet the broad exploratory intentions of this research. The approach was 
responsive to the varied study sample and enabled th  evaluation and collation of 
both descriptive and theoretical data to meet the research objectives, as will be 
demonstrated in subsequent chapters.  
I still believe that narrative analysis would be a useful approach in this area of work. 
However, given my difficulties in detecting a ‘liver disease story’ in many of the 
individual accounts, this may be better suited to a smaller sample size and a more 
focused research question. Similarly, a case study approach exploring the subjective 
experiences of a smaller number of individuals would be able to make an interesting 
contribution to current understanding.  
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4.4.4 Conducting longitudinal analysis 
There are no universally accepted guidelines for conducting qualitative longitudinal 
analysis. Typically, however, data are examined cross-sectionally, i.e. by time point, 
and longitudinally by case, and comparisons made within and across cases.  
Following the end of each patient/carer/professional cluster’s study involvement and 
having conducted initial coding of all transcripts relating to a group, I recorded the 
key issues and themes within each of these transcript  in a dedicated case summary. 
These case summaries thus provided an overview of issues for each cluster over time 
and formed the basis of my longitudinal analysis. They allowed me to take a step 
back from the detailed coding and scrutinising of the data content to gain a sense of 
the evolving picture. They also helped to consider which types of issues were raised 
by participants at which time points and how this compared between participants, 
which issues featured strongly throughout a participant’s story and what this 
suggested about the nature and level of importance of the issues in question, and how 
the individual illness experience developed and changed dynamically over time. 
Saldaña cautions that one must not simply ask time-orientated questions of the data 
such as ‘when, how often, for how long’, but also attend to the conditions underlying 
change by asking ‘how, how much, in what ways, why’ (Saldaña, 2003). He offers a 
menu of questions to stimulate the exploration of change observed over time within a 
dataset. These questions are summarised in Table 4 ov rleaf and were used to guide 
the longitudinal analysis.  
As described in Section 4.3.1, this study did not use fixed time intervals between 
follow-up interviews, but set these flexibly in response to each participant’s specific 
circumstances. As a result, participants’ accounts were captured at very different 
stages of each person’s illness pathway. Moreover, while all participants were 
deemed to be in the latter stages of advanced disease, there was great variation within 
this. At the time of their first interview for example, Kate had already lived with liver 
disease for a decade, while John and Martin had only recently been diagnosed. As 
such, I felt that comparative cross-sectional analysis across participants by data point, 
i.e. comparing all first, second and third interviews, was unlikely to yield useful 
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insights about the illness experience over time. Hence, temporal observations of the 
study data noted in the following chapters focus mainly on developments over time. 
Framing 
questions 
• What is different from one pod of data to the next? 
• When do changes occur though time? 
• What contextual or intervening conditions appear to influence 
and affect participant changes through time? 
• What are the dynamics of participant change? 
• What preliminary assertions about participant changes can be 
made as data analysis progresses? 
Descriptive 
questions 
• What increases or emerges through time? 
• What is cumulative through time? 
• What kinds of surges or epiphanies occur through time? 
• What decreases or ceases through time? 
• What remains constant or consistent through time? 
• What is idiosyncratic through time? 




• Which changes interrelate through time? 
• Which changes oppose or harmonise with natural human 
development or constructed social processes? 
• What are the participant or conceptual rhythms? 
• What is the through line of the study? 
 
Table 4: Questions to guide analysis of longitudinal qualitative data 
(Source: Saldaña, 2003) 
Challenges and benefits of using a longitudinal app roach 
Conducting the longitudinal analysis was made complex by the large volume of data 
available. I managed this by concentrating on the summaries I had written up for 
each patient/carer/professional cluster, using indiv dual transcripts only for the 
verification of detail. Field notes of telephone conversations and encounters with 
participants in hospital between interviews provided further data of longitudinal 
relevance. This proved particularly useful in the case of those participants who had 
only been able to participate in one interview, as it still allowed an insight into their 
experiences over a period of time. 
Using a longitudinal approach had a marked positive mpact on the data generated in 
this study. Increasing familiarity and trust between researcher and researched 
promoted a gradual moving from public to more private ccounts of the lived 
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experience of advanced liver disease. The former are designed to present the person 
and their circumstances in accordance with acceptable social norms, while the latter 
reflect their personal experiences, thoughts and feelings (Cornwell, 1984). The 
development of more intimate relationships with participants over time also allowed 
more sensitive topics to emerge in their accounts. I terviews became increasingly 
reflective through time, especially in the existential domain. Conversations during 
first interviews tended to be mostly medical and factu l. Moreover, many 
interviewees were rather guarded at this stage. There are a number of possible 
explanations for these narrative changes over time:  
• By necessity, a first interview needs to establish a certain amount of baseline and 
background information from participants such as illness origin, the period of 
diagnosis, or current care arrangements. There is thu not always scope for 
people to open up more intimately. Consequently, the conversation will be 
largely factual and clinical. Moreover, at this point participants will not know 
what to expect from the interview process and are therefore likely to share more 
factual information similar to what they are used to from a medical encounter.  
• It is easier to relay feelings and expectations about current events as they are 
experienced in real time, when they are having their most tangible effect on 
people’s lives. While the first interview seeks to establish a lot of background 
information then, there is less scope or prompt to reflect on current emotional 
matters for example. 
• The evolving narratives suggest that a longitudinal approach helps to build 
rapport and relationships with participants, and that is allows the interviews to 
change qualitatively over time. As participants become used to the interview 
process and trust is established, people feel increasingly more comfortable to let 
down their guard, to show vulnerability, and to speak from the heart.  
• Several participants professed to drawing therapeutic value from our interview 
encounters. As this value was recognised after the first interview, it may have set 
the stage for more private and open conversations on subsequent occasions. 
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Finally, there was some evidence of accounts being subject to reinterpretation 
through time as participants rethought or retold experiences or feelings. The 
longitudinal and multi-perspective aspects of the study also encouraged my own 
reinterpretation of some participants’ stories. Getting to know participants more 
intimately through time helped me to better understand some of the accounts 
proffered in interviews as well as to re-evaluate some of their data, which in turn 
prompted me to look at some of their data in a different light.  
4.4.5 Analytical challenges 
Following participants over time generated a signifcant amount of data and provided 
rich material describing the interaction between individual and care domains. This 
not only made managing the data challenging, but also made data analysis complex 
and time-consuming.  
The nature of this study also created specific challenges for data analysis. About half 
the sample lived with alcohol-related liver disease. A number of these participants, 
when asked about their liver disease, tended to reply in relation to their alcohol 
problems, which to many was the more tangible, acute oncern, as an inability to 
overcome these problems was key to their prognosis. Their liver disease was 
therefore often equated with alcohol dependency, and s a result many of these 
accounts were dominated by issues around alcohol rather than the resultant liver 
disease. Similarly, Sarah’s friend Pamela commented on Sarah’s fluctuating moods. 
However, it was unclear whether these were due to Sarah’s ongoing depression (a 
long-standing diagnosis pre-dating her liver disease) or low moods relating to being 
seriously ill with liver disease, the challenge of remaining abstinent, or dealing with 
general life challenges such as her difficult family relations. Consequently, it was at 
times challenging to determine with any certainty which feelings and experiences 
related to which aspect of patients’ illness. At the same time, these issues 
demonstrate the complex circumstances within which many people have to negotiate 
a life with advanced liver disease.  
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4.5 Working with a lay advisory group 
As described in Section 3.3, I was keen for this reearch to benefit from the 
involvement and expert insights of lay individuals representative of my study 
population. Early on in the study I sought out a consultative relationship with a large 
and well-established regional liver support group. Initially, information on the 
proposed study was shared through the support group's newsletter (reaching a 
readership of around 2000 patients) and comments invited. I also presented the 
proposed study at one of the group’s monthly meetings, providing an opportunity to 
hear the views of around 50 attending liver patients and their caregivers. A subgroup 
of support group users subsequently agreed to advise on and contribute to different 
aspects of the study for the duration of the project. This group met quarterly from 
June 2011 to January 2014. In addition, I continued to provide study updates to the 
main liver support group newsletter throughout the duration of the research so as to 
give opportunity to others to comment and contribute. 
I had hoped to achieve a representative spread of aeti logies, gender and ages in the 
advisory group similar to my study sample. I was alo keen to involve lay carers 
where possible. As this was a self-selected group, however, I was unable to exert 
much control over its membership. I also accepted that volunteers would be unlikely 
to include people at the advanced stages of disease as they would generally be too 
unwell to participate. Three volunteers dropped out along the way. The single lay 
carer volunteer also withdrew due to conflicting priorities. Finally, the core advisory 
group members comprised of five females and one mal ranging in age from 30 to 69 
years. Three members had PBC, one had PSC, and one had xperienced acute liver 
failure. Three had received a liver transplant. One volunteer was a liver disease 
patient, but had also previously supported a parent with liver disease and so was able 
to provide views from both patient and carer perspectiv s. 
4.5.1 Benefits of working with a lay advisory group  
While this group was not an ideal match to the study sample, it still made an 
invaluable contribution to this study in the following ways: 
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1.  Most group members lived with an autoimmune type of liver disease - an under-
represented group in the study sample. While I was unable to use group members’ 
stories and comments as study data, they served to confirm that their experiences 
were in fact comparable to those of study participants, despite the differing 
aetiologies. This observation thus adds weight to some of the study findings.  
2.   Only two people with ALD had volunteered to participate in the advisory group. 
One person died suddenly before the first meeting, he other found speaking about 
their illness too challenging and did not return after attending one meeting. Group 
members confirmed that it was difficult to attract patients with ALD and NAFLD to 
their support group, as many struggled with guilt and perceptions of stigma. This was 
valuable information for future patient recruitment and relates to a point made in 
Section 4.2.1. I recruited my study participants from a hospital liver ward where the 
predominant disease cause represented was ALD, making it difficult to achieve a 
spread of aetiologies across the sample. It appeared to be the opposite when 
approaching the support group. This suggests that a multi-site recruitment strategy 
may be best if a sample of different liver disease etiologies is the aim.  
3. The group discussions gave an opportunity to explore issues raised in the 
interviews in more detail. The typical interview situation is fast-paced and time-
limited, with many issues raised only briefly or in passing, making it difficult to pick 
up on all in detail during the interview itself. There is also not always an opportunity 
to follow these up with the participant at a later stage due to attrition. The advisory 
group thus provided an invaluable opportunity to consider some issues in depth, 
helping to evaluate their relative importance and whether they warranted being 
explored with other participants in subsequent interviews. Hence, discussions with 
the lay advisory group ensured that potentially interesting or important issues raised 
by study participants were less likely to go unnoticed and unexplored.  
4.  None of the advisory group members were at the advanced, decompensated stage 
of liver disease. Those who had undergone liver transplantation tended to speak from 
the perspective of their post-transplant life with its ongoing challenges and care, 
unless specifically asked about their experiences prior to transplantation. However, I 
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was struck how, regardless of the stage of liver disease a person was at, many of the 
psychological, social and care-related experiences mirrored those expressed by the 
study participants living with very advanced disease. Indeed, the main difference 
along the liver disease trajectory seemed to relate to the physical complications 
experienced, although fatigue was universally cited as the main debilitating issue. 
5.  Consulting with the advisory group provided an opportunity to get an ‘insider’ 
opinion on the emerging coding framework and its fit with the everyday experience 
of living with liver disease. This feedback gave meconfidence in the framework’s 
suitability and validity to support ongoing data analysis. 
Overall I feel that I, the researcher, and the study itself benefitted immensely from 
the involvement of the lay advisory group. Especially s a PhD researcher working 
predominantly in an independent and isolated manner it was reassuring to link with a 
group of ‘expert’ co-researchers throughout the research process, and to have my 
thoughts and perceptions confirmed and challenged in equal measure. I was also 
pleased to note that group members themselves enjoyed and benefitted from their 
involvement. One member in particular commented how participating in the group 
had helped them to feel less isolated about living with their illness, and to realise the 
value of sharing experiences with others.  
4.6 Evidencing the quality of study conduct 
As described in Section 3.7.1, I followed Rolfe’s approach to facilitating quality 
judgements to be made regarding the conduct of this study by recording a detailed 
audit trail (Rolfe, 2006).  Procedural decisions taken during the recruitment and data 
generation phases of the research were recorded in xte sive field notes, which also 
document contextual information about interactions, observations and personal 
reflections. Using qualitative data analysis software has been noted as a useful means 
by which to leave a comprehensive audit trail (Seale, 2001). My analytical decision 
trail is documented in NVivo through a detailed data nalysis journal, copies of the 
coding structure at different time points, and time-stamped memos showing my 
evolving analytical ideas about cases, codes and categories. Minutes of meetings 
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with the study’s lay advisory group detail discussion  around challenging or 
emergent issues during all phases of the study.  
4.7 Ethical and safety considerations 
As stated in Section 3.2.3, longitudinal research has t e potential to magnify some of 
the ethical issues inherent in qualitative research (Neale and Hanna, 2012). The 
developing relationship between researcher and resea ch d over time is particularly 
critical in this respect (Watson, Irwin and Michalske, 1991). Appendix 7 presents an 
ethical dilemma which arose in the course of this study. Participant and researcher 
welfare were safeguarded throughout this study in the following ways.  
4.7.1 Protecting the participant 
Interviews were conducted in accordance with previous recommendations regarding 
safe research practices (Pratt, 2002). These note the importance of understanding the 
characteristics of one’s particular participant group so that interviews may be 
planned and conducted in the safest and most appropriate way. I achieved this by 
consulting with the lay advisory group in advance of the first interviews to develop 
my understanding of potentially challenging or distre sing issues in this context. 
Further protection was sought by conducting interviews, where possible, in the 
patient’s own home, a comfortable and familiar setting. Consent was renewed before 
each interview and participants reminded that they could pause or terminate the 
interview at any time. Offering joint or separate interviews gave patient and lay carer 
a choice about how to engage with the researcher. In the case of separate interviews, 
great care was taken not to divulge information from another interviewee in that 
patient/carer/professional cluster. I also tried to be sensitive to participants’ 
wellbeing during the interview encounter and followed guidance for dealing with 
distress by employing active listening, offering breaks, giving the opportunity to talk 
through the distress, and allowing interviewees to change the subject to a less 
threatening or emotive topic (Pratt, 2002).  
Finally, all participants were anonymised at the time of recruitment by the use of a 
unique identification code separate to their personal details, thereby ensuring 
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anonymity and confidentiality throughout the research process. For the purposes of 
this thesis, however, patient and lay carer participants were subsequently assigned a 
pseudonym to return the human voice to the data present d and help the reader 
connect and empathise with participants’ experiences.  
Interviewing vulnerable people 
Commenting on the impact of research participation on palliative patients, Gysels 
and colleagues acknowledge that they were unable to assess whether their 
participants experienced any distress following the researcher’s departure (Gysels, 
Shipman and Higginson, 2008). They suggest that this could be given attention by 
using a longitudinal research format. While some participants in the present study 
became distressed during their interviews, none wished to pause or break off the 
interview at that point. More importantly, all were happy to remain in the study for 
further interviewing. This finding lends support toobservations on interviewing 
patients and caregivers respectively (Lowes and Gill, 2006, Funk and Stajduhar, 
2009). Where participants experienced distress during interviews, this was seen as 
them expressing and dealing with the upsetting nature of their situation. Research 
interviews may consequently constitute a means of coping for some interviewees.  
The willingness of the participants of the present study to continue their involvement 
despite at times struggling emotionally during the interviews, as well as many of 
them commenting on how helpful they found taking part in the research, suggests 
that the interviews were indeed contributing to their coping. Participants can exercise 
their power over the interview situation, and thus protect themselves, by choosing 
what, how and in what detail to answer (Kvale, 2006). This strategy was employed 
by several participants in this study, who circumvented any questions that prompted 
them to contemplate a possible decline in the future.  
4.7.2 Protecting the researcher 
Building a relationship with and hearing the experiences of those nearing the end of 
their life and their lay caregivers during the research process has the potential to 
cause distress for the researcher. I benefitted from being part of a large research team 
which is extensively experienced in end-of-life research and able to provide peer 
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support and supervision. Access to independent counselling sessions was also 
available, and encouraged to be used, through the University.  
Particular consideration was given to the potentially volatile nature of some patients’ 
home environment, particularly in the case of those with alcohol or drug-related liver 
disease. These individuals may live in chaotic home environments that are unsafe for 
a lone researcher to visit. Background information on each patient where this may be 
the case was ascertained from ward staff. Lone worker precautions such as reporting 
in and out of interviews, maintaining mobile phone contact, and carrying a personal 
alarm were also taken when visiting participants at home. 
4.8 The reflexive researcher 
As described in Section 3.7.2, the practice of reflexivity centres on the notion that 
both researcher and researched are actively engaged in the co-construction of 
knowledge and directly impact on research in a number of ways. As a researcher, it is 
important to be mindful of one’s influential role in shaping the research process and 
to consider the implications arising from this. Reflexivity thus closely relates to 
ethical practice, as it is the sensitising tool which enables the researcher to recognise 
and address ethical dilemmas as they arise (Guillemin and Gillam, 2004).  
In reflecting upon my role as researcher, two factors stand out as having impacted on 
the research process. Firstly, I was conscious of the way in which my status as 
doctoral researcher was understood. I had recruited patients from an acute hospital 
ward, so it was conceivable that I would be perceived as a type of healthcare 
professional, despite explaining my background and role to participants at the time of 
recruitment. I had also learned from my informal discussions with a patient during 
the planning stages of the study that ‘doctoral research’ was prone to being 
misinterpreted as a clinical endeavour. Indeed, over th  course of the study several 
participants asked me for medical advice despite my repeatedly reminding them that 
I was not a clinician. An enduring perception of meas a healthcare professional may 
have influenced some participants’ accounts. Indeed, when I asked Rebecca after our 
first interview how she had felt about speaking about her experiences she likened it 
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to a medical encounter, stating that she hadn’t minded it because, “I do it with the 
doctor practically every time I’m there anyway.”  
I was further aware of my age as an influential factor in the research process. Five of 
the participants were in their mid-30s to early 40s, and therefore of a similar age to 
me. This fostered the development of a much deeper relationship than was the case 
with older participants; some participants referred to me as a friend. I also found it 
easier to relate to these individuals’ lives and the impact the disease was having on 
them, and as a result I was considerably more emotionally affected by their stories.  
In general, despite my professional role as research r, I could not help but be touched 
by participants’ struggles and worries, especially s I got to know them better over 
time. During the recruitment phase I was also occasion lly faced with witnessing 
first-hand the last days and hours of a participant’s life as they lay dying in the very 
hospital ward from which I was recruiting. Furthermore, having grown close to 
participants over their months of study involvement, the sudden death of a patient 
was often upsetting, as was saying goodbye to those still alive at the end of the study. 
Emotional involvement is unavoidable in relational research (Bondi, 2005, Watson, 
Irwin and Michalske, 1991). Longitudinal research in particular can leave researchers 
emotionally vulnerable (Dickson-Swift et al., 2009); indeed, considerable effort was 
required to manage my emotions throughout the reseach process. This experience 
highlighted to me the importance of self-care throughout the research process as well 
as access to appropriate counselling support for the esearcher. I was grateful to have 
access to excellent support, both from members of the research team and at home.   
4.9 Summary 
15 patients, 11 lay carers and 11 case–linked professionals were recruited to the 
study. 53 interviews were conducted in total. Using a alytical strategies of grounded 
theory proved an effective approach to meeting the ov rall research aim. The 
involvement of a lay advisory group aided both the research conduct and the 
researcher experience. A safe and ethical study conduct was sought throughout. The 
successes and challenges encountered in respect of the study design and the research 
process provide valuable learning for future research. 
 
  79 
The next five chapters outline the main study results and discuss these in relation to 
the wider empirical and theoretical literature. Chapter 5 describes participants’ 
accounts of becoming ill, their physical experience of advanced liver disease, and 
their understanding of the condition. Chapter 6 shows how everyday life was 
negotiated in light of the illness. Chapter 7 focuses on patient participants’ 
experiences in the care setting. Chapter 8 outlines their considerations and 
experiences in relation to deterioration and death. Finally, Chapter 9 presents the 
perspectives of lay and professional carers about providing support for people with 
advanced liver disease.  
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Chapter 5: Onset, manifestation and 
understanding of the disease 
This chapter first presents findings in relation to the lead up to and experience of 
receiving a diagnosis of advanced liver disease. It then details patient participants’ 
accounts of the physical complications they faced as a consequence of their illness, 
and how these impacted on their everyday lives. It also illustrates the extent to which 
they understood their illness and its implications. Finally, these findings are 
discussed in relation to other research and relevant theoretical literature.  
5.1 First symptoms 
As shown in Section 4.1.1, a range of aetiologies wre represented in this sample. 
Most participants found their first symptoms vague and difficult to interpret. 
I didn’t feel particularly well, but I couldn’t tell you why I didn’t feel well. I just had put 
it down to the fact I was a bit stressed out. (Kate, 41, cryptogenic LD, first interview) 
I was extremely anaemic, I was tired all the time, I had no energy. I was just, I was 
feeling sick, I was nauseous, I was, you know, generally I just felt crap, you know? I 
don’t know any other way to put it, I just felt so bad. (Sarah, 38, ALD (HCV), first 
interview) 
The uncertainty surrounding early symptoms meant that for many the first indication 
of their illness came with the emergence of physical complications already associated 
with advanced disease; that is, decompensated cirrhos s (the point at which the 
patient’s liver is irreversibly damaged and on a likely pathway towards liver failure). 
Among this sample, the first tangible complication was commonly an appearance of 
ascites (fluid accumulation in the abdominal cavity causing abdominal distention). 
We were in Turkey for, on holiday. The second day I was there I started going up like a 
balloon. And that is not an exaggeration, it was like a balloon. (Thomas, 75, NAFLD, first 
interview) 
It was only with this stomach here that I found outabout the liver and the kidneys. I 
hadn’t a clue. I never had any pain or didn’t hold me back any, nothing at all. (Martin, 77, 
ALD (NAFLD), first interview)  
Other early symptoms preceding diagnosis were difficulties with limb coordination, 
poor balance, lack of appetite, sickness, stomach pins and mild jaundice.  
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5.2 Receiving a diagnosis 
At the time of recruitment, patient participants had been aware of their diagnoses of 
chronic liver disease from around 10 years in Kate’s case to only a month in John’s. 
In most cases, participants had been alerted to problems with their liver two to five 
years earlier. Due to non-specific symptoms, however, many only received an actual 
diagnosis of liver disease when the condition was already advanced.   
Participants with alcohol-related liver disease (ALD) in particular had often received 
warnings by their GPs in the past regarding raised liver function tests, but had not 
heeded them. Many admitted that they had had a hunch about their health slowly 
declining due to continued drinking. Some had even understood the meaning of 
symptoms, but had remained in denial.  
Ben: I could see I was getting a bit yellow and, like, I knew that was the danger signs. 
BK: But you still needed to get to quite a bad state before you accepted for yourself you 
needed to go and see someone? 
B: Aye. I did know, but as I say I was scared to go in because I knew it was going to be 
really bad.  
(Ben, 35, ALD, first interview) 
 
There was also evidence of collusion from their lay c rers in this regard. 
It was quite a few years ago we first heard that he had slight damage to his liver. And 
obviously it was really worrying, but I think like Ben I kind of sort of blocked it out, just, 
that it’s not going to be that bad. And you never think it’s going to get really serious. 
(Tamsin, partner of Ben, 35, ALD, first interview)  
The signs were there, but I’m just as bad. You hope it’s just going to go away again, yet 
you know it’s not. (Jane, partner of John, 68, ALD, first interview) 
Despite recognition of the warning signs many did not appreciate the seriousness of 
their situation at the time. Receiving a diagnosis of advanced disease consequently 
still came as a shock.  
I think I knew it was my liver, well I did know. I didn’t know how bad it was, so it came 
as a bit of a, I don’t know if it was a shock when I was told how bad it was, but it 
certainly knocks you back a bit. (Aidan, 58, ALD, first interview) 
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Professionals’ use of the word ‘cirrhosis’ in this context was particularly confusing 
for those with disease causes other than alcohol misuse, as people tended to associate 
the term with such problem behaviour. 
BK: What did you make of that, being told that you’ve got cirrhosis? 
Fay: Well I just thought it was a drunken condition. (…) I’ve never heard of anybody else 
having it other than heavy drinkers. 
(Fay, 84, NAFLD, first interview) 
Donald: They just told me that I had liver…they called it another name, it sort of fooled 
me for a wee while. (…) 
BK: Cirrhosis? (…) 
D: That was it. And it wasn’t until I seen it printed in a letter they sent me, when I got the 
letter that’s when I realised it was [primary liver] cancer. 
(Donald, 74, HCC (NAFLD), first interview) 
Patients’ experience of the onset of their illness was therefore one marked by 
uncertainty. This uncertainty related to the insidious nature of their early symptoms, 
resulting for many in a late diagnosis of their condition. Receiving a diagnosis was a 
similarly ambiguous event, magnified by unclear professional vocabulary used to 
communicate the diagnosis. 
5.3 Physical complications 
Several participants experienced recurring varices (dilated blood vessels prone to 
rupturing), which required ongoing surveillance and regular treatment. Only two 
participants occasionally experienced jaundice, a symptom commonly associated 
with liver damage. Memory problems, anaemia and weight loss were all mentioned. 
The following section presents the physical complications most commonly described 
by the participants.   
5.3.1 Fatigue 
The most debilitating issue across all patient participants was fatigue, which was 
marked by extreme tiredness and physical weakness.  
I fall asleep quite a lot during the day just for n apparent reason. (Kate, 41, cryptogenic 
LD, second interview) 
I never moved out of my bed at all yesterday. I was so lethargic I felt I’d no strength at 
all. (…) I was lucky if I could hold my head up, never mind anything else. (Mary, 66, 
autoimmune hepatitis, second interview) 
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The  onset of fatigue was unpredictable and often sudden, adding uncertainty to daily 
life. 
Sometimes I can become ill within a couple of hours. Like I could be completely well, go 
shopping, come home, have a wee rest ‘cause I’ve been shopping and then just be totally 
exhausted within a couple of hours and just have absolutely no energy at all, like, be 
totally wasted. (Sarah, 38, ALD (HCV), first interview) 
Persistent fatigue curbed participants’ ability to engage in valued activities.  
I’ve always liked housework and I’ve never been the person that would sit and look at 
something. But nowadays I think, “I’ll do that tomorr w.” It’s not really like me (…) but 
I’ve just not got the energy. (Fay, 84, NAFLD, second interview) 
In many cases the experience of fatigue was related to insomnia. Nocturnal sleep 
problems caused enduring tiredness, which in turn made people sleep during the day. 
I'm up quite early, well I was up at 7 o'clock this morning and watched, put the TV on. 
Probably by about 1.30pm I sleep. Sometimes I fall asleep at tea time and then when it 
comes to night time it’s like, well I've already slept so I can't sleep. So that makes me 
agitated. I can't get comfy. (Rebecca, 37, ALD, first interview) 
The physical exhaustion also interfered with sleep by causing anxiety. 
Sometimes I’ll not sleep because (…) sometimes I’m really exhausted, almost passing out 
with exhaustion, I’m scared to sleep so I’ll sit up, because I’m scared if I do go to sleep 
then I won’t wake up. (Sarah, 38, ALD (HCV), first interview) 
Insomnia was also a disruptive problem in its own right, with some simply unable to 
fall asleep. 
I want to sleep, I try to sleep, but I just can’t seem to fall over if you know what I mean. 
(Aidan, 58, ALD, first interview) 
5.3.2 Ascites 
Ascites, marked by a gradual swelling of the abdomen due to fluid accumulation, 
was the other major physical complication disrupting participants’ lives. The first 
onset of ascites was again marked by uncertainty. 
I got the doctor out one morning because my tummy was really, really big and it wasn’t 
going anywhere. And I’d put up with it for about 3 weeks because I thought (…) I was 
maybe constipated. (…) I phoned up to get the doctor in and I says, “Look I’ve got an 
awfully sore tummy.” (Nadia, 56, ALD (HCV), first interview) 
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This huge swelling appeared and we were all laughing and carrying on, you know, saying 
it looks like, because it did look like I was pregnant. (…) I had a pregnancy test done 
because everybody else round about me’s saying, “Are you sure you’re not pregnant?” 
(Kate, 41, cryptogenic LD, first interview) 
Six of the 15 patients experienced refractory ascite  requiring regular paracentesis 
(an inpatient treatment to drain off the reaccumulating fluid). The frequency of this 
event was a source of great frustration for them. 
I says, “How long does this last or what?” [The doctor] says, “It could last forever, it just 
depends. But they’ll control it a bit.” I thought when he said they would control it it 
would be every, maybe 3 to 6 months or something, not every fortnight. (Martin, 77, ALD 
(NAFLD), third interview) 
However, for those whose ascites could generally be controlled with diuretic 
medication infrequent problems with ascites were equally as disruptive. The sporadic 
experience of fluid accumulation also left people uncertain as to how to best manage 
these incidents.  
My stomach just got huge. My ankles were huge. And I'm like well, do I actually do more 
exercise, do I do more walking? But I just didn't have the energy. So I didn’t actually 
know what was best. So did I have to lay and rest and have my legs elevated, or to 
actually try and walk it off? (Rebecca, 37, ALD, first interview) 
Ascites were often accompanied by a shortness of breath due to the accumulating 
fluid pressing against internal organs. 
Mary: I went up [to the hospital] (…) and I had to sit on the benches outside for about 10 
minutes before I could catch my breath. And I had to get a taxi home. (…) 
BK: Was that because you had so much fluid? 
M: It was, yes. 
(Mary, 66, autoimmune hepatitis, second interview) 
Ascites was not only a burden by causing discomfort, but by impacting on 
participants’ ability to engage in even the most basic of tasks such as personal 
hygiene and getting dressed.  
[Friend] will be coming in in a wee while because she’  going to give me my shower. I 
mean I can’t even take a shower, that’s how bad it is. I can’t get my arms round, you 
know, to my back. (Mary, 66, autoimmune hepatitis, second interview) 
I can’t really put my socks and shoes on now, because I can’t bend. (Fay, 84, NAFLD, 
third interview) 
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Finally, the following excerpt from my field notes reflecting on an encounter with 
Thomas on the hospital ward summarises well the pervasive disruptive impact of 
ascites on the lives of patients and lay carers alike. 
He’d just had 15 litres drained off him yesterday and seemed understandably relieved to 
shed this weight once again. He said his life really was just unbearable now, with the 
recurring ascites rendering him immobile again within days, and the immobility in turn 
making him physically inflexible and all-round uncomfortable. He said his wife was 
really feeling the strain of the situation too, commenting that he effectively became a 
baby in those days where she had to do everything for him. 
5.3.3 Motor coordination and mobility problems  
Several participants described occasional problems with motor coordination. 
There’s a funny thing going on, it’s like I’m thinking to myself I want to go to such and 
such a place, but when I stand up my legs don’t seem to want to take me there. It’s like 
they’re not getting the message, you know, and theystart to go all wobbly and all this 
kind of carry on. (Kate, 41, cryptogenic LD, first interview) 
A wee while ago I kept falling. I would miss a step going up over the curb or something 
and just, bang. And I was going to the job centre the other day and I just got to the top 
stair, top step, I did, I went down with a thump. I can’t get back up when I’m down. I’ve 
got to get a hand to get up (…) my legs will no work. (Aidan, 58, ALD, first interview) 
Poor mobility also proved a challenge for many. This was often linked to carrying 
fluid, general physical weakness and fatigue. 
Fraser: Just moving about, getting up from [the settee], I can’t do it. Well I can, but it 
takes a while. Getting out my bed it takes a while, ken, so it’s either I go to my bed or 
stay up here. It was five o’clock this morning befor  I went to my bed. 
BK: Oh, why was that? 
F: I just couldn’t get up [from the settee], I was stuck. 
(Fraser, 60, ALD, second interview) 
Several participants recounted incidents of falling. These falls triggered a loss of 
confidence in their abilities and a restriction of their activities to avoid further falls. 
I’m terrified to go out in case I fall. (Fraser, 60, ALD, second interview) 
Uncertainty then was also evident in participants’ problems with mobility and motor 
coordination. This related both to their lack of understanding of the source of these 
problems and their unpredictable occurrence, which affected their levels of activity 
and ability to engage socially. 
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5.3.4 Pain 
Only Fraser mentioned regularly experiencing pain to debilitating levels, though he 
did not elaborate on the nature of this pain. As pain is a common feature in advanced 
chronic disease, I was struck by the lack of mention of it in participants’ accounts. I 
consequently enquired directly about the incidence of pain relating to their liver 
disease in later interviews. Several participants denied experiencing any pain related 
to their illness. 
You don’t feel as if you’ve got a problem with your liver, ken, it’s not a pain. So your 
liver can be damaged and you don’t know. That’s the s range thing about the liver, there’s 
no pain. (Ben, 35, ALD, first interview) 
The pain comes from treatment at the hospital rathe t an…you know, trying to stick 
needles in you (…) but I can’t really say that it’sbeen painful, no. (Kate, 41, cryptogenic 
LD, third interview) 
For those who confirmed instances of pain, these were typically related to their 
recurrent ascites, with the accumulating fluid eventually starting to press on internal 
organs causing discomfort.  
I’m never really in any pain. The only pain I get in o is if this [ascites] gets really bad 
then I tend to get a bit of a pain across the back, but they tell me this is just pressing on 
the lungs, you know? (Thomas, 75, NAFLD, first interview) 
Having the fluid drained off in hospital then removed this pain.   
I was saying to the doctor that I’m getting an awful pain down here, like a stabbing pain. 
She says that’ll be the pressure of the fluid pressing on whatever, she says. She says it’ll 
go away when this is taken away, and it did. (Aidan, 58, ALD, first interview) 
Some were rather grateful for the absence of pain, as it helped them not to worry 
unduly about their illness.  
It just makes it easier to not worry, because with the state my liver’s still in, if I had the 
pain to go with that I’d be just sitting completely worried all day going, “Oh my liver, oh 
God, oh no,” you know what I mean? (Ben, 35, ALD, first interview) 
There was some indication that pain may have become mor  of a feature in the final 
stages of the illness, however. In my last interview with Martin and his wife Cora, 
conducted two months before his death, Cora suggested that pain was starting to 
become a regular occurrence. 
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Cora: When you were getting up out of your bed, that’s when he used to feel the pain and 
then it would go away. But this last, after the last drain, not that drain but the drain 
before, it seems to be a regular occurrence and it’s lasting longer, the pain. 
Martin: Yes, well, that was this morning when I got up and I sat here, and it was quite 
painful there. 
(Martin, 77, ALD (NAFLD), and Cora, wife of Martin, third interview) 
Donald’s GP also indicated that Donald had experienced pain towards the end. 
Pain control didn’t really become an issue until later on. (GP of Donald, 74, HCC 
(NAFLD)) 
5.3.5 Medication 
To manage these and other physical complications arising from their liver disease, 
participants were subject to an extensive and complex medication regime. This 
ranged from laxatives to diuretics and fortifying supplements, alongside medication 
for any co-morbid conditions. Given this complexity, many felt rather overwhelmed 
by the number of tablets they were required to take nd relied on support from 
friends and family to manage their medication. 
Honestly, if it was me I’d just say, “Oh, pfff, drop kick.” I wouldn’t bother taking them. 
(…) It would be ok if it was one or two that’s fine, but that’s 17, 19, I mean 19 tablets, 
eh? And eye drops. And puffers. Oh pfffff. (Martin, 77, ALD (NAFLD), first interview) 
One day I got confused, I’m not kidding you, I was so confused I didn’t know what I was 
doing. So I phoned [friend]. I said, “[Friend], you’ll have to come down. I’m so confused 
with the tablets.” (Mary, 66, autoimmune hepatitis, second interview) 
Indeed, without access to similar support, some had given up trying to get to grips 
with their medication regime. 
The amount of pills I take it’s unbelievable and you get sick of taking some of them, they 
go in the bucket. I put them in the bucket, they ken I put them in the bucket. I can’t be 
bothered taking them. (Fraser, 60, ALD, first interview) 
Fluctuations in participants’ condition and unexpected side effects meant that their 
medication was frequently reviewed and amended, which added to their confusion.   
I don't know what they're all for. [To Martin] You don't know what they're all for either. 
They'll say they’ve changed that, that, that, and I'll say, "What?" How am I supposed to 
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Taking diuretics for the management of ascites was particularly disruptive to daily 
life. 
If you want to go for a walk or something, you know, you can’t really, you know? You 
got to either take them really early on and then go after they stop working, or, you know, 
take the tablets later on and then during the night you’re maybe needing the toilet. (Sarah, 
38, ALD (HCV), second interview) 
When I’m on these tablets I can’t be outside because I get, like even from here to that 
toilet, you know, it just, it hits me like that. (Rebecca, 37, ALD, second interview) 
Dealing with a complex and ever-changing medication regimen was thus a further 
source of uncertainty for patients and caregivers alike. This uncertainty related to the 
nature of the tablets they were expected to take and their safe management. Diuretic 
medication added further uncertainty with respect to its timely administration to 
allow patients to engage in planned activities.  
5.3.6 Changes in physical status over time  
Most participants experienced a general progressive physical decline. This was 
particularly tangible where it manifested in an increase in hospital admissions for 
repeat paracentesis. While some could sense the steady deterioration in their 
condition, they were not always able to articulate this. 
Mary: I feel as though I’m getting weaker and weaker. 
BK: So you actually feel like physically, you’re physically deteriorating? 
M: Yes. But how can you explain that to a doctor? This is what I don’t know. 
(Mary, 66, autoimmune hepatitis, second interview) 
In many cases, however, participants’ wellbeing fluctuated over days and weeks, 
offering brief windows of respite or improvement.  
He was fine for a wee while. He was looking well and my granddaughter come up and cut 
his hair and all that. He really looked healthy and then all of a sudden he went down 
again. (Betty, neighbour of Fraser, 60, ALD, bereavement interview) 
Successful management of their ascites led to a brief increase in motivation for some 
participants to become more active.  
Maybe about three weeks you feel better, you feel a wee bit more energetic, yes, you 
want to walk that wee bit further, and then it just starts going down again so…I suppose 
it’s all to do with this [ascites], everything. (Aidan, 58, ALD, first interview) 
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Fatigue was unpredictable and could vary from day to day. 
Sometimes I’ll get up and, like, do the ironing or whatever or go for a walk along the road 
and I’ll come back and be absolutely exhausted, and other days I can do it no problem. So 
it’s just all about kind of up one day, down the next kind of thing, so it’s very 
unpredictable. (Kate, 41, cryptogenic LD, second interview) 
Participants spoke of having good days and bad days, relating both to their physical 
and psychological wellbeing on any given day.  
It’s day by day. I don’t know how I’m going to feel. (Rebecca, 37, ALD, third interview) 
Sometimes you meet [Sarah] and she’s on great form and she’s like a full person, and 
other times you meet her and she’s like just a less than half a person and just can’t seem 
to cope. (Pamela, friend of Sarah, 38, ALD (HCV), first intervi w) 
Uncertainty was therefore also a feature of participants’ physical experience over 
time. Complications were unpredictable in both onset and nature. This allowed 
people to experience occasional instances of ‘good days’, while never allowing them 
to fully recover to their previous levels of health.  
Although most participants experienced a slow but steady decline in their physical 
condition, a key difference must be noted between people with ALD and those with 
liver disease from other causes. Unlike their non-ALD counterparts, ALD patients 
have the opportunity to take control of their illness due to its self-inflicted nature by 
alcohol misuse. Success with sobriety varied across ALD participants, but a small 
number of cases demonstrated positive change throug time. John and Sarah, who 
succeeded in overcoming their alcohol dependency in the course of the study, both 
experienced increasingly improved health.  
I am getting better every day. I mean, I’ve got my tired days but I am getting stronger 
every day. (Sarah, 38, ALD (HCV), second interview) 
BK: So have you got any physical symptoms at all leftover from…? 
John: Not really. (…) I feel a lot better I think than I ever did. 
(John, 68, ALD, third interview) 
5.4 Understanding liver disease 
The following sets out participants’ understanding of their condition and its 
implications for the future. Regardless of aetiology, most had had little knowledge of 
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liver disease prior to their diagnosis, reflecting a eneral lack of public discourse in 
this respect. 
Until I had an alcohol problem I didn’t have a clue what your liver was actually for. (Ben, 
35, ALD, first interview) 
I know there is drinking, cirrhosis of the liver. That’s the only one that I know of. (Mary, 
66, autoimmune hepatitis, first interview) 
As a result, Nadia was rather alarmed when she was first diagnosed with hepatitis C. 
At first I thought it was AIDS, I was convinced it was AIDS I had. (…) That’s how naïve 
I was, I thought it was the same as AIDS. (Nadia, 58, ALD (HCV), first interview) 
Those with liver disease caused by alcohol misuse were clear about the origin of 
their illness. Similarly, most participants with NAFLD accepted that their condition 
was likely to be linked to their having diabetes. However, some participants 
struggled to understand why they were ill.  
I’ve not got a clue how or why I’ve got the liver complaint. I’ve not got a clue. I don’t 
even know how you catch a liver complaint. (Mary, 66, autoimmune hepatitis, first 
interview) 
I don’t know what’s the cause because, I mean, I never ver done anything for it to be 
like this, you know? (Polly, 68, NAFLD, first interview) 
As this uncertainty about the origin of their illness was frequently reiterated within 
and across interviews, it clearly constituted a matter of great concern to these 
participants. There was also widespread uncertainty bout which physical symptoms 
to ascribe to their liver disease. 
This lack of energy thing, I mean, is that quite normal for somebody who’s got liver 
disease (…) or am I just milking it a bit? Should I be ok or what? I don’t know what all 
this is about. (Kate, 41, cryptogenic LD, first interview) 
I’ve had a sore back for the last few years, and it’s like when I’m bending, cutting in the 
kitchen, like chopping, it gets worse. Does the livr, does your bending, can that give you 
a sore back? (Ben, 35, ALD, first interview) 
Patients’ uncertainty about what constituted typical symptoms of liver disease also 
manifested itself during the recruitment phase. Some inpatients I approached about 
the study were reluctant to participate as they felt unable to comment on their 
experience of living with advanced liver disease duto a lack of definite symptoms. 
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Despite both their accounts highlighting several physical complications typical of 
liver disease, Fay and Polly also echoed this sentim t. 
Fay: I can’t say I’ve got anything wrong with my liver because I don’t feel any different. 
BK: So you don’t know if the symptoms that you have ar  in any way linked to the liver 
or not? 
F: That’s right. 
(Fay, 84, NAFLD, first interview) 
Polly: Well, you’ve got the same symptoms all the time (…) 
BK: OK. So what sort of symptoms are they then? 
P: Well to be honest I don’t know, because I mean the only thing I can tell you is I get 
anaemic, that’s the only thing I can tell you. 
(Polly, 68, NAFLD, first interview) 
This ambiguity in relation to the origins and characteristic features of their condition 
thus made it difficult for participants to make sen of their physical illness 
experience.    
5.4.1 Wishing to understand liver disease 
Despite the uncertainty their lack of understanding was causing them, some preferred 
to remain ignorant of the nature of their condition. 
I’m scared to ask because the more complicated it gets, the more it seems real and scary. 
(Ben, 35, ALD, first interview) 
I was going to go down to the library and get out a doctor book about the liver and I went, 
“No Mary, you don’t want to ken.” (Mary, 66, autoimmune hepatitis, first interview) 
Although some participants felt well informed about some aspects of their condition, 
the consensus was that information-sharing by professionals was generally poor. 
It’s not so much misinformation, it’s no information. (Kate, 41, cryptogenic LD, first 
interview) 
Participants were generally prepared to proactively ask questions of professionals. 
However, their poor understanding of their condition left them unsure about the 
questions they should be asking.  
I don’t know what it is I want from them. I think that’s half of the problem, because I 
don’t know what the right questions are to ask or what it is I should be asking. (Kate, 41, 
cryptogenic LD, second interview) 
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BK: So do you feel that you’re kind of confident enough or happy enough to ask the 
doctors questions? (…) 
Nadia: Not really no, because I don’t really ken what I’m asking. 
(Nadia, 58, ALD (HCV), first interview) 
Even where answers were offered by healthcare professi nals, they were often 
considered unsatisfactory.  
I don’t mind asking the doctors questions, it’s theanswers that I get back! It’s a “I don’t 
know,” or “I’m not quite sure,” or “What do you think?” I’m not the one to think or make 
sure or whatever, it’s up to the doctor to tell me what’s what! And if you don’t get an 
answer from the doctor that does worry you, which can make the complaint, the 
complaint that you’ve got worse than what it is. (Mary, 66, autoimmune hepatitis, first 
interview) 
Clarity about one’s situation was also hampered by conflicting information received 
from different sources.  
You’re seeing lots and lots of different doctors all the time and you know, one of them is 
telling you one thing and another one’s telling me something else and you’re thinking, 
“Well, what’s all that about then? Who am I supposed to be listening to here?” (Kate, 41, 
cryptogenic LD, first interview) 
Both the seeking and receiving of information about their condition was thus yet 
another aspect of  participants’ illness experience that was beset with uncertainty. 
5.4.2 Knowing what to expect 
Participants were particularly poorly informed about what to expect from their 
illness, and where it was likely to lead in the future. This left them uncertain and 
worried as to how to behave to appropriately support their health. 
Somebody should be able to sort of say, “Well this will happen sometime or that will 
happen sometime,” and you know, warn you that it’s going to do and what you’ve got to 
do when it happens. (Thomas, 75, NAFLD, first interview) 
However, not everyone was keen to know what the future held in store for them. 
I don’t know how excruciating this is going to be. Not got a clue, don’t want to know. I’ll 
just take it as it comes. (Rebecca, 37, ALD, third interview) 
From Michael’s perspective as a caregiver, dealing with the uncertainty in this 
respect was not so much about professionals imparting more factual information. 
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Rather, he felt that they should alert patients andtheir families to the realities of 
managing an illness as unpredictable and uncertain as advanced liver disease.  
People get frustrated about not knowing what’s goin o  (…), but if you say right at the 
onset this is what’s going to happen, it’s going to be a big rollercoaster, it is going to be 
full of ups and downs, there’s going to be lots of times of nothing happening, people will 
come and change opinions by the second and that’s what is literally going to happen, be 
ready for it, it’s fair to challenge it and ask questions but don’t be surprised if that again 
changes, you know, that information that comes through. So if you can get that 
information across to the patient (…) that in itself for me is understanding what’s going 
on. (Michael, husband of Kate, 41, cryptogenic LD, second interview) 
5.4.3 Knowing how to self-manage  
One type of information that nearly all participants hankered for was clear advice on 
how to self-manage the illness in everyday life. The only guidance typically given 
was to abstain from alcohol and reduce the intake of salt. Overall, this was 
considered insufficient information. 
It’s all very well saying don’t touch alcohol. I mean I know that, so there’s no point 
telling me again and again and again. (…) Is there anything else you can do to at least 
give what’s left of my liver a chance to function? (John, 68, ALD, third interview) 
The lack of guidance on how to help promote their own health left participants 
feeling frustrated and annoyed. 
You know how they say maybe, like for cancer patients, eat this or eat that or eat the next 
thing. I’m not getting told, “Well you could eat this, you could eat that or the next thing,” 
or “This’ll help you,” or “It’ll help you with your immune system,” blah blah. I don’t 
know! And it’s unanswered questions. It does my head in, it really does. (Mary, 66, 
autoimmune hepatitis, first interview) 
I’m uptight at the way they’re treating me because, you know, I feel as though I’m getting 
it in bits and pieces and all that. (…) There should be a list or something handed to me or 
somebody should sit down with you and go over all these points and say, “Thou shalt not 
and thou cannot and thou can.” (Thomas, 75, NAFLD, first interview) 
Seeking self-management advice may be considered on way in which participants 
sought to regain some control in the context of a largely uncertain and alien illness 
experience. The absence of such guidance therefore constituted a major source of 
frustration in their lives. How participants coped in light of this lack of self-care 
opportunity will be described in Chapter 6.  
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5.5 Discussion of findings 
The above findings reveal uncertainty as the defining feature of the onset of 
advanced liver disease. This uncertainty caused partici nts much anxiety and 
frustration in relation to many aspects of their condition: its origins, nature, 
management and implications. In light of uncertainty emerging as such a salient and 
influential characteristic, a closer look at current u derstandings of uncertainty in 
chronic illness is first needed in order that the pr sent findings can be located and 
understood in this context.  
5.5.1 The theory of uncertainty in chronic illness 
The dynamic and unpredictable nature and timing of physical, cognitive and lifestyle 
changes in the course of a chronic illness make uncrtainty a key characteristic of 
that experience (Mast, 1995). Uncertainty is described as a person’s inability to form 
a cognitive schema, or internal representation, of a situation on account of a paucity 
of cues (Mishel, 1988). It occurs, “when details of situations are ambiguous, 
complex, unpredictable or probabilistic; when information is unavailable or 
inconsistent; and when people feel insecure in their own state of knowledge or the 
state of knowledge in general” (Brashers, 2001, p478). The person is consequently 
unable to confidently appraise their circumstances, make sense of events and 
experiences, anticipate likely outcomes, and determine their resources to cope with 
them, which may increase the stressfulness of the si uation (Lazarus, 1993). 
Mishel (1981) was the first to apply the concept of uncertainty in the context of 
health and illness. Drawing on several theories of c gnitive appraisal, her 
Uncertainty in Illness theory was originally conceptualised around the experience of 
acute illness events, but later reformulated in recognition of the specific 
characteristics of the chronic illness experience (Mishel, 1990). She proposed that 
uncertainty in illness can take four forms: ambiguity regarding the state of the illness, 
the complexity of treatment and system of care, lack of information about diagnosis 
and illness severity, and the unpredictability of the disease trajectory and prognosis 
(Mishel, 1988). More recently it has been suggested that, in addition to these medical 
sources of uncertainty, personal and social sources also exist (Brashers et al., 2003). 
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In the illness context then, uncertainty constitutes a potential stressor and an 
important factor in a person’s ability to adapt and cope, although this 
conceptualisation has been recognised as being subject to a Western cultural 
preference for predictability and control (Mishel, 1990). Figure 5 below illustrates 
the main components and pathways of Mishel’s theory of uncertainty.  
 
Figure 5: Model of perceived uncertainty in illness 
  (Source: Mishel, 1988) 
According to the model, three antecedents are thougt to influence uncertainty:  
1. The individual’s stimuli frame: this relates to the consistency of symptoms, the 
person’s familiarity with events, and the predictability of events.  
2. The person’s cognitive capacity to process information, which may be affected 
by factors such as stress or medication. 
3. The presence of structure providers: these are resou ces which assist the person 
with the interpretation of illness-related events or information. 
Much of applied research links uncertainty in illness to adverse experiential 
outcomes such as anxiety and depression. However, Mishel (1990) asserts that the 
experience of uncertainty is not inherently negative, but is in fact a neutral cognitive 
state. Its impact on a person’s illness experience is dependent upon the value that is 
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put upon it, i.e. whether it is appraised as a danger or an opportunity. For example, 
remaining ignorant of their prognosis may be anxiety- nducing for some individuals, 
but the preferred cognitive state for others. As shown in Figure 5, the appraisal of a 
situation involves two processes: inference, which is informed by the person’s traits, 
experience and knowledge as well as contextual clues, and illusion, which relates to 
beliefs that are constructed out of uncertainty andtypically result in its appraisal as 
an opportunity.  
The appraisal of a situation as a danger or opportunity affects the coping strategies 
people will adopt. Danger appraisal encourages strategies to reduce uncertainty 
through mobilising actions (such as direct action or information-seeking) and 
emotion management (e.g. through faith or disengagement). Conversely, appraisal as 
an opportunity results in attempts to uphold uncertainty by actively blocking new, 
and potentially negative, stimuli (e.g. through avoidance or re-prioritisation). Over 
time, individuals may also revise their evaluation of uncertainty from one status to 
the other (Mishel, 1990). However, both approaches to coping, where effective, will 
facilitate adaptation and thus a more positive illness experience.  
Uncertainty theory has been widely employed to assess the experiences of patients 
and their families in a range of acute and chronic health problems (Hummel, 2013, 
Neville, 2003). In liver disease, studies have shown that uncertainty plays a major 
role in the patient experience both pre- and post-transplantation (e.g. Bjørk and 
Nåden, 2008, Brown et al., 2006, Lasker et al., 2010), but there is scant application 
of the theory to the experience of living with chronic liver disease more generally 
(e.g. Bailey et al., 2009). In the following, I consider the findings presented in this 
chapter within the specific context of current understandings of uncertainty in 
chronic illness as described above, while also making reference to the wider disease-
specific literature.  
5.5.2 Receiving a diagnosis  
For many participants, receiving a diagnosis of liver disease came late in the disease 
trajectory. Their first symptoms of liver damage had commonly been non-specific, 
causing uncertainty about their nature. Eventually the first tangible symptoms, 
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already typical of advanced liver disease, prompted a firm diagnosis. The often late 
identification of liver disease due to its clinically silent nature has been noted 
previously (Heneghan and O'Grady, 2001, Wainwright, 1997), and was borne out in 
this sample.   
It is conceivable that this characteristic of early liver disease contributed to the 
finding that those misusing alcohol had not heeded th ir GPs’ warnings following 
raised liver function test results. To a lay person, blood test results are likely to be a 
rather abstract and elusive indicator of ill health; an absence of actual symptoms 
causing tangible discomfort might therefore mean that ey do not grasp that their 
health is in fact damaged and requires restorative action (Charmaz, 2000). 
Alternatively, early warnings may have been dismissed due to a lack of treatment 
offered by health professionals, an action which may facilitate patients’ appreciation 
of the seriousness of the situation (Blaxter and Cyster, 1984).  
However, the anticipation of a loss of valued roles, r ponsibilities or self may also 
cause individuals to suspend seeking help (Charmaz, 2000). This notion may serve to 
explain the finding that even where ALD participants had recognised early symptoms 
as an indication of possible liver damage, they had opted to deny these for as long as 
possible. In this context then, the cognitive process of illusion looks to have been at 
play. Uncertainty about their health status was employed as an opportunity and 
consciously maintained to help preserve their identity in the face of a likely threat. 
Receiving an explicit diagnosis of advanced liver disease was an unexpected and 
alarming event for many. This experience was heightned by healthcare 
professionals’ use of ambiguous terminology when communicating the diagnosis. 
Several participants were left uncertain about their status when given a diagnosis of 
‘cirrhosis’, a term they were only familiar with in relation to people misusing 
alcohol. Use of similarly unhelpful professional language has been reported in the 
context of receiving a diagnosis of lung cancer (Yardley, Davis and Sheldon, 2001). 
The authors cautioned that professionals need to bemindful of the language they use 
and, given the impact of receiving a diagnosis of serious illness, individualise their 
approach in the context of a patient’s specific background and circumstances. 
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Doctor-patient communication as a key area of interest in this study will be 
elaborated on in Chapter 7 in the context of participants’ accounts of their care. 
5.5.3 The physical experience of advanced liver dis ease 
Patients had often received their diagnosis at a point where for many their liver 
damage was irreversible, treatment options limited an prognosis poor. From that 
point forward their illness was erratic, unpredictable and disruptive to everyday life, 
alongside slow but steady deterioration. The physical complications experienced 
were manifold and pervasive. They could also be seen to interrelate, such as the link 
between fatigue, sleep problems and mental wellbeing, a d ascites contributing to 
mobility problems. As the physical features of advanced liver disease have been 
extensively described in the literature, I will only briefly discuss some key 
observations made in relation to this aspect of participants’ illness experience.  
Fatigue 
Fatigue constituted the most debilitating issue across all patient participants, 
reinforcing findings in similar, cross-sectional qualitative studies in advanced liver 
disease (Bjørk and Nåden, 2008, Wainwright, 1997). This finding also contributes to 
results reported elsewhere that fatigue is pervasive in various malignant and non-
malignant chronic diseases including organ failure (Janssen et al., 2008, Solano, 
Gomes and Higginson, 2006). Moreover, the longitudinal format of this study gives 
insight into the severity and unpredictable yet enduring nature of the everyday 
experience of fatigue in advanced liver disease. The data also highlight patients’ 
uncertainty regarding the legitimacy of fatigue as a typical feature of their condition.  
The data also support the notion that fatigue is a multi-dimensional experience with 
physical, emotional and mental features (Rodrigue et al., 2010). In the present study, 
fatigue could be seen to relate to participants’ sleep, anxiety and understandings of 
self. In heart failure, it has been argued that any ttempt to relieve patients’ fatigue 
should not simply focus on symptom management to minimise severity and distress, 
but should also support patients to draw on their prsonal resources and abilities to 
manage the fatigue experience (Falk et al., 2007). In light of the psychological 
impact of fatigue witnessed in the present sample, I agree with this stance. 
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Finally, given the range of aetiologies represented in this sample, the data also 
reinforces work by Jones et al. (2009) that the experience of fatigue is comparable 
between different groups of liver patient. Moreover, as their study did not include 
patients with ALD, the present study adds to their findings by showing that fatigue 
was just as crippling an experience for people with this particular disease cause.   
Motor coordination and mobility issues  
Problems related to motor coordination and mobility emerged as more troublesome 
than previously indicated in the liver disease litera ure. It has been suggested 
elsewhere that many of the more ‘minor’ complications experienced by cirrhotic 
patients, such as problems with motor function, memory or sleep, may be indicative 
of subclinical levels of hepatic encephalopathy (HE), a condition affecting the central 
nervous system and common in people with liver cirrhosis (Groeneweg et al., 1998). 
The study findings imply support for this notion; however, it is also conceivable that 
these problems were linked to patients’ fatigue as discussed above.  
The present findings intimate that motor and mobility problems are possibly more 
widespread and unsettling for patients than previously acknowledged. Indeed, these 
problems were also confirmed by members of the study’s lay advisory group. The 
relatively poor consideration of these difficulties may be due to them falling victim 
to the time pressures of a typical medical consultation, where more acute and critical 
clinical issues are prioritised by healthcare professionals in that time. Alternatively, it 
may be that patients ascribe them comparatively less importance and so omit them 
from conversation during a medical encounter. In light of the participants of this 
study feeling uncertain about the typical features of advanced liver disease, another 
explanation is that patients simply do not connect these problems to their condition. 
Possibly as a consequence of some of the above points, issues related to motor 
coordination and mobility are not always available for selection on the quality-of-life 
questionnaires commonly used to assess liver patients’ physical experience, thus 
leading to a relative underreporting of their preval nce and impact in the current 
literature.  
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This study has found psychomotor and mobility difficulties to impact negatively on 
patients’ quality of life. The uncertainty associated with these problems additionally 
challenges their sense of identity by curbing their ability to engage in valued roles 
and activities, and fosters social isolation. Irrespective of the underlying cause then, 
patients should be more routinely assessed for such problems and corrective 
treatment provided where possible. Some of the uncertainty expressed in relation to 
these complications could be alleviated by forewarning and reassuring patients that 
difficulties with motor coordination and mobility constitute a characteristic part of 
their condition.  
Pain   
Pain was noteworthy by its absence in participants’ accounts. Among this sample, 
pain was not experienced as the pervasive and disruptive problem typically seen in 
advanced disease. These findings challenge those of previous studies reporting 
substantial pain among people with advanced liver disease (Bianchi et al., 2003, Roth 
et al., 2000). Also, as these were cross-sectional questionnaire studies, they were 
unable to offer insight into the nature and extent of the pain experienced over time. 
In the present study, pain was generally associated with intermittent episodes of 
discomfort only, until it emerged as a more permanent f ature in the final stages of 
the illness.  
This study demonstrates the value of qualitative research for extending our 
understanding of patients’ illness experiences. It is possible that quantitative survey 
tools do not exclusively identify the persistent levels of pain typical in advanced 
disease and comparable to that reported in other conditi ns. Indeed, some have 
questioned the absence of longitudinal comparisons a d the arbitrary timing of 
quality-of-life research (Cirrincione et al., 2002). Depending on the timing of their 
completion by the patient, questionnaire responses may thus reflect short-lived 
episodes of pain related to, for example, ascites, nactivity or medical treatments, 
thereby giving a distorted picture of liver patients’ pain experience. Moreover, the 
participants in the study by Roth et al. (2000) were hospitalised patients. It is 
conceivable that their pain perception was affected by these circumstances, 
especially if the reason for their hospitalisation re dered them in pain at that time. 
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Relatedly, given my study data suggesting the emergence of more permanent and 
problematic pain towards participants’ final days and weeks alongside an erratic but 
steady downwards trajectory in general, it may be that previous studies captured pain 
experiences relating to these later, final stages of the illness. Lastly, in light of 
participants in this study admitting to great confusion with regard to their medication 
regimen, it is possible that they were unaware that basic levels of pain were in fact 
medicated for. Regardless, it must be concluded that pain does not dominate the 
illness experience among people with advanced liverdisease.   
5.5.4 The psychological experience of advanced live r disease 
Low mood 
The nature of this study does not allow a firm statement to be made about the 
incidence of depression and anxiety among this sample. Some participants declared 
an existing diagnosis of depression, but its relationship with their liver condition was 
unclear. However, low mood was frequently expressed by all participants and was 
evident in their demeanour during interviews. The vulnerability of one’s body and 
resultant dependency can impact greatly on individuals’ psychological wellbeing 
(Charmaz, 1997). Moreover, there is extensive evidence that uncertainty, where this 
has been appraised as a danger, fosters a pessimistic outlook as well as anxiety and 
depression. The ubiquitous uncertainty found in relation to both patients’ physical 
experience and their understanding of advanced liver disease consequently provides 
a plausible explanation for the widespread low mood identified here. 
This finding is also consistent with previous assertions that psychological status, 
levels of coping, and quality of life of cirrhotic patients are extremely poor (Bianchi 
et al., 2005, Singh et al., 1997). Psychological distress and depression have also been 
linked with disordered sleep (Bianchi et al., 2005). Insomnia was also a common 
problem among my study participants, reflecting the existing literature in advanced 
liver disease (Bianchi et al., 2003, Mostacci et al., 2008). Combined with 
participants’ expressions of low mood then, this finding may in fact be indicative of 
affective disorder.  
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As low mood affects patients’ clinical experience, psychological wellbeing should be 
regarded a priority to improve the patient experience in advanced liver disease. This 
may include pharmacological and therapeutic interventions; however, I would argue 
that exploring and subsequently addressing some of the uncertainties experienced by 
patients may go a long way towards alleviating their low feelings. It has been 
suggested that nurses could play a key role in promoting positive coping by 
addressing and pre-empting some of the uncertainties experienced by patients and 
their families (Hilton, 1992, Madar and Bar-Tal, 2009). 
Impact on patients’ sense of self 
The constant fluctuation and unpredictable onset of the above and other physical 
challenges made everyday life uncertain and frustrating. They interfered with basic 
tasks like personal hygiene and restricted previously valued activites. They also 
affected social relationships by rendering patients reliant on others for support, while 
at the same time reducing their ability to engage with ider social networks. Similar 
experiences have been witnessed in heart failure (Murray et al., 2002). As a result, 
participants struggled to align the self they knew and aspired to with the uncertain 
and challenging reality of their lives (Charmaz, 1997).  
The results of this study lend support to the notion that four particular challenges 
affect the sense of self of those living with chronic illness: living a restricted life, 
social isolation, discrediting definitions of self, and becoming a burden (Charmaz, 
1983). All four issues were clearly represented in the data. Managing this assault on 
one’s identity was thus an additional, and possibly competing, challenge for patients 
alongside the need to manage the many uncertainties presented by the disease itself.    
The uneven trajectories that define many chronic illnesses commonly allow patients 
periods of respite from acute ill health and a temporary return to previous or 
redefined levels of normality and self (e.g. Pinnock et al., 2011). In the context of 
advanced liver disease, however, its relentless pervasive impact across physical, 
psychological and social domains made any sustained distancing from the condition 
impossible. Constant fluctuations and disruptive evnts defied adaptation to its pace. 
Conversely, the nature of the condition increasingly necessitated patients’ immersion 
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in their illness, whereby the requirements of the condition dominated and defined 
patients’ actions (Charmaz, 1997). 
5.5.5 Understanding liver disease 
The absence of open, public discourse about liver disease through government 
policy, health systems or the media (over recent deca s seen most prominently in 
the realm of cancer) contributes to the lack of both public and private understanding 
about the condition and its typical features identified in this study. The influence 
public discourse carries was evidenced by participants’ alarm at being diagnosed 
with ‘cirrhosis’, a term they associated with alcohol dependency in line with past 
celebrity media coverage to that effect. A similar lack of public understanding has 
been noted in COPD (Momen et al., 2012). 
This lack of even a basic awareness of the nature of liver disease formed the basis of 
participants’ uncertainty regarding the origins of their illness and related 
complications. Patients were faced with circumstances and symptoms of which they 
had no experience or knowledge, and no general referenc  point. This uncertainty 
was further increased by an apparent a lack of education as part of their ongoing 
medical care. These findings resonate with previous research in ALD, where patients 
showed similarly poor understanding of the nature of their condition and its clinical 
features (Blaxter and Cyster, 1984). 
Understanding a disease and its implications, from the causal factors to treatments to 
a likely prognosis, can give patients a sense of control over the situation (Fan and 
Eiser, 2012) and may serve to reduce their loss of self (Charmaz, 1983). Moreover, a 
medical understanding of the disease may promote its conceptualisation as an entity 
separate from the ill person’s self, thus helping idividuals distance themselves from 
the disease (Bury, 1982). However, as I have argued earlier, the data suggest that in 
advanced liver disease it is not easily possible to create such distance due to the 
condition’s persistent and all-encompassing nature. In spite of this, access to 
unambiguous information is desireable as an important means by which to inhibit the 
stressful experience of uncertainty (Brashers, 2001, Mishel, 1988).   
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Poor understanding of their condition, its symptoms and management has also been 
reported in cardiorespiratory patients (Exley et al., 2005) and people with heart 
failure (Boyd et al., 2004, Murray et al., 2002). Understanding symptoms and 
treatment have been shown to help reduce uncertainty in heart failure (Winters, 
1999). In the present study, the absence of factual understanding left participants 
struggling to make sense of and legitimise some of the physical difficulties they were 
experiencing, thus adding to their psychological illness burden.   
5.5.6 Information needs 
Uncertainty, alongside patients’ poor understanding, also impacted on their ability to 
proactively seek a better understanding of their illness and its implications. Some 
were confused and uncertain about what they would want to know more about. At 
the same time, there was evidence that living with uncertainty about one’s condition 
was a preferred state for some, a finding also report d in COPD (Pinnock et al., 
2011). In these instances, uncertainty could again be seen to be employed as an 
opportunity. Faced with potentially threatening information, these individuals chose 
to actively maintain their uncertainty (Mishel, 1990). Remaining ignorant was 
utilised as a preferred positive option for safeguarding one’s self and wider 
psychological wellbeing - not knowing was considere b tter than knowing (Neville, 
2003). Uncertainty was thus managed based on the person’s assessment of whether 
having certainty about their condition would empower or undermine them (Cohen, 
1993). This finding confirms that reducing uncertain y is not necessarily a person’s 
desired goal (Brashers et al., 2000).  
Most patient participants felt frustrated about what t ey perceived to be a paucity and 
poor quality of information provided by care professionals. At the same time, they  
displayed differing levels of need regarding the nature of the desired information. 
Some participants displayed a real tension between wishing to gain more information 
and not wanting to know, which added to their anxieties. Evidently then, information 
has the potential to increase or decrease uncertainty. Even where new information 
fails to reduce the ambiguity of the person’s situat on, it may serve to prompt a re-
evaluation of uncertainty (Brashers et al., 2000). The findings of this study also 
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remind us of the importance of tailoring information to individual need and 
imparting this in the right manner, context and setting. It is essential that 
professionals ascertain patients’ level of understanding and encourage them to ask 
questions in order to establish how much information they wish for and their 
readiness to receive it (Parker et al., 2007, Sell et a ., 1993). 
Contemplating the perceived lack of information about their condition among this 
group, I considered that a number of scenarios werelikely to be at play here:  
• The deliberate omission of information in an area, perhaps in an attempt by 
professionals to uphold patients’ hopes and not unduly alarm them. However, 
professionals may be acting overcautiously in this regard. An interview study of 
lung cancer patients about their experience of receiving a diagnosis revealed that 
none felt they had been given too much information; n fact, they would have 
appreciated more (Sell et al., 1993). 
• Clincial or professional uncertainty about particular features of the disease 
rendering healthcare providers unable to provide certain information. In such 
instances, professionals should alert patients and their families to these 
uncertainties, and support them in accepting that uncertainty is a reality of their 
life with chronic illness (Mishel, 1999). 
• Information that was in fact provided, but was too medicalised, complex or 
piece-meal to be taken on board by the participants. The quality of information 
given by professionals can impact upon the patient’s appraisal of an uncertain 
situation and is dependent on the quality of its features: clarity, accuracy, 
completeness, volume, ambiguity, consistency, applicability and patients’ 
confidence in the source of the information (Babrow, Kasch and Ford, 1998). 
• Information provided by professionals and received by participants, but 
conflicting that given by other professionals involved in their care, leaving 
patients confused. This scenario will be examined in more detail in Chapter 7 in 
the context of patient participants’ care experiences.  
 
  106 
• Information provided, but forgotten about or not taken on board due to a lack of 
cognitive ability by patients to comprehend, assimilate and apply the 
information. This could be due to information overload, its content being too 
upsetting to be absorbed, or fatigue or minimal HE interfering with information 
retention or processing. 
• Information that was provided, but deliberately ‘buried’ by patients as it was too 
emotional to contemplate and threatened the person’s sense of self. 
• Information that was simply overlooked and so not passed on by professionals, 
or not necessarily considered relevant or important o patients to be offered up 
front, but that would have been readily available if patients had asked for it. 
However, the data showed that people were often unsure about what questions to 
ask or lacked the confidence to ask them.  
Finally, it is worth considering to what extent participants were actually alert to a 
lack of information before they started to talk about their experiences as part of the 
interviews. My prompting questions may have served to highlight to them certain 
issues they had not been told about or had been uncertain of, and as a result now 
perceived these as important and lacking. At the same time, the interviews may have 
constituted the first time that these patients had got to contemplate and articulate 
what they would want more of, or were lacking at the moment, as regards 
information. It is therefore conceivable that the interviews contributed to the creation 
of ‘dissatisfied customers’.  
5.5.7 The special case of alcohol-related liver dis ease 
The results point towards some specific characteristics of the patient experience in 
ALD that are worth noting. The findings suggest that the physical challenges and 
experiences are comparable between aetiologies. The main observable difference 
was that ALD participants were generally better able to take on board and come to 
terms with their illness as they fully understood its cause and, to some extent, had 
‘seen it coming’. This finding diverges from previous research where ALD patients 
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displayed considerable ignorance and confusion regarding their diagnosis (Blaxter 
and Cyster, 1984).  
Moreover, these participants had the ability to interrupt and influence their illness 
trajectory by ceasing their harmful alcohol consumption. This change in their 
behaviour was able to halt further progression of the disease and stabilise their 
condition. Both John and Sarah were examples of this scenario. In both cases, 
traumatic acute hospital admissions on account of their liver damage served as the 
turning point in their illness experiences. An experience may be considered a turning 
point where it can be seen to have a transformationl effect on a person’s life 
(Denzin, 1989). Faced with uncertainty relating to b th present and future, both 
participants recognised sobriety as the single factor in the context of their illness that 
they would be able to exert control over. As such, pursuing sobriety constituted both 
a means of managing uncertainty and an opportunity for change. This finding lends 
support to the notion that uncertainty is an evolving process, in that individuals may 
gradually revise their evaluation of uncertainty from danger to opportunity (Mishel, 
1990). Embracing uncertainty may subsequently facilit te a new orientation to life. 
The ability to have relative control over the progression of their illness resulted in 
these particular participants having markedly different experiences in some aspects 
of their illness. Further related observations in this respect will be highlighted and 
discussed throughout the following chapters where appropriate.  
5.6 Concluding remarks 
Participants’ accounts of the beginnings and everyday physical and psychological 
experience of advanced liver disease were marked by pervasive and enduring 
uncertainty. Consequently, I found that uncertainty theory as applied to chronic 
illness provided explanatory power for many of the study’s findings (Mishel, 1990). 
Uncertainty is beset with ambiguity, vagueness, unpredictability and a lack of 
information (Mishel, 1981). All of these aspects were clearly represented in the data 
described in this chapter. To my knowledge, this is the first time uncertainty theory 
has been used to illuminate the lived experience of advanced liver disease.  
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Uncertainty was an important mediating factor in respect of people’s poor 
understanding of liver disease and information-seeking behaviour. The information 
shared by professionals was perceived as limited and of poor quality. Being explicit 
about the uncertain nature of the condition may in itself serve to reduce patients’ 
anxieties in this respect. 
The results in this chapter contribute some new insight  to the literature in advanced 
liver disease. They show the ubiquity and complexity of some of the complications 
experienced, such as fatigue and ascites, and give an indication of their relative 
impact on participants’ everyday lives. Issues relating to patients’ motor co-
ordination and mobility emerged as more widespread and troublesome than 
previously intimated. Conversely, pain was notable y its relative absence. The 
ability of ALD patients to delay disease progression by way of sustained sobriety, 
and to consequently embark on a divergent illness pathway to that of their 
counterparts, was highlighted. 
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Chapter 6: Negotiating everyday life 
The previous chapter indicated that the experience of advanced liver disease was 
from its very beginning defined by widespread and euring uncertainty, which 
related to the unpredictable nature of the disease  well as patients’ poor 
understanding of their condition. 
This chapter considers the experience of negotiating everyday life with the disease. 
First, it highlights some life-related stressors affecting participants’ lives. It then 
shows how patients coped, and the strategies they employed to manage their 
challenging circumstances. It further describes the impact the illness had on their 
social relationships. Lastly, it sets out patients’ holistic support needs and some of 
the barriers to accessing appropriate support. A discussion of these findings in the 
context of previous research and the theoretical literature concludes this chapter.  
6.1 Life-related stressors 
In addition to the physical challenges and a poor general understanding of their 
disease as described in the previous chapter, partici nts’ illness experience was also 
affected by factors which related to general life crcumstances beyond their illness.   
6.1.1 Inability to work 
Many patient participants of working age had been forced to take long-term sickness 
leave from work; in some cases their employment had since been terminated. The 
inability to work was felt acutely in this group, particularly by the younger 
participants, and contributed to their low mood.  
The more that you’re not working the more depressed you get, sitting in here. (Ben, 35, 
ALD, first interview) 
Uncertainty about the likelihood of being able to wrk again in the future added to 
their sorrow. 
I still get a bit down when I think about what’s going to happen with work and if I’m ever 
going to be able to work again. (Carol, 45, ALD, second interview) 
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Participants actively missed not being able to go work as it had made them feel 
‘normal’. Over time, they started to struggle with the lack of purpose to their days, as 
it made days feel long and frustrating to endure. 
Stuck in this house day after day, it’s just like I xist. It’s not like a life. (Ben, 35, ALD, 
third interview)  
6.1.2 Financial pressures 
The inability to work put these individuals under great financial pressure, which 
added to the burden of their illness.  
It’s the financial side of things that’s bothering me more than anything else, just because I 
know there’s going to be no money coming in at the end of the month. (Kate, 41, 
cryptogenic LD, first interview) 
As time passed, younger participants found themselve  increasingly financially 
dependent on their families to make ends meet. Given th  uncertain circumstances, 
however, their caregivers felt similar pressure. 
We’re not quite sure where we are going to go now, because Kate contributes financially 
and she can’t do that anymore and won’t be able to for some time. Do we sell the house? 
Do we move? Do we do it now when Kate’s quite well? Do we wait, keep our fingers 
crossed that things are going to be ok? (Michael, husband of Kate, 41, cryptogenic LD, 
first interview) 
6.1.3 Accommodation issues 
Some participants were also dealing with worries rega ding their accommodation. In 
some cases this was related to the suitability of their current abode, especially with 
regard to having to negotiate stairs in their often weakened and unstable condition. 
For those with a lack of social support, regular rehousing by social work services 
added to the challenges of their illness experience.  
I think there were problems in some of the tenancies that he was in. So sometimes he 
would come in[to hospital] and he would become homeless while he was in with us and 
we would have to try and sort out further accommodati n for him. (Consultant of Fraser, 
60, ALD) 
Aidan lived in temporary social care accommodation, which demanded that residents 
were absent for no more than three days at a time or risked being removed from the 
abode. Aidan’s regular inpatient attendance for paracentesis therefore meant that 
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every admission put his home at risk, with the regular delays in having the procedure 
carried out causing additional stress and uncertainty in this respect. 
I phoned up [the temporary accommodation] last night and they said, (…) “I thought you 
would have got it done today,” and I says, “Aye so did I,” I says. “But they’re coming to 
do it tonight,” which they didn’t. So we’ll wait and see what happens today but I says to 
him, “If I get it done today I’ve still got to get out tomorrow.” (Aidan, 60, ALD, first 
interview) 
6.1.4 Alcohol dependency 
The illness accounts of participants who identified as alcohol dependent were 
dominated by their struggles to overcome this harmful behaviour. They recognised 
the urgent necessity to conquer their alcohol problems in order to gain control over 
their advancing liver disease, while at the same time struggling with uncertainty 
about their ability to achieve this. 
Ben: There’s going to be problems in life and I don’t k ow what I’m going to turn to, 
because I can’t turn to alcohol now. I’m going to have to deal with stuff like adults 
instead of panicking and going into the fridge. 
BK: How does that prospect make you feel?   
B: Scared. Because it’s going to get a lot worse before it gets better in the future.   
(Ben, 35, ALD, first interview) 
For these participants, the quest to achieve abstinence occupied their minds over and 
above any concerns about their liver disease, which added considerably to their 
psychological burden. 
The above illustrates how the illness related to participants’ wider life circumstances, 
with a knock-on effect on their psychogical wellbeing, sense of self, and close 
relationships. All of these factors constituted furthe  sources of uncertainty in the 
overall illness experience.  
6.1.5 Stigma 
Participants were acutely aware of the stigmatising reputation of liver disease, and 
especially its popular association with alcohol misuse. Some participants related 
incidents of stigma in relation to this common assumption in the healthcare setting. 
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People automatically assume that you’ve got an alcohol problem. It’s an automatic, even 
doctors in the hospital (…) they’ll say to me, “So h w’s the drinking going?” And I’ll 
say, “I don’t know, because I don’t drink.” (Kate, 41, cryptogenic LD, first interview) 
While most denied any actual experience of stigmatising behaviour by professionals, 
several participants with ALD perceived stigma due to the nature of their illness. 
Rebecca: I might just be paranoid but I feel like th y treat me different to other patients. 
BK: OK. In what way? 
R: Because they get more attention than me. (…) They’re always really nice to them. 
Sometimes I feel like they just walk past me. 
(Rebecca, 37, ALD, third interview)  
Participants also perceived illness-related stigma in everyday life. The largely 
invisible nature of their illness was one factor in this respect. 
I see people looking at me on the bus too because I got a bus pass as well, and you see 
people, even the drivers, two of the drivers said to me, “How did you manage to get a bus 
pass then?” (Kate, 41, cryptogenic LD, third interview) 
There was concern about people’s assumptions tarnishing one’s reputation.  
I went down to the Co-op the other day on Tuesday, and [neighbour] next door, his mum 
was standing outstanding the Co-op and she went, “Oh Mary,” she says, “what a weight 
you’ve put on.” I said, “It’s not weight, (…) it’s fluid.” Another woman accused me of 
drinking. I says, “You spread that about [the village],” I said, “I’ll take you to the 
cleaners. Defamation of character.” (Mary, 66, autoimmune hepatitis, second interview) 
The anticipation of stigma was thus a further source of uncertainty in participants’ 
lives and led many to adopt strategies for avoiding potentially stigmatising situations, 
such as pre-empting false assumptions or avoiding disclosure altogether. 
I go to (…) great lengths to make sure they know it as not drinking, because that’s the 
first thing I say to them, I say, “It’s not drink-related, because I didn’t drink a lot.” 
(Thomas, 75, NAFLD, first interview) 
BK: Is there a reason why you don’t give people anydetails [about wife’s illness]? 
Jeff: No. The way I look at it is that’s our business, you know? You’re better keeping it 
because somebody maybe says something, somebody adds something else onto it, you 
know? You know what people are like. 
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6.2 Coping 
6.2.1 Characteristics of patients’ coping 
Increasing physical complications over time negatively affected participants’ 
psychological state, often due to a realisation that continued physical decline was 
likely as well as feelings of uncertainty and fear about future developments. 
Participants’ coping with their illness varied betwen individuals and over time. 
Some expressed acceptance of their situation. Despite the added ambiguity of having 
liver damage through unidentified causes, Kate was philosophical about her lot. 
It’s just one of them, you know? You live with what you’ve got and everybody’s got 
something, that’s how I think of it. (Kate, 41, cryptogenic LD, third interview) 
Those with liver disease from self-inflicted causes such as alcohol were equally 
accepting of their plight. 
There’s not point feeling sorry for yourself. What’s done is done. And I’ve done it 
myself, so. (Rebecca, 37, ALD, second interview) 
Older participants found it easier to accept their fate on account of their age. 
I can’t do nothing else. (…) It’s no as if I’m a young man or anything. I’m 75, so I’ve had 
a good life ken, and I’ve had a good time. (Donald, 74, HCC (NAFLD), first interview) 
Learning to cope with their situation was a process which evolved over time. 
Julie: I think if you worried about it that much you would really, wouldn’t go out the 
house, you wouldn’t do anything. 
Rebecca: I did for a wee while. 
(Rebecca, 37, ALD, and Julie, mother of Rebecca, second interview) 
I don’t feel the need to be in people’s company all the time, you know? I was really 
lonely before, but I don’t feel lonely, even when I’m alone I’m not lonely now. (Sarah, 
38, ALD (HCV), second interview) 
For those enjoying an overall more stable physical condition, feeling physically well 
promoted a more positive mindset and thus better coping. 
If I wasn’t feeling terribly well it would certainly be worrying me, I wouldn’t be happy at 
all. But I feel fine so that’s that, that’s an advantage. (John, 68, ALD, third interview) 
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One notable exception to the above was Ben, who experienced an inverse 
relationship between his physical and psychological condition. Feeling progressively 
better with debilitating symptoms subsiding owing to successful abstinence, Ben was 
eager to return to work and his previous levels of activity in general. However, his 
overall condition remained too poorly to allow him to do so. Being forced to 
recuperate at home without a focus to his days and little to distract him from the 
enduring uncertainties of his situation therefore aff cted his coping negatively. 
As you’ve said before, what’s the worst that can happen? In the past I used to agree with 
you, but now... Well, I could go to hospital again. I could end up dead. I could end up 
losing [partner and son] again. I might never get back to work or full fitness again. See, I 
was positive last time I spoke to you, but now it’sall negative thoughts. (Ben, 35, ALD, 
second interview) 
Indeed, despite expressions of acceptance and an indication of a positive outlook 
from some participants, low mood was widespread across the sample.   
Before I was happy-go-lucky, laughing and joking with everybody and anybody, but now 
it’s, I don’t know, I just want to curl up now. (Mary, 66, autoimmune hepatitis, second 
interview) 
Uncertainty and a fear of the unknown contributed to participants’ poor coping.  
I’m scared to get out my bed now every day, because s I say the fear, you know, of what 
I’ve done to myself, the damage that I might’ve caused myself, I can’t get out of my 
mind. (Ben, 35, ALD, second interview) 
6.2.2 Impact on self-image 
Several participants were also preoccupied with the p ysical stigmata of their liver 
disease, which affected how they felt about themselve  and their experience.  
We were going to go down to [town] tomorrow, [friend] and I, but the way I look I feel 
that I’m an embarrassment. (…) I’m an embarrassment with the bulge. (Mary, 66, 
autoimmune hepatitis, second interview) 
My arms are like sticks. I’ve no muscle in them and like, it disgusts me, like, looking at 
my body in the mirror because of how skinny I’ve got, and that dents your confidence. 
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All patient participants engaged in comparisons betwe n their present and their past 
selves. Several described themselves as strong and determined characters. The 
changes brought about by their illness therefore unsettled their existing self-image, 
making them feel increasingly anxious and low.  
I don’t want to have to rely on other people. That’s the frightening part, because I’ve 
never had to do it. Other people always rely on me and I don’t like that feeling at all, 
having to rely on other people. (Kate, 41, cryptogenic LD, first interview) 
The loss of previous abilities was particularly acutely felt. 
Sometimes I lie in the room and cry and just think about things, you know, things that 
you could remember that you could do and now you can’t. (Fraser, 60, ALD, first 
interview) 
Importantly, being able to engage in treasured activities such as travel, work or 
physical activity was what had made participants feel ‘normal’, a status they were 
yearning to reclaim. For those with underlying alcohol problems, having to remain 
abstinent constituted an additional barrier to feeling ‘normal’. 
I’d like to be normal and have a social drink, not ge drunk, but have a social drink. But I 
can’t do that. (Sarah, 38, ALD (HCV), second interview) 
Participants also felt that the illness had changed th m as a person. This was an idea 
many found difficult to come to terms with. 
It feels like I’m...this isn’t my life like, I’ve stepped into somebody else’s shoes. Like a 
few years ago that was me, that was Ben, that was my life, and now I don’t know who I 
am. (Ben, 35, ALD, third interview) 
John and Sarah were notable exceptions in this respect. Unlike some of their ALD 
counterparts, both succeeded in remaining abstinent throughout the course of the 
study and as a result were able to enjoy improved overall health and quality of life. 
They too felt that their illness experience had changed them as a person. However, 
they perceived this as a positive event, as they were able to reclaim their original 
selves prior to alcohol dependency. 
In a sense I am more normal than I was when I was normal, because alcohol’s been taken 
out of the equation. (John, 68, ALD, third interview) 
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6.2.3 Coping strategies  
Participants displayed a range of coping strategies to manage their challenging 
circumstances. The following were the most prominent approaches employed across 
the sample. 
Getting on with it 
Many participants had resigned themselves to their fate and felt that all they could do 
was to ‘just get on with it’.  
There’s no way out of it, no even a short cut. You’ve just got to grin and bear it. (Fraser, 
60, ALD, first interview) 
This stance of ‘getting on with it’ was evident in some people’s quests to continue to 
lead a ‘normal’ life. However, success in this regard proved elusive for most. 
I do try. I make an effort, like, appearance-wise and cleaning-wise and cooking-wise and 
stuff, but after it I’m knackered. (Rebecca, 37, ALD, third interview) 
Taking one day at a time 
One strategy which helped participants control these challenges was to narrow their 
focus to one day at a time.  
You can’t turn around and plan for the future or nothing, you know? You just take 
everything as it comes, day by day. (Jeff, husband of Polly, 68, NAFLD, first interview) 
Because of the liver I don’t know how long I’ve got left (…) so I live for today. (Sarah, 
38, ALD (HCV), first interview) 
Not dwelling on it 
Many participants also consciously averted their focus away from their situation so 
as to not add to their own, and others’, worries. 
What’s the point in thinking about it the now, because it’s just going to stress me out. It’s 
going to make me feel even worse about myself and everybody else around me. 
(Rebecca, 37, ALD, third interview) 
Comparing self to others 
While there was a reluctance to contemplate the details of their own situation, many 
participants found it helpful to compare their illness experience to that of others. 
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Despite their own poor wellbeing, they generally considered themselves more 
privileged than others.  
There’s always somebody worse than yourself. (Fay, 84, NAFLD, first interview) 
Participants’ inpatient episodes proved particularly useful for making comparisons, 
as they afforded an opportunity to observe the plight of others with liver disease.  
When you’re in and out of hospital all the time, it k nd of makes you stop looking at 
yourself and think, “Well look at all these people that are a lot worse off than I am.” (…) 
And that kind of spurs me on a bit, because I think, “Now what am I making all this noise 
about?” (Kate, 41, cryptogenic LD, second interview) 
Those with ALD also compared themselves to other heavy drinkers. These 
participants typically concluded that a weaker constitution or predisposition must 
have contributed to their illness developing.  
Sometimes I do think maybe my liver was or is weaker than other people’s, because I’ve 
seen the amount of people that, it’s incredible how much they drink and they’ve never 
been in hospital and they never go jaundiced and they drink every day. (Ben, 35, ALD, 
second interview) 
Focusing on a positive outcome 
Another prominent coping strategy was a conscious mental focus on a positive future 
outcome. Given the advanced and incurable disease st tus of all participants, this 
stance must be considered a deliberate cognitive and emotional distancing to enable 
better coping in the face of uncertainty.  
As far as I’m concerned I have a problem. I’ve got a liver that doesn’t work and the only 
way it’s going to be fixed is if they take it out and give a new one, and that’s what’s 
going to happen. I don’t know when it’s going to happen, but it’s going to happen. And 
after that life’s going to be hunky dory. And there is no doubt in my mind whatsoever that 
anything other than a positive outcome is going to be. (Kate, 41, cryptogenic LD, third 
interview) 
A key strategy to maintaining a positive mindset was to put their faith in healthcare 
professionals and their abilities and commitment to achieving the best possible 
outcome.  
I don’t really worry about my health because I’m in good hands here. As far as I’m 
concerned they know what they’re talking about. Whether they do or not that’s another 
matter. (Mary, 66, autoimmune hepatitis, first interview) 
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Taking responsibility for health improvement 
At the same time, there was an appreciation that one also needed to make a personal 
effort towards health improvement.  
What’s the point in coming in here, getting them to do all of this for me, if I’m not even 
going to help them, you know? (Aidan, 58, ALD, first interview) 
Consequently, participants spoke of committed attemp s to adhere to their medication 
regimes, dietary stipulations, and refraining from alcohol consumption. They also 
looked towards popular lifestyle advice to support their health further. Indeed, in the 
absence of understanding and guidance regarding their illness as described in 
Chapter 5, many participants resolutely put their energy into improving their 
condition by pursuing self-care strategies of their own design. 
I don’t think that every time they drain [the fluid] off that they’re getting me back to 
where I was. I think there’s just a bit, a bit heavi r, a bit heavier. So I’m actually putting 
myself onto a diet to try and lose some weight to see if that’ll help. (Thomas, 75, NAFLD, 
first interview) 
This eagerness to better their situation made some push themselves to unsafe levels. 
[Friend] says, “You’re trying too much for it to make yourself better Mary. Let yourself 
get better in its own time.” I says, “I can’t wait that long.” But I feel I can’t wait that long. 
I want to get better yesterday, not today or the morn. (Mary, 66, autoimmune hepatitis, 
first interview) 
Faith 
Three of the 15 patient participants declared an active faith from which they drew 
strength to help them cope with their illness. While most denied any form of 
spirituality, some participants did indicate a level of spiritual engagement in the 
context of their illness.  
I believe there’s someone looking after me, but I always talk about it as a guardian angel. 
(Sarah, 38, ALD (HCV), third interview) 
It’s very difficult to articulate it, because it’s not what most people would think of as a 
faith. It’s more an attitude. (John, 68, ALD, first interview) 
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6.3 Social relationships 
With few exceptions, levels of social contact remained poor or declined over time. 
This means that those already isolated from their pr vious social networks remained 
socially isolated throughout their illness. Several factors contributed to this isolation. 
Some participants lived a distance from family and close friends due to previous life 
choices. Others were estranged from their relations. This scenario was true across 
disease causes and was not exclusive to those with troubled backgrounds such as 
alcohol dependency. Indeed, participants with alcohol problems were just as likely to 
have the support of a loving family as those withou.  
For some participants, their failing health meant that levels of activity and social 
contact decreased as they became increasingly less motivated, energetic and able to 
travel around. 
Polly: I’m a quiet person, eh? I mean, I never go out. Yes. 
BK: Has that always been like that or just since you g t ill? 
P: No, just since I got ill. 
(Polly, 68, NAFLD, first interview) 
The loss of an active working life also contributed o this segregation from previous 
social networks, as did frequent hospitalisation. 
Julie: We have a lot of parties for people's birthdays, engagements, anniversaries and 
things like that. (…) And it's a shame you [Rebecca] can’t go to them, eh? (…) She's 
usually in the hospital at the time. She couldn’t go to my 60th. She couldn’t go to her 
brother's 40th. What else now, Rebecca? What else did you miss? 
R: Everything. 
(Rebecca, 37, ALD, and Julie, mother of Rebecca, first interview) 
In contrast, some ALD participants were able to improve social contact over time; 
this was usually due to their condition stabilising with sustained abstinence. This 
motivated dedicated efforts to rekindle intimate relationships after previous 
estrangement due to alcohol problems or ill health.  
I’m meeting my friends a lot more regular as well and I’m trying to see my family as 
much as I can. (Sarah, 38, ALD (HCV), third interview) 
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6.3.1 Discussing the illness 
Patient participants were acutely aware of the pressur  their illness was putting on 
those close to them. They consequently avoided adding to this burden by hiding their 
emotions and worries from them. 
I don’t hide the problem from people, I hide the feeling from people. I’m always 
conscious that other people get quite upset by the things you tell them, so I tend to kind of 
keep my feelings to myself a bit or hold back and try and pick my moment. (Kate, 41, 
cryptogenic LD, second interview) 
There was also great reluctance to discuss the illnss with others beyond the 
immediate family circle.  
I wouldn’t be prepared to tell my friends what I’ve b en through, you know? Maybe it 
will come in time with [best friend], maybe I’ll be able to tell her, but not at the moment. 
(Carol, 45, ALD, first interview) 
For some, avoiding discussion additionally provided a means of keeping the illness at 
bay as much as possible.  
I don’t like talking about it because I don’t want to be reminded of it. (Ben, 35, ALD, first 
interview) 
6.4 Support needs 
When asked directly about their support needs, several participants reported feeling 
well supported and managing fine with available resources. 
I feel like I’m, you know, I’ve been supported at the moment pretty well. (Carol, 45, 
ALD, first interview) 
However, not everybody agreed that all their needs were well attended to. 
I feel as though it’s a bit of a shambles, is how I feel about it. I know everybody’s busy 
and I know, you know, all this, but I think if I wasn’t the type of person that I am, if I had 
been on my own with nobody else there to support me, i.e. no husband and no family, 
then I think I would have probably gone into a shell and not come out again. (Kate, 41, 
cryptogenic LD, second interview) 
I feel I’m neglected. (Mary, 66, autoimmune hepatitis, second interview) 
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Indeed, even among those expressing satisfaction with the support they were 
receiving, their narratives revealed a range of needs that appeared in fact poorly 
addressed. 
6.4.1 Types of support need identified 
Practical support needs 
As highlighted in Section 5.3, the physical complications associated with advanced 
liver disease posed a number of practical challenges which needed negotiating on a 
daily basis and for which assistance was frequently required.  
 [My sister], she’ll like go down the post office for me if I feel like, I’m unwell in the 
morning and like, maybe get my money for me and get shopping and stuff. She’ll hoover 
for me if I’ve got a sore back. (Rebecca, 37, ALD, third interview) 
Sarah, who lived alone and had no immediate support available to her, anticipated 
struggling with basic household tasks in the wake of her latest discharge.  
When I get out of hospital it’s gonna be difficult, you know? I won’t be able to carry a lot 
of messages home, plus I won’t be able to cook, I won’t be able to stand and cook very 
long either. So it’s gonna, you know, be quite basic foods. (Sarah, 38, ALD (HCV), first 
interview) 
Many participants required assistance with personal hygiene due to being rendered 
inflexible by ascites or problems with their balance. Several also required support 
with attending medical appointments. This not only related to needing to be 
transported to them due to frailty and mobility problems, but also to the ability to 
compute the information being discussed.  
[Friend] sits in with basically everything that I do, because my memory’s a bit funny at 
the moment (…) and [friend] will pick up on things that I don’t pick up on. (Mary, 66, 
autoimmune hepatitis, second interview) 
Many participants’ homes became increasingly unsuitable as their condition 
deteriorated. Negotiating stairs in particular became a problem as they struggled with 
poor mobility, imbalance and breathlessness due to ascites. Mary had enquired about 
the option of installing a stairlift in her home, but to no avail. 
Walking up these stairs and back down again kills me. (…) They’d no even listen to me 
when I spoke about that electric chair. (Mary, 66, autoimmune hepatitis, second 
interview) 
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Patients’ physical support needs generally increased as their condition, and thus 
abilities, declined over time. At the start of his study involvement for example, 
Martin was solely supported by his wife Cora. By his third interview nine months 
later, Martin’s condition had deteriorated to a point where he needed professional 
care at home four times daily. 
Psychological support needs 
Participants’ accounts indicated a lack of psychological and emotional support in 
relation to living with advanced liver disease. Indee , patients voiced dissatisfaction 
with healthcare professionals’ approaches to addressing their psychological needs.  
They just gave us anti-depressants and I don’t want anti-depressants. (Mary, 66, 
autoimmune hepatitis, second interview) 
Several participants expressed their appreciation of the chance to discuss living with 
their illness as part of the research interviews and wished for access to more such 
opportunities.  
It’s good to be able to talk to someone you know is listening, you know, rather than just, 
‘Aye I’ve got this wrong with me, I’ve got that wrong’ and they’re away talking about 
football or something, or just not taking it in. (Aidan, 58, ALD, first interview) 
Exposure to other patients and an opportunity to compare illness experiences with 
them was considered particularly beneficial. 
What Kate’s really wanting is probably just somebody to talk to about how she’s feeling, 
how her condition is developing. Debate, almost, the fact that she’s feeling this way, and 
does this other person feel the same and stuff like that. (Michael, husband of Kate, 41, 
cryptogenic LD, second interview) 
The need to speak about their situation was also heightened by participants’ 
reluctance to further burden their loved ones, as mentioned earlier in Section 6.3.1.  
I don’t know what there is that could support Ben, because as he says he needs somebody 
to talk to, because he’s really only got me and [son] and as he says he doesn’t want to 
keep boring me, (…) venting off to me all the time. So he starts to keep it inside and then 
he explodes because he’s built up all of this in his head. (Tamsin, partner of Ben, 35, 
ALD, second interview) 
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Abstinence support 
Those with a history of alcohol misuse had additional support needs in relation to 
helping them overcome this damaging habit to enable their liver condition to 
stabilise. There was a sense that care professional did not appreciate the reality of 
living with alcohol dependency. 
You’ve got to have something in place to support you to come off alcohol. It’s alright for 
doctors and that to say to stop drinking and then w’ll get you treatment. (…)  If you stop 
drinking, what else is there to stop you going back to it? (…) It’s really difficult to give 
up alcohol because it’s like your friend, you know? (Sarah, 38, ALD (HCV), third 
interview) 
Many ALD participants had previously accessed alcohol support services. There was 
consensus, however, that available services were not always suited to their needs, 
especially with regard to them having to cope with serious illness in addition to their 
alcohol problems.  
I got referred to an alcohol referrals group, but they weren’t very helpful. (…) Because of 
the shock of the illness and everything I kind of withdrew and isolated myself into myself 
and they kind of gave up quite quickly, perhaps just felt that I didn’t want the help. But 
it’s not that I didn’t want the help, it’s just I wasn’t coping particularly well. (Sarah, 38, 
ALD (HCV), first interview) 
In addition, the time delay between hospital discharge and referrals being picked up 
by community-based services was considered too long.
In the past the alcohol liaison team would refer Ben to [local town], but by the time they 
got in touch with Ben and sent a letter and an appointment it was a good few weeks later. 
It might be good if they could get in earlier and give you a bit of a boost as soon as you’re 
home, like a follow-up phone call, “Well you were in hospital because of this, how are 
you doing? Is there anything I can help you with?” (Tamsin, partner of Ben, 35, ALD, 
first interview) 
The professionals interviewed were in agreement that current support arrangements 
for those with additional alcohol problems were inadequate. Ongoing support once 
abstinence was achieved was similarly considered unsuitable for some, thus putting 
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6.4.2 Barriers to accessing support 
The interviews served to identify a number of barriers to accessing support. Having 
to proactively ask for support from others proved a ch llenge for several participants, 
due to a lack of confidence or reluctance to impose n others. Moreover, many did 
not like the idea of accepting outside support even when this was offered to them.  
They’re wanting me to have a carer that comes in to get you out of bed and help you 
wash, but I’m not wanting that. No, I have been independent too long. (Fay, 84, NAFLD, 
third interview) 
We’re not a couple that want people to come into our house. (Jeff, husband of Polly, 68, 
NAFLD, first interview) 
There was also concern about the potential costs involved in accepting outside help.  
I don’t know what care I’ll get when I go [home]. [Friend] says put in for a home help but 
then I’d have to pay for a home help. (Mary, 66, autoimmune hepatitis, first interview) 
Physical access to support services where these weravailable proved another 
barrier, as many participants relied on others to take them places due to their poorly 
condition. Interestingly, distance was also a barrier where participants considered 
support services too local or familiar.  
Rebecca: There’s a place along the road actually (…).
Julie: That’s for all [neighbourhood], aye. The thing is you walk into it, Rebecca, and you 
ken half the folk. 
R: I know. I don’t want to broadcast all my stuff. 
(Rebecca, 37, ALD, and Julie, mother of Rebecca, second interview) 
A lack of knowledge of what support services were avail ble emerged as another 
barrier. Many participants felt unable to articulate what support they would value 
most as they were unaware what may be available to them. Michael questioned the 
availability of support services specific to the needs of those living with liver disease, 
and in particular outside of large cities. 
I don’t think it exists. That’s my point, you know? I don’t think there is anything in 
between there for liver disease or...You can go to Macmillan for cancer care, which I get 
because it is one of the bigger, you know, illnesses out there, I understand that. But there 
is nothing specifically around what Kate is going through just now, particularly in a rural 
place. (Michael, husband of Kate, 41, cryptogenic LD, second interview) 
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Even where local, disease-specific support services were available, this information 
was not always communicated by care professionals. For many months Sarah had 
been unaware that there were organisations local to her, which supported people 
living with hepatitis C like her. She only found out about these services by chance 
after mustering the strength to seek counselling for her psychological problems. 
It wasn’t till the counsellor had said that there was organisations out there to provide 
support that I even thought about it. It never even w t into my head that there’s actually 
organisations to support people [with HCV]. But as I say, by the stage I was able to ask 
the doctor for it I probably didn’t need it as much as what I could’ve done with it, you 
know? (Sarah, 38, ALD (HCV), third interview) 
However, professionals themselves appeared unaware of which support services may 
be available to those with advanced liver disease. 
I don’t know of many support services. That’s a bit of a worry actually, considering that 
I’m the last point of contact for people. (…) Are there any specific services for folks with 
liver conditions? I don’t know any of them if there are any. (Community palliative care 
nurse of Martin, 77, ALD (NAFLD)) 
The barriers to accessing support identified in this study related mainly to personality 
factors, access and a lack of awareness. There is thus scope to address some of these 
issues to improve the patient experience in advanced liv r disease. 
6.5 Discussion of findings 
The above results illustrate the everyday challenges participants faced beyond the 
physical aspects of their condition and as the illness progressed over time. Again, 
uncertainty emerged as a key factor in their experiences. In line with Brashers et al. 
(2003), a number of personal and social sources of uncertainty could be seen to add 
to their illness burden. The threats upon their sense of self first described in Section 
5.5.4 emerged as disruptive to their entire biography (Bury, 1982). Participants 
employed a number of coping strategies to manage the uncertainties they felt in 
relation to their condition and wider circumstances. Beyond these uncertainties, the 
data revealed several domains in which support proved inadequate. I will now 
examine each of these issues in turn. 
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6.5.1 Personal sources of uncertainty 
Having advanced liver disease impacted on participants’ wider life circumstances 
such as employment and finance, with a negative effct on their psychological 
wellbeing, sense of self, and close relationships. This was especially true for younger 
participants. This mirrors previous research with crrhotic patients (Marchesini et al., 
2001, Roth et al., 2000), but differs from people with COPD (Small and Graydon, 
1993), possibly on account of this constituting a rel tively older patient group.  
Financial concerns were mainly linked to uncertainty about one’s social role and the 
future. The impact of chronic illness on financial wellbeing and the loss of a 
productive working life can trigger a gradual loss of positive self-images; 
maintaining a positive and life-affirming view of one’s self requires daily 
reaffirmation to that effect (Charmaz, 1983). This was difficult to achieve for those 
with an increasingly reduced ability to actively engage in everyday life. In addition, 
the resultant challenge of having too much time uninterrupted by the ‘trivia of daily 
life’ encouraged increased reflection and thus questioning of one’s identity 
(Charmaz, 1997).  
For those with ALD, overcoming their harmful drinkig habits posed an additional 
challenge and source of uncertainty, as they worried about their ability to remain 
abstinent long-term. Their anxiety appeared considerably greater than that expressed 
by people with COPD who found themselves unable to stop smoking (Eklund et al., 
2012). The implications of not achieving abstinence were at the forefront of most 
ALD participants’ minds. This added significant psychological pressure which they 
struggled to cope with, in turn threatening this very goal. This observation is a useful 
reminder for healthcare professionals to be mindful o  the wider psychosocial context 
of these patients’ lives as their liver problem, however advanced, may not in fact 
constitute their key priority. Likewise, compliance in ALD has been linked to 
communication, understanding and the person’s social environment (Blaxter and 
Cyster, 1984). With the patient’s social environment generally outwith professionals’ 
sphere of influence, enabling a clearer understanding of their condition and its 
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implications and providing opportunities for clarification are consequently important 
facilitators towards the desired behaviour change.  
6.5.2 Social sources of uncertainty 
Social uncertainty was a key feature of the lived experience of advanced liver 
disease. Experiences and perceptions of stigma, the changing nature of familiar 
relationships, and increasing social isolation constituted social sources of uncertainty 
in this sample. Similar experiences have been described by HIV-positive adults 
(Brashers et al., 2003). These findings confirm theimportance of the social 
dimension in a person’s illness experience (Charmaz, 1983, Radley, 1994, Radley 
and Green, 1987). 
Stigma 
Stigma, while not always directly experienced, was acutely felt by participants 
(Scambler and Hopkins, 1986). The sociocultural aspect of living with advanced 
liver disease was especially evident in this context (Kleinman, 1988), with 
participants’ experience of stigma borne out of public ignorance and prejudice 
regarding the nature of liver disease as well as its largely invisible character. The 
common assumption that their liver disease was caused by alcohol misuse has 
previously been shown to rile liver patients (Vaughn-Sandler et al., 2014, 
Wainwright, 1997).  
Participants recounted instances of enacted and felt stigma in both their clinical care 
and everyday life. This finding parallels the patien  experience in lung cancer 
(Chapple, Ziebland and McPherson, 2004), and reflects a counts by liver patients 
reported elsewhere (Sogolow et al., 2010, Vaughn-Sandler et al., 2014). Stigma in 
the healthcare setting has been linked to patients being less likely to access care and 
having a poorer quality of life (Earnshaw and Quinn, 2012, Vaughn-Sandler et al., 
2014). Therefore, while subjective perceptions of stigma may be unavoidable, care 
professionals must educate themselves about the many c uses of chronic liver 
disease beyond those related to substance misuse, and be mindful of how their 
language and actions may be received by liver patients. 
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The anticipation of stigma and associated fear of social rejection constituted a further 
source of uncertainty. Participants managed this by avoiding potentially stigmatising 
situations and adopting a “policy of non-disclosure” (Scambler and Hopkins, 1986, 
p38). This was true of all participants regardless of their actual disease cause. This 
finding again reflects the actions of other cirrhotic patients (Vaughn-Sandler et al., 
2014), and echoes findings in the realm of HIV infection (Carricaburu and Pierret, 
1995). Where non-disclosure of their illness was challenged, participants went to 
great lengths to ensure that others knew that their illness was not subject to an 
alcohol problem or were selective in the detail that w s being disclosed. Avoiding 
disclosure not only serves to manage uncertainty by limiting the likelihood of 
stigmatisation, but also supports a patient’s prefer d self-image by enabling them to 
present as a person not exclusively defined by their illness (Charmaz, 1997). In 
addition, participants censored disclosure of information to discourage discussion of 
their condition. This may indicate another attempt at upholding uncertainty to protect 
their self from deep-seated fears they themselves harboured about their situation. 
Social isolation 
Social isolation in this sample was widespread and persistent, irrespective of disease 
cause. Physical limitations, repeated hospitalisation, unemployment, embarrassment 
and the anticipation of stigma contributed to even those with previously good social 
contact becoming increasingly isolated. However, the ability of those with ALD to 
influence their illness experience was again demonstrated in this respect. While in 
most cases social relationships diminished over time, a gradual improvement in the 
psychological wellbeing of Sarah and Ben, prompted by sustained sobriety, 
motivated a proactive approach by both to actively seek out and maintain familiar 
relationships.  
Social networks are an important source of validation for a person’s sense of self. 
Consequently, experiencing social isolation can be detrimental to the maintenance of 
one’s self-concept (Charmaz, 1983). A disruption of s cial relationships is not 
merely due to restrictions inflicted by the illness, however, but may in part be 
actively imposed by the ill person (Bury, 1982). This was evident in the present 
study, where several participants deliberately isolated themselves by restricting their 
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social contact. Given their awareness of the stigmatising reputation of liver disease, 
this can be understood as another way of managing the uncertainty they perceived in 
relation to social encounters and the potential for embarrassment or rejection on 
account of their illness. Likewise, their actions may reflect a conscious ‘pulling in’ in 
order to retain some control in their lives and reduce distractions and pressures to 
preserve strength for coping with their illness (Charmaz, 1997).  
Managing information flow, avoiding disclosures and deliberate distancing from 
others are thus all means by which ill people can exert some control over their 
uncertain situation (Charmaz, 1997, Mishel, 1988). In this study, participants 
employed these approaches to safeguard their identity, exposure to information, 
emotional response and quality of life more widely.   
6.5.3 Biographical disruption 
Biographical disruption, as described in Section 2.3.2, could be witnessed in the 
accounts of all participants (Bury, 1982). This resonates with previous findings in 
advanced liver disease (Brown et al., 2006), but con rasts with  the illness experience 
in COPD (Pinnock et al., 2011). At the same time, different characteristics of the 
concept were evident. For Mary and Thomas for example, biographical disruption 
was dramatic and traumatic. Indeed, by the time the tangible complications of 
advanced liver disease had set in (for many the point f diagnosis or conscious 
acknowledgement of their illness) the illness was often too disruptive and uncertain 
to allow participants to hold on to their previous self and retain biographical 
continuity. Nevertheless, many older participants appeared to cope more stoically 
with their biographical disruption than younger counterparts. This finding is 
consistent with previous research in liver disease (Marchesini et al., 2001) and 
reflects similar observations in stroke patients (Pound, Gompertz and Ebrahim, 
1998). This easier acceptance did not appear to relate to their living with more co-
morbidity, with liver disease just another condition to deal with - its nature was too 
disruptive and tended to dominate their other healt challenges. They did, however, 
express a greater sense of acceptance on account of their older age, with ill health 
simply a feature of this life stage. 
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Kate’s relatively longer experience of living with c ronic liver disease compared to 
most other study participants evidenced not just one, but two biographical 
disruptions. The first came at the time of diagnosis 10 years prior with what was then 
a manageable, relatively unobtrusive illness experience. Biographical disruption at 
that point was short-lived, with Kate formulating a new self which accommodated 
the new circumstances (Frank, 1993). However, she exp rienced another disruption 
when her illness deteriorated into decompensated cirrhosis, and the appearance of 
disabling complications resulted in inpatient episodes and an inability to work. 
Repeated disruptions of biography have also been observed in other chronically ill or 
disabled people over time (Larsson and Grassman, 2012). The present finding 
supports the notion that biography is in fact a continual process of dynamic revision 
(Williams, 2000).    
Receiving a diagnosis of ALD did not immediately disrupt the lives of some 
participants like Sarah and Ben, whose biographies ad already been upset by 
alcohol dependency. This echoes the experience of haemophilic men, who 
considered their HIV infection merely a continuation f their already challenging 
biography (Carricaburu and Pierret, 1995), and supports the notion that existing 
difficult life circumstances may lessen the impact of a new illness diagnosis (Lawton, 
2003). However, biographical disruption did occur in ALD patients eventually, 
typically through a tangible brush with death due to their deteriorating condition. 
They initially managed to retain relative continuity by accommodating developments 
into their already difficult life circumstances. Once the physical complications of 
advanced liver disease and their management started to noticeably disrupt their lives, 
however, maintaining continuity became impossible. Participants were forced to 
rethink their previous status and contextualise their diagnosis. This finding again 
mirrors the patient experience in haemophilia (Carric buru and Pierret, 1995). In this 
context then, biographical disruption could be seen to encompass an element of 
biographical reinforcement.  
For a few ALD participants, this series of events re ulted in an active reworking of 
their identities and the setting of new priorities. For John and Sarah, and at a later 
stage in the study for Ben, being faced with advanced, life-limiting illness acted as a 
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catalyst for biographical disruption towards the positive, their actions reflective of a 
quest narrative (Frank, 1995). These participants de erminedly worked on mastering 
sustained sobriety, while, given their advanced disease state, remaining aware of the 
enduring uncertainty regarding future outcomes. They could thus be seen to appraise 
this uncertainty as an opportunity to re-evaluate their lives and formulate priorities 
for the future. This finding evidences the potential of uncertainty as a positive force 
for personal growth (Mishel, 1990).  
In summary, the data afford the following observations regarding the concept of 
biographical disruption in the context of advanced liver disease: 
1. The findings support the assertion that the severity of biographical disruption 
experienced is subject to person-specific factors (Lawton, 2003, Williams, 2000).  
2. Biographical disruption was sometimes a positive experience, leading to the 
creation of a new self which not only accommodated, but sought to transcend the 
illness.  
3. Biographical disruption constituted a gradual process which required tangible 
symptoms to take effect, and one that could happen more than once. This highlights 
the temporal aspects of this concept. 
6.5.4 Coping with uncertainty 
Coping relates to a person’s efforts to master harmful, threatening or challenging 
circumstances. In the context of illness, Hinton (1984, p228) suggested that, “the 
question of coping does not arise until the condition becomes manifest and its lethal 
nature subsequently recognised.” The experience of advanced liver disease described 
in this and the previous chapter supports this statement.  
Participants’ levels of coping varied with age, symptom severity and over time, and 
related to the uncertainty inherent in participants’ circumstances. Uncertainty 
challenges a person’s ability to cope with and successfully adapt to chronic illness 
(Hilton, 1992). As highlighted, uncertainty did not necessarily constitute a negative 
experience among this sample. Nevertheless, uncertainty drove participants’ choice 
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of coping strategies, which reflected a tendency to appraise uncertainty as an 
opportunity in order to manage emotions and keep negative cognitive stimuli at bay. 
This approach is possibly due to a lack of scope for reducing uncertainty given the 
general complexity and ambiguity of the illness.  
Managing the amount and flow of information has alre dy been highlighted as one 
means by which participants sought to control uncertainty to preserve hope and 
protect their sense of self, and this finding echoes th  literature (Brashers, Goldsmith 
and Hsieh, 2002, Mishel, 1988). Taking one day at a time also served to manage the 
self in the face of uncertainty, as narrowing their focus on daily illness management 
allowed them to avoid contemplation of the wider consequences of their situation 
(Charmaz, 1997). Positive thinking was another tactic employed for managing 
uncertainty, despite constituting a rather optimistic sentiment given participants’ 
advanced disease stage. This finding thus supports Mishel’s notion of illusion as a 
cognitive process underlying the appraisal of uncertainty as an opportunity (Mishel, 
1988). Adopting a stance of unrealistic optimism can be a protective strategy for 
people faced with relatively uncontrollable disease (Fournier, de Ridder and Bensing, 
2002), and has been reported in patients rejected for liver transplantation (Heyink et 
al., 1989). Positive thinking and living for the day have also been noted as coping 
strategies used in COPD and heart failure (Small and Graydon, 1993, Winters, 1999). 
Placing their confidence and trust in healthcare professionals was another coping 
strategy used by participants. Viewing clinicians as able to control one’s illness has 
been recognised as a strategy which can reduce uncertai ty in the chronically ill 
(Madar and Bar-Tal, 2009). 
As described in the previous chapter, participants’ self-image was affected by 
physical changes related to their disease and a gradual loss of their independence and 
previous abilities. A loss of self ensued, both in relation to their previous sense of 
self and in the context of wider social and cultural norms. This constituted a 
significant contributor to poor psychological coping, and was consistent with the 
observation that, “In a society which emphasizes doing, not being, those who cannot 
perform conventional tasks and social obligations lo e the very means needed to 
sustain a meaningful life.” (Charmaz, 1983, p191) In this context, downward 
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comparison is one way in which a person may bolster th i  sense of self and manage 
uncertainty by neutralising their circumstances. This coping strategy has previously 
been observed in patients rejected for liver transplantation (Heyink et al., 1989), and 
was employed by participants in the present study. They compared themselves to 
fellow liver patients during hospital stays, and overall considered others less 
fortunate. Making comparisons with others in similar circumstances facilitated the 
evaluation and legitimisation of their feelings, actions and experiences in relation to 
their illness. This helped to alleviate uncertainty, strengthen self-esteem, and thus 
improve subjective wellbeing.  
Self-managing advanced liver disease 
Patients’ yearning for more and improved self-management guidance constituted a 
task-oriented approach to coping with their uncertain circumstances, and highlighted 
again the limited information they perceived to hold about their condition. This 
resonates with reports that cirrhotic patients lacked adequate knowledge to allow 
them to effectively self-manage their illness (Volk, Fisher and Fontana, 2013), but 
that they were eager to do so (Wainwright, 1997). Similar findings exist for patients 
with COPD (Wortz et al., 2012). The lack of opportuni y for patients with advanced 
liver disease to engage in self-care despite its benefits for disease progression has 
been observed before (Volk et al., 2010). 
Three models of self-management have been proposed: m ical, collaborative, self-
agency (Koch, Jenkin and Kralik, 2004). In the present study, the medical self-
management model dominated. Participants accepted responsibility for supporting 
disease management and were generally committed to the lifestyle changes and 
medication regimes stipulated by healthcare professionals. Interestingly, despite this 
model effectively discounting individuals’ life contexts and self-agency, participants’ 
desire for more extensive guidance in this respect indicates that this model was in 
fact preferred over a more collaborative approach.  
In the absence of satisfactory levels of medical self-management, several participants 
had adopted a self-agency approach to the everyday management of their condition, 
mostly based on popular lifestyle advice and remedial actions of their own design. 
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Participants engaging in direct action by making up their own self-care approaches 
suggests a coping strategy designed to actively reduce uncertainty (Mishel, 1988), 
and is thus counter to their overall tendency to maintain uncertainty in preference of 
negative certainty. Direct action is a coping strategy rarely seen in catastrophic 
illness (Mishel, 1988). Its presence in the context of this study may be explained by 
the data indicating that participants generally lacked awareness of the devastating 
nature of their condition.  
Having structures and routines to follow can help to create a ‘cocoon of certainty’ 
which moderates the effects of uncertainty (Brashers, 2001). Being able to take an 
active role in their illness management has been shown to diminish uncertainty in 
people with heart failure (Winters, 1999). I would also argue that this action-focused 
approach helps to reinforce people’s focus on the present as described earlier, and 
therefore additionally supports their coping in line with this preferred stance. It has 
been suggested that sometimes healthcare professionals can unwittingly fuel an ill 
person’s loss of self by failing to provide adequate or appropriate advice, thus 
leaving the person unaware of options for treatment or support that could facilitate a 
more active participation in daily life (Charmaz, 1983). I would therefore argue that 
any absence of self-care opportunities beyond those already commonly instructed, 
such as abstinence and dietary change, should be communicated to patients in order 
to reduce any anxieties in this respect.  
6.5.5 Patient support needs 
Participants displayed a range of support needs relating to their condition. The 
physical challenges associated with the disease necssitated practical support with 
various everyday activities, such as household tasks, personal hygiene and 
transportation. Practical support needs increased ov r time. This finding supports the 
suggestion that homecare needs may be underestimated in this patient group (Roth et 
al., 2000). Likewise, hospitalised COPD patients expr ssed uncertainty about how 
they would manage at home after discharge (Small and Graydon, 1993). Similar 
concerns were also raised in the present sample and borne out by the level of 
practical support need evidenced. 
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Support for people with ALD seeking to overcome alcohol dependency was 
perceived as inadequate by patients, lay carers and professionals alike. A lack of 
consideration was seen to be given to the considerable impact of abstinence on that 
person’s emotional and social world, individual personality factors, and patients’ 
additional burden of living with advanced disease. As mentioned earlier, the need to 
achieve abstinence in itself constituted a major stres or in these patients’ lives. 
However, all participants, regardless of their particular stage and context of illness, 
desired better psychological support. A need for psychological support was evident 
from the point of diagnosis and related to the need to come to terms with not only the 
condition itself, but its pervasive impact and consequences. Nevertheless, support of 
this nature remained largely absent. 
This psychological burden adds to that identified in the previous chapter and lends 
further support to the widespread low mood and depression reported in cirrhotic 
patients (Bianchi et al., 2005). Patient participants’ care appeared to focus 
predominantly on disease management. Alcohol dependency, where this featured, 
received some but overall inadequate attention, meaning that related psychological or 
emotional problems similarly remained unresolved. The psychological wellbeing of 
patients without alcohol problems went largely ignored, despite evidence of low 
mood and depression. Some participants reported taking nti-depressants, yet anxiety 
and low mood suffused their accounts. This suggests an urgent need for routine 
psychological assessment of these patients, particul rly of those with underlying 
alcohol problems, and increased attention on alleviting what appears to be a 
considerable psychological illness burden. 
Relatedly, social support can provide the ill person with an opportunity to discuss 
and contemplate their illness and express emotions and feelings, which may facilitate 
increased clarity and understanding of their situation. Social support thus benefits 
health-related quality of life (Sherbourne et al., 1992). However, in this study 
participants could be seen to hold back from confidi g in their loved ones so as to 
not burden them, which suggests that intimate relationships may perhaps be too close 
to be helpful for expressing emotions and feelings i  the context of serious illness. At 
the same time, wider social engagement became increasingly scarce for reasons 
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outlined earlier in Section 6.5.2, leaving few opportunities for them to gain emotional 
support from another source. Some felt that the intrview itself provided the sort of 
opportunity to talk which they would value in general. Some expressed a need for 
confirmation that their feelings were valid and mattered.  
Given the evident need and expressed desire for psychological support in this study 
then, emotionally neutral sources of social support must be considered. Several 
participants were keen to compare their experiences and feelings with others in the 
same circumstances to help them make sense of what as happening to them. As 
highlighted earlier, social comparison can strengthen a person’s sense of self and 
help alleviate uncertainty. Peer support may thus present a possible means of 
effective social and emotional support for this patient group.  
Barriers to accessing support identified in this study were manifold. Individual 
reasons were: personality attributes, not wanting to impose on others, and giving up 
one’s independence. This supports previous findings that independence is key to 
those with life-limiting illness (Cotterell, 2008). Perceived cost, distance and 
transportation were further barriers to accessing support. Additionally, both patients 
and professionals showed poor awareness of available sources of support. While 
personality-based factors may be difficult to address, there is scope to improve the 
awareness of supportive resources by mapping these and ducating patients and their 
families about their availability and any associated costs. Given the many varied 
challenges people with advanced liver disease experience that may affect their ability 
to physically access services, support provision should show sufficient flexibility in 
its set-up and delivery to facilitate maximum reach nd uptake.    
6.6 Concluding remarks 
This chapter has added some rich detail to our understanding of the lived experience 
of advanced liver disease. In addition to the medical sources of uncertainty described 
in Chapter 5, personal and social sources of uncertainty emerged as extensive and 
influential (Brashers et al., 2003). Moreover, the different types of uncertainty could 
be seen to interconnect (Brashers, 2001). For example, uncertainty experienced in 
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relation to their condition caused uncertainty regading one’s sense of self (e.g. the 
‘working self’), financial wellbeing and social relationships.  
In addition to further evidence of a potentially divergent experience by ALD patients 
related to achieving sobriety, age differences emerged both in relation to some of the 
life-related stressors reported and patient coping. Patients’ coping strategies were 
largely aimed at managing the pervasive uncertainty. Orientating towards one day at 
a time, avoiding active contemplation of the illness, managing information flow 
(seeking versus avoiding), and evading potentially stressful social interactions were 
all ways in which this was achieved. Faced with the possibility of negative outcomes, 
this suggests a shared tendency to appraise the uncertai ty of their circumstances as 
an opportunity. It also resonates with the notion that, “the erstwhile taken-for-granted 
world of everyday life becomes a burden of conscious and deliberate action” (Bury, 
1982, p176). In addition, guidance to enable greate self-management of their illness 
was desired but lacking.  
Biographical disruption proved a prominent feature in this condition. The data 
advances our understanding of this concept by highlighting its characteristics in the 
context of advanced liver disease. This includes the observation that biographical 
disruption does not always constitute a negative event. Adding to the high level of 
information need identified in the previous chapter, his patient group also exhibited 
extensive practical, psychological and social support needs. Psychological and social 
support in particular are key to helping patients manage uncertainty and thus achieve 
improved wellbeing, but both were found lacking. The data in this and the previous 
chapter thus evidence all three areas of ‘work’ the c ronically ill person is said to 
have to contend with: illness work, everyday life work and biographical work 
(Corbin and Strauss, 1985). 
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Chapter 7: The patient experience of care 
The previous chapter confirmed and extended the finding that uncertainty dominated 
life with advanced liver disease. This uncertainty proved pervasive, multi-faceted and 
interconnected. Its impact has thus far been noted in relation to the physical 
experience of the disease and the management of everyday life.  
This chapter describes patient participants’ use of services to support them with their 
illness, and their perceptions of the extent to which these services met their needs. It 
first shows the types of services people engaged with and their care relationships 
within these settings. It then presents participants’ experiences and perceptions of 
their medical care. The chapter concludes with a discussion of these findings in 
relation to existing research and theory. 
7.1 Contact with services 
Due to some of the disease-related physical challenges such as extreme fatigue and 
poor motor function and mobility, travel to medical re services proved a challenge 
for several participants.  
The GP, he wasn’t wanting to come down and see me. He says, “Is there any way you 
can go up and come up and see me.” There isn’t, I cannae walk that way. And he says, 
“Well, why don’t you get a taxi up?” I says, “Well, are you going to pay for the taxi?” 
(Fraser, 60, ALD, first interview) 
Accessing the hospital proved particularly challenging because, as a regional base 
with a large catchment area, people often had to travel a considerable distance. This 
posed a problem not only for patient participants, but their lay carers too. 
My mum and dad (…) had to depend on other people coming in [to town] to bring them 
in because my mum doesn’t drive, my dad can’t drive now, and it was just a nightmare. 
(Carol, 45, ALD, first interview) 
Arranging patient transport to travel the distance was fraught with difficulty for 
patients and professionals alike.  
They’ve been good in arranging patient transport, bu  you’ve got to sort of kind of plead 
with them a wee bit, you know? (Carol, 45, ALD, second interview)  
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If she was to be admitted the next day for a blood transfusion (…) we had to pretend it 
was an emergency ambulance, because you can’t pre-book an ambulance for the next day. 
(GP of Polly, 68, NAFLD) 
7.1.1 Contact with secondary care 
All participants had a named liver consultant allocated to their case, whose outpatient 
clinic they were called to attend every few months. Many participants felt positive 
about their designated consultant. 
I get on well with him and he gets on well with me. (Fraser, 60, ALD, first interview) 
He’s a brilliant doctor. He is brilliant. (Mary, 66, autoimmune hepatitis, second interview) 
At the same time, people were often unclear about hw to access their consultant in 
case of a query. 
“Get in touch with my secretary,” and things like this. I haven’t the foggiest idea how to 
get hold of his secretary. (Kate, 41, cryptogenic LD, first interview) 
He said, “Oh, I wish you had let me know about that.” How was I to do that, because he 
is surrounded by secretaries and people who answer phones and all that, and they’ve got 
their agenda and that is, seems to be to prevent you from talking to him at all. (John, 68, 
ALD, second interview) 
In addition to outpatient clinic appointments, many participants also regularly 
accessed inpatient services. Appendix 4 shows the number of hospital admissions 
(related to their liver disease) for each patient during their study involvement, and for 
those who died also at 6 months and 12 months priorto their death. Participants’ 
experiences and perceptions of their inpatient carewill be described in Section 7.2. 
7.1.2 Contact with primary care 
Primary care involvement in their liver disease care varied across participants, but 
was generally limited compared with their engagement with secondary care. 
Participants viewed the role of the GP mainly as providing referrals or prescriptions.  
I see my GP maybe once a month or twice a month, but I never really go because I’m ill. 
It’s usually because I need another sick line or I’m needing new medication or something 
like that. (Sarah, 38, ALD (HCV) second interview)  
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This narrow understanding of the role of the GP result d in a general perception that 
there was little value in seeking their support anddvice. 
BK: So are you going to pursue trying to get an appointment with your GP do you think? 
Nadia: Do you think there’s any point? 
(Nadia, 58, ALD (HCV), first interview) 
Most participants saw the practice nurse when attending their local practice for 
occasional blood tests. District nursing input was limited across the sample; only 
Donald and Martin mentioned the involvement of a district nurse in their home care.  
7.1.3 Contact with allied professions 
During inpatient stays, some participants had specialist input by occupational health 
practitioners, dieticians and, where necessary, a physiotherapist. Those with alcohol 
problems underlying their liver disease were also seen by the hospital-based alcohol 
liaison team, whose role was to assess individuals’ readiness for abstinence and refer 
them to community-based services as appropriate. In particularly critical cases the 
alcohol liaison nurse would continue to see a patient on an outpatient basis. This was 
the case for Ben, who was at first uncertain what te purpose of these meetings was.  
BK: Did you find the involvement of the alcohol liaison person helpful? (…) What’s the 
support that she’s providing at the moment? 
Ben: I’m not quite sure. I was going to ask yesterday but I thought it was quite rude. 
(laughs) We just had a chat for about an hour. 
(Ben, 35, ALD, first interview) 
However, over time Ben started to appreciate the value of the nurse’s involvement. 
She’s making me feel a lot more positive about myself, giving me things to work on and 
like, about how to cope with it all. (…) She’s basically there for to ask her things that 
like, explain more what the doctors mean like, like, if I want to ask any questions she can 
sort of answer them. And she can show me my [blood] levels and that on the computer if 
I want to have a look at them. Basically it’s just somebody to talk to as well about how 
it’s all affecting me. (Ben, 35, ALD, third interview) 
It was credit to this intense therapeutic support by he alcohol liaison nurse that, by 
the end of his study involvement, Ben was at last successful in achieving sustained 
abstinence from alcohol and consequently a stabilistion in his liver condition. 
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Only two participants had had contact with community palliative care services, 
arranged by their GPs in recognition of their poor prognosis. This referral initially 
caused uncertainty and alarm due to the popular perce tion that palliative care 
constituted a service for cancer patients. 
That Marie Curie nurse, oh I wasn’t happy about tha. But then that’s when they told us 
it’s not just for cancer patients, it’s for everybody. I said, “Oh, that’s fine.” (Martin, 77, 
ALD (NAFLD), third interview) 
7.2 Medical care 
Participants’ medical care was predominantly delivered in the secondary care setting. 
They had regular, usually 6-monthly, outpatient appointments at their consultant’s 
clinic to monitor their condition. They also attendd for outpatient endoscopy 
procedures to prevent potential gastrointestinal bleeds. As highlighted earlier, many 
patients also had regular admissions to the hospital ward. This was commonly for 
non-acute events such as draining of their ascites, but occasionally involved acute 
exacerbations such as bleeds or anaemia. 
7.2.1 Hospital experience  
Given the regularity with which many of them attendd hospital, several participants 
expressed a sense of ‘coming home’ to the ward. 
It kind of feels like home. It’s my second home. (laughs) (Rebecca, 37, ALD, second 
interview) 
When I go into the hospital, oh I’m a real kent face now. When I walk in I know the 
doctors, I know the surgeons, I know them all. (Martin, 77, ALD (NAFLD), first 
interview) 
Kate valued her care at the regional hospital so much that she chose to travel a long 
distance from her home in preference over accessing more local hospitals.  
Over the years I’ve had two or three bleeds where I’ve ended up in hospitals in other 
places. (…) Not really been that terribly enamoured with the care that I’d received, so 
I’ve always tried to keep coming back to [regional hospital] because I like it here. It feels 
like coming home. (Kate, 41, cryptogenic LD, first interview) 
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Not everyone was so positive about their hospital experience, however. Repeat 
admissions for paracentesis were experienced as particul ly irksome by several 
participants. Some were growing weary of having to undergo the same initial 
procedures, like being weighed and having blood taken, at the start of every 
admission. Further upset was caused by conflicting instructions given by doctors and 
nursing staff as to the correct protocol to follow for getting booked onto the ward.  
Thomas: It was supposed to be that, “Oh well ok, we know all about you and that now, if 
it happens again you phone up the ward and, you know, we’ll get you in right away or the 
next day” sort of thing. So we try that. “Oh you can’t do that! Oh no no no, you’ve got to 
go through emergency or you’ve got to go through your own doctor.”  
BK: Who told you that?  
T: This was the nurse that answered it on the ward.  
(Thomas, 75, NAFLD, first interview) 
Despite many speaking of the liver ward as a ‘home from home’, participants 
described a real desperation to be able to leave as soon as possible.   
You’ve got the nurses, but you do have that feeling of aloneness when you’re in a 
hospital. (…) It’s a horrible feeling just lying there and you’re so ill and you just pray to 
be out. (Ben, 35, ALD, second interview) 
The amount of time spent waiting for things to happen added to their frustration, and 
fostered a perception that being in hospital made one worse and slowed recovery. 
I don’t want to go back into hospital again. Every time I went into hospital, I actually felt 
iller when I came out than when I went in. (…) You’re just sitting there vegetating and 
the air’s not healthy (…) You’re never going get beter sitting doing nothing, you know? 
(Sarah, 38, ALD (HCV), second interview) 
7.2.2 Perceptions of the quality of care 
Many patient participants felt that doctors were doing a good job in caring for them 
through their illness.  
Anybody you phone, the doctor, the nurses, the hospital, never a problem. (Martin, 77, 
ALD (NAFLD), third interview) 
Just got to thank everybody involved actually because it’s overall really, really good. 
(Kate, 41, cryptogenic LD, third interview) 
Lay carers were equally satisfied with the care that had been offered to patients.  
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Everybody supported Fraser. Even the nurses in the hospitals, the doctors, they were 
really, really kind to him. I mean, you could probably get people who say, "Oh he's just a 
drunk, don't bother," you know? He got all the attention that he needed in [hospital] and 
[by] the carers at home. (Betty, neighbour of Fraser, 60, ALD, bereavement interview) 
However, participants whose accounts displayed the greatest uncertainty regarding 
their situation tended to hold a less favourable view of their medical care. 
BK: How do you feel about the care that you’ve been g tting so far? 
Nadia: Terrible. 
BK: Terrible. Is that in hospital or in general? 
N: Just the whole thing, just the way I’ve been dealt [with].  
(Nadia, 58, ALD (HCV), first interview) 
The medical profession has a lot to be desired as far as I’m concerned. I don’t feel as 
though I’ve been treated well by them. (Thomas, 75, NAFLD, first interview) 
Quality of hospital care 
Participants were generally pleased with the staff they encountered at the hospital. 
That ward I go in, they’re awfully nice. (Polly, 68, NAFLD, first interview) 
Some participants, however, recounted instances where t y had been made to feel 
ignored and insignificant by ward staff. 
A nurse comes along and she opens up the locker and she gives me pills out and she 
doesn’t speak. And she puts them on the table and then she walks away. By this point it’s 
now about 10.30pm at night and I’ve been in the ward since 6.30pm and nobody has 
actually said a word. Not one word. And I’m getting more upset and more upset and more 
upset until the flood gates just open and out it comes and I think, “Jesus, I’m just 
insignificant.” (Kate, 41, cryptogenic LD, first interview) 
Nursing staff were perceived as not always sufficiently caring and lacking 
understanding of the realities of alcohol dependency and mental ill health. Moreover, 
some participants recounted incidents during their hospital stays which they 
considered outright neglectful. 
He gets a bath every morning and he gets three diffrent creams on cos he’s got bad 
psoriasis. He was in the [hospital] and he come out, you want to have seen the mess that 
man was in. (…) He wasn’t getting a shower every day and he wasn’t getting his creams 
every day. (Betty, neighbour of Fraser, 60, ALD, first interview)  
Rebecca was fed up with the amount of times she was being asked to accommodate 
student doctors during her inpatient stays. 
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You just feel like a guinea pig in there. (…) You get them one after another, one after 
another, one after another. (Rebecca, 37, ALD, second interview) 
For many participants, paracentesis was the main reson for their repeat admissions 
to hospital. As this procedure required inpatient treatment, it constituted a disruptive 
event for patients and lay carers alike. Regular shortfalls in staff or draining 
equipment and being rendered weak and poorly after th  procedure saw many 
participants in hospital for several days at a time. 
BK: This is now Saturday and nothing’s happened you said? 
Aidan: That’s it. Thursday night, well I think I got in here about half five or so by the 
time I got into the ward, getting into bed, the doctor came round he says, “Well I know 
what you’re in for and I can see what it’s doing, but as you know there’s not a team of 
staff nurses at nightshift to look after, take your bottles away and empty them and such 
like so,” he said, “we don’t do it at night.” (…) Yesterday I seen the doctor in the 
morning, it was a doctor I’d never seen before, and he just told me what I already knew. 
And then the two doctors that was going to do the drain (…) they said, “Aidan, we’ll see 
you in a wee while, we’ll be back to get it done.” (…) I never heard a word after that, 
never seen them again. (…) And then I seen him this morning and (…) he said, “We’ll 
get it done today,” he says, “but the thing is,” he says, “there’s five people waiting on the 
same thing, so we’re going round to pick who’s goin to get done and who’s not, because 
we’re short of…” Seemingly he was telling the nurse, you know, it’s a long needle that 
they put in and they’re running short of them. (Aidan, 58, ALD, first interview) 
Opinions differed on how to best handle routine admissions of those with recurrent 
ascites requiring regular draining. Fay expressed a preference for scheduled 
appointments, while such an arrangement had previously proven unworkable for 
Martin. Thomas’ GP considered the hospital’s approach of leaving it to patients to 
judge when further draining was required inappropriate and an unnecessary source of 
uncertainty.  
Leaving it until his ascites then built back up again and he had to go back in, to me I think 
(…) it just left him (…) unnecessarily symptomatic for long periods of time, and also I 
think it probably left him and his family with too much uncertainty, so he’d be sitting at 
home for a week or two at a time going, “Oh, should I, should I really be going, calling 
the ward and going back in?” (GP of Thomas, 75, NAFLD) 
Quality of primary care 
Several participants had a good relationship with their GP, who would visit them at 
home to check on their health, and considered them approachable and supportive.  
The help I’ve had with my GPs has been great, you know? I can’t fault them really. 
(Carol, 45, ALD, second interview) 
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However, some criticised their GP’s support due to a perceived lack of motivation 
and empathy. 
It’s just a job to him. (…) If it’s just something like a bug he can prescribe something for 
you, that’s fair enough. But to actually do anything over and above, you just don’t get 
that from [GP]. (John, 68, ALD, third interview) 
I went to my GP and I told him my esteem was on the floor. “What do you want me to do 
about it?” I went, “Nothing,” and I walked out the surgery. (Mary, 66, autoimmune 
hepatitis, first interview) 
Many participants also felt that their GP lacked confidence and knowledge in matters 
relating to their liver disease. 
I’m not sure that the GP actually gets all the ins a d outs of it because (…) I said, “I’m on 
the transplant list,” and he said, “Now how long are you going to have to wait for a liver 
then?” which I thought was a very strange thing fora doctor to ask. (Kate, 41, 
cryptogenic LD, third interview) 
When he first came he didn’t know very much about this drainage, he was asking me 
questions. (Martin, 77, ALD (NAFLD), third interview) 
This poor disease-specific understanding is likely to be a contributing factor to GPs’ 
limited involvement in participants’ liver care. Indeed, some GPs were seen to 
deliberately hold back on their involvement and leave their patients’ liver care in the 
hands of secondary care professionals.   
He tended to seem to want to take a back seat and le ve it in the hands of the consultant. 
So apart from monitoring my bloods that was about it, you know? (John, 68, ALD, 
second interview) 
7.2.3 Doctor-patient communication  
A key factor in the care experience of any patient s the nature and quality of the 
communication between the patient and their professional carers. Professionals’ 
communication with patient participants generally aimed to promote a positive 
outlook. Michael considered this the right approach for professionals to take. 
He was very upbeat and positive and ‘everything’s goin  to be fine, don’t worry about it’, 
and all that kind of stuff, which is absolutely the right thing for a GP to say. (Michael, 
husband of Kate, 41, cryptogenic LD, third interview) 
At the same time, several participants expressed a preference for professionals’ 
frankness about their condition. 
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I’m very practical. I don’t take well to people bullshitting me basically. So the doctor and 
[consultant] have always been quite open and honest with me and I do appreciate that. 
(Kate, 41, cryptogenic LD, first interview) 
Being truthful proved a delicate balancing act for professionals, however.  
You’re trying to kind of be honest with them, but you don’t want to be completely 
terrifying and lose their faith/confidence in you as well. (Consultant of Fraser, 60, ALD) 
Indeed, Sarah’s experience with her GP exemplified this challenge for professionals. 
I stopped going to her. She was just so negative and I found it really… I want them to be 
honest but I don’t want them to, you know, be so negative. I’m trying my best, you 
know? (Sarah, 38, ALD (HCV), third interview) 
A number of factors contributed to participants’ exp riences of ineffective doctor-
patient communication. Importantly, the time available during medical appointments 
was seen as too limited for effective information exchange. 
You’re sitting in the surgery and you’re aware that you’ve got a 10 minute slot and 
everything’s all about timing and, you know, there’s another 20 people with coughs and 
colds outside waiting to see him and he’s running late and all that’s going on in your 
head. (Kate, 41, cryptogenic LD, second interview) 
Participants appreciated that this lack of consultation time was due to professionals 
needing to attend to the needs of others also. Neverthel ss, it discouraged them from 
asking questions or from opening up about their concerns.  
You just get the feeling that the doctors are unapproachable because they’re so busy. You 
feel like you can’t say, “Doctor, can we have 5 minutes,” because you feel you’re holding 
them back and why should I be more special to get more of your time than everybody 
else. (Ben, 35, ALD, first interview)  
The choice of language used by professionals also impacted significantly on the 
perceived quality of doctor-patient encounters. Several participants felt that 
explanations were often too medicalised to be readily understood by them. 
What they’re saying is, “Right, your potassium level’s at such and such, your sodium 
level’s at such and such,” what else, “your blood cunt was this, your blood pressure was 
that.” All these different things, and they don’t actually tell me what it means. It is good? 
Is it bad? Is it happy medium? I don’t know. (Rebecca, 37, ALD, second interview) 
A few participants recounted instances where a professional’s inappropriate choice of 
words had left them feeling uncertain or alarmed. 
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Every time I went to the doctor or to see the specialist or something, I was coming away 
thinking I was dying. (Sarah, 38, ALD (HCV), second interview) 
Several participants also commented on what they considered poor bedside manners 
during their stays on the hospital ward. Some doctors discussed patients among 
themselves in front of the person, thus fuelling peopl ’s sense of being insignificant. 
All these things were getting said about me and it was like I wasn’t there, you know? 
(Kate, 41, cryptogenic LD, first interview) 
Participants also criticised hospital staff for regularly approaching and advising them 
on their care without prior introduction, leaving them uncertain which authority these 
instructions were coming from.  
You often don’t know where their advice is coming from (…) and I always felt it was sort 
of a bit impolite to say, “Hey hold on a second, who are you?” I don’t think you should 
have to do that. (John, 68, ALD, first interview) 
Problems with doctor-patient communication were thus manifold and had great 
potential for adding further uncertainty to the overall illness experience. 
7.2.4 Continuity of care 
Participants highlighted issues relating to continui y in their care relationships and in 
the provision and coordination of their care. 
Continuity in care relationships 
Continuity in seeing the same GP for their liver-relat d care varied across 
participants. Some benefitted from a continuous relationship with one key primary 
care contact. This was often the case for those with an underlying diabetic condition 
like Martin and Thomas, who had often already been known to the same practitioner 
on account of their ongoing diabetic care. Others had acquired a named contact by 
virtue of that professional taking a particular interest in their case. 
 [GP] did come round to speak to Rebecca once and sys, ken, “Could I take on your 
case?” (Sue, sister of Rebecca, 37, ALD, third interview) 
However, several participants did not benefit from ne consistent primary care 
contact. 
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BK: You don’t have one sort of doctor that… 
Fay: No, no. They change all the time. 
(Fay, 84, NAFLD, third interview) 
Similarly, many participants were lacking relational continuity with their designated 
consultant.  
Sometimes I get him and sometimes I get somebody else. (Rebecca, 37, ALD, first 
interview) 
If you didn’t get so many different people. (…) Every time I go to the clinic you see, 
they’ve got a list of names and you just get the onthat takes your file through. (Fay, 84, 
NAFLD, first interview) 
Changes in their care arrangements left some participants uncertain as to the status of 
their relationship with their named consultant.  
I don’t really know who’s in charge. One time it was [consultant], now it’s another 
doctor. (Fay, 84, NAFLD, third interview) 
I don’t know whether he’s even my consultant anymore, because he passed me into the 
care of the transplant team. (Kate, 41, cryptogenic LD, second interview) 
Indeed, Fraser was alarmed by an unexpected change in his consultant care, 
interpreting this as an indication of a declining condition. 
Fraser: I usually have my own consultant coming down but it’s [another consultant] that’s 
coming down. Now I thought, “There’s something going on here.” 
BK: What do you mean? 
F: Well, why is it [designated consultant]’s no coming, why is it [other consultant] 
coming? It must be pretty bad. 
(Fraser, 60, ALD, second interview) 
Discontinuity of care also existed on the hospital ward, with many participants 
commenting on the frequent turnover of nursing and clinical ward staff. 
A lot of the nurses were really, really nice but (…) they swap around even though they're 
at the same nurses’ station. John’s her patient one day and he’s not her patient the next 
day. (Jane, partner of John, 68, ALD, first interview) 
Every day it’s different people coming in to see you. (…) You just start thinking this wee 
team knows my case and then they change them the next week. (Ben, 35, ALD, first 
interview) 
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While some did not perceive the regular staff turnover as a problem, most 
participants expressed a desire for better relationl continuity in their liver care. 
I see an awful lot of doctors and professional people who I don’t really know who they 
are sometimes. (…) I just feel sometimes that it’d be quite nice just to, you know, have 
that one person who can say, “Hey, how’s it going?” (Kate, 41, cryptogenic LD, third 
interview) 
Relational continuity of care was thus wanting across both primary and secondary 
care settings. Discontinuity in their medical care relationships could be seen to add 
further uncertainty to the patient experience. 
Continuity in care provision and coordination  
Patients received follow-up care through attendance at outpatient clinics at the 
hospital and a regular monitoring of their bloods commonly conducted in the primary 
care setting. Some participants, however, questioned the usefulness of these 
appointments. 
It’s just basic. They just ask how I’ve been feeling, have I had a drink, are you eating 
well? And then they’ll put you on the bed and have  wee prod about and then take your 
blood and that’s it. (Ben, 35, ALD, second interview) 
Attendance at follow-up appointments proved challenging for many as this could be 
impeded by illness-related factors as well as a lack of support.  
BK: So what is the reason that you don’t always make it along to the clinic appointments? 
Rebecca: Well, like, good and bad days. (…) It’s to do with the jaundice as well, more so, 
you know, people staring. (…) But other times it’s because I just can’t make it. I’ve not 
got the energy or I’m constantly (…) on the toilet and haven’t slept. Loads of things, eh? 
Or I’ve not go anybody to go with me. 
(Rebecca, 37, ALD, second interview) 
People’s ability to attend appointments was also affected by their frequent 
admissions to hospital.  
I hadn’t seen him in the clinic for a wee while, because he’s been in and out of hospital. 
(Consultant of Fraser, 60, ALD) 
Non-attendance at medical appointments thus contributed to the poor relational 
continuity of care described earlier. However, the reverse also held true, with 
guaranteed access to one’s key professional an incet ve for attendance. 
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There’s no point, because he’s always in the hospital anyway. (…) If it was [named 
consultant] we would go, because we’d like to see him again, but it’s just his clinic. 
(Cora, wife of Martin, 77, ALD (NAFLD), third interview) 
Despite doubting their overall value, being offered regular check-ups reassured 
participants that a close eye was kept on their conditi . 
If they’re doing scans and different things all theime then they’ll pick up on anything 
else wrong, you know? (…) And even blood tests, the blood tests can pick up on 
something wrong as well. So it’s not too, you know, I’m not too worried about it. (Sarah, 
38, ALD (HCV), third interview) 
Gaps between follow-up appointments were considered unhelpfully long, however. 
GPs in particular expressed concern at the lack of foll w-up from liver specialists.  
What tended to happen was he would be in hospital very unwell, have fluid, his ascites 
drained off and then he’d come out and I’d say, “So when’s your next follow-up 
appointment?” and he would say, “Oh, I’m seeing [consultant] in three or four months,” 
and to me that didn’t seem appropriate and he, it semed far more appropriate that he was 
seen on a more regular basis. (GP of Thomas, 75, NAFLD) 
Patients also expressed frustration about the long gaps between clinic appointments, 
as they made them feel forgotten about. 
If I am being 100% honest with you, I don’t really feel that I’m being supported at all by 
the hospital. It’s almost like you go away and that’s you forgotten about till you come 
back again. I’ve had no contact with anybody at all apart from coming to the clinics. 
(Kate, 41, cryptogenic LD, second interview) 
In many cases, aftercare plans appeared lacking or poorly communicated.  
Nadia: When I came out of hospital all I got was a letter just saying what my tablets are 
and I’ve got to get a blood check, and that’s what I done. Other than that pffff. 
BK: So are you due to go back to see somebody in the clinic at some point? 
N: Not that I know of. I’ve not got a clue. Nobody told me, I don’t know. 
(Nadia, 58, ALD (HCV), first interview) 
Where aftercare plans had been mentioned to participants, these were not always 
followed through.  
Three times he was in that hospital when he took the hypos and the doc says, “Oh we’ll 
have to get your stomach drained.” (…) Three times. Even our doctor said, “We’ll get 
your…,“ and they never done it. (Martha, wife of Donald, 74, HCC (NAFLD), 
bereavement interview) 
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Effective continuity of care provision was also affected by the quality of 
interprofessional communication. This topic will bediscussed in Chapter 9 in the 
context of professionals’ accounts of supporting peopl  with advanced liver disease. 
Overall, however, continuity of care in this sample proved to be consistently 
inadequate, both in terms of care relationships and provision, throughout the illness 
trajectory and added a further dimension of uncertainty to the illness experience. 
7.3 Discussion of findings 
Three particular areas of interest emerged from the above findings. These pertain to 
participants’ experiences and perceptions of their medical care, the quality of doctor-
patient communication, and the continuity and consistency of patient care. According 
to the study findings, improvements are indicated in each of these areas. These 
improvements relate to reducing the uncertainty these issues contribute to the illness 
experience, and the overall management and co-ordination of patient care in 
advanced liver disease. 
7.3.1 Patients’ experiences and perceptions of thei r care 
Participants’ ongoing care for their liver disease was mostly located in the hospital 
setting. A named liver consultant was allocated to each person’s care. However, there 
was a perception that one’s designated consultant was difficult to contact, even 
where this had not been attempted before. Some consulta ts had invited patients to 
contact them in case of any questions; however, this was not considered a realistic 
offer. Participants could be seen to fashion excuses for not attempting this route such 
as not knowing how to contact the consultant's secretarial staff or anticipating gate-
keeping. In the context of uncertainty theory, this may again be reflective of the 
ongoing ‘knowing versus not knowing’ conflict seen in the previous chapters. Their 
stance of being unable to make contact may again repres nt a deliberate generation 
of illusion intended to maintain uncertainty for the sake of protecting their sense of 
self (Mishel, 1988). This provides another example of patients employing uncertainty 
as an opportunity to help them cope with their illness. However, other findings may 
also contribute to this apparent reluctance to takeup professionals’ offers of support. 
Participants’ actions may reflect a deliberate minis ng of their need for answers in 
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light of professionals’ perceived busy-ness as wellas their tendency to view others as 
being worse off than them.  
Primary care involvement in patients’ liver care was comparatively limited. Several 
participants had a positive and active relationship with their GP, although this was 
usually on account of pre-existing chronic conditions. Many participants, however, 
had little contact with their named GP, or primary care professionals more widely. 
This was in part due to long delays in getting an appointment with their named GP, 
but also because patients held a narrow interpretation of the GP role. GPs were 
mainly considered a source for referrals, precriptions and sick lines. There was little 
appreciation of what further support they might be able to provide in relation to 
patients’ liver condition.  
Relatedly, despite advanced disease and very poorly verall health, some participants 
did not consider themselves ‘ill enough’ to warrant  more involved relationship with 
their GP. Given the pervasive and relentless nature of their condition as well as the 
frequency of hospitalisations, this finding is unlike y to constitute evidence of 
adaptation and normalisation similar to that observed in other chronic illnesses. 
Rather, I feel that this mindset is more likely to again be a reflection of participants 
seeking to preserve their valued self by insisting o  a healthier vision of their person. 
The data indicate that the holistic care role of the GP is not appreciated by patients, 
which is consistent with findings elsewhere (Beernat et al., 2014). Their perception 
may be borne out of previous experiences of primary care encounters, which are 
typically time-pressured and symptom-focused and thus not generally geared towards 
the holistic needs of the chronically ill (Wagner, Austin and Von Korff, 1996). 
Indeed, participants’ frustration with GPs’ apparent lack of knowledge and 
confidence regarding liver disease suggests an expectation that consultations should 
focus on the physical aspects of their condition. This notion finds support in other 
research (Deveugele, Derese and De Maeseneer, 2002). Moreover, the perceived lack 
of GPs’ competence regarding liver disease is in itself likely to constitute a reason 
why participants did not tend to seek out their GP for support. This contention 
receives backing from research in motor-neurone disase (Hughes et al., 2005). 
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Finally, there was evidence of some involvement of allied health or social care 
professions during inpatient episodes, but scarcely an  such support in the 
community setting. (The dearth of palliative care input noted will be elaborated upon 
in Chapters 8 and 9.) This reinforces observations n previous chapters that patient 
care in this group was predominantly focused on urgent or acute care to the detriment 
of their psychosocial wellbeing. The value of attending to patients’ holistic needs 
was illustrated by Ben’s improved illness experience as a result of the ongoing, 
individualised support offered by the alcohol liaison nurse. Furthermore, all of those 
who had received input from allied professions commented positively on the 
experience. This again highlights the importance of identifying ways in which the 
psychosocial needs of people with advanced liver disease may be addressed within 
current medical structures and cultures. As much of everyday chronic illness 
management happens in the person’s home, the potential of harnessing existing 
primary care and community-based resources should be explored. 
Sources of dissatisfaction in patients’ care 
Despite numerous reports suggesting that hospital-based care in liver disease is 
inadequate (Ghaoui et al., 2014, Kanwal and El-Serag, 2013, Moore and Sheron, 
2009, Juniper et al., 2013, Williams, 2005, Williams, 2009), most participants in this 
study considered the overall quality of their medical care to be satisfactory. 
However, this finding may be influenced by the fact that this sample was recruited 
and received their main liver care from a specialist unit, thus giving access to 
expertise less likely to exist in a general hospital (Williams, 2009).  
Nevertheless, participants also reported instances of inadequate care in the hospital 
setting. While not as traumatic as acute events, non-acute admissions caused much 
uncertainty and upset due to conflicting instructions regarding the admission process, 
treatment delays and consequent length of time in hospital, as well as the overall 
inconvenience of frequent hospitalisation to the patient and their family. Several 
participants felt ignored, neglected and devalued in their encounters with hospital 
staff, reflecting care experiences relayed by cancer patients and their family carers 
(Janssen and Macleod, 2010). Given patients’ increasing social isolation, as 
described in Chapter 6, occasional social encounters such as medical appointments or 
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inpatient stays can take on a significant role in that person’s life. The doctor-patient 
relationship considered in this context highlights ow critical its experience can be to 
the patient’s sense of self (Charmaz, 1983). A positive encounter with someone the 
ill person considers significant can strengthen their s lf-concept, while a negative 
experience can threaten their identity and leave thm feeling demeaned and 
discredited (Coyle, 1999). Indeed, perceptions of por care may contribute to 
depression, hopelessness and declining health among people awaiting liver 
transplantation (Brown et al., 2006).  
Patient satisfaction with primary care is determined by the nature and quality of the 
doctor-patient relationship and the professional’s skill (Calnan et al., 1994). In this 
study, several participants perceived their GPs as omewhat reticent in their support 
relating to their liver condition. This observation may be linked to GPs’ apparent 
lack of understanding and confidence with regard to the disease. Perceptions of 
doctors as lacking competence negatively influence patients’ views of the overall 
quality of their care (Janssen and Macleod, 2010). Indeed, compared with generalists, 
healthcare professionals holding specialist knowledge engage in more active care and 
achieve improved patient outcomes in a range of conditi s (Harrold, Field and 
Gurwitz, 1999). Uncertainty theory posits that the more credible the patient perceives 
a healthcare professional, the less uncertainty they will experience in relation to their 
illness (Mishel, 1988). A lack of trust in GPs’ abilities therefore means that GPs are 
less likely to be able to alleviate patients’ perceptions of uncertainty and 
consequently improve their overall wellbeing; the opp site may in fact be true.  
In this study, people generally valued their medical care and put their faith in their 
healthcare professionals. At the same time, the medical system constituted a major 
source of frustration, confusion and uncertainty. These findings support the 
contention that medicine as a system is both support and hindrance to patients’ quest 
for meaning (Bury, 1982). Current models of medical re are focused on disease 
management and the data suggest that this holds true fo  the care of people with 
advanced liver disease. However, especially in chronic disease this approach is too 
limited (Larsen, 2013). The present study is consistent with the wider chronic disease 
literature in highlighting the pervasive, individual nature of the illness experience 
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and its impact on all domains of the affected person’s life. Adopting a more patient-
centred care management approach in organ failure can also reduce patient 
uncertainty (Dudas et al., 2013), and is therefore indicated in advanced liver disease. 
7.3.2 Doctor-patient communication 
The quality of communication between patients and healt care professionals proved 
an influential factor in patients’ perceptions of their medical care. Importantly, a 
number of issues were found to contribute to experiences of ineffective doctor-
patient communication. Lessons from patient satisfaction research show consistent 
reports of dissatisfaction with information-sharing in all care settings, insufficient 
opportunities to discuss concerns, and a lack of assur nce or suitable advice (Coulter 
and Fitzpatrick, 2000). All these issues, as well as others, were identified here.  
In the present study, short appointment times were found to limit opportunities to 
discuss patients’ concerns and assess their psychosocial support needs (Dugdale, 
Epstein and Pantilat, 1999). Research with patients awaiting transplantation 
highlighted their lonely suffering (Bjørk and Nåden, 2008). The authors questioned 
whether this was due to patients not communicating their distress to professionals, or 
professionals lacking awareness, knowledge or interes  in this respect. The present 
data suggest that the former may be the case, owing to patients’ acute awareness of 
time constraints as well as a lack of opportunity to share such information in a brief 
consultation encounter, a stance of seeing others as worse off, and inconsistent care 
relationships. Likewise, GPs appreciate the importance of attending to patients’ 
holistic support needs, but perceive a lack of time and skill to actually do so (Grant et 
al., 2004).  
It is clearly a challenge to impart and discuss all necessary information to the 
appropriate depth and in the most suitable manner within the typical medical 
encounter. According to uncertainty theory, access to relevant education constitutes 
one of the key elements providing structure in the context of uncertainty and can 
exert a positive impact on its appraisal (Mishel, 1988). Section 6.4.2 highlighted a 
current lack of awareness by both patients and professionals regarding 
complementary sources of support for this patient group. In light of systemic 
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consultation time restrictions then, healthcare professionals may still be able to 
alleviate uncertainty by raising their own and patients’ awareness of, and enabling 
better access to, complementary sources of information and support, e.g. leaflets, 
websites, and charitable or community-based support organisations, to those living 
with advanced liver disease.  
Participants described some healthcare professional displaying poor interpersonal 
skills; an issue also noted by others (Janssen and Macleod, 2010). A lack of 
introductions and poor bedside manners for example impacted negatively on 
participants’ sense of self as well as their perceptions of their overall care. The use of 
unsuitable language related to both a poor choice of words that alarmed patients 
unnecessarily, and to overly medicalised explanatios that rendered their meaning 
inaccessible to patients. Despite the ambiguity andu certainty such poor quality 
communication generates, there is a tendency by both patients and professionals not 
to ask for clarification (Deveugele, Derese and De Maeseneer, 2002). The 
discrepancy in language used by professionals and patients has been recognised 
previously (Ong et al., 1995). In this study, its problematic nature was first indicated 
in Section 5.2 in the context of receiving a diagnosis of ‘cirrhosis’, which suggested 
an erroneous assumption by professionals that a shared understanding existed as to 
the meaning of this term (Hadlow and Pitts, 1991). However, the inappropriate use of 
medical jargon could be seen to remain a challenge throughout participants’ illness 
journeys. 
Participants indicated an appreciation for both positivity and frankness from 
professionals in relation to their illness. This finding is consistent with previous 
research in ALD (Blaxter and Cyster, 1984) and other conditions (Parker et al., 2007, 
Sell et al., 1993). However, professionals in this study commented on the challenge 
of striking the delicate balance between honesty and t ct. The difficulty of achieving 
this was highlighted by Sarah’s experience, who changed her GP after deeming that 
person’s approach to be too negative. Viewed in the context of uncertainty theory, 
her action may again be understood as a means of managing uncertainty. The rather 
realist, frank approach of her first GP promoted negative certainty and led her to 
interpret her situation as a danger. This  prompted a coping response that saw her 
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take direct action by seeking out an alternative car  professional. The more positive 
approach employed by Sarah’s new GP promoted uncertainty to be appraised as an 
opportunity and in turn facilitated a sense of hope, which served to improve her 
psychological wellbeing. This finding again demonstrates the critical role healthcare 
professionals play in mediating patients’ experiences of uncertainty.  
Multiple aspects of doctor-patient communication could thus be seen to constitute 
further sources of uncertainty in the overall illness experience in advanced liver 
disease. Where communication proved to be of poor quality, it had the potential to 
negate the positive influence a credible authority like a care professional could exert 
on patients’ perceptions of uncertainty (Mishel, 1988). 
7.3.3 Continuity of care 
Continuity of care reflects the coherence and quality of a patient’s care over time 
(Gulliford, Naithani and Morgan, 2006). Three interrelated dimensions of continuity 
of care have been identified: relational continuity, management continuity and 
informational continuity (Haggerty et al., 2003). The relative emphasis on 
dimensions varies between settings and conditions, but all constitute important 
elements in the care of people with long-term conditions (Waibel et al., 2012). In this 
study, continuity of care was found to be inconsistent, fragmented and inadequate in 
all three dimensions and throughout participants’ illness journeys.   
Relational continuity 
Continuity in care relationships was poor across prima y and secondary care settings, 
and both inpatient and outpatient care. This was true in relation to both the longevity 
and the consistency of care professionals involved in supporting the participants. 
Despite patients generally having a designated consultant contact, actual contact with 
that person varied greatly due to the sharing of responsibilities across specialist care 
teams. Those with rarer types of liver disease were more likely to have contact with 
their named consultant. Changes in designated care contact were poorly 
communicated and experienced as disruptive, confusing and alarming, thus adding 
further uncertainty to the patient experience. 
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A caring relationship can foster feelings of safety, trust and respect in the patient 
(Janssen and Macleod, 2010). The degree of trust and co fidence patients feel about 
their relationship with a healthcare provider is important given its influence on their 
experience of uncertainty and thus their overall ability to manage their illness 
(Mishel, 1988). A steady, trusting care relationship encourages patients to disclose 
sensitive information and raise concerns or question . It also reduces the need for 
unnecessary and repeated sharing and interpreting of patient data. As such, relational 
continuity constitutes a key factor in achieving informational continuity.  
An absence of relational continuity makes the development of trust and confidence in 
the doctor-patient relationship less likely, to the d triment of all involved and the 
quality of the care provided. However, relational continuity is only beneficial if the 
care relationship is a positive one. The study data h ve already shown the harmful 
impact experiences and perceptions of stigma, excessive negativity, 
unsupportiveness, and poor interpersonal and communication skills by professionals 
can have on the patient. Having access to multiple perspectives must also be 
considered advantageous for successful care management, especially where these 
involve different discliplines (Mellinger and Volk, 2013). In this study, however, the 
lack of relational continuity was strongly felt, with many participants looking for that 
‘familiar face’ as they moved within and between care settings. This situation also 
fostered uncertainty regarding the who and how of seeking help when necessary. 
The current organisation of healthcare systems around teamworking does not 
promote the provision of a single caring relationship. The involvement of multiple 
care providers does not need to constitute a problem, however, as long as their 
involvement is complementary and well co-ordinated. Nevertheless, I feel that the 
disruptive, all-encompassing and importantly long-term nature of conditions like 
advanced liver disease favours access to one steady, reliable and trusted source of 
advice and support for patients and their families along their illness journey. The 
importance chronically ill patients attach to having a continuing care relationship 
over time has been noted previously (Waibel et al., 2012). Moreover, access to a 
single co-ordinating care professional can positively affect preventable 
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hospitalisation (Billings and Teicholz, 1990), and is a key factor in providing good 
end-of-life care (Lynn, 2001). 
In many comparable conditions this central supportive, and often co-ordinating, 
function is provided by a nurse specialist, but this role is scarce in the realm of liver 
disease (Williams, 2009). At the same time, relational continuity has been found to 
improve with increased GP consultations (Gulliford, Cowie and Morgan, 2011). This 
again points to the value of developing currently underused primary care resources to 
better support the ongoing care of people with advanced liver disease. Indeed, 
contrary to what the present data intimate about participants’ dissatisfaction with 
GPs’ condition-specific understanding, when it comes to relational continuity 
patients are willing to forego clinical expertise in favour of a familiar, trusted family 
clinician (Haggerty et al., 2013). 
Management continuity 
Management continuity refers to how coherently patient care is organised within and 
across care settings and providers, and the extent to which provision is 
complementary. Patient interviews in this study highlighted mainly issues relating to 
the co-ordination of care within the hospital setting on account of the bulk of 
participants’ ongoing care taking place in this environment. Issues relating to care 
co-ordination between settings featured in the professional interviews, however, and 
will therefore be discussed in Chapter 9 in the context of care professionals’ views 
on providing care in advanced liver disease more generally. 
In the present study, ongoing patient care consisted of infrequent outpatient clinic 
appointments, which participants judged too short and symptom-focused to be of 
benefit for them. The unlikelihood of getting to see their named consultant on those 
occasions added to this negative perception. Moreover, these appointments, typically 
several months apart, were considered too infrequent. GPs felt that the unpredictable 
and fluctuating nature of the disease as well as patients’ advanced disease status 
warranted more regular attention from liver specialists. Patients, on the other hand, 
felt forgotten about in the intervening time; an exp rience reinforced by their limited 
engagement with primary care services as highlighted earlier.  
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Infrequent clinic follow-up and reliance on patient-i itiated attendance at primary 
care make it more likely that complications and deterioration of the condition are 
detected late. As mentioned in Section 5.5.3 for example, some of participants’ 
physical complications such as problems with motor function or sleep may indicate 
the presence of subclinical levels of hepatic encephalopathy (HE) (Groeneweg et al., 
1998). At the same time, they may be linked to transie t episodes of overt HE which 
would benefit from targeted care at the time, but which go undetected on account of 
the long gaps in follow-up. More regular care contact is also important in the context 
of patients’ increasing social isolation highlighted in Chapter 6. As mentioned 
earlier, social isolation can make the care relationship more significant to the ill 
person (Charmaz, 1983). More frequent interaction with care professionals can also 
serve to improve patients’ opportunities for social contact (Charmaz, 1997), which 
may impact positively on their psychological wellbeing.  
Despite their scarcity, clinic appointments served to reassure participants that their 
condition was being monitored. Their existence, albeit infrequent, therefore 
constituted an important means of reducing patient uncertainty. However, attendance 
at appointments could be impeded by a number of illness-related factors such as poor 
overall health, physical stigmata of the disease rendering patients embarrassed in 
public, hospital admissions, or a lack of support wi h respect to access to 
appointments or their immediate after-care. Patient attendance at follow-up clinics is 
an important health behavioural indicator, but the factors affecting attendance are 
still poorly understood (O'Carroll, 2011). The present data describe various physical 
and psychosocial issues that may impact on patients’ ability to attend medical 
appointments. These factors sit alongside those discussed earlier with regard to 
participants’ perceptions of the value of these consultations and their preference for 
being able to see their designated consultant when att ding. All of the above factors 
are thus important barriers to achieving management co tinuity. 
These findings again point towards the value of a better sharing of care activities 
across settings, and the promotion of patients’ utilisa on of primary care resources in 
order to facilitate closer monitoring and support of b th their condition and holistic 
support needs. Improving the frequency of care in decompensated liver disease by 
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sharing patient care between gastroenterologists and primary care professionals has 
shown to impact positively on patient outcomes (Bini et al., 2001, Morando et al., 
2013). Potential improvements in the current care pathways for people with 
advanced liver disease will be considered in more detail in Chapter 9 in the context 
of care professionals’ views on that matter.  
Informational continuity 
Informational continuity pertains to continuity in both disease- and person-focused 
documentation and accumulated understanding across individual care providers and 
care episodes (Haggerty et al., 2003). This dimension of continuity is thus influenced 
by the quality and consistency of both care relationships and care management as 
described in the previous sections. In addition, informational continuity is likely to 
be affected by the duration and quality of medical consultations and the manner in 
which information is shared with patients. Participants’ views of their medical care 
and doctor-patient communication presented earlier in this discussion are 
consequently also of relevance here. Finally, informational continuity will be 
affected by the quality and effectiveness of interprofessional communication. This 
particular issue will be considered in Chapter 9 in the context of professionals’ 
experiences of supporting people with advanced liver disease. 
7.4 Concluding remarks 
The literature in advanced liver disease highlights a need to enhance the current care 
provision for this patient population, but research on patients’ own views and 
experiences in this context is lacking. This study contributes insight by exploring 
patient participants’ use of care services and their p rceptions of that care. Most 
considered their overall medical care satisfactory, but also described sources of 
dissatisfaction and uncertainty in this respect. Unlike in other organ failure, the care 
of these patients centred predominantly around hospital-based services. Primary care 
services were underused and undervalued. Care provision in advanced liver disease 
presented as largely symptom-focused, episodic and reactive, and thus constituted a 
poor fit with the long-term support needs of chronically ill people.  
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Complexity in the organisation of treatment and healt c re as well as inadequate 
information-sharing are both indicated in illness uncertainty. Furthermore, trust and 
confidence in one’s healthcare provider is key to reducing uncertainty in the ill 
person (Mishel, 1988). Poor doctor-patient communication and relations as well as 
discontinuous care can thus foster uncertainty in a patient, which in turn challenges 
their ability to manage their illness more generally. Inadequate follow-up and 
intervention management, poor facilitation of self-management, and insufficiently 
managed psychosocial needs may lead to undesirable p ti nt outcomes (Wagner, 
Austin and Von Korff, 1996). Likewise, bedside manners, listening, time, continuity 
and consistency of care, competence, clear and sensitiv  information-sharing, and 
empathy are important aspects in patients’ experiences and perceptions of their care 
in advanced disease (Janssen and Macleod, 2010). All these factors were found 
wanting in this study.  
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Chapter 8: Deterioration and death 
The previous chapter marked out the care experience in advanced liver disease as 
another issue beset with ambiguity and complexity. Thus far then, uncertainty has 
been seen to permeate the physical and psychosocial domains of the illness 
experience, persist from illness onset, and extend hrough patients’ everyday life at 
home and their experiences in the care setting.  
This chapter focuses on patients’ accounts regarding their future with advanced liver 
disase. It first presents their experiences of receiving a prognosis. It then illustrates 
their expectations and concerns regarding the future, and their thoughts on death and 
dying from their illness. It also describes some patients’ end-of-life experiences as 
related by their lay carers in bereavement interviews. The chapter concludes with a 
discussion of these issues in relation to the wider l terature.  
8.1 Prognosis  
Prognosis constituted the ‘elephant in the room’ in the context of advanced liver 
disease. The issue of receiving a prognosis was subject to great uncertainty. The 
unpredictable nature of the disease was one aspect of this. 
It’s very difficult to pinpoint when they’re coming to the end, because they’re generally 
not very well for quite a long time and then they get slightly worse and you’re never 
really sure. (GP of Martin, 77, ALD (NAFLD)) 
Sometimes people are given, “You’ll only live for a year,” or that kind of thing, but I 
suppose you have to be quite cautious about it becaus , for example, I would never have 
thought Ben would have survived this. His bilirubin was so high it was death defying. 
How he survived this beggars belief. (Alcohol liaison nurse of Ben, 35, ALD)) 
This uncertainty was also played out in the differing prognoses offered by healthcare 
professionals. Some GPs felt that liver specialists were being overly optimistic in 
their judgement of patients’ prospects. 
They said two or three years (…) I told them I thought that was very optimistic and I 
thought we were looking at a matter of months. And I think it was probably four or five 
months before he died that he came in to speak to me and I said, “Look, I think six 
months or a year is more an accurate time period.” (…) I suppose I saw him regularly and 
I knew what he was like beforehand. (GP of Thomas, 75, NAFLD) 
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However, participants tended to trust liver specialists’ opinions over those of their 
GP. This may be due to specialists’ disease-specific expertise, but also because their 
more optimistic outlook helped patients feel more hopeful.  
I was really quite worried about it for a while, the illness, but I kind of went to my [liver 
consultant] and went, you know, "Be truthful and tell me," and he was actually quite 
positive. Because the [GP] I had went to before, sh’d told me, “Make happy memories 
now, because you don’t know how long you’ve got.” And that really, that played on my 
mind a lot (…) so I asked [consultant] and he told me that it could be decades before I’m 
affected and my quality of life could be great for decades, you know? (Sarah, 38, ALD 
(HCV), third interview) 
In only a minority of cases had the topic of their prognosis been broached with 
participants. Where participants had received an explicit prognosis, it had been 
experienced as a rather shocking and upsetting event.   
You’re absolutely shattered, it’s like running into a brick wall, you know? “My God,” 
you know, “what am I gonna do?” (…) I actually told the doctor the next visit I was in, I 
says, “Well if it’s that bad then life’s not worth living.” I was actually contemplating 
suicide. (Thomas, 75, NAFLD, first interview) 
Most commonly it was those with alcohol problems who had received a prognosis. 
This had usually come in the form of a stark warning that continued drinking would 
kill them within months. 
[The consultant] basically says if I keep on drinking I’ll be dead in 6 months (…) which 
was a harsh statement but had to be said because, well, you need to be shocked into 
knowing how serious it is. Cos it is serious. I mean, your liver is serious. (Sarah, 38, ALD 
(HCV), first interview) 
The last time they virtually told me my liver would get back to normal, and it did. 
Whereas this time it won’t. I have been warned, well arned, “If you drink again, you 
will die.” So if I do drink again, I’m signing my own death certificate. (Ben, 35, ALD, 
first interview) 
Participants in this study were split on whether thy wished to be told their prognosis 
or not. Some appreciated clarity on the matter. 
The last time I went to see the specialist I was just like, “Just go and be honest with me 
and just tell me exactly,” you know? (Sarah, 38, ALD (HCV), second interview) 
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BK: So have the doctors told you anything about what to expect, how things might 
develop with time? 
Donald: No, I’ll no ask him. (…) I don’t want to ken. 
(Donald, 74, HCC (NAFLD), first interview) 
BK: When you say you don’t want to know, what is it that specifically that you don’t 
want to know? 
Rebecca: My lifespan. 
(Rebecca, 37, ALD, third interview) 
Giving and receiving a prognosis then was a further issue beset with uncertainty; this 
was true for both patients and professionals. As a result, patients’ prognoses were 
rarely discussed.  
8.2 Contemplating the future 
Participants also differed in the way they felt about their future prospects. Some were 
rather worried about what lay in store for them.  
BK: Do you worry at all where it might end or where it might take you? 
Aidan: Oh aye I do, aye. 
(Aidan, 58, ALD, first interview) 
When I’m on my own I keep taking wee panic attacks because I start thinking about the 
future. (Ben, 35, ALD, third interview) 
Others tried to stay hopeful that things would turn out fine for them in the long run.  
BK: So are you feeling reasonably confident about the future? 
Carol: I have to. I just have to. 
(Carol, 45, ALD, second interview) 
Yet others had stopped looking towards the future, th ir deteriorating condition 
making them resigned to an inevitable decline. 
I don’t see a future. (Nadia, 58, ALD (HCV), first interview) 
The uncertainty and unpredictability inherent in the illness trajectory in advanced 
liver disease contributed to participants’ difficulties in envisaging their future.  
If there’s an episode, let’s call it an episode, of any description you kind of start to worry 
about is this progressing? Is it getting worse? You know, what’s going to happen next? 
(…) And as time goes on that impact and fear and worry and whatever starts to become 
more frequent, because the events start to become mor frequent as you move along 
through time. (Michael, husband of Kate, 41, cryptogenic LD, third interview) 
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At times I panic. Things are happening too quick so I’m panicking. (Mary, 66, 
autoimmune hepatitis, second interview) 
8.2.1 Returning to work 
Worries about the future were not limited to likely developments in relation to 
participants’ health. In contemplating their future, the issue of if and when they 
would be able to return to work preoccupied the minds of younger participants. All 
were eager to work again, but there was uncertainty whether they would be able to.  
The way I’m feeling at the moment, I don’t know if I’ll be back at work. (Carol, 45, 
ALD, first interview) 
What chance have I got when all these fit people and ble people can’t get a job, and 
students with degrees and everything, fit and healty? Christ, I’m not long out of hospital 
about dead, what chance have I got of getting some sort of job? (Ben, 35, ALD, second 
interview) 
For participants with ALD, this uncertainty also relat d to their ability to halt the 
progression of their illness by achieving sobriety long-term. Given their poor state of 
physical and psychological health, however, some were r signed to the fact that they 
would never be able to work again. 
I know I’m not going to be able to get a job. (…) I couldn’t cope with a job. (…) Health-
wise issues and how I’m feeling and…I know I wouldn’t. If I actually had a job it maybe 
would give me a wee bit of drive, but I don’t think it would last for long. (Rebecca, 37, 
ALD, third interview) 
8.2.2 Liver transplantation 
Kate was the only study participant for whom a liver transplant became a tangible 
possibility in the course of the study. For the majority of participants liver 
transplantation was contraindicated due to co-morbidities or continued drinking. 
Some participants considered themselves too old to even contemplate taking up such 
an option should it be offered to them. 
I’m 77 and I’ll be 78 when, this time I’ve got, four to six months, I says, well I’m no that 
fussy really. Even my grandchildren, they’ve all grown (…) I wouldn’t bother anymore. 
(Martin, 77, ALD, first interview) 
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Others felt that they were undeserving of a new liver on account of the self-inflicted 
nature of their condition. 
Rebecca: I don’t deserve it. (…) 
BK: You feel you don’t deserve it or you’ve been told you don’t deserve it? 
R: No, I feel I don’t deserve it. (…) It’s self-inflicted. 
(Rebecca, 37, ALD, second interview) 
Interestingly, receiving a transplant was not considered a final safety net in the battle 
against their deteriorating condition. On the contrary, participants appeared 
particularly fearful of the thought of undergoing transplantation. 
That’s always been my biggest fear, probably more than, I wouldn’t say more than dying 
but on a par with dying. I don’t think I could handle that if I was told that I needed, my 
liver was kaput and I needed a transplant. (Ben, 35, ALD, second interview) 
Mary was similarly alarmed at the thought of requiring a transplant.  
I said, “Are we talking, down the road, transplant then?” It was me that brought it up. 
[Consultant] says, “Yes.” Well, my mouth went…” (drops jaw). I says, “Oh God 
almighty.” (Mary, 66, autoimmune hepatitis, second interview) 
Mary never did get assessed for transplantation, however, as she died suddenly only 
one week after this conversation. Her story thus exemplifies the uncertain nature of  
advanced liver disease and the difficulty of determining a prognosis as indicated 
earlier in this and previous chapters. 
8.2.3 Contemplating death and dying 
While issues around death and dying were rarely raised in the interviews, many 
participants acknowledged at some level that death was a possible outcome. In 
particular, brushes with death during acute exacerbations and observations of 
deterioration in one’s condition promoted participants’ reflecting on this and 
existential issues more generally.  
I’ve never thought about death so much since I’ve…you know, you don’t think about it at 
my age. But since all this has happened I’ve been thinking about it. We’ve all got to think 
about it one day, but normally not till you’re about 80. (Ben, 35, ALD, third interview) 
For younger participants especially, contemplating death proved a frightening 
process. 
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You always plan your life ahead and you think, “Oh well, this year I’m going to do this 
and next year I’m going to do that,” and kind of reality is beginning to sink in a little bit 
that if this all goes tits up there won’t be next year. Jesus. (Kate, 41, cryptogenic LD, first 
interview) 
There was a suggestion that some participants mentally acknowledged their 
imminent demise, but refrained from voicing this publicly.  
I think she knew herself, you know, but she didn’t want to say to me. (Jeff, husband of 
Polly, 68, NAFLD, bereavement interview) 
In the context of the research interviews, participants’ level of willingness to engage 
in a consideration of death and dying remained constant throughout their study 
involvement. Martin for example, despite having received an explicit prognosis of 
four to six months and being fully accepting of his fate, remained reluctant to 
acknowledge this aspect of his illness in his interviews. In contrast, Fraser was 
consistent in his expression of a wish to die soon and see the end of his suffering.  
I wish honestly, I wish somebody would just give mea jag and put me to sleep and that’s 
it. That’s what I do. (Fraser, 60, ALD, second interview) 
In others, the threat of death inspired an unfailing strong will to live despite their 
unpredictable and poor condition. 
I’m quite a determined person. I refuse to sit down and die, you know what I mean? 
(Sarah, 38, ALD (HCV), first interview) 
The uncertainty inherent in advanced liver disease could thus be seen to both prompt 
and influence participants’ considerations of death nd dying in relation to their 
illness. 
8.3 Planning for the future 
Given the many uncertainties they experienced relating o their illness, most 
participants felt unable to make plans for the future. 
You can’t turn around and plan for the future or nothing, you know? (Jeff, husband of 
Polly, 68, NAFLD, first interview) 
In contrast to their counterparts, Kate and Michael t ckled the uncertainty of their 
situation head on by making plans around both a positive and a negative outcome.   
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It’s not an easy thing to talk about, but the reality is you have to make plans, both positive 
and negative plans, because in these situations thigs can happen and change very, very 
quickly. You don’t want to be in a position where something really bad happens and you 
don’t know what the answers are to what Kate wants for her estate so to speak, or her 
family or funeral arrangements (…) So it’s definitely something that should be done. 
Absolutely. But equally it’s nice to plan for the future as well, you know? (Michael, 
husband of Kate, 41, cryptogenic LD, second interview) 
The week after I got out of, from the [transplant] assessment week, I went home and 
wrote a massive, massive long letter to my husband. A  he knows it’s there and he 
knows where it is, and it’s telling him what to do with me and what to do with all my 
things should the worst come to the worst. And thatw s quite difficult. However, it’s 
done. It’s done. (Kate, 41, cryptogenic LD, second interview) 
Some of the older participants had also made plans for the future. Their plans 
focused solely on a negative outcome, however.  
Just about maybe a couple of months before she died we were talking about different 
things, you know, she told us what she wanted if anythi g happened to her. (Jeff, husband 
of Polly, 68, NAFLD, bereavement interview) 
Martin and his wife Cora had made wills and funeral arrangements prior to Martin’s 
diagnosis with decompensated liver disease. Despite these plans being in place and 
Martin accepting of the fact that he only had a short time to live, he was reluctant to 
plan for the time of his final deterioration.  
It was really tricky to have conversations with him about being less well or planning for 
when he died. I think a lot of the barrier to that w s because of his ascitic taps being done, 
it was just the next one after the next one. "That will keep me alive, that is all I have to 
do, I can’t think beyond that. Two weeks will come, I’ll be symptomatic, I’ll need the tap 
done. Marie Curie can’t give me a tap, so I’m not gin  to Marie Curie." So because we 
don’t do invasive procedures as you would on wards, my feeling was that that’s why he 
was not wanting to go there. (Community palliative care nurse of Martin, 77, ALD) 
8.4 Experiences of death and dying 
Nine of the 15 patient participants died during their involvement in the study. Of 
these, eight died in hospital following either acute or routine admissions. Only 
Donald died at home, in line with his and his family’s wishes. Interestingly, Donald 
was the only study participant whose disease cause was primary liver cancer. His 
end-of-life care arrangements had been put in place with the help of his GP and 
community palliative care services. His wife Martha w s pleased about the care and 
support provided by both professions in Donald’s final days.   
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Top marks, definitely. They were perfect. I mean they were in there in the morning, 
afternoon and night. Then [GP] come in every day. I mean, that was over four days but 
that felt like weeks. Oh no, the nurses were perfect. (Martha, wife of Donald, 74, HCC 
(NAFLD), bereavement interview) 
As mentioned previously, Martin was the only other participant to benefit from 
similar arrangements with community palliative care services to allow him to die at 
home. However, these plans were not in fact followed through at that critical time 
and he died in hospital following an acute admission. Interestingly, while Martin was 
eventually persuaded to accept palliative care input in his own home, he was not 
prepared to completely relinquish his end-of-life care to a hospice. His designated 
palliative care nurse suspected that his fortnightly ospital admissions to drain his 
ascites had lured him into the illusion that these treatments were prolonging his life.  
He didn’t want to go into Marie Curie, but he was quite happy to be in an acute setting, 
which is quite unusual. A lot of people don’t want to go near the hospital. But I think he 
almost viewed that (…) as a life line. (Community palliative care nurse of Martin, 77, 
ALD (NAFLD)) 
At the same time, there was a sense that hospital was in fact an appropriate place for 
some these patients to be in their dying phase. While it was not possible to ascertain 
the circumstances around all the participants who died in hospital, the bereavement 
interviews conducted suggest that the lay carers of those who had died in hospital did 
not regret this experience.  
The staff at [local hospital] were, to be honest, they were brilliant, you know? (…) They 
put her into a wee room for about a fortnight (…) and I took some photographs (…) and 
we had them on the window ledge and everything, you know? They were definitely quite 
good, you know? (Jeff, husband of Polly, 68, NAFLD, bereavement interview) 
Fraser’s consultant agreed that liver patients dying o  the hospital ward was not 
necessarily a negative event, given the familiarity that usually existed between 
patients and ward staff on account of their repeat admissions.  
To some degree I think that’s a reasonable thing because I think we know them and, you 
know, for Fraser we were more of a family, you know, r not a family is the wrong term 
to use but, you know, he knew all of us lot better han anybody else, and I think you 
know, he would have been comforted by being in with us. (Consultant of Fraser, 60, 
ALD) 
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8.5 Discussion of findings 
The above findings illustrate participants’ views and experiences in relation to 
anticipating, contemplating and planning for deterioration and death. Again, each of 
these areas was subject to considerable uncertainty which affected participants’ 
perceptions and actions. Discussing prognostic and e -of-life issues, facing an 
uncertain future, and contemplating and planning for death emerged as particularly 
challenging issues. 
8.5.1 Discussing prognosis and the end of life 
Prognosis constituted a further source of uncertainty in participants’ illness stories, 
and one that was shared by patients and professional  alike. Prognostication in 
chronic liver disease is complex and dependent on several person and disease-
specific factors (Propst et al., 1995). Determining a precise prognosis on an 
individual basis is therefore difficult. Doing so is further undermined by the 
fluctuating, unpredictable nature of chronic liver disease, and the potential of those 
with lifestyle-related aetiologies being able to alter the illness pathway through 
behaviour change.  
Guidance has been put forward to help healthcare professionals manage prognostic 
uncertainty in non-malignant disease including advanced liver disease (Highet et al., 
2013). Nevertheless, it is important that professionals acknowledge and explain to 
patients the uncertainty that remains in providing a prognosis in relation to their 
specific circumstances (Hancock et al., 2007b). In this study, conversations between 
patients and professionals about the patient’s prognosis were mostly absent. This 
mirrors the experience of patients with other types of organ failure (Barclay et al., 
2011, Davison, 2010, Murray et al., 2002). Professionals are more likely to conduct 
prognostic conversations with cancer patients than with people with other 
progressive types of illness (Exley et al., 2005, Heyland et al., 2009). 
Participants in the present study were more likely to have been given an indication of 
their prognosis if their liver disease was related to alcohol misuse. The data relating 
to ALD participants presented so far suggests an illness experience that is in some 
respects more in line with the cancer experience than with other causes of liver 
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disease. Like cancer patients, people with ALD have  concrete diagnosis, an 
opportunity to overcome their disease which would faciliate are more stable, slower 
disease progression, and a relatively more predictable life expectancy based on their 
ongoing drinking behaviour. This makes prognostication in this particular liver 
patient group easier to gauge, and may be the reason why such conversations were 
more likely to occur in this context. Alternatively, care professionals may use  
prognostic conversations as a motivational tool to sh ck ALD patients into behaviour 
change, i.e. abstinence, to curb disease progression. As this option is not available to 
people with liver disease of other causes, it might offer another explanation as to why 
professionals generally omitted similar conversations with them. 
Characteristics of prognostic and end-of-life conve rsations 
Where conversations had taken place about participants’ prospects, the study data 
indicated that the opinions of liver specialists were regarded more highly than those 
of GPs. In the context of prognostic predictions, their disease-specific expertise 
combined with a tendency to express more optimism about future developments. 
This disparity between specialists and generalists ha been reported previously 
(Christakis and Lamont, 2000). Specialists’ communication therefore served to 
alleviate patient uncertainty regarding future developments by promoting a sense of 
hope, which might further explain participants’ tend cy to favour their input.  
At the same time, actual developments observed in several participants’ illness 
journeys support the view expressed by GPs in this study that specialists were in fact 
being unrealistic in their verdicts. Research elsewhere confirms that healthcare 
professionals are inclined to consciously misjudge patients’ survival (Lamont and 
Christakis, 2001). At the same time, promoting a sense of life remaining open-ended 
has been found to aid coping (Johnston and Abraham, 2000). Expressing over-
optimism to nurture hope in the patient, as employed by liver specialists in this study, 
should therefore not be considered inherently harmful. It is critical that patients’ 
overall volatile health status remains acknowledged, however, and that professionals 
undertake advance care planning to allow for a sudden deterioration in a patient’s 
condition. Indeed, having prognostic conversations can facilitate the advance care 
planning process (Heyland et al., 2009). The topic f advance care planning will be 
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examined more closely in Chapter 9 in the context of pr fessionals’ views on caring 
for people with advanced liver disease. 
Barriers to prognostic and end-of-life conversation s 
Professionals agree that people with progressive, lfe-limiting conditions deserve 
open dialogue about their prognosis and end of life, but remain reticent to initiate 
such discussions for reasons such as a lack of time, personal apprehension, and 
uncertainty about the illness trajectory (Hancock et al., 2007a, Hancock et al., 
2007b). All these factors were indicated in the present data and may therefore have 
contributed to the relative absence of such conversations between participants and 
their care providers. Similar barriers to prognostic communication exist in heart 
failure (Barclay et al., 2011, Hjelmfors et al., 2014) and COPD (Momen et al., 2012). 
Previous research also suggests that professionals tend to rely on patients to raise 
such matters, and that they interpret an absence of questions as an indication that 
patients do not wish to have this information (Hancock et al., 2007a). However, the 
present study has already identified several factors which are likely to affect patients 
bringing up issues of personal concern during medical encounters, such as a poor 
understanding of their condition, lack of confidenc, discontinuity in their care 
relationships, and the symptom-focused, time-pressud and infrequent nature of 
consultations. The widespread coping strategy of focusing on one day at a time is 
also likely to work against patients raising issues about their future with 
professionals. 
It has been suggested that prognostic accuracy in progressive disease is subject to not 
only clinical uncertainty, i.e. actual limitations in current medical knowledge, but 
also to ‘functional uncertainty’ (Davis, 1960). Uncertainty in this context is deployed 
to provide a critical function, that of informational gatekeeping. As such, uncertainty 
is actively preserved by professionals even where prospects are relatively clear in 
order to make their ongoing care efforts and relations with a patient more 
manageable. This again highlights not only the influence professionals may exert on 
the patient experience of uncertainty, but also hints at patients’ uncertainty being 
actively manipulated at times in order to achieve a favourable outcome for other 
stakeholders in their illness. The idea of ‘functional uncertainty’ thus provides a 
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further explanation for the relative absence of prognostic conversations observed in 
this study.  
Patients and their families consider prognostic information important and their desire 
for it is high (Davison, 2010, Lowey et al., 2013, Parker et al., 2007). However, 
participants in this study were split in their wish to know details of their life 
expectancy and what to expect in the future. Similar differences have been noted in 
patients with a range of conditions including advanced cirrhosis (Heyland et al., 
2009). This finding may reflect participants’ strategic coping by employing a stance 
of denial with respect to their future prospects. Similarly, participants may have 
sought to protect their sense of self by limiting their exposure to such information. 
This indicates another instance of uncertainty being appraised as an opportunity and 
thus actively maintained in the context of their illness.  
However, participants’ poor understanding of their condition and liver disease more 
widely as described in Chapter 5 suggests an alterntive explanation. It is 
conceivable that people did not in fact appreciate the life-limiting nature of their 
condition and thus did not feel a need to consider th ir prognosis. This notion has 
some support from research in heart failure and COPD, where patients demonstrated 
little awareness of the deadly nature of their illness (Lowey et al., 2013, Murray et 
al., 2002, Pinnock et al., 2011). Poor awareness in this respect may also have been 
influenced by the fact that advanced liver disease is a chronic illness predominantly 
managed in the acute care setting, as demonstrated in the previous chapter. This 
experience may shape people’s perceptions of their illness as one that is treatable 
long-term, thereby enforcing their ignorance (or possibly denial) regarding the likely 
terminal nature of their condition. 
The above finding consequently underlines the importance of prognostic and end-of-
life conversations being initiated by the care professional, while at the same time 
giving due attention to cues indicating patients’ preparedness to engage with this 
topic. Inappropriate and poorly timed prognostic conversations can foster uncertainty 
and anxiety (Rogers, Karlsen and Addington-Hall, 2000). Conversely, effective 
communication of such challenging issues can promote understanding, acceptance 
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and adjustment in the patient (Fallowfield and Jenkins, 2004). In light of the rapid 
and erratic trajectory in advanced liver disease, I believe that healthcare professionals 
should start raising awareness of potential deterioration with the patient from the 
point of diagnosis. This is particularly critical where that person’s liver condition is 
already decompensated, as their eventual decline is guaranteed. This notion receives 
support from a systematic review indicating that patients want prognostic 
information at the time of diagnosis or shortly thereafter (Parker et al., 2007). 
However, it is imperative that professionals be sensitive to patients’ needs and 
preferences in this respect, tailor such conversations to the individual case, and 
ascertain patient understanding (Hancock et al., 2007a, Hancock et al., 2007b). 
8.5.2 Facing an uncertain future 
Uncertainty relating to disease progression and future prospects left many 
participants feeling anxious, while others chose to remain hopeful in the face of their 
uncertain circumstances. The same uncertainty also affected participants’ ability to 
envisage their future. This observation has also been made in COPD, where patients 
are similarly unable to plan for the future on account of the unpredictability of their 
condition and its uncertain trajectory (Small and Graydon, 1993). Given the 
relatively more pervasive and traumatic consequences of the illness on their lives, 
younger participants expressed more anxiety about the uncertainty shrouding their 
future. This finding is consistent with the literature in other conditions indicating a 
greater negative impact of chronic illness on the liv s of younger patients (Hummel, 
2013). 
The anxieties expressed over one’s future also provide further evidence that people 
with advanced liver disease experience biographical disruption, as noted in Section 
6.5.3 (Bury, 1982). Uncertainty draws the ill person’  attention to what is a normally 
taken-for-granted future (McCormick, 2002), and highli hts to them the unsettling 
impact of their illness upon previous expectations a d plans for their future. Younger 
participants were particularly concerned about the likelihood of them one day being 
able to return to work. There was also uncertainty over the necessity of undergoing 
liver transplantation at some point in the future.  
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Interestingly, liver transplantation was not considered the ultimate safety net in the 
context of a precarious existence. Conversely, its contemplation appeared to create 
considerable uncertainty and fear. Although professionals had raised this issue with 
only a few participants in this sample, there was widespread awareness of the 
dangers inherent in this intervention. Moreover, those with ALD considered their 
chances of being selected for transplantation poor given the self-inflicted nature of 
their illness. This negative perception is in fact borne out by research into public 
attitudes towards the allocation of scarce organ resources to people with alcohol 
problems (Rodrigue et al., 1998), although it does not reflect the views of clinicians 
(Neuberger et al., 1998). Nevertheless, it again indicates the acute sense of stigma 
participants perceived, as highlighted in Chapter 6. What is more, several ALD 
participants considered themselves undeserving in comparison with patients they 
regarded innocent victims of their liver condition. Numerous studies have explored 
liver transplant candidates’ views of facing transplantation while waiting for a donor 
organ. Research into how liver patients more generally view and rationalise the 
possibility of requiring a transplant in the future is lacking. In light of the anxiety this 
issue appears to cause in this patient group, and in particular for people with ALD, 
this topic warrants further exploration in order that any uncertainties, misconceptions 
and concerns may be addressed and the psychological burden on patients alleviated 
as they progress through the illness. 
8.5.3 Death and dying in advanced liver disease 
Contemplating death 
Patients with primary liver cancer are reported to experience a constant fear of death 
(Fan and Eiser, 2012). The present data suggest that this is not necessarily the same 
for people with other causes of liver disease. This discrepancy in findings may be 
explained by the relatively greater societal awareness of the implications of a cancer 
diagnosis compared to that of liver disease. Nevertheless, while rarely openly 
acknowledged, participants’ accounts indicated a general awareness of the potential 
for deterioration towards death. This finding reflects observations in heart failure 
patients, who were similarly uncertain of their progn sis but recognised the severity 
of their ill health (Boyd et al., 2004). Given participants’ poor understanding of the 
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life-limiting nature of advanced liver disease, their awareness was prompted by 
episodes of exacerbation serving as a reminder of the volatile nature of their 
situation, as well as a sense of a slow but steady deterioration in their condition. 
Those with ALD were additionally conscious of the explicit threat of impending 
death if they failed to stop drinking. Thus, different sources of uncertainty related to 
their condition could be seen to promote existential contemplation in participants.  
Recognising the precariousness of their situation injected participants with fear and 
determination alike. Some actively avoided overt contemplation of death. This can 
again be understood as a way these people managed the uncertainty that existed over 
this issue, which related to both an uncertainty rega ding one’s prognosis and 
participants’ general understanding of the implications of a diagnosis of advanced 
liver disease. In avoiding thinking about death, uncertainty was again employed as an 
opportunity and served as a way of protecting not only their own sense of self, but 
the wellbeing of their loved ones also.  
Planning for death 
Uncertainty also played a key role in participants’ ability and intent to plan for future 
eventualities. This was a task rarely undertaken in this sample. Research in similarly 
unpredictable conditions like heart failure and COPD suggests that patients wait for 
health professionals to prompt them when the time is right to plan for death (Lowey 
et al., 2013). No such expectations were expressed by participants in this study, 
however. Older participants had commonly prepared for death by making a will, 
although this had usually been undertaken in recogniti n of their age and general life 
stage rather than their illness. Some participants again chose to embrace the 
uncertainty surrounding death as an opportunity in th s respect, however. Kate and 
her husband Michael for example opted to make plans for both a positive and a 
negative future outcome. Similarly Martin, despite being aware and accepting of his 
short prognosis, used his repeat hospital admission f r paracentesis to avoid 
engaging with the issue of his imminent decline. In this context, ongoing restorative 
care could be seen to interfere with patients’ willingness to engage with their death. 
It offered a source of stability within an illness experience dominated by uncertainty, 
and a welcome distraction from thinking about the future by facilitating a focus on 
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the present. This fact has also been observed in the experiences of cancer patients 
(The et al., 2000).  
End-of-life care planning was generally absent among participants. Even where 
arrangements had been put in place, it did not guarantee these plans being followed 
through; a finding that resonates with previous observations of this kind (Rhee, Zwar 
and Kemp, 2013). There was a lack of appreciation among the participants of when 
death was imminent, which was exacerbated by the lack of prognostic discussion 
highlighted earlier and the ‘rescue culture’ of modern healthcare (Gott et al., 2013). 
As intimated previously, continued active treatment served as an additional challenge 
to patients truly appreciating the life-limiting nature of their illness, and consequently 
as a barrier to the implementation of appropriate end-of-life care. Being accepting of 
one’s death facilitates the provision of end-of-life care (Zimmermann, 2012). Clearly 
then, in order to accept death the person needs not only to be fully aware of and 
understand the terminal nature of their illness, but be supported by care structures 
which enable this process to take place.  
Place of death 
Lack of appropriate planning, of coordinated care and services, and regular acute 
exacerbations meant that most participants died in hospital. This is consistent with 
recent figures suggesting that nearly three quarters of liver deaths in England occur 
in the hospital setting (National End of Life Care Intelligence Network, 2012). 
Hospital deaths are also common in other organ failure (Murray et al., 2002). 
Numerous surveys suggest that most people prefer to die at home and current end-of-
life care policies strive for this to happen wherever possible and appropriate. In the 
present study, however, there was a sense among lay carers and professionals alike 
that the hospital was in fact not a wholly inappropriate place for liver patients to die. 
Indeed, the bereavement interviews with lay carers indicated positive experiences of 
patients dying in hospital.  
Care professionals agree that death should be facilitated in a familiar environment 
(Reyniers et al., 2014b). The previous chapters as well as the hospital admissions 
data presented in Appendix 4 highlight the frequency with which participants 
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attended hospital as inpatients and explain the resultant sense of ‘homecoming’ for 
many. Similar sentiments have also been expressed by patients with kidney disease 
(Gott et al., 2013). In the case of advanced liver disease then, hospital constitutes a 
familiar and trusted environment for many patients. This is particularly true when 
one recognises the considerable number of individuals in this patient group living in 
difficult social circumstances related to drug or alcohol misuse. For these individuals, 
their home environment may not constitute the safest or most supportive 
environment to accommodate their end-of-life care. The acute hospital setting on the 
other hand, a familiar surrounding with valued care relationships, may represent a 
‘safe haven’ and thus a more appropriate place of death (Reyniers et al., 2014a). The 
increasing social isolation witnessed among participants in this study provides 
further support for this notion. Moreover, hospital admissions at the end of life may 
not always be inappropriate or unwelcome (Morris et al., 2013). Indeed, if the patient 
requests being admitted to hospital then doing so must be considered justified 
(Reyniers et al., 2014b). This may in fact be the reason for Martin dying in hospital 
despite care plans to enable him to die at home being in place. The expectation, 
borne from previous experience, that he would be well cared for at the hospital may 
have driven the decision to have himself admitted in favour of contacting his GP or 
community palliative care nurse. Unfortunately the data did not allow an insight into 
patient participants’ views on the matter. However, f edback from the members of 
the study’s lay advisory group lends support to this idea, by confirming that they 
valued and trusted their hospital-based care and healthcare professionals to the extent 
that they would be perfectly accepting of hospital as their place of death. 
The above suggests a somewhat divergent stance from that currently dominating the 
literature around preferred place of death. Taking a person’s place of death as a 
proxy for the quality of the death experience is clearly too simplistic. Given the 
unpredictability and frequency of acute exacerbations in advanced liver disease and 
the current paucity of community-based palliative care provision for this patient 
group, deaths in the hospital setting in this group are likely to remain common (Clark 
et al., 2014). Moreover, a considerable number of pe ple with advanced liver disease 
are averse to the idea of receiving care in a nursig home (Roth et al., 2000), and 
 
  180 
might in fact be too young to qualify for such provision. Professionals working in 
acute hospital care have previously commented that contrary to popular opinion their 
setting is able to ensure a good death (Gott et al., 2013). At the same time, findings in 
this and other studies indicate that hospital care is currently too focused on continued 
life-prolonging interventions and that professionals l ck appropriate communication 
skills (Reyniers et al., 2014a). It is therefore imperative that staff in acute hospital 
services are upskilled accordingly (Barclay and Arthu , 2008). Barriers relating to the 
current organisation and culture of the acute care setting also need addressed to 
ensure that hospitals and their staff are adequately equipped to deal with the needs of 
the person at the end of their life (Gott et al., 2011). 
8.6 Concluding remarks 
Issues around death and dying in the context of advanced liver disease were beset 
with further ambiguity and uncertainty. Notably, uncertainty in this regard existed 
not only for patients, but professionals alike. Uncertainty was a key barrier to 
effective prognostic and end-of-life communication and planning in the care setting. 
Similar to other conditions that are subject to an uncertain disease course, patients’ 
needs in this respect were poorly attended to. ALD patients could again be seen to 
constitute an exception, however. The need for professionals to take the lead in 
initiating prognostic and end-of-life conversations, and to do so early on in the illness 
trajectory, was indicated.  
There was little appreciation among patients of the life-limiting nature of their 
condition, and in turn a lack of due consideration of or planning towards possible 
decline and death. At the same time, patients saw their future shrouded in 
uncertainty, which added to their psychological burden. The prospect of needing a 
liver transplant in the future presented a particular threat in this respect and warrants 
further attention. Finally, the data make an important contribution to current debates 
regarding preferred place of death and the appropriateness of the acute hospital 
setting as a provider of end-of-life care. The question  it raises in this regard 
indicates avenues for further research. 
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Chapter 9: Caring for people with advanced 
liver disease 
The previous chapters described the patient experience in advanced liver disease. 
Uncertainty emerged as an enduring and pervasive chara teristic of this experience. 
Uncertainty affected all stages of the illness: from diagnosis to the everyday 
experience of living with advanced liver disease to issues around contemplating and 
planning for death. Moreover, uncertainty was observed in all settings within which 
life with the illness had to be negotiated – home, care settings and the wider social 
environment. There was also an indication that uncertainty was not only a feature of 
the patient experience in advanced liver disease, but that it was similarly felt by lay 
and professional carers.  
This chapter focuses on the experiences of lay and professional caregivers with 
regard to caring for people with advanced liver disease. The first part of this chapter 
outlines the experiences and perceptions of patients’ lay carers with regard to caring 
for someone with liver disease at home, and the support they received in this respect. 
The second part of the chapter describes the views of  professionals on the challenges 
they encountered in providing care for people with advanced liver disease, and their 
thoughts on how existing services for this patient group might be improved. Finally, 
there follows a discussion of these findings in relation to the empirical and 
theoretical literature. 
9.1 Lay carer experience  
As described in Section 4.1.2, 11 lay carers nominated by patient participants agreed 
to be interviewed. The majority of them were family members living with the patient. 
When given the option, most patient and carer participants chose to be interviewed 
together, to which I agreed respecting their wishes. The data obtained gives an 
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9.1.1 Being a carer 
Given patients’ complex support needs described in the previous chapters, it is not 
surprising that carers felt the strain of their role.  
I'm emotional. You know, it gets you down sometimes. (Cora, wife of Martin, 77, ALD 
(NAFLD), second interview) 
This strain was felt not just by them, but gradually ffected wider family networks. 
It’s not just about us, it’s about the wider family circle as well. They start to worry more 
and there’s more contact and more stress and it almost pulls people together a little bit for 
the wrong reason. So you do tend to see people moreoften because they worry and they 
stress. (Michael, husband of Kate, 41, cryptogenic LD, third interview) 
It does put a strain on the whole family trying to support him and trying to say the right 
thing and knowing when to butt out and when to try and help. (Tamsin, partner of Ben, 
35, ALD, second interview) 
A variety of concerns played on carers’ minds, causing feelings of uncertainty. Some 
worried about being faced with challenges beyond their capabilities. 
I worry about him in case he falls or, ken, has an accident, and I can’t help him, ken? I 
couldn’t lift Fraser up. (Betty, neighbour of Fraser, 60, ALD, first interview) 
Michael was mindful of the fact that he needed to make plans in preparation for 
Kate’s likely deterioration, but felt uncertain about the best course of action.  
I’m now thinking about my work side of things that if Kate’s well, great, if she’s not will 
we need care packages? Financially, how does that affect me? When does it affect me? 
(…) Do I work for another few months? Do I need to st p and sell and move into 
something smaller and so I can afford to get support? What finances are out there? 
(Michael, husband of Kate, 41, cryptogenic LD, first nterview) 
At least in relation to patients’ physical condition, however, carers felt reassured by 
the medical care provided.  
The only worry is on the, his own mental side of things, his mood and trying to move on 
in his life, trying to live with it and accept what’s happened and try and move forward. 
I’m more worried in that way, but with regard to the liver and seeing the liver doctors, 
I’m not really worried about that because I’m sure th y’ll flag up if anything’s amiss. 
(Tamsin, partner of Ben, 35, ALD, first interview) 
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Coping strategies 
Carers’ coping strategies were motivated by the practic l and emotional complexity 
of their caregiving role.  
I have to give my boss reminders every so often that I’ve got to go and do this today, or, 
you know, there’s an appointment coming up. Even then there’s a daily challenge of 
feeling guilty about not being at work and the impact that it has on them. And the 
challenge of not being with Kate because of the impact that it has on her. And in between 
that the impact it has on me because I’m worried about work and I’m worried about Kate. 
(laughs) So it’s quite a hard one to manage, but yo just have to get on with it and deal 
with it and try and bury your feelings towards both sides of it. (Michael, husband of Kate, 
41, cryptogenic LD, second interview) 
Carers’ coping approaches by and large mirrored those of patients. They similarly 
dealt with the uncertainty of the situation by adopting a stance of simply ‘getting on 
with it’ and hoping for the best.  
I'm not a defeatist. I don’t crack up. I might have a few tears sometimes with worry, but 
at the end of the day you've just got to face it and get on with it and hope for the best. 
(Julie, mother of Rebecca, 37, ALD, first interview) 
At the same time, carers were conscious of protecting patients from further burden 
by withholding their own concerns from them. 
Not that I can’t talk to Kate but it does make you a little bit, you got to suck it up yourself 
a little bit and try and get on with it, because Kate doesn’t want to hear negative thoughts 
and attitudes which is quite right, but then equally I’ve still got to deal with it. I’ve still 
got to deal with the stuff that chucks around your head, you know? (Michael, husband of 
Kate, 41, cryptogenic LD, third interview) 
Being able to go to work served as an escape from the strains of the caring role.  
I think having [son] and my job keeps me going. (Tamsin, partner of Ben, 35, ALD, first 
interview) 
BK: What helps you cope? Are you spiritual at all? 
Cora: I'm working. 
BK: You're working? Ok. 
C: I work. I was gonna give up my job eh, and Martin said no and the family said, “No, 
keep working as long as you can.”  
(Cora, wife of Martin, 77, ALD (NAFLD), second intervi w) 
In contrast, some felt that having to go to work only added to their worries.  
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You don’t particularly want to be there because you’d rather be with Kate to see her 
through things and look after her. And you’re kind of torn between financially having to 
go and work to earn money to pay the mortgage versus looking after Kate. (Michael, 
husband of Kate, 41, cryptogenic LD, first interview) 
Similar to patient participants, faith did not seem to generally be part of carers’ 
coping repertoire. However, Michael felt that his challenging circumstances had 
reawakened a sense of spirituality in him.  
I haven’t been to church for a very long time. But interestingly, and I’m sure it happens to 
many, many people who go through illnesses like this, is you do start to question, you 
know, stuff like that. (…) In fact the last 2 or 3 times we’ve been down, I’ve gone into the 
church in the hospital just for even just 10 minutes. It’s peaceful, it’s quiet. I don’t know 
if it is a particularly religious thing or not, but it just lets you gather your own thoughts 
sometimes. (Michael, husband of Kate, 41, cryptogenic LD, second interview)  
Putting the patient first  
Carers’ lives were increasingly centred around patients’ needs. 
I’m never out. If I’m on my way out I go up to the shop there to get a paper and that, or 
down to the clinic. It’s only down the street. But I’m never, otherwise I’m never out. 
(Jeff, husband of Polly, 68, NAFLD, first interview) 
By necessity, this meant carers curbing their own activities, isolating them from their 
own social networks.  
Any spare time that I have I tend to be with Kate as opposed to possibly going and doing 
my own thing, going to the gym or spending time with friends or whatever. (Michael, 
husband of Kate, 41, cryptogenic LD, second interview) 
At the same time, a number of carers’ accounts suggested that guilt played a key role 
in this context.  
I tend not to organise that much because I feel guilty saying, “I’ve got this,” and “I’ve got 
that.” (Tamsin, partner of Ben, 35, ALD, second interview) 
9.1.2 Carers’ support needs 
When asked directly about their own support needs, many carer participants were 
uncertain what kind of help would benefit them. 
BK: What sort of thing do you think might help you? 
Jeff: I don’t know. I just, I’ve been a person I’ve n ver relied on nobody.  
(Jeff, husband of Polly, 68, NAFLD, bereavement interview) 
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Given the unpredictability of the illness and its progression, carers felt similarly 
uncertain about the support they might need to helpthem care for the patient in the 
future. 
If she becomes confused and such like, then would I have the skill and ability to deal with 
that? ‘I don’t know’ is the answer, I may need some help with that. If her liver 
deteriorates and her muscles start to waste more she may need some personal care and 
stuff like that, you know, possibly. (Michael, husband of Kate, 41, cryptogenic LD, 
second interview) 
Indeed, Cora greatly appreciated receiving professional help at home when Martin’s 
condition deteriorated to a point where she no longer felt able to cope. 
Now that I've got the four carers in a day I feel I can cope now. (…) Especially when he 
was, when he couldn't walk, you know, when his mobility was going downhill, I was 
beginning to panic. And with him falling…It was one week, remember, you fell three 
times and I thought ‘oh’, you know? It was getting to me. And anyway, that's why we got 
the help, the extra help. So it's great now, it really is. I've no problems now. (Cora, wife of 
Martin, 77, ALD (NAFLD), second interview) 
Others wished for psychological and emotional support to help clarify their thoughts 
and worries.  
Just sometimes you want be able to offload. “Am I thinking the right things? Am I being 
too negative? Is what I’m going through and thinking the right thing to be thinking or 
not? Are the facts actually 100% right or wrong?” (…) Do I make it worse than what it 
is?” (Michael, husband of Kate, 41, cryptogenic LD, second interview) 
While carers felt uncertain about their own support needs, psychological support 
needs were evident throughout their experience. Practical support needs emerged 
with patients’ increasing debility. 
9.1.3 Support provision for carers 
Most carer participants had little involvement with, or direct support from, the 
patients’ care professionals. There were two reasons f r this. Some patients, like 
Donald and Thomas, chose not to involve their lay crer in medical appointments  to 
protect them from upsetting information. Therefore, while many professionals 
considered it part of their role to support carers, they did not always get the 
opportunity to engage with them. However, some carers b nefitted from being able 
to access the patient’s GP by virtue of being regist red with the same practice. 
 
  186 
I specifically asked to have [the same GP] the last time I was there for my appointment 
because I knew he knew Kate’s circumstances, and when I brought it up he understood 
and knew what was going on and stuff, so that was quite nice to be able to get that 
facility. (Michael, husband of Kate, 41, cryptogenic LD, third interview) 
Sue: [GP] has been absolutely brilliant for Rebecca and well, for my side as well.  
I: So is she somebody that you kind of confide in as well? 
S: Aye. 
(Sue, sister of Rebecca, 37, ALD, third interview) 
At the same time, professionals appeared to give littl  proactive attention to the 
specific needs of their liver patients’ lay carers. Indeed, Fraser’s consultant admitted 
that supporting carers was not a priority within his remit. 
I particularly see my remit as the patient rather tan the carers and the family I suppose, if 
we want to put it as harshly as that. My priority is obviously them, while informing the 
carers and so on, but it’s not something I’ve got a lot of experience or knowledge about to 
be honest. (Consultant of Fraser, 60, ALD) 
Information-sharing between professionals and carers also appeared to rely 
predominantly on the initiative of carers themselves.  
Sometimes when she's in the hospital they don’t tell m  much, you know, you've got to 
ask. (Julie, mother of Rebecca, 37, ALD, first interview) 
Not everybody felt confident enough to approach staff with their questions, however.  
The staff are very nice. It’s just my own personal shyness and (…) just feeling that I don’t 
want to cause any hassles. (Tamsin, partner of Ben, 35, ALD, first interview) 
Some made a point to attend clinic appointments in order to keep abreast of 
developments for themselves. 
If I wasn’t there I wouldn’t know a lot of stuff. (Michael, husband of Kate, 41, 
cryptogenic LD, third interview) 
Despite being relatively neglected within the current care provision, caregivers felt 
assured that they would receive support from care professionals if they requested it. 
BK: Do the professionals at any point ever sort of take you to the side and give you 
attention particularly? 
Michael: No. I’ve never asked for it though to be fair and (…) I’m quite sure if I asked 
for that I’m quite sure they would do that for me.  
(Michael, husband of Kate, 41, cryptogenic LD, second interview) 
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The accounts proffered by lay carers described an experience marked by strain, 
uncertainty and isolation. There was little contact with care professionals and carers’ 
support needs were largely neglected. Psychological and information needs were 
evident throughout the carer experience. Carers’ practical support needs increased 
over time in line with patients’ deteriorating condition, as did their social isolation.  
9.2 Professional carer experience 
This section describes the experiences relayed by the 11 case-linked healthcare 
professionals interviewed for this study. To recap, this group comprised of eight 
general practitioners, one consultant hepatologist, one hospital-based alcohol liaison 
nurse and one community palliative care nurse. It presents their views on caring for 
people with advanced liver disease, the challenges of doing so, and their perspectives 
on potential areas for improvement.  
9.2.1 Providing professional care in advanced liver  disease 
GPs professed to having little expertise in treating people with advanced liver 
disease. 
I’m talking from a position of a sort of lack of knowledge really, you know? (GP of 
Donald, 74, HCC (NAFLD)) 
Having never really dealt with somebody with non-alcoholic fatty liver disease to this, at 
this stage, I found it difficult to be absolutely certain about what I was telling them being 
true or not. (GP of Thomas, 75, NAFLD) 
Not everybody considered having a limited understanding of advanced liver disease a 
problem, however. 
If you ask me if I know enough about the subject probably not, but I think being a GP is 
often about knowing a man who can, so I think that’s fair enough. (GP of Kate, 41, 
cryptogenic LD) 
Nevertheless, there was evidence that a lack of confidence in one’s expertise on the 
subject could hinder GPs’ decision-making regarding a patient’s care.    
He did have quite marked ascites and I’m never quite sure exactly what the feeling is 
about draining ascites (…) and once or twice I thought maybe I should phone the liver 
people and see if they’ll take him in and drain off his ascites, and it never happened for 
some reason, you know? (GP of Donald, 74, HCC (NAFLD)) 
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Perhaps as a result of GPs’ limited disease-specific knowledge, they largely opted for 
a reactive approach to caring for their patients with advanced liver disease. 
Kate hasn’t come to me saying, “Look, I feel that this is…,” you know, “I’m 
unsupported.” I think had she done that, you know, had she felt that there wasn’t enough 
going on I might have started to, sort of looked into it a bit more, but things in her case 
have been ok so I haven’t really taken it any further. (GP of Kate, 41, cryptogenic LD) 
Some also felt that patient care was affected by factors outwith their control, such as 
a patient’s willingness to engage with services. 
GP: I think that some needs are unmet, but often thy are unmet because of circumstances 
outwith the medical control. 
BK: Right. Could you give an example? 
GP: Just people who drink. We know that their liver disease is going to be terminal and 
they really just don’t want help.  
(GP of Carol, 45, ALD) 
Likewise, the quality of hospital care was perceived as a potential barrier to effective 
patient care.  
Far more people just refuse to go into hospital or self-discharge, and it’s just their hospital 
experience is more negative than it used to be. (…) It does affect our ability to look after 
patients. If somebody with end-stage liver disease has to lie in a corridor bed for 4 hours, 
it massively affects my ability to persuade them into hospital the next time. (GP of 
Rebecca, 37, ALD) 
There was also consensus that the relatively younger age of liver patients could make 
their care more difficult. 
Quite often folk are at the stage really where you think this person would be better in 
some sort of supported care, sheltered accommodation type scenario, but often they are 
too young for that. (GP of Rebecca, 37, ALD) 
9.2.2 Interprofessional communication 
Services commonly communicated about patients through written correspondence. 
This process, however, could be slow and the information related of poor quality. 
Still seems to be the case, you know, of getting a clinic letter dictated and then it gets put 
in a pile to be signed at some point and then seen again at some other point and then sent 
to us. You know, a few weeks later we will get a letter by which time the patient may 
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I didn’t feel as if we were really given enough information from the liver unit. It was, it, 
lots of the discharge summaries were just quite short and to the point and quite factual, 
there wasn’t really much made about what discussion had been made with Thomas and 
his family about follow-up. (GP of Thomas, 75, NAFLD)  
Despite these frustrations, many GPs considered their relations with hospital-based 
colleagues good and did not feel the need for more dir ct contact. Few GPs had 
discussed their patient’s care directly with the patient’s named consultant, but those 
that had had valued the exchange. 
I think all of us are aware that consultants tend to be busy and that can then make 
bleeping and ringing difficult. (…) So consultants who are willing to respond on email is 
really good, and [Rebecca’s consultant] does. (GP of Rebecca, 37, ALD) 
While GPs expressed their dissatisfaction at the limited information shared by 
secondary care professionals, there was an acknowledgement that primary care 
communication could also be improved upon. Martin’s GP recognised that he had 
most likely failed to communicate Martin’s anticipatory care plan to his hospital 
team, thus contributing to him ultimately dying in hospital instead of his home.  
BK: Would they have been aware that things had been put in place in the community? 
GP: It would have been in his discharge summary but no, I didn’t formally let them know 
and maybe the family didn’t either, and then obviously that is where the conflict comes 
from. So yes, possibly a fault of ours as well for just not communicating well with them.  
(GP of Martin, 77, ALD (NAFLD)) 
There was agreement across the care professions that communication relating to 
patients with advanced liver disease was poorer than t t in oncology. 
Compared with maybe someone going through kind of the palliative stages of cancer I 
thought the communication really didn’t stack up to how good communication we would 
probably get from, say, oncology or the palliative care services or something like that. 
(GP of Thomas, 75, NAFLD) 
There never seemed to be a consistent person who I ould speak to from [the hospital].  
When he was admitted he would go to the same ward I think, and I would speak to 
different people, but there was never anyone who seemed to take ownership from the 
[hospital] who would be a link. (…) Oncologists, we all get letters from all the time. We 
will have phone calls with them and discuss patients wi h them. But there was no one for 
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9.2.3 Advance care planning 
Identifying the appropriate time 
The majority of professionals interviewed had not cnducted anticipatory care 
conversations with their liver patients. The unpredictable nature of the condition 
made it difficult for them to pinpoint the appropriate time at which to raise this issue.  
In non-cancer cases it can be much more challenging, you know, just judging when to 
have that discussion and…because it would be very eas for the patient just to be left 
with the feeling that, you know, ‘there’s nothing you can do for me’ whereas there’s 
obviously a lot that you can do for someone and the palliative management just can’t cure 
them. (GP of Donald, 74, HCC (NAFLD)) 
Carol’s GP had not yet had an anticipatory discussion with her when she died, as she 
did not have a ‘terminal’ phase. 
[Carol] was very positive and she didn’t think, she actually thought she would just get 
better, so it didn’t seem appropriate to talk about tha  because she wasn’t unwell, she was 
still functioning. (…) At no time did I feel that she was imminently about to die and 
needing to embark on any terminal care. (GP of Carol, 45, ALD) 
Fraser’s consultant raised this topic with patients only when they had clearly entered 
their dying phase, by which point conversations could be difficult to conduct. 
BK: What would normally be your sort of trigger point for initiating those sort of 
conversations? 
Consultant: Well, I think when you are clear people ar  dying, you know? I mean [Fraser]  
was still coming in for a period of time, getting drained, going back home again, you 
know, mobile, eating, drinking, whatever, independent, but (…) there’s a different group 
of patients who come in and they’re very jaundiced or have encephalopathy or, you 
know, liver failure effectively. The difficulty is with these patients is that often by the 
time that you know they are dying they’re often too confused or unwell or sleepy to 
actually have that conversation so, you know, it can be difficult. 
(Consultant of Fraser, 60, ALD) 
GPs also seemed reluctant to discuss details about patients’ likely disease 
progression and outlook. When specialists decided to withdraw futile treatment for 
Donald, it paved the way for his GP to discuss the likely turn of events, if not actual 
timescales. 
Well it happened very early and it meant we could have that discussion quite early and it 
was a very general discussion about, you know, sort of obviously trying to avoid sort of 
likely timescales and things. (…) There was an early wareness of the likely outcome, 
just not a sort of discussion around timescales or, y u know, how things were likely to 
progress. (GP of Donald, 74, HCC (NAFLD)) 
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Likewise, even after Kate had been included on the liver transplant register, her GP 
avoided discussing end-of-life needs and options with her. 
No, I haven’t actually. And I suppose that just reflects the fact that, you know, she’s 
remained upbeat. (…) I would wait until she brought it up rather than kind of get into 
that, you know? (GP of Kate, 41, cryptogenic LD) 
Reflecting on Thomas’ experience of living and dying with advanced liver disease, 
his GP regretted not having responded to his palliative care needs in good time. 
Three or four months prior we should maybe have been thinking of involving the 
palliative care team for a bit more support at home wh n he wasn’t in the hospital, but 
that didn’t happen. Well, it didn’t happen partly maybe because of my uncertainty as to 
exactly what his prognosis was, and it didn’t happen b cause the secondary care team 
didn’t appear to flag that up as something they thoug t was then appropriate, which I 
suppose kind of maybe left me a little bit uneasy in the fact that we probably hadn’t taken 
a holistic approach as we would normally do with some ne in the palliative stages of 
their condition. (GP of Thomas, 75, NAFLD) 
Advance care planning at the primary/secondary care  interface 
Another reason for the absence of timely advance car  planning conversations 
appeared to be GPs’ reluctance to contradict secondary care specialists.  
Maybe I should have written a letter to the consultant o say, “Look, we’re treating this as 
palliative care, is it possible to step back on the thing?” But somehow you don’t feel that 
it’s your place to say that, because they’re under th  care of a liver specialist who 
obviously knows what they’re doing. (GP of Martin, 77, ALD (NAFLD) 
He’d been told on the ward that there was a hope or xpectation that he would survive 
two, three, four years. And in those circumstances as a GP it is quite difficult to then say, 
“Look, we should be filling out a DNAR form,” and all that, and it’s quite difficult for us 
to do that because it sends out the signal that we don’t really believe what the hospital are 
saying. (GP of Thomas, 75, NAFLD) 
At the same time, GPs wished conversations about progression and prognosis to be 
conducted by their specialist colleagues. 
I think when it was apparent that this was really him entering, being in liver failure due to 
it, I don’t know whether he was, he did sit down with the consultant and it was just never 
fully taken on board and he…but I felt somebody in a very senior position should have 
sat down a little bit sooner with him and his family and had a full discussion about really 
where we were going with this. (GP of Thomas, 75, NAFLD) 
The continued routine treatments provided by the hospital also put GPs off 
considering patients’ palliative care needs. 
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BK: Was there any particular point or event from where you felt that she needed a 
palliative care approach or maybe put her on the regist r? 
GP: No, not particularly, you know? I mean they kept transfusing her, so they didn’t say, 
“Stop transfusing her.” So, you know?  
(GP of Polly, 68, NAFLD) 
Indeed, specialists’ tendency to continue routine treatments until the final stages of 
the illness caused GPs uncertainty about the status of their patient’s condition.  
We have this increasing number of patients that are owards the end of their lives that are 
basically being managed by us, almost solely by us. They’re still being admitted to 
hospital for acute things. It’s confusing for them and it’s confusing for us about what’s 
happening. (GP of Martin, 77, ALD (NAFLD)) 
Martin was one of only two participants who had benefitted from palliative care 
arrangements through his GP and community palliative care services. However, this 
process too was hampered by his continued routine admissions for paracentesis. 
He was a tricky one to keep in the community because he had so many taps done. He’d be 
constantly in and out of hospital, and it was really difficult to coordinate our meetings 
around that. (Community palliative care nurse of Martin, 77, ALD (NAFLD) 
Despite having arrangements in place to allow Martin to die at home according to his 
wishes, he died in hospital following an acute admission. Martin’s GP felt that the 
habit of turning to the hospital for support may have interfered with the care plans 
put in place for him.  
All these plans for things he had to die peacefully at home, actually when he had the 
[gastrointestinal] bleed instead of maybe calling the GP and maybe getting things sorted 
he probably felt it was ok for him to go to hospital, because he was so used to it. So that’s 
why he ended up in hospital. (GP of Martin, 77, ALD (NAFLD)) 
Advance care planning then was largely absent in this sample. This omission was a 
result of uncertainty related to several factors: appropriate timing, GPs’ lack of 
expertise, poor interprofessional communication, distribution of care responsibility 
across settings, and the ongoing active and curative care provided by hospitals. 
9.2.4 Improving service provision in advanced liver  disease 
There was consensus among all the professionals interviewed that palliative care for 
people with advanced liver disease deserved improved att ntion and effort.  
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Chronic liver disease is a perfectly valid reason fr, you know, patients being managed in 
a palliative way and having access to, you know, the range of palliative care services that 
anyone else would. (GP of Donald, 74, HCC (NAFLD)) 
However, the uncertainty inherent in the disease made the provision of palliative care 
in this patient group especially challenging. There was also a recognition that the 
right pathways for effective palliative care in liver disease had yet to be defined.  
It’s different with cancer patients because (…) thecancer pathways are pretty clear. 
Actually, when you decide to go on a palliative care pathway it’s pretty good for that, the 
hospital tend to step back a little bit and we kind of take over. It works quite well. But 
with other palliative care diseases it’s very difficult. (GP of Martin, 77, ALD (NAFLD)) 
There isn’t an obvious, you know, move-on place from us, you know? There are patients 
that we are confident are not going to get better and get out of hospital, but because we’ve 
known them so well and there isn’t really another facility, you know, hospice facility 
we’ve occasionally been able to access but not frequently, they tend to die with us, (…) 
but it is an acute busy medical hospital and it’s not always the best place for these people 
to be looked after. (Consultant of Fraser, 60, ALD) 
In contrast, the community palliative care nurse felt that the ability to support people 
with advanced liver disease already existed, but that the importance of palliative care 
provision for these patients needed to be championed by liver specialists themselves. 
I think we have the ability to meet the needs, but I think we need to spread the word a bit 
more and encourage people. (…) You need someone who is an expert at liver disease that 
says, “These patients have a need that maybe we could meet better when they get to this 
point, so let’s try and do it and let’s make it big for us.” (…) There is a big drive in heart 
failure, we get lots of heart failure patients. Big campaign between British Heart 
Foundation and Marie Curie, who are working together o try and promote that for people 
with heart failure. (Community palliative care nurse of Martin, 77, ALD (NAFLD)) 
There were various areas in which professionals appreciated support or 
improvement. Most commonly, they wished for more access to specialist advice. 
GPs do need some, you know, guaranteed access to specialists. (…) Some specialties do 
have sort of email-based advice lines which, you know, are helpful (…) even if you’re 
just needing some advice about medication changes, symptom control, or whether or not 
you do need to refer somebody back or not, whether or not they need to be admitted, you 
know, in a planned way. So no, just an on-going commit ent to providing access to 
specialist advice is always important. (GP of Donald, 74, HCC (NAFLD)) 
Several GPs mentioned the usefulness of specialist nurses available in other 
specialities, although they were uncertain whether se in fact already existed in the 
realm of advanced liver disease. 
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I think they probably, well, might have this for hepatitis C anyway, but you know for sort 
of liver disease in general whether, you know, nurse specialists - having said that they 
probably do exist and maybe we don’t use them as much as we should do - are quite a 
good link with services (…) you know, a kind of link g service like that with a nurse 
specialist (…) that GPs can access freely just for advice. (GP of Sarah, 38, ALD (HCV)) 
Some wished for disease-specific education to build knowledge and confidence.  
I think specific education would be really good, yes, because as I said, I do have two 
other Hep C patients which are on my caseload and we would have patients who would 
have liver disease and other co-morbidity. So I think something more formal would be 
beneficial, yes. I don’t know how they would run that, or who would run that, but yes. 
(Community palliative care nurse of Martin, 77, ALD (NAFLD)) 
Professionals also called for improved interprofessional communication.  
It’s always good to have, you know, more written information, perhaps we could have 
had a bit more of that. (GP of Kate, 41, cryptogenic LD) 
In particular, GPs wanted to be informed of what long-term plans their specialist 
colleagues were pursuing in relation to a patient’s care. 
I guess it’s just a more consistent approach in the hospital with regards to the 
management of this patient. We like to be kept informed about what’s happening, which 
they did. But we actually weren't informed of the plan, which they often don’t do, you 
know, the ongoing plan. (GP of Martin, 77, ALD (NAFLD)) 
There was also a wish for guidance from liver specialists regarding when to initiate 
palliative care conversations with their patients.   
Really a little bit more communication would be all that would be necessary, and giving 
us an idea of what they think is to be the prognosis and kind of we respond to these kind 
of triggers, and yes we’ll, we’re more than happy to take on lots of the palliative type 
discussions and maybe it will be more appropriate from us rather than the liver unit, but 
it’s really getting the triggers to say that that’s really what we should be speaking about 
now. (GP of Thomas, 75, NAFLD) 
The community palliative care nurse felt that having a direct link to hospital-based 
staff would help improve the overall care of the mutual patient. 
Communication between treating teams, I think that w s a big one for me, not having a 
link directly with the hospital. It’s always a bit tricky, you’re all trying to work towards 
the same goal and keep someone happy and comfortable and that, but if the chain is 
broken and people aren’t communicating you are effectiv ly stuffed. (Community 
palliative care nurse of Martin, 77, ALD (NAFLD)) 
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Finally, some felt that having referral pathways directly to the liver unit would 
promote better patient care. 
If you could directly admit to the ward and say, “You will know where you’re going, you 
are going up to ward X, that’s the ward you know, I can get you straight in there,” then it 
helps in getting people acute care when they need it. (GP of Rebecca, 37, ALD) 
Professionals across healthcare settings were thus in agreement on the need for 
enhanced service provision for people living and dying with advanced liver disease. 
The interviews identified several areas for improvement at both strategic and 
operational levels that provide a starting point for further discussion in this respect.  
9.3 Discussion of findings 
While both participant groups profiled in this chapter - lay and professional carers - 
constituted small study samples, the inclusion of their views benefitted this study in 
two ways. Firstly, it provided a helpful means by which to illuminate and 
contextualise the experiences and perceptions relayed by patient participants. 
Secondly, the views of carers served to highlight several personal and structural 
challenges in providing appropriate care to people with advanced liver disease. 
Similar to patients, uncertainty also emerged as a key feature in carers’ accounts. 
9.3.1 The experiences and support needs of lay care rs 
The multi-dimensional sources of uncertainty pervading patients’ illness experiences 
as described in Chapters 5 to 8 were also the foundation of many carers’ anxieties. 
Caregivers worried about their capacity to provide appropriate care, especially in the 
event of the patient’s  deterioration. Only patients’ ongoing medical care constituted 
a source of reassurance in this respect. A lack of inf rmation and concerns about 
one’s caring ability have been noted as considerabl sources of stress for carers of 
people on the liver transplant list (Miyazaki et al., 2010). Having to manage the 
needs and distress of the wider family circle in addition those of the patient and their 
own augmented this strain, as did the financial burden caused by patients’ inability to 
work and carers needing to curtail their own professional activities to accommodate 
their caring role. Their own employment provided both respite and additional strain. 
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The considerable financial and emotional burden experienced by carers of people 
with cirrhosis has been highlighted previously (Bajaj et al., 2011, Roth et al., 2000).  
Given their similarly uncertain experience, carers were found to display similar 
coping approaches to those used by patients. They generally chose to simply ‘get on 
with it’ and, like patients, consciously concealed their personal concerns so as to not 
add to the illness burden. Carers also prioritised patients’ needs to the detriment of 
their own. This was in part driven by feelings of guilt, and contributed to carers 
becoming increasingly socially isolated themselves. At the same time, the data 
highlighted that carers were also acutely aware of the stigmatising reputation of liver 
disease. Therefore, while only hinted at in some car r interviews, it is conceivable 
that their choosing to forego social contact may in part have been driven by an 
uncertainty surrounding people’s reactions in relation o their circumstances. 
The support and behaviour of those close to the ill person play a critical role in 
preserving, bolstering or discrediting that person’ sense of self (Charmaz, 1983). 
Evidently, the stress related to the patient’s illness left carers overwhelmed and in 
need of support themselves. This would have challenged their ability to provide 
patients with the necessary positive validation of their self-image. Biographical 
disruption was also witnessed among carers in this sample, forcing them to 
reconsider professional activities and future plans in order to accommodate the needs 
of the patient (Bury, 1982).  
Carers’ support needs 
Carers felt uncertain about their own support needs. They did, however, speak of a 
possible need for practical support in the event of patients’ condition deteriorating. 
This finding echoes previous research, which found carers prioritising improving the 
needs of the patient over self-care (Lasker, Sogolow and Sharim, 2005). Increased 
practical support needs were indeed indicated in some carers’ accounts where the 
patient’s physical condition had declined to a point where they were unable to 
manage without professional help.  
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The need for psychological support for caregivers wa  evident throughout the study. 
Uncertainty regarding the nature and potential development of the patient’s condition 
made some wish for opportunities to validate their thoughts and feelings on the 
matter. This need was reinforced by the fact that carers opted to withhold their 
concerns from the patient, and had progressively fewer opportunities to confide in 
members of their wider social network. The need for psychological support for lay 
caregivers receives backing from research in primary biliary cirrhosis. A content 
analysis of an online message board used by PBC patients’ friends and family 
showed that socio-emotional topics dominated their discussions (Lasker, Sogolow 
and Sharim, 2005).  
Similar to patients, the range of concerns impacting o  the lay carer experience 
points towards the utility of a multi-disciplinary approach to their support, 
encompassing clinical, psychological and social work expertise. Targeted 
professional support for caregivers was found to be lacking in this study. They relied 
on their own initiative to keep abreast of developments affecting the patient and to 
seek support for themselves. However, doing so could be hampered by a lack of 
confidence, which also related to the stigma associated with the condition. The 
discontinuity of patient’s care highlighted in Chapter 7 further impedes carers’ access 
to information (Guy, 2006). Being left out of the loop thus fosters their uncertainty 
and isolation. Carers have previously reported struggling to obtain information 
regarding the patient’s condition and prognosis (Rogers, Karlsen and Addington-
Hall, 2000). Carers in this study sought to, where possible, attend medical 
appointments with the patient in order to gain access to information they would 
otherwise be unlikely to receive. However, caregivers’ information needs differ from 
those of patients and increasingly so as the illness progresses (Parker et al., 2007), 
and so this route is consequently unlikely to satisfy heir demands.  
Good palliative care must include targeted support for patients’ lay carers (Hudson, 
2013, Shipman et al., 2008). Healthcare professionals i  this study acknowledged the 
importance of supporting caregivers, but considered the patient their primary 
concern. This view is understandable given the focus of clinical training, the time 
contraints of medical consultations, and their limited opportunities to engage with 
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carers as alluded to earlier. However, carers’ anxieties may negatively affect their 
ability to provide appropriate support to the patient. Reducing their feelings of 
uncertainty and promoting better coping is thus key to achieving improved outcomes 
for both patient and carer. While carers in this study felt assured that they would be 
given help if they asked for it, there is a need to pr actively improve access to 
information and support that is tailored to their specific requirements. A few carers 
expressed their appreciation for being able to access support from the patient’s GP 
through being registered at the same general practice. Families commonly being 
registered with the same GP supports palliative care provision in the community 
(Barclay, 2001), and highlights again the value of nhancing the role of primary care 
in supporting people with advanced liver disease and those that care for them. 
9.3.2 The views of professional carers 
This sample was predominantly made up of general practitioners. Many issues raised 
therefore pertain to the particular circumstances and challenges that exist within the 
primary care setting. While this limits conclusions in this area, the repeated 
indications over previous chapters that liver patients and their families would be well 
served by improvements in their community-based care render the views of GPs of 
particular value to this study.  
Providing professional care in advanced liver disea se 
GPs acknowledged their limited knowledge of advanced liver disease. This finding 
confirms the perceptions of patient participants decribed in Chapter 7. The findings 
in Chapter 7 add to this by showing that patients saw little value in seeking GP 
support for their liver disease-related care, thereby further reducing GPs’ 
opportunities to engage with this patient group. These factors combined to leave GPs 
feeling uncertain when faced with a patient in the advanced stages of liver disease, 
and impacted on their confidence to proactively support them.   
Caring for people with advanced liver disease was considered a complex endeavour, 
and one that was affected by patients’ willingness to engage with care providers. The 
quality of interprofessional communication between care settings added to these 
challenges. A typically slow information transfer by written correspondence proved 
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unhelpful given the erratic pathway of the disease nd the frequency of patients’ 
admissions. In addition, the information shared by specialists on a patient’s ongoing 
care was often considered too limited. These factors left primary care practitioners 
uncertain as to the appropriate and timely follow-up of these patients in the 
community. The lack of continuity in patients’ care identified in Chapter 7 further 
contributed to these communication difficulties, and proved a particular barrier to the 
effective involvement of allied care providers. Having direct email contact with a 
liver specialist proved a great help for the few GPs who had this facility. All agreed 
that interprofessional communication compared poorly with that in other specialties.  
Poor communication and information exchange as well as inequities between 
different conditions have previously been noted as barriers to effective palliative care 
provision (McIlfatrick, 2007). Inadequate interprofessional communication affects 
patients’ perceptions of the quality of their care (Cotterell, 2008). Moreover, recent 
research with people with advanced liver disease suggests that improved 
interprofessional communication may be a determining factor in reducing mortality 
and healthcare costs in this population (Morando et al., 2013). The development of 
electronic registers shared between primary and secondary care constitute an 
important step towards improving the speed of information transmission. This must 
be considered key to facilitating appropriate and timely care for people with 
uncertain and erratic illness pathways like that in advanced liver disease.  
Advance care planning 
Advance care planning in Scotland entails the development of a written anticipatory 
plan, which details a patient’s care goals and preferences in the event of a sudden 
deterioration in their condition (Murray, Sheikh and Thomas, 2006). Holistic, goal-
focused patient care is increasingly recognised as preferable over disease-focused 
care, and is especially appropriate for those with limited life expectancy (Reuben and 
Tinetti, 2012). Failing to discuss patients’ goals means that their most appropriate 
care is not assured (McGrew, 2001). Advance planning also reduces the burden on 
the patient’s family as it avoids the need to make important decisions close to the 
patient’s death, which is typically a fraught and upsetting time (Wright et al., 2007). 
Advance planning is especially relevant in conditions like advanced liver disease 
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where patients may experience episodes of mental inc pacity, and is one reason why 
this process should be undertaken early in the illnss trajectory (Larson and Curtis, 
2006). Discussions in this regard should be conducted by a trusted, knowledgeable 
professional over multiple sessions and in response to a patient’s willingness to 
contemplate the topic (Conroy et al., 2009, Hjelmfors et al., 2014).  
Advance care planning was largely absent in this study. A number of factors 
contributed to this situation. Professionals felt uncertain about the appropriate timing 
in the face of an unpredictable illness trajectory, a common observation in organ 
failure research (Barclay et al., 2011, Exley et al., 2005, Pinnock et al., 2011). 
Professionals differ in their interpretation of the term ‘end of life’ and the time period 
it signifies (Shipman et al., 2008). GPs’ uncertainty i  this respect, alongside a lack 
of confidence on account of their limited liver exprtise, further contributed to their 
reluctance to address advance care planning. Similarly, specialists tended to only 
recognise the need to plan for a patient’s forthcoming death when patients were often 
already too unwell to engage in such conversations.    
Delaying care planning conversations until a terminal phase, as typically occurs in 
cancer, reduces the opportunities for patients to ascertain important information and 
engage in decision-making and preparation in a timely anner. It also has financial 
implications, as in the UK those with a terminal prognosis are entitled to claim 
special disability benefits which would help alleviate some of their and their carers’ 
concerns, especially with regard to the potential costs involved in accessing 
additional care or aids. Current UK guidance on end-of-life care includes in its 
definition of ‘approaching the end of life’ any patient with an advanced, progressive, 
incurable condition (General Medical Council, 2010). It has been suggested that in 
advanced liver disease the onset of signs of decompensated disease such as ascites or 
gastrointestinal bleeding present clear trigger points for end-of-life discussions 
(McGrew, 2001). Generalists may benefit from using prognostic indicators to aid 
their decision making (Boyd and Murray, 2010, Shipman et al., 2008). More generic 
clinical markers to trigger conversations have also been suggested (Quill, 2000). 
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As well as their uncertainties relating to limited xpertise and appropriate timing, 
GPs in this study were reluctant to initiate advance care planning discussions for fear 
of taking away patients’ hope and causing anxiety. Consequently, they opted to wait 
for patients to raise questions in this regard, an expectation which was subject to 
several barriers identified earlier in Section 8.5.1. While GPs’ sentiments are 
understandable, they are inconsistent with the ethical principle of autonomy guiding 
professional conduct in healthcare, whereby patients have a right to informed 
decision-making about their care (see Section 3.8). Their concerns also appear 
misplaced. A systematic review of interventions in palliative and end-of-life care 
indicates that advance care planning does not harm patients and may even be 
experienced as positive (Lorenz et al., 2008). This notion has support from research 
into advance care planning in kidney disease (Davison and Simpson, 2006).  
GPs’ relative lack of knowledge and confidence also played out in a reluctance to 
discuss details for fear of contradicting their specialist colleagues. Moreover, there 
was uncertainty about whose role it was to initiate dvance care conversations. In 
this sample, GPs felt that the primary responsibility for this lay with specialists, with 
appropriate follow-up provided in the primary care setting. A similar sentiment has 
been expressed by specialist nurses in heart failure. Despite feeling competent in 
conducting end-of-life discussions with patients, they consider it the responsibility of 
specialists to do so and do not wish to interfere with this process (Hjelmfors et al., 
2014). Current advance care planning guidance in the UK suggests that such 
conversations should be undertaken by a trustworthy individual who is 
knowledgeable about the condition (Conroy et al., 2009). Given their limitations in 
this respect, this view confirms the perceptions of GPs in this study that specialists 
are best placed to take the lead. The earlier finding that patients tend to trust the 
opinions of specialists over those of their GPs lends further support in this respect. 
However, the discontinuity in patient care described in Chapter 7 indicates that 
current care arrangements for people with advanced liver disease do not lend 
themselves to facilitating an appropriate, patient-centred advance care planning 
process in the secondary care setting. This issue demands further consideration. 
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Patients’ continued hospital treatments, even if actually palliative in nature such as 
blood transfusions, further contributed to GPs’ uncertainty as to the appropriateness 
and timing of undertaking advance planning with them. They also challenged the 
management of patients’ care in the community. Ceasing ongoing curative care only 
when death is deemed certain can be too late for initiat g care planning as patients 
may already be too unwell. Conversely, attending to patients’ holistic supportive and 
palliative care needs early and in parallel with disease-focused treatment can serve to 
counter overzealous treatment and promote quality of life in advanced, progressive 
disease (Murray, 2009). Indeed, while medical care tends to focus on prolonging life, 
managing a patient’s end of life satisfactorily should be considered a success in itself 
(Wright et al., 2007). It is thus imperative that ptients are given the opportunity to 
engage with their future care planning early and frequently throughout their illness.  
However, as seen in the present study, even where an existing anticipatory care plan 
existed its implementation was not guaranteed. The data suggests that this process 
may have been hampered by poor information exchange between professionals and 
care settings. Individual and organisational factors were also indicated. The multi-
factorial challenges in implementing advance care planning decisions have been 
noted (Rhee, Zwar and Kemp, 2013). Issues relating to poor information transfer 
should be eradicated with the introduction of shared el ctronic patient registers. 
Professionals’ views on improving care provision 
All interviewees agreed on the need to enhance service provision for people living 
and dying with advanced liver disease. There was a consensus that it was easier to 
organise appropriate supportive and palliative for people with cancer than for those 
with non-malignant disease, a view also reported elsewhere (Exley et al., 2005). 
Professionals expressed a need for a clear, structured care pathway similar to those in 
operation in cancer care. An agreed, shared care pln would provide a framework 
and consistency in these patients’ ongoing care. The data indicates that this is 
especially important in relation to clarifying care roles and responsibilities across the 
primary and secondary care interface, and in particular regarding the management of 
ongoing acute care in parallel with supportive and palliative care.  
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There was uncertainty as to the options for referral as patients deteriorated. Patients 
whose care needs became too complex to manage at home were challenging to place, 
as their relatively younger age meant that they often did not qualify for services such 
as nursing home care. Likewise, hospices were considered to have limited capacity to 
support this patient group. Furthermore, the uncertainty regarding a clear terminal 
phase in liver disease makes it difficult to determine the most appropriate time at 
which to make a hospice referral. Interestingly, contrary to the perceptions of the 
other professionals, the community-based palliative care nurse participating in this 
study felt that community palliative care services had the capacity to attend to the 
needs of this patient group. It has previously been argued that palliative care can be 
easily accommodated within standard liver disease management (Sanchez and 
Talwalkar, 2006). As such, what is required is not an introduction of new structures, 
but a renaming and rethinking of current practice, with the most critical factor that 
palliative care is recognised as a valid and important concept by all professionals 
involved (Dunn, 2006). This notion ties in with professionals in this study arguing 
for the need to more vociferously champion the care ne ds of people with advanced 
liver disease similar to recent endeavours seen in other conditions, so as to prompt 
their consideration and active promotion across all care settings.  
Improving interprofessional communication and support was considered a key factor 
in enhancing current care provision in advanced liver disease. With modern 
healthcare operating in a context of scarce resources, this may be most usefully 
achieved by way of developing better electronic information transfer. However, the 
data suggest that there is also a need to improve on the quality and detail of the 
information shared. Interviewees spoke highly of the availability of specialist nurses 
in other conditions and advocated for a similar role in advanced liver disease. 
Specialist nurses offered not only a consistent point f contact, but also a source of 
disease-specific expertise when aspects of care or referral criteria required 
clarification. Some professionals also highlighted an interest in more disease-specific 
education, although the value of developing specialist knowledge in generalists is 
disputed (Wagner, Austin and Von Korff, 1996).  
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One model of care that may inform suitable care pathw ys in advanced liver disease 
is that currently used in heart failure (Volk et al., 2010). For the last decade, 
community-based heart failure nurses have been operating in the UK. Some of these 
also engage in palliative care support. While heart f ilure patients’ medical 
management remains mainly located within secondary care, this care model 
facilitates their holistic, long-term care in the primary care setting. This approach 
also promotes better continuity of all aspects of care, which is likely to impact 
positively on the extent of uncertainty experienced by patients, lay carers and 
professionals alike. However, despite its virtues, a model of care that serves patients 
with various long-term conditions including multi-morbidity would be more 
advantageous and should be investigated. 
9.4 Concluding remarks 
Uncertainty also constituted a core feature in the experiences and perceptions of both 
lay and professional carers. In many ways this uncertainty related to the same issues 
already noted in patient participants’ accounts such as the uncertain and 
unpredictable nature of the condition, poor disease-specific understanding, 
inadequate information-sharing and communication, and confusing, discontinuous 
care arrangements. As such, all stakeholders in advanced liver disease emerged as 
operating in a context of uncertainty, ambiguity, complexity and lack of direction.  
The accounts of lay carers evidenced their need for in mation and psychological 
support at all stages of the patient’s illness, while their practical support needs and 
social isolation increased over time. The needs of lay carers of people with advanced 
liver disease are relatively neglected and should be given more focused attention. 
This is not only an important undertaking in its own right, but is also key to 
achieving a good end-of-life experience for patients and a better bereavement 
experience in due course. The disruptive impact of chronic illness on carer 
biographies is currently lacking in the literature and may warrant further attention.  
The professional care of people with advanced liver disease compared poorly to that 
of other conditions. Both service provision and advance care planning were impeded 
by the complexities of the condition itself as well as existing care and 
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communication structures. GPs emerged as a currently disempowered group and 
should be enabled to play a greater role in attending to the holistic care needs of 
these patients. At the same time, the data suggest that advance care planning 
conversations in advanced liver disease might be best initiated by specialists. 
Several areas for service improvement were put forward. At a strategic level, 
professionals advocated for clearly defined care pathw ys and a more vocal 
promotion of the needs of this patient group. At an operational level, improved 
interprofessional communication and support to strengthen current practice, 
refinement of procedural pathways and referral criteria, and access to disease-
specific education were indicated. Learning should be sought from recent service 
improvements in comparable conditions such as heart failure. 
The final chapter to follow will integrate and reflect on all the results presented in the 
previous chapters as well as on the study methodology employed, and put forward 
recommendations for future practice and research. 
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Chapter 10: Integration of findings, implications 
and recommendations 
This study sought to broaden our understanding of the experience of living and dying 
with advanced liver disease. Current trends in some f the risk factors associated 
with chronic liver disease as well as diminishing donor organ resources indicate a 
dramatic increase in the number of patients living a d dying with the disease in the 
coming years. At the same time, supportive and palliative care provision is 
traditionally focused on the needs of cancer patients a d ill-equipped to effectively 
support those with non-malignant illnesses. Consequently, this study was informed 
by the following research objectives: 
1. To explore the dynamic experiences, priorities and support needs of people with 
advanced liver disease, their lay carers and key health or social care 
professionals, and in particular their physical, psychosocial, existential and 
information needs in the last year of life. 
2. To explore the use of health, social and voluntary sector services by this group 
and the extent to which existing services are perceived to meet their needs. 
3. To contribute to the methodological knowledge base regarding the effectiveness 
of longitudinal, multi-perspective qualitative methods in end-of-life research. 
The first section of this chapter will integrate the empirical study findings presented 
in Chapters 5 to 9 in order to address research objectives 1 and 2. It will also respond 
to objective 3 by setting out my learning and conclusions regarding the effectiveness 
of using longitudinal, multi-perspective qualitative research methods with this patient 
group. This section will be followed by a consideration of the limitations of the 
study, and a discussion of its contribution to theory and policy. Finally, I draw on the 
present findings to put forward recommendations for cur ent care practices as well as 




10.1 Integration of study findings  
10.1.1 Research objective 1: Experiences, prioritie s and     
 support needs  
Pervasive, enduring, multi-dimensional uncertainty defined and unified the 
experiences of all stakeholders in this study – patients, lay carers and professionals. 
Uncertainty is characterised by ambiguity, vagueness, unpredictability and 
incomplete information (Mishel, 1981), which were at the heart of each of their 
accounts through time. This uncertainty was multi-dimensional and individually 
complex. Medical sources of uncertainty were experienced across all three groups 
and related to the vague and unpredictable nature of the disease, individuals’ limited 
understanding of the condition and its likely progression, poor communication, and 
discontinuity of care. Patients and lay carers were additionally faced with several 
personal and social sources of uncertainty (Brashers et al., 2003), which further 
unsettled their illness experience. Moreover, these factors combined to result in a 
loss of patients’ sense of self. Finally, uncertainty ot only defined all stakeholders’ 
experiences, but was a key mediating factor in relation to their perceptions and 
actions in the context of the illness.  
Insofar as can be deducted given the small size and make-up of the study sample, the 
physical and psychological experience of living with advanced liver disease was 
largely uniform across patients regardless of the underlying cause of their liver 
disease. Some exceptions to the shared patient experi nc  of advanced liver disease 
must be noted, however. Age differences were indicated in relation to patients’ 
coping, the biographical disruption of their lives a well as their considerations of 
death and dying. Moreover, the ability of ALD patients to influence their illness and 
thus overall illness experience through sustained sobriety must be recognised. This 
saw some embark on a divergent trajectory to that of heir counterparts, with 
subsequent differences in their physical, psychosocial and existential experiences. 
Furthermore, those with ALD were additionally burdened with the challenge of 
achieving abstinence, a matter which dominated their psychological illness 
experience and necessitated additional support.  
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All participants considered fatigue and ascites themost disruptive physical 
complications related to their illness. Motor co-ordination and mobility were also 
widespread. Surprisingly, pain as an enduring featur  of their advanced illness was 
universally absent. Patients’ physical experience generally evidenced a slow but 
steady decline over time, which was interspersed with relatively short-lived routine 
exacerbations such as ascites, and more dramatic acute exacerbations such as 
gastrointestinal bleeding, both of which required inpatient treatment.  
Advanced liver disease constituted a prominent featur  in the lives of those affected. 
The effects of their debilitating complications as well as a significant treatment 
burden marked by an extensive and complex medication regimen, medical check-
ups, blood tests and regular hospital admissions kept their condition firmly in the 
foreground. Even where the condition was controlled by a modification of harmful 
behaviour, the challenge of maintaining sobriety served as a daily reminder of the 
damage done and the uncertainty of sudden deterioration remained. This meant that 
patients were unable to normalise and adapt to their illness over time.   
The experiences of debilitating physical complications and pervasive uncertainty 
combined to produce a substantial and enduring psychological burden throughout. 
This burden was added to by a social experience marked by stigma, the changing 
quality of familiar relationships, and increasing social isolation. The psychosocial 
experiences of patients and their lay carers were comparable, and perhaps as a result 
they were seen to employ similar coping strategies which principally focused on 
managing the ubiquitous uncertainty of their situaton. There was little explicit 
consideration of existential issues by patients and l y carers, although their turmoil in 
this respect was evident throughout. Issues around death and dying were beset with 
further ambiguity and uncertainty and as a result were largely disregarded by 
patients, carers and professionals alike.  
There was overlap as well as variance regarding the information and support needs of 
patients, carers and professionals. Lack of information and the quality of 
communication were concerns raised by all three groups. Patients generally desired 
more information about their condition and its likey progression, guidance and 
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opportunities to take on more self-care, and increased recognition and support of 
their psychological needs. Lay carers similarly showed a need for increased 
information-sharing and psychological support, but also required advice and 
reassurance regarding the care they provided for patients. There was a lack of 
awareness across all groups with regard to available support resources for these 
patients. Patients and carers were particularly interested in opportunities to engage 
with peers. GPs, who made up the majority of the professionals interviewed, 
prioritised better access to specialist knowledge rega ding symptom management in 
advanced liver disease. This disease-focused concern suggests a lack of recognition 
of the widespread multi-dimensional impact of the condition on the lives of those 
affected, and evidently conflicts with patients’ and carers’ priorities. Psychosocial 
support in particular is key to the successful management of uncertainty and thus 
better coping, but was notably absent for both patients and carers. 
The opinions and experiences of professionals, regardless of discipline, converged on 
most matters relating to the care of this patient group. Their perceptions were mainly 
informed by the complexities inherent in the condition and the care structures they 
operated in, which rendered care provision for these patients a challenge in all 
settings. GPs in particular emerged as a currently disempowered group on account of 
a lack of exposure, confidence and competence relating to caring for people with 
advanced liver disease and uncertainty regarding their role in these patients’ care.  
10.1.2 Research objective 2: The use and fit of ser vices 
Both inpatient and outpatient care of patients with advanced liver disease was 
primarily located in the hospital setting. Primary care services were undervalued as a 
source of support by patients and consequently under sed. However, patients’ lack of 
appreciation of the holistic care role of the general practitioner must be considered 
alongside GPs’ apparent preoccupation with disease management as mentioned 
above, and highlights a need for better delineation of the GP role in the care of these 
patients. Involvement of allied professions was generally absent. Palliative care 
involvement relied on a recognition that a patient may be imminently dying and in 
light of all three parties’ uncertainty in this resp ct was rarely facilitated. 
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Patients and carers were generally in agreement that the overall medical care 
provided was satisfactory. However, they also described sources of dissatisfaction 
and uncertainty in this respect. Patients perceived GPs as lacking confidence and 
competence in relation to liver disease, and this impression was confirmed by the 
GPs in this study. All three participant groups felt that the overall quality of care was 
affected by limited and poor quality information exchange between care 
professionals as well as between clinicians, patients a d carers. Inadequate as well as 
contradictory information from different care sources, limited confidence in some of 
their care providers, a lack of continuity and consistency of care, and inadequate 
management of their psychosocial needs constituted key sources of uncertainty for 
both patients and carers.  
This study highlights the experience of advanced liver disease as one in which care 
needs constantly alternate between acute care and chroni  illness management. In 
general, patient care was symptom-focused, episodic and reactive, both in primary 
and in secondary care settings, and was consequently poorly aligned with the chronic 
multi-dimensional needs of this patient group. While patients’ acute medical care 
appeared largely adequately organised, the data sugge t that their ongoing care in the 
community was lacking structure and dedicated focus. In addition, the relatively 
younger age of this patient population is incompatible with current systems for long-
term care provision.  
Professionals considered the care of people with advanced liver disease to compare 
unfavourably with that of other conditions, and in particular towards the end of life. 
The complex nature of the condition itself as well as current structures of care and 
interprofessional communication impeded their care provision overall, but in 
particular the process of advance care planning. Uncertainty was again a key barrier 
in this respect and resulted in a notable absence of prognostic and end-of-life 
conversations, and consequently an absence of anticipatory care in this patient group. 
At the same time, professionals were vocal about the current inadequacy of palliative 
care provision in advanced liver disease. Patients a d carers did not generally 
comment on their expectations in this respect, possibly on account of their general 
lack of appreciation for the life-limiting nature of their condition. With all except one 
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of those patients who passed away during the study dying in hospital, palliative care 
activity was thus limited to their final days in tha  setting.   
The concerns of patients and carers regarding service improvements related mainly 
to improved communication and information-sharing as well as relational continuity 
of care. In contrast, professionals put forward several areas for improvement at both 
practice and policy levels. Recommendations in relation to current care provision 
based on the findings of this study will be presented in Section 10.4.1. 
10.1.3 Research objective 3: Using longitudinal, mu lti-  
 perspective methodology in end-of-life research  
Employing a qualitative longitudinal, multi-perspective research design proved a 
challenging but ultimately successful means by which to meet the objectives of this 
study. My reflections on the study design and conduct in general were outlined in 
Chapter 4 and indicate a number of learning points for future research. In this 
section, I respond to research objective 3 by specifically considering the benefits and 
challenges of using a longitudinal, multi-perspective approach in the context of 
advanced liver disease.  
Exploring multiple perspectives 
In this study, I sought the views of patients, their lay carers and case-linked care 
professionals. Doing so generated context-rich accounts of how living with advanced 
liver disease is experienced, negotiated and interpreted by different stakeholders. The 
addition of the professional perspective on their patient’s care, but also on that of 
people with advanced liver disease more generally, served to link the complex and 
varied needs of patients and lay carers with the current challenges and barriers faced 
by professionals in the care setting. Inferences and recommendations drawn from the 
data may therefore be argued to be more meaningful, as they are grounded within 
key stakeholders’ realities.  
Conducting single versus joint interviews 
Most patient/carer dyads in this study were interviewed in pairs. In a number of 
cases, however, circumstances meant that some of their interviews were conducted 
individually or that one person was out of the room for a portion of an interview. 
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This afforded an opportunity to reflect upon the difference in accounts proffered by 
each party when interviewed singly or jointly. It was for example evident that 
individuals in joint interviews were more likely tohold back thoughts and emotions 
in order to protect the other’s feelings. While this might be looked upon as a 
limitation, I also noted real benefits in conducting joint interviews. Given these 
patients’ advanced disease status, they commonly suffered from poor mental focus 
due to fatigue, a mild encephalopathic episode, or periods of relapse into alcohol. 
Consequently, their memory of events was prone to inconsistency, distortion or 
vagueness. Having their carer present on those occasi ns allowed them to jog 
patients’ memory or clarify their accounts, thus benefitting the overall data 
generation. 
One disadvantage to joint interviewing was that it proved difficult for the carer’s 
story to be heard. Even when asked directly about their own needs or challenges, 
many carers quickly reverted the focus of the conversation back to the patient. It may 
be that they were reluctant to reveal their own struggles with the situation in front of 
the patient so as to not cause feelings of hurt, guilt or worry. It may also be the case 
that they did not feel that their own difficulties warranted any real attention in the 
face of the great challenges faced by the person they cared for. As a result, there is 
comparatively less information on the carer experience in advanced liver disease that 
can be gleaned from the data.  
Observations of data development over time 
A longitudinal study design allows the consideration f changes in participants’ 
narratives (Lewis, 2007). There was clear evidence of the longitudinal format of the 
study prompting changes in participants’ stories over time. In particular, being able 
to build a relationship over time, and to revisit and explore issues with participants 
on multiple occasions was key to the development of both the content and depth of 
narratives over time. Some of the generic benefits in this respect have already been 
described in Section 4.4.2. As explained in Section 3.5.1, interviews were based on a 
loose guide to facilitate maximum flexibility in letting participants raise issues of key 
importance to them. Faced with the unexpected absence of mentions of pain in 
patients’ accounts for example, the longitudinal study format allowed the interview 
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guide to evolve accordingly, so that pain was incorporated for targeted follow-up in 
future interviews. As pain typically constitutes a core feature in advanced chronic 
disease, the longitudinal design thus facilitated the capture of what must be 
considered key information in the realm of end-of-life research.  
Considerations of timescales 
This research followed patient and carer participants over 12 months, which proved 
to be an appropriate timespan for investigating the ne ds and experiences of this 
study population. It allowed observation of the lived experience of advanced liver 
disease over a number of months in most cases, but incl ded some participants who 
died during the study period. This allowed an insight into events leading up to their 
death, supplemented by retrospective accounts of their final days from lay and 
professional carers where available. The average length of study enrolment for 
patient participants was 7.7 months (see Table 3, Section 4.3, for details of each 
patient’s length of enrolment).  
As indicated earlier, follow-up interviews were scheduled flexibly to capture key 
changes in the trajectory while being sensitive to the needs of the participant at that 
time. This approach proved successful with this study population. Advanced liver 
disease is characterised by an erratic illness progression. Taking a flexible approach 
to timing follow-up interviews ensured that I was able to respond to critical events or 
changes in participants’ trajectories. It also meant that I was able to gain multiple 
interviews from some participants I would have otherwise lost to a sudden death had 
I followed a fixed schedule.   
Where distinct trigger events in a patient’s illness xperience were lacking, it proved 
difficult to determine when to schedule the next interview. The unpredictability in 
non-malignant disease means it is not always the sicke t patients who die first (Fox 
et al., 1999). Leaving longer intervals between follow-up interviews could therefore 
mean a loss of participants to the study. However, choosing relatively short intervals 
could result in a lack of discernible progression or change in participants’ stories, 
thus limiting the insight gained from their experienc s. Moreover, determining a time 
point for follow-up did not guarantee that interview taking place. Interviews had to 
 
 214 
be rearranged repeatedly owing to fluctuations in patients’ condition and frequent 
readmissions to hospital; delays of several weeks were common and added to the 
challenges of conducting this research.  
Building and maintaining relationships 
Keeping in touch with participants was critical to the successful conduct of this 
study. I kept in touch with participants through bi-monthly telephone calls. This 
proved time-consuming, as participants would be frequently too unwell to chat or 
unavailable due to a return to hospital. However, I did benefit from my regular 
attendance at the liver unit in this respect. I often saw participants as they returned to 
the ward and was thus able to keep abreast of changes in their condition or 
circumstances that way. In future research, where pa ticipants may be recruited from 
settings other than a liver ward and catching up with them at times of admission is 
therefore not an option, it may be beneficial to arrange monthly telephone 
conversations to increase the opportunities to keep engaged with participants.  
Regular contact with participants was not only key to keeping informed about their 
developments. As alluded to earlier, it also served to foster a closer relationship with 
participants, which positively impacted on the range and quality of data obtained. 
Participants also shared a lot of additional information during these interim 
conversations, both about their situation and their f elings about it. This 
supplementary information often informed the content of follow-up interviews, 
allowing me to clarify and explore some of these issues later within a formal 
interview context. As indicated earlier, it also provided useful additional insights 
about those participants who I had only been able to interview once or twice, thus 
adding to my observations of developments over time. As I had not sought ethical 
approval to record my telephone conversations with participants, I kept thorough 
field notes of their content and my thoughts and reactions, which provided important 
contextual information during data analysis. Future studies should consider seeking 
ethical approval to request participants’ permission to record these interim telephone 
conversations in order to benefit from the additional pool of data.   
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Developing closer relationships with participants over time was also found to have 
an unexpected positive effect on recruitment. Some nominated lay carers had initially 
declined participation in the study. However, increas d familiarity with me through 
my telephone calls fostered an interest in the study, and they subsequently agreed to 
take part. Interviewing participants at home also contributed positively here as carers 
would not only meet me in person, but also see for themselves what the interview 
process entailed.   
Being able to build rapport with participants over time also facilitated the 
opportunity to request bereavement interviews with lay carers some months after the 
patient’s passing. Recruiting bereaved carers for a ne-off interview having had no 
prior contact with that person is likely to be challenging. The longitudinal aspect of 
this study made this aspect more amenable to investigation as I was able to benefit 
from the relationships that had developed. Nevertheless, not all lay carers I 
approached about a bereavement interview were willing to participate.  
It is conceivable that the opportunity to nurture relationships also aided participant 
retention. As stated earlier, no participant opted to leave the study despite some 
rather upsetting interview encounters. On the contrary, several participants were 
positively eager for their follow-up interviews to c me around. Thus, I believe that 
the longitudinal design of the study promoted participant retention. At the same time, 
developing close relationship with participants raised some ethical challenges at 
times. An example of such a scenario which presented during the course of the study 
is given in Appendix 7. 
Data management and analysis 
Keeping in touch with participants on a regular, continuous basis as well as the 
random and often spontaneous scheduling of interviews made keeping up with 
interview transcription and preparation for follow-up interviews challenging. 
Preparing for subsequent interviews required a thorough familiarisation with and 
broad, preliminary analysis of the content of the pr vious conversation. This was 
therefore a considerable and time-pressured task, which had to be undertaken 
alongside continuous recruitment and data collection. Receiving support with 
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interview transcription provided considerable relief in this respect. Any future study 
of similar design would benefit from outsourcing interview transcription to allow the 
researcher to remain responsive to the study’s organisational needs. 
10.2 Limitations of this study 
While this study offers advancement on our understanding in the realm of advanced 
liver disease, it is subject to a number of restrictions. Section 1.4 set out the scope of 
this study, the boundaries of which must be borne in mind. In addition, the following 
limitations need to be recognised: 
• This study was conducted in a specific locality of the UK, with all patient 
participants receiving their liver-related care from the same regional hospital. 
Their experiences and services may therefore differ from other localities in this 
country and elsewhere.  
• Similarly, patient participants were recruited from a specialist inpatient liver 
unit. Their care experiences may therefore differ from those of patients 
accessing general hospitals, which are likely to have comparatively limited 
disease-specific expertise. 
• In the absence of a single agreed definition of advanced or end-stage liver 
disease, the study’s inclusion criteria constitute an empirical measure that may 
not be representative of this patient population at large. Relatedly, while ascites 
is the most common physical complication in cirrhosis of the liver affecting 
nearly 60% of patients with compensated liver disease within 10 years of 
diagnosis (Ginés et al., 1987), not everyone will develop this complication. 
• Identification of potential research participants by different ward staff is likely to 
have introduced selection bias as well as an element of gatekeeping, for example 
excluding people considered too poorly to participate. (However, this particular 
issue was circumvented by the longitudinal study format, which meant that some 
patient participants deteriorated during their study involvement, thus enabling 
the stories of those nearing death to be heard too.) 
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• Self-selection bias among patient participants must be recognised. For example, 
patients who cope with their illness through denial or disavowal are less likely to 
engage with research (Thorne and Paterson, 2000). Similarly, as described in 
Section 5.4, some patients did not feel able to comment on their condition on 
account of their poor understanding and thus declind participation.  
• Carers’ bereavement interviews and professionals’ accounts of caring for patient 
participants and their families were likely to be subject to recall bias. 
• There were a number of voices missing in the study sample, namely:  
o Ethnic minorities and those on the margins (e.g. the homeless or severely 
socially deprived). Both groups are traditionally hard to reach and were 
poorly represented on the hospital ward I recruited from. Moreover, while 
chronic liver disease is widespread in the homeless population (Davis et 
al., 2011), the specific complexities of this group as well as the use of a 
longitudinal format requiring long-term study involement mean that 
homeless participants were not pursued.  
o Secondary care professionals and allied professions. Asking patient 
participants to nominate the professionals to be int rviewed meant that 
there was no control over the type of professions that would be 
represented, resulting in a sample that was dominated by GPs. 
10.3 What this study contributes 
In responding to the study’s research objectives in Section 10.1, this study 
contributes new insights to both empirical and methodological understanding. The 
study adds to what is currently only limited understanding of the experience and 
associated challenges of living, dying and caring i advanced liver disease. It also 
contributes to the emergent knowledge base with regard to the effectiveness of 
qualitative longitudinal, multi-perspective methods in end-of-life research by testing 
and describing their utility in the realm of advanced liver disease. In this section I 
will delineate the specific contributions this study makes to existing understanding 
and theory, and suggest some implications for policy.  
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10.3.1 Contribution to theory 
A small number of previous studies noted the presence of uncertainty in the 
experiences of people with advanced liver disease. However, this study contributes 
new understanding in this regard by bringing to the for  an enduring dominance and 
influence of uncertainty across all dimensions, throughout the illness trajectory, and 
affecting patients, carers and professionals alike. Furthermore, in this study the 
challenges of life with advance liver disease were r gularly managed by an appraisal 
of uncertainty as an opportunity. This finding not only confirms the notion that 
uncertainty is not in itself a negative phenomenon (Mishel, 1990), but also that 
reducing uncertainty is not necessarily a person’s desired goal (Brashers et al., 2000). 
This finding then has implications for the way in which uncertainty in chronic illness 
is understood and addressed in clinical encounters and therapeutic interventions. 
Similar to other chronic illness, biographical disruption emerged as a key 
phenomenon in relation to the psychological experience of both patients and lay 
carers (Bury, 1982). The study contributes to current understanding of this concept 
by describing for the first time its characteristic in the context of advanced liver 
disease. Importantly, this includes the observation that biographical disruption does 
not always constitute a negative event. To my knowledge this notion, and the 
experience of biographical disruption in the carer experience, have not previously 
been noted in the literature. These findings thus sggest further exploration to 
establish their potential for extending our understanding of this core theoretical 
concept in chronic illness research. 
The study contributed some interesting new insights regarding patients’ physical 
experience of advanced liver disease specifically. Challenges with motor co-
ordination and mobility have so far only had scant cknowledgement in the liver 
literature, but emerged here as a pervasive and key concern. The observation that 
pain was only of marginal concern among this group contrasts several previous 
studies in advanced liver disease and indeed much of t e wider chronic illness 
literature. Both these findings warrant further investigation. The study also highlights 
the pervasiveness and complexity of the complications experienced, and the relative 
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impact of specific problems on the quality of life of patients and their families. 
Moreover, the qualitative longitudinal format of this research offered new insight 
into the severity as well as the unpredictable and e uring nature of some of these 
complications, for example fatigue. Overall then, the findings of this study have 
served to extend current understanding of the nature and relative importance of some 
of the physical challenges of advanced liver disease, nd draw attention to some 
areas requiring follow-up.   
While the current literature in advanced liver disea  acknowledges that care 
provision for this patient group is in urgent need of improvement, there is scant 
research on patients’ own views in this regard. This study thus adds insight by 
eliciting participants’ experiences and perceptions f their care service use. The 
shortcomings in care provision identified in the present study may support current 
endeavours to identify pathways for improved patient care across settings and care 
providers in advanced liver disease (Mellinger and Volk, 2013, Morando et al., 2013, 
Wigg et al., 2013).  
The finding that dying in hospital may not necessarily be inappropriate for people 
with advanced liver disease challenges current debates regarding preferred place of 
death and the appropriateness of the acute hospital et ing as a provider of end-of-life 
care. This finding therefore has implications for current theoretical discourse and 
research in this respect, and may stimulate considerat ons regarding current care 
practices in this setting.  
Finally, the benefits and challenges of employing a qu litative longitudinal, multi-
perspective study design in the context of advanced liv r disease were outlined in 
Section 10.1.3, and echo those highlighted in other conditions (Kendall et al., 2009). 
The overall success of this methodology in meeting the aims of this study as well as 
the specific learning its use generated with regard to this particular patient group 
therefore adds to the methodological knowledge base in nd-of-life research, and 
may usefully inform the design and conduct of future research in the realm of 
advanced liver disease. 
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10.3.2 Contribution to policy 
Scotland’s national action plan, Living and Dying Well, sets out the government’s 
vision for a patient-centred approach to delivering equitable, consistent and timely 
palliative and end-of-life care for all patients (Scottish Government, 2008b). Many of 
this study’s findings can be seen to reflect and reinforce its priorities, in particular 
with respect to the early identification of patients who may need palliative care, 
advance care planning, interprofessional information ransfer, and the provision of 
palliative and end-of-life care in acute hospitals (NHS Scotland and Scottish 
Partnership for Palliative Care, 2012). What is more, the study provides a patient and 
carer perspective on how care may be usefully improved, and as such offers valuable 
insights to the new national strategic plan for palliative care currently under 
development in Scotland. 
The study shows that the aspiration of ensuring equitable access to palliative care 
regardless of condition is still unmet as far as liver disease is concerned. Access 
requires the timely identification of a person’s palliative care needs. The Gold 
Standards Framework, a widely used UK programme design d to support 
community-based healthcare teams with the identifica on, organisation and quality 
of care of those requiring palliative care with any life-limiting condition, provides 
guidance in a number of non-malignant conditions but omits liver disease (Royal 
College of Practitioners, 2006). The recently validted SPICT (Supportive and 
Palliative Care Indicators Tool) includes a section t  aid the identification of liver 
patients coming towards the end of their lives (Highet et al., 2013), but it is too early 
to gauge its long-term impact in this regard.  
I am thus in agreement with a recent suggestion that focus should be shifted from 
asking, “Is it time yet?” to “What are the problems and who can manage them?” 
(Johnson and Gadoud, 2011, p41). This study contributes insight in this regard. 
Importantly, this insight is provided through the views and experiences of those 
whose welfare sits at the heart of this challenge. Th  study also highlights the need to 
clearly define integrated care structures for peopl with advanced liver disease so as 
to better support professionals in providing appropriate care to these patients. 
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Furthermore, options need to be explored that allow for the specific characteristics of 
this group, particularly their younger age and propensity to die unexpectedly in 
hospital, to be better accommodated in the current management of care provision. A 
recent English publication has made first inroads in th s respect by applying the care 
pathway put forward in the national End-of-Life Care Strategy (Department of 
Health, 2008) to the needs of those with advanced liver disease (Kendrick, 2013). 
However, further development is needed. 
As advocated by the professionals interviewed, there is a need to champion the 
considerable needs of this currently disadvantaged patient group in order that their 
supportive and palliative care needs may be better recognised and more effectively 
addressed. Given the increasing numbers of these patients and thus relative urgency 
of this endeavour, this should ideally involve a joint effort between government, 
health boards and third sector services as successfully employed in other conditions 
such as cancer or, more recently, heart failure. Some progress to this effect was 
recently made in England with first steps towards the formulation of a national 
strategy for liver disease, but similar efforts arestill lacking in Scotland.  
Finally, more realistic societal discourse about liver disease must be promoted. This 
relates to greater awareness-raising regarding its insidious nature and a dispelling of 
myths in order to reduce its stigmatising reputation. This will not only improve the 
psychological burden of those living with the disea, but may also facilitate better 
access to funding and support for liver-related projects. This endeavour will benefit 
from engagement with the media. Lessons may be learned from HIV/AIDS, a 
similarly stigmatised condition, which has over time been successful in promoting 
better public understanding.  
10.4 Recommendations for practice and research 
10.4.1 Developing practice 
The data indicate a number of areas for practice dev lopment regarding the care of 
this patient group and their families. These relate to improvements with respect to 




• Explaining the insidious nature of liver disease and its potential consequences 
when discussing raised liver function tests may help some individuals better 
appreciate the potential dangers of continued harmful behaviours such as 
excessive alcohol consumption, and prevent their deterioration towards liver 
failure. 
• Given the impact of patients’ poor understanding of their condition on their 
overall illness experience, there is a need to better educate patients and their 
families about the typical features and progression of advanced liver disease. 
While this should be done early on in the illness trajectory, opportunities to ask 
questions and clarify issues should be provided and encouraged at all times. In 
this context, the data showed that it is important ha professionals are mindful of 
the language they use in order to avoid causing confusion and anxiety. In light of 
the time pressures of medical consultations, this process may be aided by a 
better use of information booklets and other sources of complementary 
information. 
• Relatedly, professionals should be upfront with patients about the uncertain 
aspects of their illness, such as likely prognosis and pathway. Being aware of 
inevitable uncertainty is important and empowering i  itself and is likely to aid 
coping. Acknowledging the enduring uncertainties related to the condition may 
also facilitate the introduction of advance care planning conversations by 
encouraging the idea of ‘hoping for the best, but preparing for the worst’.  
• Professionals should seek to remedy patients’ uncertainties regarding the 
legitimacy of their complications by educating them about common problems 
they may encounter, in particular fatigue and difficulties with motor co-
ordination and mobility.  
• Professionals should assess patients’ perceptions of uncertainty (whether they 
appraise issues as negative or positive) to make information and interventions 
complementary to the person’s approach and thus support their coping.  
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• Given the erratic and rapid trajectory of advanced liver disease, professionals 
should alert patients and their families to the danger of eventual deterioration at 
or around the time of diagnosis, and especially where this coincides with the first 
signs of decompensation.  
• Optimal pathways and quality of interprofessional communication must be 
defined and enhanced to enable improved integration of care between primary 
and secondary care settings. Avenues for better electronic data sharing should be 
explored. Communication pathways also need to be clarified and strengthened 
with community-based palliative care services and other allied professions in 
order that their involvement can be maximised. As communication in cancer 
care was deemed effective by all professionals interviewed, lessons should be 
learned with regard to its set-up and management. 
• Specialists should ensure that they keep primary care olleagues abreast of their 
long-term care plans for a patient. They should also advise when key 
conversations, e.g. about prognosis or end-of-life care wishes, have been 
conducted with the patient and specifically when a palliative care approach is 
indicated, so that this can be followed up in the community. 
Support provision 
• The data confirms that chronic illness requires extensive amounts of ‘work’ by 
the patient relating to illness, everyday life and biography (Corbin and Strauss, 
1985). In light of these findings, professionals should take account of the effort 
of work required by patients to master everyday life, and focus support on 
extending their opportunities to remain engaged in life for as long as possible.  
• There is a need for emotionally neutral sources of upport, and in particular peer 
support. In light of the finding that both patients and professionals lack 
awareness of available resources, current sources of support in the care setting, 
community and online should be identified, coordinated and mobilised so that 
they can be promoted accordingly. Gaps in provision hould be noted and ways 
of addressing these within existing resources considered. Given patients’ 
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problems with accessing services due to their condition, support provision 
should be flexible in both set-up and delivery.  
• Relatedly, the information and support needs of lay c rers should be given 
focused attention so as to promote their own wellbeing as well as that of the 
person they care for. 
• ALD patient participants’ preoccupation with the need to overcome their alcohol 
dependency highlights the need for professionals to remain alert to the wider 
psychosocial context of these patients’ lives, as their liver disease may not in 
fact be their priority concern. (This of course also holds true for those with other 
causes of liver disease and may similarly relate to other health issues, especially 
in older patients.) This shows the reality of living with advanced liver disease to 
be complex and reminds of the importance of holistic, goal-centred patient care. 
Care arrangements 
• Given the study data indicating their significant impact on psychosocial 
wellbeing, patients should be routinely assessed for potential difficulties with 
motor co-ordination and mobility and offered support where appropriate. 
• Being able to self-manage one’s illness is an important means of managing 
uncertainty. Patients’ expressed willingness to share responsibility of their 
condition and take on self-care activity should be considered and incorporated 
into treatment plans. Similar to the importance of acknowledging the enduring 
uncertain aspects of the condition as stated earlier, patients should be made 
aware of any absence of self-care opportunities beyond those already instructed 
in order to alleviate their anxieties in this regard.  
• Care in advanced liver disease is currently focused on acute care and symptom 
management. This study highlights the importance of addressing patients’ and 
lay carers’ abundant psychosocial needs. The widespread low mood identified 
and its impact on patients’ quality of life suggests a need for their routine 
psychological assessment, and in particular those with underlying alcohol 
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problems. At the most basic level, ascertaining and ttending to patients’ 
uncertainties with respect to their illness experience will go some way towards 
improving their psychological wellbeing. 
• Much of everyday chronic illness management takes place in the person’s home. 
However, this study suggests that primary care and community-based services in 
this patient group are currently underused. Opportunities for developing and 
promoting these resources should be explored. Moreove , the manifold barriers 
to patients attending services identified in this study indicate that rather than 
relying on patient-initiated contact, practice-led approaches to follow-up care 
such as telephone calls, telemedicine, or offering a  appointment or home visit 
might be beneficial (Wagner, Austin and Von Korff, 1996, Wasson et al., 1992). 
• Relatedly, there is a need to promote the holistic nature of general practitioner 
care in order to encourage uptake of this apparently undervalued resource. 
Although patients seemed put off by GPs’ lack of liver expertise, there may be 
little value in developing their specialist knowledge (Wagner, Austin and Von 
Korff, 1996). Moreover, the data suggest that patients consider their medical 
care satisfactory, but lack focused support of their psychosocial and existential 
needs. GPs and primary care services more generally should develop and 
promote their strengths in this regard and thus foster a more patient-centred 
approach to the care management of this patient group. 
• Cognitive behavioural therapy has been suggested as a potential way of 
alleviating fatigue and assisting patients to better d al with the associated 
emotional distress (Blackburn et al., 2007, O'Carroll, 2011). This avenue should 
be explored further, and highlights the potential for increased involvement of 
psychologists in the care of these patients. Engagement of psychologists in end-
of-life care is currently underdeveloped, but can provide a wealth of important 
support (British Psychological Society, 2008). 
• Patients’ frequent admissions for routine interventions such as paracentesis were 
found to interfere with advance care planning and their care in the community. 
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Resources and opportunities should be explored in which such routine 
procedures may be undertaken in the community setting, for example at 
hospices. Good practice in this respect exists, but relevant literature is scarce. 
Lessons learned should be shared to inform developments in this regard.  
• We should seek to learn from care pathways used in iseases with similar 
uncertain characteristics and pathways such as heart failure. In particular, the 
utility of a generic specialist liver nurse role should be considered as 
professionals deemed this a success in other conditi s. This role might take the 
lead in managing and co-ordinating patients’ ongoin care in the community, 
which would address a number of the shortcomings ident fied in their care 
provision, with additional support from palliative care specialists. 
Professional training 
• The choice of language used by some professionals ws indicated in patients 
feeling stigmatised, confused and uncertain. Professionals should be reminded, 
and their confidence and skills developed, with rega d to effective doctor-patient 
communication. This includes the importance of ascertaining patient 
understanding and encouraging patients to ask questions or raise sensitive issues. 
The data identified several reasons why patients are unlikely to do so off their 
own back, so professionals should take the lead in this respect while remaining 
sensitive to patients’ needs and willingness to engage with certain topics, 
especially with regard to advance care planning and end-of-life conversations.   
• As highlighted earlier, professionals need to educate themselves about the 
resources available to support patients and their families in the community and 
promote these.  
• Given the number of hospital deaths in this patient group, there is a need to 
ensure that acute hospital staff are upskilled to recognise imminent death and 




10.4.2 Directions for future research 
The findings of this study point towards a number of p tential directions for 
research, both with respect to improving the care of people with advanced liver 
disease and some of the theoretical concepts that served to explain the data. In 
addition to research which addresses some of this sudy’  limitations outlined in 
Section 10.2, key areas to consider are as follows:  
• The findings of this study and wealth of potential venues for service 
improvement identified in the previous section point towards the utility of 
follow-on focus group research with key stakeholders such as clinicians, 
managers and commissioners. This research would aim to discuss the study 
findings and suggested service improvements, determin  priorities for action, 
and identify ways of trialling and evaluating these.   
• Uncertainty emerged as the key mediating factor in the psychological wellbeing 
of patient and lay carers. This suggests value in utilising uncertainty theory to 
inform and trial both educational and behavioural interventions to alleviate the 
effects of uncertainty by addressing some of its modifiable sources. 
Alternatively, interventions may be trialled which seek to support patients to 
better accept and live with the enduring uncertainty herent in their condition. 
All of these constitute potentially important non-pharmacological approaches to 
ameliorating the pervasive low mood common in this patient group. 
• The study sample included only one participant with primary liver cancer 
(HCC), who also died shortly after his first interview. As such, there was little 
insight into how these patients’ illness experience compares with that of people 
with other liver disease causes. However, there was a suggestion that support 
provision in particular may differ due to the ‘cancer label’. The literature also 
indicates potential differences in the way HCC is experienced (Fan and Eiser, 
2012). There may thus be value in investigating more closely the similarities and 
differences in the illness experience of those with HCC and other causes of liver 
disease in order to identify potentially divergent care and support needs.  
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• This study similarly intimates that the illness pathway of those with ALD may in 
some respects bear close similarities to that of cancer patients. Also, ALD 
patients’ experiences were similar to those with oter aetiologies in many 
respects, but differed in some important ways. This may indicate divergent needs 
from the wider liver disease population and is thus an area which warrants 
further investigation.   
• There is a dearth of research into how people perceive and rationalise the idea of 
potentially facing liver transplantation in the future. Better understanding in this 
realm may be beneficial as it was found to create much anxiety among patient 
participants, and especially those with ALD.  
• The data raises questions regarding preferred place of death and the 
appropriateness of the acute hospital setting as a provider of end-of-life care in 
advanced liver disease. How the hospital setting is viewed as a potential place of 
death by this patient group would benefit from dedicated research. This would 
add to the wider academic and clinical discourse on achieving a ‘good death’, 
and help to inform end-of-life care arrangements which are appropriate and 
sensitive to the specific needs and wishes of people with advanced liver disease.  
• Focused research relating to the concept of biographic l disruption is indicated, 
both with regard to its potential to instigate positive change and the disruptive 
impact of chronic illness on carer biographies (Bury, 1982). Research in this 
realm will serve to clarify and develop further this seminal concept in the 
chronic illness literature and research.  
10.5 Final statement 
Since embarking on this research in 2010, recognition has grown with respect to the 
neglected care needs of people with advanced liver dis ase, and research activity in 
this realm is gaining momentum. This study found the current support and care for 
this patient group to be lacking from diagnosis to bereavement. Ubiquitous 




This study is timely and important, adding the neglected perspectives of patients and 
carers, and informing how their quality of life and care in their last months of life 
may be improved. It evidences an urgent need to ensur  that people living and dying 
with advanced liver disease and their families benefit from appropriate, equitable and 
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Appendix 3: Interview topic guides 
PATIENT INTERVIEW GUIDE (v.1, 01/06/11) 
Topic area Questions / Prompts 
Background  
The person Tell me a little about yourself - Family? Work? 
Illness to date How long have you had this illness? When and how did you 
find out about it? What were you told about it? (cause, 
treatment, prognosis) How did you deal with this? What has 
happened since? (How is it managed? Has it stayed the 
same, got worse?)  
Current situation 
Symptoms/complications How are you feeling at the moment? Are there any current 
physical problems? How do they make you feel? Are they 
different at different times/days?  
What has happened since the last time (interview)? 
(treatment/care, hospital admissions etc)  
Do you understand what the medication/tests/treatments are 
for? How do they make you feel? 
Practicalities How do you manage your life on a day-to-day basis? Are 
there any things you have difficulty with due to your illness? 
(household, getting around etc) How do you manage them?  
Where do you get practical support from and what type of 
support is it?  
Who looks after you at home? How do you feel about this? 
Relationships What is your relationship with your carer like?  
How does your illness affect your relationship with your 
(other) family members? With friends?  
Do you feel you can/want to talk to them about your illness? 
How do you feel about doing so?  
Wider social network? Do you still get out and about?  
Have you experienced any stigma?  
Have you had any positive experiences related to your 
illness? 
Feelings How do you feel within yourself? How does this compare to 
before the illness? How do you feel about what is 
happening/your illness?  
Do you ever feel low or depressed? Do you worry about 
anything? How do you cope with this? Does anyone help 
you cope? (how?)  
Has anyone ever asked you how you feel living with the 
illness?  
Do you share your feelings with anyone/do others know how 
you feel?  
What do you particularly value in life? Has this changed 
since becoming ill? 
Would you consider yourself a spiritual person? 
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Services / support How do you feel about the care you receive?  
Has anyone ever asked you what your main issues/priorities 
are?  
Do you tend to see the same people? (consultant, GP etc) 
Do you feel they adequately understand your needs? If not, 
how could this be improved?  
Who tends to be your first port of call and why?  
Has anyone ever asked you what support you need at 
home?  
What services have you used? (NHS, social work, charities, 
patient support group, faith group etc) How did you find out 
about them? What are your experiences with them?  
Are you aware of other services available that you are not 
using? Why not? How did you hear about them? How do 
you feel they might be useful to you? 
Information needs Do you feel well enough informed about your illness?  
What do you know about your illness? Where do you get 
information from? What areas are you less sure about?  
How do you feel about asking doctors/nurses questions 
about your illness? Are you encouraged to ask questions?  
In which ways do you prefer to receive information about 
your illness? (conversation, leaflet, internet) 
Future 
Planning/Preparing Do you ever think about the future? What do you expect will 
happen? How does this make you feel?  
Has anyone spoken with you about the future?  
Has anyone asked what you would like to happen if you 
illness was to get worse? What would you like to happen? 
What type of help would you want? Can you talk to your 
carer/family/friends about this? 
Improving QOL How do you feel the quality of your life could be improved?  
What would make life easier for you?  
How could services be improved for liver patients more 
generally?  





CARER INTERVIEW GUIDE (v.1, 01/06/11) 
Topic area Questions / Prompts 
Background  
The person What is your relationship to X (patient) (e.g. 
family/friend/neighbour; duration of relationship)? 
Tell me a little about yourself  
What is your own health like? 
Illness to date How have things been for you since X became ill? 
How did you come to become the main carer? 
What sort of help or support does X need? How do you feel 
about providing this care? 
Current situation 
Being a carer Are there any particular problems for you as carer? (e.g. 
physical, understanding, other commitments, own health) 
Do you have any concerns about the care you provide? (safety, 
appropriateness, effectiveness) 
Do you worry about any particular aspects of X’s illness (e.g. 
symptoms, unexpected changes, treatment)? 
How have sudden changes in the X’s condition been handled 
previously? 
Has anything positive come out of taking on the caring role? 
Relationships How has your relationship to X changed since taking on their 
care? 
How openly are you able to talk to X about the illness/their 
feelings/family affairs? 
How openly are you able to talk to X about any problems or 
concerns you have with being their carer? 
How has X’s illness affected family life in general? (if applicable) 
And your social life?  
Feelings How do you feel in yourself these days? Do you have good and 
bad days? 
How do you feel about being a carer to your ... (relationship to 
patient)? 
Do you worry about what might happen in the future? 
Who can you talk to about how you are really feeling? 
What helps you cope with things?  
Services / support Where do you get your own help or support as a carer from? 
How did this support come about? (if arranged) 
Are you in contact with any health or social work professionals 
about X’s illness? What sort of help or support do they give 
you? What do you find particularly helpful? Do they give you the 
opportunity to ask questions or discuss how you feel?  
Has anyone ever asked you what your main issues/priorities 
are?  
Has anyone ever asked you what support you need at home? 
Are you included in discussions between X and professional 
carer? How do you feel about this? 
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Do you that feel you and X are getting enough help, information 
and support? If not, what could be improved? 
What other type of support would you find helpful? 
Are you aware of any other services that offer support to people 
like you caring for someone with a serious illness (NHS, social 
work, charities, support group, faith group etc)? How did you 
hear about them? Have you or are you using any of them? What 
are your experiences with them? 
Have you thought about what kind of help you might want in the 
future/if X’s illness fails to get better? 
Information needs What have you been told about X’s illness? (cause, treatment, 
prognosis) 
What are your main sources of information? 
Has anyone discussed with you what you can expect as a 
carer? 
Has anyone discussed with you what is likely to happen in the 
future? 
Do you feel you are getting enough information about the 
illness, the treatment, the future? What areas are you less sure 
about? 
Future 
Planning/Preparing Have you thought about why this has happened, the meaning of 
life…? 
Do you ever think about the future? What do you expect will 
happen? How does this make you feel?  
What would you like to happen? What type of help would you 
want? Can you talk to others about this? 
Improving QOL Have you any other suggestions about how the needs of people 
in your situation might be better met? How can services be 
improved (for patient/for carer)? 
How could the quality of your life be improved? 







PROFESSIONAL INTERVIEW GUIDE (v.1, 01/06/11) 
Topic area Questions / Prompts 
Relations hip with 
patient/carer 
Can you tell me about your involvement in the care of patient X 
and carer Y? 
How long have you been X’s professional carer? 
What is the type of support you provide? 
Do you also have a care/support responsibility or role for Y? 
Care provision  
 
As far as you know, who is most involved in the care of X (e.g. 
GP practice, community nurses, social services)? 
From your point of view, what are the main issues or problems 
in providing support for X and Y? 
How well do you feel their needs are being met? How could this 
be improved? 
Did you change your care of X in response to any recent 
hospital visits/admissions? 
Do you have a care plan in place for managing acute 
complications? 
Would you consider X for inclusion in a practice palliative care 
register? What informs this decision? How would this impact on 




Are there any problems or particular areas of concern for you as 
regards X’s treatment/care? 
How well do you feel X and Y are coping with their situation? 
How do you see the illness impacting on their lives? 
Do they talk to you about their needs, concerns, values?  
Do you feel they are getting enough help and support? Do X 
and Y speak about their experiences with this help/support? 
How was it arranged? 
Have you discussed the illness or prognosis with X and/or Y? 
Are there any issues you choose not to discuss with them? 
Why? 
Do you think X will continue to be able to be looked after at 
home in the future? Do you have any concerns in this respect? 
(physical/mental, carer wellbeing, shortage of appropriate 
home-based services…) Do you think that Y is able to care for 
them adequately?  
Have you talked with X and Y about care arrangements for 
when the illness progresses? Have you discussed their end-of-
life care and preferences? Do you keep a record of their 
wishes? What happens to this information? 
Communication 
with other services 
 
What information have you received about X’s illness, treatment 
and prognosis and from what source? 
How do you link with other services involved in X’s care? How 
effective do you find this communication between services? Is 
there anyone you feel you should link more closely with? What 
in your view are the barriers to making this happen?  
What services/support/people/interventions have been 
especially good or helpful? 
How do you feel services could be improved to more effectively 
meet X’s/Y’s needs? 
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Appendix 4: Overview of patient demographics and 
hospital admissions 
The following table outlines supplementary patient-related information such as 
participants’ individual DEPCAT  and MELD scores at recruitment in order to give 
additional context to the experiences described. It also provides additional care-
related information by showing the number of hospital admissions over different 
time periods. The range of number of admissions over time in this sample must be 
noted, with the majority reflecting routine admissions for paracentesis. Overall, these 
figures illustrate the increasingly disruptive nature of the disease as patients approach 




Patient  Age Primary 
(secondary) 
aetiology  
DEPCAT      
(1 least dep - 














Admissions            
6 months  
pre-death 
Admissions                
12 months 
pre-death 
John 68 ALD 4 14 0 12 0 Alive -----  ----- 
Sarah 38 ALD, HCV 5 20 4 12 3 Alive -----  ----- 
Mary 66 AIH 4 20 6 5 5 Dead 6 9 
Fraser 60 ALD 5 17 6 7 6 Dead 6 10 
Fay 84 NAFLD 4 9 1 11 13 Dead 8 15 
Donald 74 HCC (NAFLD) 7 17 1 1 0 Dead 4 6 
Martin 77 ALD (NAFLD) 6 9 3 9 21 Dead 15 25 
Thomas 75 NAFLD 3 21 4 6 9 Dead 12 15 
Ben 35 ALD 4 24 4 12 5 Alive -----   ----- 
Aidan 58 ALD 5 13 6 6 7 Dead 8 13 
Kate 41 Cryptogenic 3 10 0 8 5 Alive -----   ----- 
Nadia 56 ALD, HCV 4 13 0 6 0 Alive -----   ----- 
Carol 45 ALD 3 16 0 7 2 Dead 3 3 
Polly 68 NAFLD 3 15 7 5 9 Dead 12 14 
Rebecca 37 ALD 7 26 3 9 2 Alive  -----  ----- 
Table 5: Overview of patient demographics and hospital admissions
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Appendix 6: Example of evolving coding structure  










Appendix 7: Example of an ethical challenge in 
qualitative longitudinal research 
As indicated in Section 4.7, the deeper connection which developed between 
researcher and researched as a result of the longitudinal nature of this study at times 
challenged professional boundaries. Lonely and isolated participants in particular 
thrive on the non-judgemental, sympathetic role of the researcher providing a rare 
opportunity to speak openly about their feelings and concerns (Watson, Irwin and 
Michalske, 1991). Research interviews exploring individuals’ ‘intimate sphere’ are 
particularly prone to being considered therapeutic engagements by some participants 
(Birch and Miller, 2000). A lack of appropriate community-based support services 
can contribute to the threat of such ‘privatisation’ f the research relationship and the 
development of over-dependence on the part of the participant (Hemmerman, 2010).  
Some of these issues were borne out in this study. For example, both Sarah and 
Fraser would occasionally phone me to see how I was getting on, while eagerly 
pushing for their next interview to take place. Ben freely admitted that he found our 
interviews cathartic and that being able to speak openly and honestly with someone 
about “all that stuff in his head” made him feel better. Our catch-up telephone 
conversations were also significantly longer than with other participants for that 
reason. He would give me a detailed run-down of what had been happening over the 
previous weeks and share his feelings on the situation. It did not feel appropriate to 
cut him short on these occasions and of course this information was also of value to 
the study in terms of timing the next visit and planning follow-up questions. 
However, granting him so much of my attention appeared to have blurred the 
boundaries of our relationship over time, as he subsequently asked whether I would 
consider visiting him and his partner informally, as ‘friends’, as he really enjoyed 
and benefitted from our conversations.  
In situations such as these the task of relationship maintenance was a challenging one 
as I had to be mindful of the ethical boundaries I was subject to. I had to be careful 
not to compromise trust and rapport whilst being supportive of participants’ needs. 
Thankfully Ben appreciated the professional limitations placed upon our relationship 
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and was happy to continue with the study despite my declining his request, although 
I did feel that he was more distanced and guarded with me after this incident.  
This example demonstrates the unpredictable, evolving, situated and relational nature 
of ethical decision-making in qualitative longitudinal research, which adds to the 
challenges of appropriate research conduct by requiring the researcher to be alert to 
and react to any unforeseen ethical dilemmas as they arise.   
 
